Short Name,Full Name,Faculty,Category,Instructors,TAs,Session title,Section,Location,Guest teacher,Type,length,Date,Teaching strategy,Instruction type,topics,Specific objectives,Course Outcomes: all,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,"Healthy Diet, Canadian Health Food Guide",,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-08,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition and Life Stage: Fructose,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-11,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition and Life Stage Part I,,MS 231,Hoon Sunwoo,lecture,80 minutes,2016-01-12,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition and Life Stage Part II,,MS 231,Hoon Sunwoo,lecture,80 minutes,2016-01-14,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Protein Hydrolysates: Seniors/Patients/Athletes,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-15,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Introduction/Nutrition Overview,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-04,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,"Macro Nutrients, Energy; Metabolism, Metabolic syndrome",,MS 231,Hoon Sunwoo,lecture,80 minutes,2016-01-05,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,"Micro Nutrients, Oxidative stress, Immunity",,MS 231,Hoon Sunwoo,lecture,80 minutes,2016-01-07,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Phytochemical Nutrition: Safety and Efficacy,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-18,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition in Clinical Medicine,,MS 231,Stephen Genius,lecture,80 minutes,2016-01-19,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Q/A,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-20,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Food and Drug Interaction,,MS 231,Raimar Loebenberg,lecture,50 minutes,2016-01-22,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition-related Disease:Osteoporosis,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-25,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition-related Obesity,,MS 231,Blaine Colton,lecture,80 minutes,2016-01-26,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Case Studies of Obesity,,MS 231,Blaine Colton,lecture,80 minutes,2016-01-28,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition and Autoimmune-Inflammatory Disease,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-01-29,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Parenteral Nutrition,,MS 231,Justine Turner,lecture,50 minutes,2016-02-01,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Nutrition and Celiac Disease,,MS 231,Hoon Sunwoo,lecture,80 minutes,2016-02-02,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Case Studies of Celiac Disease,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-02-03,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Natural Health Products,,MS 231,Hoon Sunwoo,lecture,80 minutes,2016-02-04,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Q/A,,MS 231,Hoon Sunwoo,lecture,50 minutes,2016-02-05,Direct Lecture,,,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,,,,,lecture,50 minutes,2016-12-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,,,,,lecture,50 minutes,2016-12-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,,,,,lecture,50 minutes,2016-12-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,,,,,lecture,50 minutes,2016-12-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,,,,,lecture,50 minutes,2016-12-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Insulin in T1 DM,,MSB 227,Yeung,lecture,80 minutes,2016-02-02,Direct Lecture,,,,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Describe the toxicity of medications used in the management of endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Course Introduction/Anatomy and Physiology,,MSB  227,Necyk/Patrick,lecture,80 minutes,2016-01-05,Direct Lecture,,,,Identify the main anatomy components of the endocrine system.,"Describe the physiological effects of the following: adrenal, thyroid, parathyroid, neurohypophyseal and pancreatic hormones.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Anatomy and Physiology,,Online,Patrick ,lecture,80 minutes,2016-01-07,Direct Lecture,,,,Identify the main anatomy components of the endocrine system.,"Describe the physiological effects of the following: adrenal, thyroid, parathyroid, neurohypophyseal and pancreatic hormones.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Anatomy and Physiology,,Online,Patrick,lecture,80 minutes,2016-01-12,Direct Lecture,,,,Identify the main anatomy components of the endocrine system.,"Describe the physiological effects of the following: adrenal, thyroid, parathyroid, neurohypophyseal and pancreatic hormones.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Introduction to Diabetes,,MSB 227,Simpson,lecture,80 minutes,2016-01-14,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Medicinal Chemistry â€“ Antidiabetic Drugs,,MSB 227,Velazquez,lecture,50 minutes,2016-01-19,Direct Lecture,,,,Describe pharmacokinetic and pharmacodynamic principles to the treatment of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Pharmacology â€“ Antidiabetic Drugs,,MSB 227,Ussher,lecture,80 minutes,2016-01-21,Direct Lecture,,,,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Medicinal Chemistry â€“ Thyroid Drugs,,MSB 227,Velazquez,lecture,80 minutes,2016-03-08,Direct Lecture,,,,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Thyroid Disorders,,MSB 227,Hughs,lecture,80 minutes,2016-03-15,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,"Vitamin D, PTH & Bone Metabolism",,MSB 227,Doschak,lecture,80 minutes,2016-03-17,Direct Lecture,,,,"Describe the physiological effects of the following: adrenal, thyroid, parathyroid, neurohypophyseal and pancreatic hormones.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Seminar: Thyroid Disorders (Hypo/Hyperthyroid),,TBA,Hughs/Necyk,seminar,110 minutes,2016-03-18,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Describe the toxicity of medications used in the management of endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Disorders of the Pituitary and Adrenals,,MSB 227,TBA,lecture,80 minutes,2016-03-22,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Describe the toxicity of medications used in the management of endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Complimentary & Alternative Medications for Diabetes & Thyroid,,MSB 227,Khamba/Necyk,lecture,80 minutes,2016-03-24,Direct Lecture,,,,Describe actions and adverse effects of common natural health products used for management of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the toxicity of medications used in the management of endocrine disorders.,Identify ethical and cultural issues surrounding endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Type 2 Diabetes â€“ Treatment (Part I),,MSB 227,Eurich,lecture,80 minutes,2016-01-26,Direct Lecture,,,,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Type 2 Diabetes â€“ Treatment (Part II),,MSB 227,Eurich,lecture,80 minutes,2016-01-28,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Seminar: Diabetes (Type 2) Management,,TBA,Necyk,seminar,110 minutes,2016-01-29,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Seminar: Insulin Dosing and Management,,MSB 227,Necyk,seminar,110 minutes,2016-02-04,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the toxicity of medications used in the management of endocrine disorders.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Insulin in T2 DM,,MSB 227,TBA,lecture,80 minutes,2016-02-04,Direct Lecture,,,,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the toxicity of medications used in the management of endocrine disorders.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Gestational Diabetes,,MSB 227,Ryan,lecture,80 minutes,2016-02-11,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Long-term Complications of Diabetes,,MSB 227,Simpson,lecture,80 minutes,2016-02-23,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Current issues in Diabetes Management,,MSB 227,Simpson,lecture,80 minutes,2016-02-25,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Recognize the main structural features of drugs used to manage endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Course Overview and Education,,,Lisa Guirguis,lecture,80 minutes,2016-01-05,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Online Self-Study: SBAR technique and SMART Goal Setting,,,Lisa Guirguis,lecture,50 minutes,2016-01-07,Direct Lecture,,,,Describe the SBAR technique for communicating with other healthcare professionals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Time in Lieu during PDW (Video Review),,,Lisa Guirguis,lecture,50 minutes,2016-01-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Shared Decision Making and Intro to Motivational Interviewing,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-01-12,Direct Lecture,,,,Identify core principles and key skills of motivational interviewing,Select and integrate communication techniques to effectively communicate risk to patients,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Engage in effective partnerships with their patients to support positive behaviour changes,Perform rapid assessments of their patients readiness for change,Help patients to increase motivation and overcome barriers to change,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Assessing Ongoing Therapy + Patient Interviewing,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-01-14,Direct Lecture,,,,Understand purpose for talking with a patient about new medication vs ongoing therapy,Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Detect barriers to patients medication taking behaviors using supportive probing techniques ,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Review Pharm 314 Lab Exam; Set Learning Goals; Patient Education Exercise (Video;)Review Pharmacy Name and Identity,,MS Lab,Lisa Guirguis,lab,80 minutes,2016-01-14,"Direct Lecture, Active Learning, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Refill Debate + Sample Patient Interviewing,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-01-19,Direct Lecture,,,,Describe the elements of a medication history,Recognize prior encounters with the patient (if applicable),Provide tailored information (verbal and written),Provide clear patient information in manageable chunks,Relate explanation to patients experiences and understandings,Check for patient understanding of medication information ,"Invite follow-up includes who, how, and when",Establish organization and flow while taking a full medication history,Listen and adapt to patient cues in differing patient scenarios,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Review Feedback on Patient Education Exercise Motivational Interviewing Video Exercise; Communication Challenge Exercise;Shared Decision Making Skit,,MS Lab,Lisa Guirguis,lab,80 minutes,2016-01-19,"Direct Lecture, Active Learning, Problem Based Learning",,,,Identify core principles and key skills of motivational interviewing,Detect barriers to patients medication taking behaviors using supportive probing techniques ,Engage in effective partnerships with their patients to support positive behaviour changes,Perform rapid assessments of their patients readiness for change,Help patients to increase motivation and overcome barriers to change,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Medication Adherence,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-01-28,Direct Lecture,,,,"Compare and contrast concordance, compliance, and adherence frameworks ",Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Compare and contrast intentional and unintentional medication taking behaviours ,Detect barriers to patients medication taking behaviors using supportive probing techniques ,Develop strategies to help patients overcome barriers to taking their medications,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Review Feedback from MI Exercise; Prepare for the Structured Medication Review; Assess patient's ongoing therapy (Refill Situation),,MS Lab,Lisa Guirguis,lab,80 minutes,2016-01-28,"Direct Lecture, Active Learning, Problem Based Learning",,,,Understand purpose for talking with a patient about new medication vs ongoing therapy,"Compare and contrast concordance, compliance, and adherence frameworks ",Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Understand effective patient education skills,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,The Emotional Patient,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-02-02,Direct Lecture,,,,Explain the importance of stress management in professional life,Practice self-care activities to manage stress in professional life,"Recognize verbal and nonverbal cues signaling anger, conflict, and lack of trust ",Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Vision Loss,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-02-04,Direct Lecture,,,,Appreciate patient perspective in living with vision loss.,Communicate effectively with people with vision or hearing loss,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Conduct a structured medication review; Customize the medication history form; Self-Assess Video from Lab 4,,MS Lab,Lisa Guirguis,lab,80 minutes,2016-02-04,"Direct Lecture, Active Learning, Problem Based Learning",,,,Describe the elements of a medication history,Recognize prior encounters with the patient (if applicable),Provide tailored information (verbal and written),Provide clear patient information in manageable chunks,Relate explanation to patients experiences and understandings,Check for patient understanding of medication information ,"Invite follow-up includes who, how, and when",Establish organization and flow while taking a full medication history,Listen and adapt to patient cues in differing patient scenarios,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Lost in Translation & Hearing Loss,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-02-09,Direct Lecture,,,,Appreciate patient perspective in living with hearing loss.,Differentiate strategies to communicate with patients with hearing and hearing loss. ,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Communicate effectively with people with vision or hearing loss,Communicate effectively using a translator ,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,The Emotional Patient ,,MS Lab,Lisa Guirguis,lab,80 minutes,2016-02-09,"Direct Lecture, Active Learning",,,,Explain the importance of stress management in professional life,Identify a process to manage emotional consults,Practice self-care activities to manage stress in professional life,"Recognize verbal and nonverbal cues signaling anger, conflict, and lack of trust ","Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust ",Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Risk Communication,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-02-23,Direct Lecture,,,,Understand the complexity of communicating risk to patients,Identify several strategies for effectively communicating risk,Select and integrate communication techniques to effectively communicate risk to patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Wrap Up & Review ,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-03-01,,,,,Communicate effectively using a translator ,Select and integrate communication techniques to effectively communicate risk to patients,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Engage in effective partnerships with their patients to support positive behaviour changes,Perform rapid assessments of their patients readiness for change,Help patients to increase motivation and overcome barriers to change,Recognize prior encounters with the patient (if applicable),Provide tailored information (verbal and written),Provide clear patient information in manageable chunks,Relate explanation to patients experiences and understandings,Check for patient understanding of medication information ,"Invite follow-up includes who, how, and when",Establish organization and flow while taking a full medication history,Listen and adapt to patient cues in differing patient scenarios,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,Explain the importance of stress management in professional life,Understand purpose for talking with a patient about new medication vs ongoing therapy,Describe the elements of a medication history,"Compare and contrast concordance, compliance, and adherence frameworks ",Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Compare and contrast intentional and unintentional medication taking behaviours ,Appreciate patient perspective in living with vision loss.,Appreciate patient perspective in living with hearing loss.,Differentiate strategies to communicate with patients with hearing and hearing loss. ,Identify communication challenges associated with providing care to a patient whose first language is not English. ,Understand effective patient education skills,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Understand the complexity of communicating risk to patients,Identify several strategies for effectively communicating risk,Describe the SBAR technique for communicating with other healthcare professionals,Identify a process to manage emotional consults,Identify core principles and key skills of motivational interviewing,Practice self-care activities to manage stress in professional life,Detect barriers to patients medication taking behaviors using supportive probing techniques ,Develop strategies to help patients overcome barriers to taking their medications,"Recognize verbal and nonverbal cues signaling anger, conflict, and lack of trust ","Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust ",Communicate effectively with people with vision or hearing loss,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,"Communicate or observe patients with vision or hearing loss, requiring a translator, or engage with patients to support behaviour change",,MS Lab,Lisa Guirguis,lab,80 minutes,2016-02-23,Direct Lecture,,,,Appreciate patient perspective in living with vision loss.,Appreciate patient perspective in living with hearing loss.,Differentiate strategies to communicate with patients with hearing and hearing loss. ,Identify communication challenges associated with providing care to a patient whose first language is not English. ,Understand effective patient education skills,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Communicate effectively with people with vision or hearing loss,Communicate effectively using a translator ,Engage in effective partnerships with their patients to support positive behaviour changes,Perform rapid assessments of their patients readiness for change,Help patients to increase motivation and overcome barriers to change,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Complete a refill consult in a patient centred manner with strong communication skills,,MS Lab,Lisa Guirguis,lab,80 minutes,2016-03-07,"Direct Lecture, Active Learning, Problem Based Learning",,,,Understand purpose for talking with a patient about new medication vs ongoing therapy,Describe the elements of a medication history,Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Understand effective patient education skills,Recognize prior encounters with the patient (if applicable),Provide tailored information (verbal and written),Provide clear patient information in manageable chunks,Relate explanation to patients experiences and understandings,Check for patient understanding of medication information ,"Invite follow-up includes who, how, and when",Establish organization and flow while taking a full medication history,Listen and adapt to patient cues in differing patient scenarios,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Patient Interviewing Part 2; Student Present Shared Decision Making Skits,,MS 227,Lisa Guirguis,lecture,80 minutes,2016-01-26,Direct Lecture,,,,Describe the elements of a medication history,Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Understand effective patient education skills,Identify core principles and key skills of motivational interviewing,Develop strategies to help patients overcome barriers to taking their medications,Recognize prior encounters with the patient (if applicable),Provide tailored information (verbal and written),Provide clear patient information in manageable chunks,Relate explanation to patients experiences and understandings,Check for patient understanding of medication information ,"Invite follow-up includes who, how, and when",Establish organization and flow while taking a full medication history,Listen and adapt to patient cues in differing patient scenarios,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Federal and Provincial Drug Scheduling Cases; PBL Learning Activities/Case Based,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-21,"Direct Lecture, Active Learning, Problem Based Learning",,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Course Overview; Student and instructor expectations; Course format; Broad overview of legislation and how to access the material online.,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-01-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Intro to the Drug Use Process; PBL Learning Activities,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-05,Direct Lecture,,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Intro to the Drug Use Process; PBL Learning Activities,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-07,"Direct Lecture, Active Learning",,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Previous Topic Contd,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-01-11,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Introduction to Pharmacy Software; Introduction to the Prescription Process,H9,MSB 2_50,R. Sanghera,lab,50 minutes,2016-01-27,"Direct Lecture, Active Learning",,,,Demonstrate competency of the prescription processing software (KROLL).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Introduction to Pharmacy Software; Introduction to the Prescription Process,H10,MSB 2_50,R. Sanghera,lab,50 minutes,2016-01-27,,,,,Demonstrate competency of the prescription processing software (KROLL).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Drug Diversion Tips for identifying forged prescriptions Pharmacy security,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-28,"Direct Lecture, Active Learning",,,,Demonstrate competency of the prescription processing software (KROLL).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Introduction to Pharmacy Software; Introduction to the Prescription Process,H11,MSB 2_50,R. Sanghera,lab,50 minutes,2016-01-29,"Direct Lecture, Active Learning",,,,Demonstrate competency of the prescription processing software (KROLL).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Chat, Check & Chart",,CS 2-193,L. Guirguis,lecture,50 minutes,2016-02-05,"Direct Lecture, Active Learning, Problem Based Learning",,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Rescheduled,,CS 2-193,J. Ramji,lecture,50 minutes,2016-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Pharm Tech Students and Pharm Student Seminar,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-02-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Culture of Patient safety Contd Jurisprudence; NHP Regulations; Vitamins/Minerals & Sweeteners,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-02-26,Direct Lecture,,,,Relate the concepts of the culture of patient safety to the drug use process.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Lab 3: Prescription Processing and Assessment; Focus is on accept, input, check and consult; Verbal, transfer, prescription clarification and documentation",H7,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Lab 3: Prescription Processing and Assessment; Focus is on accept, input, check and consult; Verbal, transfer, prescription clarification and documentation",H10,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 2; F&D Act and Regulations Contd; Define Part I and II of schedule F; Vitamins and Minerals in Food; Natural Health Product Regulations,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-01-08,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 1: Accept/Input/Check,H8,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-01,"Direct Lecture, Active Learning, Team Based Learning",,,,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Drug Scheduling Contd;PBL Learning Activities/Case Based,J4,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-02-02,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 1: Accept/Input/Check,H10,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-03,Direct Lecture,,,,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 1: Accept/Input/Check,H9,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-03,Direct Lecture,,,,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 1: Accept/Input/Check,H7,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-06,Direct Lecture,,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply concepts of third party billing and prescription pricing in the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 1: Accept/Input/Check,H11,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-07,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply concepts of third party billing and prescription pricing in the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 2: Input/Check/Consult,H12,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-08,Active Learning,,,,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.","Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 2: Input/Check/Consult,H8,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-08,Active Learning,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Third Party Insurance Lecture; Alberta Blue Cross,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-02-08,Direct Lecture,,,,Apply concepts of third party billing and prescription pricing in the drug use process.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Third Party Insurance Lecture Contd,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-02-10,Direct Lecture,,,,Apply concepts of third party billing and prescription pricing in the drug use process.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 2: Input/Check/Consult,H9,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-10,Active Learning,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 2: Input/Check/Consult,H10,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-10,Active Learning,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 2: Input/Check/Consult,H11,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 2: Input/Check/Consult,H7,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Lab 3: Prescription Processing and Assessment; Focus is on accept, input, check and consult; Verbal, transfer, prescription clarification and documentation",H12,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Time off in lieu,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-03-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,LAB 4: TPP/Review of all concepts,H11,MSB 2_50,R. Sanghera,lab,50 minutes,2016-03-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,LAB 4: TPP/Review of all concepts,H7,MSB 2_50,R. Sanghera,lab,50 minutes,2016-03-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Medical Marijuana Legislation in Canada,,CS 2-193,J. Ramji,lecture,50 minutes,2016-02-03,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Drug Scheduling Contd; PBL Learning Activities/Case Based,J3,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-02-04,"Direct Lecture, Active Learning, Problem Based Learning",,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Lab 3: Prescription Processing and Assessment; Focus is on accept, input, check and consult; Verbal, transfer, prescription clarification and documentation",H8,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-22,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply concepts of third party billing and prescription pricing in the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Drug Use Process Contd Lab 2 Debrief,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-02-22,Direct Lecture,,,,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 1; F&D Act and Regulations; Part C: Drugs; Federal Requirements of a prescription; Federal requirements of a written/verbal/refill/transfer/fax prescriptions; Legislation surrounding veterinary; Federal requirements of prescription labeling; Define Part I and II/Schedules,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-01-06,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 5  Narcotic Control Regulations; Definitions/dispensing procedures/legal requirements pertaining to narcotic drugs; Destruction of narcotics; Overview of the Triplicate Prescription Program; PBL Learning Activities/Case Based,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-12,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 4  F&D Regulations; Part G And Part J; Overview of the regulations/scheduling/definitions of controlled and restricted drugs,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-01-13,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Jurisprudence Part 3  Controlled Drugs and Substances Act; Overview of the Act, schedules and definitions; Regulations (including precursors and targeted substances)",,CS 2-193,R. Sanghera,lecture,50 minutes,2016-01-15,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 6: Provincial Legislation; Overview of the Health Professions Act; Pharmacist and Pharmacy Technician Regulations,,CS 2-193,G. Eberhart,lecture,50 minutes,2016-01-18,Direct Lecture,,,,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,No Seminar (All attend Feb 25th),,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-02-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Introduction to the Culture of Patient Safety; Terms and definitions; Introduction to Canadian Patient Safety Institute, National steering committee on patient safety, Safer Healthcare Now!, Patients for Patient Safety Canada; Relevance to pharmacy practice (impact on patients/families of patients); Contributing factors to medication errors; Approaches to resolving/preventing medication errors",,CS 2-193,R. Sanghera,lecture,50 minutes,2016-02-24,Direct Lecture,,,,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Lab 3: Prescription Processing and Assessment; Focus is on accept, input, check and consult; Verbal, transfer, prescription clarification and documentation",H9,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-24,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.","Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,"Lab 3: Prescription Processing and Assessment; Focus is on accept, input, check and consult; Verbal, transfer, prescription clarification and documentation",H11,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-26,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,TBA,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-03-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,LAB 4: TPP/Review of all concepts,H8,MSB 2_50,R. Sanghera,lab,50 minutes,2016-03-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,LAB 4: TPP/Review of all concepts,H12,MSB 2_50,R. Sanghera,lab,50 minutes,2016-03-01,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply concepts of third party billing and prescription pricing in the drug use process.,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Class Wrap-Up,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-03-02,Direct Lecture,,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply concepts of third party billing and prescription pricing in the drug use process.,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,LAB 4: TPP/Review of all concepts,H10,MSB 2_50,R. Sanghera,lab,50 minutes,2016-03-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,LAB 4: TPP/Review of all concepts,H9,MSB 2_50,R. Sanghera,lab,50 minutes,2016-03-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 5  Narcotic Control Regulations; Definitions/dispensing procedures/legal requirements pertaining to narcotic drugs; Destruction of narcotics; Overview of the Triplicate Prescription Program; PBL Learning Activities/Case Based,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-14,"Direct Lecture, Active Learning, Problem Based Learning",,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Federal and Provincial Drug Scheduling; PBL Learning Activities Based,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-19,"Direct Lecture, Active Learning, Problem Based Learning",,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 6 Contd: Pharmacy and Drug Act o Pharmacy and Drug Regulations,,CS 2-193,G. Eberhart,lecture,50 minutes,2016-01-20,Direct Lecture,,,,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 7: Standards of Practice; Standards of Practice for Pharmacists and Pharmacy Technicians,,CS 2-193,D. Cooney,lecture,50 minutes,2016-01-22,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Introduction to Pharmacy Software; Introduction to the Prescription Process,H12,MSB 2_50,R. Sanghera,lab,50 minutes,2016-01-25,"Direct Lecture, Active Learning",,,,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.","For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Jurisprudence Part 7: Standards of Practice; Standards for the Operation of Licensed,,CS 2-193,D. Cooney,lecture,50 minutes,2016-01-25,Direct Lecture,,,,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Introduction to Pharmacy Software; Introduction to the Prescription Process,H8,MSB 2_50,R. Sanghera,lab,50 minutes,2016-01-25,Direct Lecture,,,,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply concepts of third party billing and prescription pricing in the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Drug Diversion Tips for identifying forged prescriptions Pharmacy security,,ECHA L1 150,R. Sanghera,seminar,80 minutes,2016-01-26,Direct Lecture,,,,Recognize issues surrounding drug diversion and security.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Introduction to Pharmacy Software; Introduction to the Prescription Process,H7,MSB 2_50,R. Sanghera,lab,50 minutes,2016-01-29,"Direct Lecture, Active Learning",,,,Demonstrate competency of the prescription processing software (KROLL).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab 1: Accept/Input/Check,H12,MSB 2_50,R. Sanghera,lab,50 minutes,2016-02-01,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.","For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Introduction to the Prescription Process (Part of the Patient Care Process) Relating the prescription process to the PCP process Requirements of a complete patient record Interpreting a prescription for completeness; Evaluating Therapy Special processes involving prescriptions (verbal and transfer); SBAR and unstructured documentation; Drug Incident Reporting; Review the current prescription payment model,,CS 2-193,R. Sanghera,lecture,50 minutes,2016-02-01,"Direct Lecture, Active Learning",,,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.","For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Apply relevant components of the Patient Care Process model to pharmacy practice.,Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 1,,MS 231,J. Shkrobot,lecture,170 minutes,2016-09-01,,face to face,Course introduction; Canadian pharmacy business environment; Pharmacy business planning,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 2,,MS 231,J. Shkrobot,lecture,170 minutes,2016-09-12,,face to face,Strategic planning; Developing and planning patient care services; Implementing and evaluating patient care services,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 3,,MS 231,J. Shkrobot,lecture,170 minutes,2016-09-19,,face to face,Financial management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 4,,MS 231,J. Shkrobot,lecture,170 minutes,2016-09-26,,face to face,Payment for prescriptions in the retail sector; Pharmacy operations; Information management systems; Technology in practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 5,,MS 231,J. Shkrobot,lecture,170 minutes,2016-10-03,,face to face,Marketing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,MIDTERM,,TBD,,lecture,50 minutes,2016-10-17,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 6,,MS 231,J. Shkrobot,lecture,170 minutes,2016-10-24,,face to face,Inventory management; Human resource management; Recruitment and hiring strategies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 7,,MS 231,J. Shkrobot,lecture,170 minutes,2016-10-31,,face to face,Performance management; Desirable workplaces; Managing conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 8,,MS 231,J. Shkrobot,lecture,170 minutes,2016-11-14,,face to face,BUSINESS PLAN PRESENTATIONS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 9,,MS 227,J. Shkrobot,lecture,170 minutes,2016-11-15,,face to face,BUSINESS PLAN PRESENTATIONS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 10,,MS 231,J. Shkrobot,lecture,170 minutes,2016-11-21,,face to face,Leadership and management; Management essentials; Managing change,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 11,,MS 231,J. Shkrobot,lecture,170 minutes,2016-11-28,,face to face,Quality assurance and improvement; Managing risk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Lecture 12,,MS 231,,lecture,170 minutes,2016-12-05,,face to face,Legal requirements; Ethical considerations; Final exam preparation / course evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,FINAL,,TBD,,lecture,50 minutes,2016-12-12,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 1,,MS 226,Dr. Siraki,Lecture,50 min,2016-09-02,,,INTRODUCTION / RADIATION PRINCIPLES: Brief overview of what to expect from this course; Begin content of next lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 2,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-07,,,RADIATION PRINCIPLES: Atomic structure; concepts of nuclear stability; radioactive isotopes; radiation emissions;Types of radioactive decay associated with nuclides commonly used for medical purposes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 3,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-08,,,QUIZ - Radiation Principles,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 4,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-09,,,"RADIATION EFFECTS ON LIVING SYSTEMS; Units of radioactivity; calculations involving radioactive decay, calculations for radiopharmaceutical dosage to allow for radioactive decay; concepts of physical, biological and effective half-life; Charged particles; electromagnetic radiation, thermal and fast neurons, physical characteristics, sources, interactions with matter, energy loss, tissue penetration (this topic presented from a health sciences viewpoint)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 5,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-12,,,"RADIATION EFFECTS ON LIVING SYSTEMS: Concepts of radiation energy in terms of transfer and absorption in biological systems; Mechanisms of radiation induced injury; Oxidative stress as a result of radiation, and biological effects; Antioxidant enzymes as deterrents to free radical induced damage.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 6,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-14,,,RADIATION EFFECTS ON LIVING SYSTEMS: Other radicals that can partake in radiation induced damage; Damage of free radicals to biological targets and its consequences; Free radicals and cell death; A description of the enzymatic and nonenzymatic systems to detoxify radiation induced free radical formation; Free radicals and cell death; Signalling mechanisms that can result in death or carcinogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,MIDTERM,,ECHA 2-190,Dr. Siraki,Exam,50 min,2016-09-16,,,"MIDTERM EXAM, MCQs based on material covered in week 1 - 3.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 7,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-19,,,RADIOSENSITIZATION AND PHOTOSENSITIZATION: Concepts and therapeutic advantage to combining radiation with pharmaceuticals; Mechanisms of radiation therapy and chemotherapy; The role of free radicals in mediating chemotherapeutic/toxic action; Chemical requirements for radiosensitizers; Radioprotection as a means to prevent damage to normal tissues; Photosensitization as a means to generate reactive species for photodynamic therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 8,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-21,,,ADJUNCT AGENTS FOR USE WITH DIAGNOSTIC IMAGING: Specific examples where organ imaging requires enhancement with drugs; Mechanism of action of drugs and how the image improves,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 9,,MS 227,Dr. Siraki,Lecture,50 min,2016-09-23,,,"QUIZ - Summary of diagnostic imaging & contrast agents;X-RAY, ULTRASOUND, MRI: X-ray, ultrasound, MRI; Contrast agents (iodinated; bismuth) in Xray; Paramagnetic contrast agents in MRI; ultrasonic contrast agents.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 10,,MS 227,Dr. Schirrmacher,Lecture,50 min,2016-09-26,,,RADIOPHARMACEUTICALS - PRACTICAL ASPECTS: Techniques for dispensing of radiopharmaceuticals; Tc99m generators,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 11,,MS 227,Dr. Schirrmacher,Lecture,50 min,2016-09-28,,,"RADIOPHARMACEUTICALS - PRACTICAL ASPECTS: Design, calibration and use of equipment for radionuclide assays; Purpose of using radiopharmaceuticals, routes of administration, and safe dispensing.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 12,,MS 227,Dr. Schirrmacher,Lecture,50 min,2016-09-30,,,RADIOPHARMACEUTICAL APPLICATIONS: Radiopharmaceuticals in clinical practice; Radiopharmaceuticals in bone scanning Radiopharmaceuticals in cardiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 13,,MS 227,Dr. Wuest,Lecture,50 min,2016-10-03,,,POSITRON EMISSION TOMOGRAPHY (PET): Positron Emissions-Tomography (PET): Molecular imaging and molecular; Positron Emission Tomography (PET): A general introduction; PET-Radiotracers as molecular probes for medical research and clinical routin; PET-RADIOTRACERS AS MOLECULAR PROBES FOR MEDICAL RESEARCH AND CLINICAL ROUTIN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,FINAL ,,CS 2-191 & CS 2-193,Dr. Siraki,Exam,50 min,2016-10-06,,,FINAL EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Ophthalmology Contd,,CS 2-193,C. Sadowski,lecture,50 minutes,2017-04-01,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice) ",,CS 2-193,R. Sanghera,lecture,110 minutes,2017-04-01,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Ophthalmology Pat II AMD Glaucoma Cataracts Age related eye changes,,CS 2-193,C. Sadowski,lecture,50 minutes,2017-04-01,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Dermatitis/Eczema/ Seborrhea/ Psoriasis,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Anatomy & Physiology of the Ear, Nose and Throat ",,Online,S. Patrick,lecture,50 minutes,2017-03-14,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Allergic Rhinitis Contd,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-15,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"PCP/Case Workup Gather relevant patient-related information. Use a systematic approach to complete a patient assessment and identify drug related problems. Given a case, develop a care plan. Describe the importance of documentation and the essential components. Develop a documentation note.",J2,ED 129,R. Sanghera,seminar,80 minutes,2017-03-24,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Time off in lieu of Physiology/Anatomy,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),,CS 2-193,R. Sanghera,lab,50 minutes,2017-04-06,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Drug-induced Skin Eruptions & Contact Dermatitis Contact Dermatitis & Adverse Cutaneous Drug Reactions,,CS 2-193,R. Sanghera,lecture,50 minutes,1900-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),,CS 2-193,R. Sanghera,lab,50 minutes,2017-04-08,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Wound Care Contd,,CS 2-193,C. Steele,lecture,50 minutes,2017-04-08,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Wound Care The process of wound healing Moist wound healing theory Wound classification Basic wound care Wound care products,,CS 2-193,C. Steele,lecture,50 minutes,2017-04-08,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Practice Discussion,,CS 2-193,A Fuller,lecture,50 minutes,2017-04-11,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Dermatology Compounding,,CS 2-193,A Virji,lecture,50 minutes,2017-04-11,"Direct Lecture, Active Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Dermatology Compounding,,CS 2-193,A Virji,lecture,50 minutes,2017-04-11,"Direct Lecture, Active Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Time off for assignment,,TBA,R. Sanghera,lecture,50 minutes,2017-04-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Time off for assignment,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Anatomy & Physiology of the Eye: Special Senses,,Online,S. Patrick,lecture,50 minutes,2017-03-14,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Course IntroductionAssignment Introduction Scholar Lecture Introduction to Scholar Counseling Self-Treating Patients Quickly and Effectively,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-14,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Allergic Rhinitis, PMCOL of Antihistamines & Decongestants  Describe the classification of allergic rhinitis  Understand the mechanism of action of antihistamines  Understand inverse agonism  Recognize potential adverse effects of antihistamines  Explain the pathophysiology of allergic rhinitis  Describe the management of allergic rhinitis (drug & nondrug)  Understand the role of immunotherapy  Demonstrate how to use emergency epinephrine products",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-15,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Corns/Calluses Class Wrap-up,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-12,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Dermatitis/Eczema/ Seborrhea/ Psoriasis  Therapeutics Dermatologic Disease  Eczema & Psoriasis Dermatologic Therapeutics Topical Corticosteroids Systemic Corticosteroids Topical Vitamin D3 Analogueso MethotrexateSunscreeno Topical HydroquinoneTopical Calcineurin Inhibitors,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Dermatitis/Eczema/ Seborrhea/ Psoriasis,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Dermatological Diseases Contd,,CS 2-193,R. Sanghera,lecture,50 minutes,1900-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Sunburn, Skin Cancer, Vitiligo &Hyperpigmentation Dermatologic Diseaseo Skin Cancero Melasmao Vitiligo Dermatologic Therapeuticso Sunscreeno Topical Hydroquinoneo Topical Calcineurin Inhibitors",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-06,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Intro to the Ear  Be able to perform an assessment of a patient who presents with hearing loss, ear pain and ear drainage  Have an awareness of some of the drugs that cause ototoxicity and the characteristics of the drug-induced ototoxicity  Describe the common disorders of the auditory canal and middle ear  Differentiate between the signs and symptoms of the following otic conditions and make recommendationso Cerumen (earwax) impactiono Otitis Externao Otitis Media  Identify the role of the following agents in the treatment of ear disorderso Anti_infectiveso Analgesicso Local anestheticso Wax softenerso Cerumenolytics Demonstrate the correct method:o Instilling ear drops( adults & children) Ear syringing",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-15,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Overview of Lab How will the labs operate?o Timingo Rotationso Roles & responsibilities What is the Patient Care Process? Scenario in relation to marking rubric,,ECHA 2 490,R. Sanghera,seminar,80 minutes,2017-03-17,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Ophthalmology Part I Contd,,CS 2-193,R. Mangat,lecture,50 minutes,2017-03-18,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Ophthalmology Part I  o Diagnosis & Management of Eye Diseaseo Care for contact lenses,,CS 2-193,R. Mangat,lecture,50 minutes,2017-03-18,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Medicinal Chemistry: Antihistamines Study histamine structure and its different chemical forms Familiarize with phamacophores for antihistamine activity Understand structure-activity relationships,,CS 2-193,C. Velasquez,lecture,50 minutes,2017-03-23,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Medicinal Chemistry/PMCOL: Corticosteroids Familiarize with structures of some important corticosteroids Relative potency of topical corticosteroids Understand structure-activity relationships Familiarize with few common antiproliferatives Define inflammation Identify inflammatory mediators Identify the three main strategies to treat inflammation Identify the three main classes of drugs that modulate eicosanoid pharmacology Describe the three mechanisms of action associated with anti-inflammatory drugs,,CS 2-193,C. Velasquez,lecture,50 minutes,2017-03-23,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Acne/Rosacea Contd,,CS 2-193,J. Carbon,lecture,50 minutes,2017-03-23,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"PCP/Case Workup Gather relevant patient-related information. Use a systematic approach to complete a patient assessment and identify drug related problems. Given a case, develop a care plan. Describe the importance of documentation and the essential components. Develop a documentation note.",J1,ED 129,R. Sanghera,seminar,80 minutes,2017-03-24,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Assignment Introduction/TBA,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-30,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice)",,CS 2-193,R. Sanghera,lab,50 minutes,2017-03-30,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Allergic Rhinitis, PMCOL of Antihistamines & Decongestants Describe the classification of allergic rhinitis Understand the mechanism of action of antihistamines Understand inverse agonism Recognize potential adverse effects of antihistamines Explain the pathophysiology of allergic rhinitis Describe the management of allergic rhinitis (drug & nondrug) Understand the role of immunotherapy Demonstrate how to use emergency epinephrine products",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-18,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Debrief Ear AssignmentPhysiology & Anatomy- Integumentary System (Online, students will be given time off in future classes. The module will be released early)",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-21,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Acne/Rosacea Therapeutics, PMCOL of Retinoids Understand retinoids are analogues of Vitamin A Mechanism of action not well understood Potential for adverse effects, especially with oral retinoids Dermatologic Diseaseo  Acne & Rosacea Dermatologic Therapeuticso Topical Benzoyl Peroxide, o Topical Retinoidso Systemic Retinoidso Isotretinoin Topical Metronidazole",,CS 2-193,J. Carbon,lecture,50 minutes,2017-03-21,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Lice/Scabies Life cycle and transmission  Epidemiology  Presenting symptoms  Treatmentdrug/non-drug Antiparasiticso  MOAo Indications/Contraindications/Precautionso Dose/Duration of Treatmento Adverse Effects Prevention (Role of the pharmacist),,CS 2-193,A Hemraj,lecture,50 minutes,2017-03-21,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Alopecia/ Hyperhidrosis,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-12,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,"Opportunistic Infections, Malignancies and Therapeutic Issues Associated with Transplant",,,Dr. Sharon Mitchell,seminar,50 minutes,2016-03-07,Direct Lecture,,,,"Understand problems associated with opportunistic infections, malignancy, metabolic effects and adverse drug effects associated with immunosuppression.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,"Pharmacology of small molecule drugs cont'd: Mycophenolate mofetil, Mycophenolate sodium,Azathioprine, Cyclophosphamide, Corticosteroids",,,Dr. Sharon Mitchell,lecture,80 minutes,2016-03-01,Direct Lecture,,,,Understand the mechanisms of action and effects and adverse effects of anti-Â_â€êrejection medication.,Understand the rationale for combination anti-Â_â€êrejection therapy following organ transplantation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,"Mechanism of action of: Polyclonal antibodies (ATG [horses/rabbits]), and monoclonal antibodies (anti-C3, anti-CD52, anti-CD20, and anti-CD25)",,,Dr. Sharon Mitchell,lecture,80 minutes,2016-03-03,Direct Lecture,,,,Understand the mechanisms of action and effects and adverse effects of anti-Â_â€êrejection medication.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Clinical pharmacokinetics of immunosuppressives,,,Dr. Dion Brocks,lecture,80 minutes,2016-03-08,Direct Lecture,,,,Understand and apply pharmacokinetic principles in the management of anti-Â_â€êrejection medications.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Renal Transplant and Renal Transplant Cases,,,Jenny Wichart,seminar,50 minutes,2016-03-16,Direct Lecture,,,,Understand issues related to organ donation,Understand the pathophysiology of transplanted organ rejection.,Recognize and manage immunosuppression and toxicity induced by anti-Â_â€êrejection therapy.,Recognize and be able to manage drug interactions with anti-Â_â€êrejection therapy.,Adjust dosages of anti-Â_â€êrejection therapy based on drug levels and therapeutic targets.,To develop an understanding of the patient perspective of receiving a transplant.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Liver Transplant,,,Dr. Dale Lien,lecture,80 minutes,2016-03-17,Direct Lecture,,,,Understand the rationale for combination anti-Â_â€êrejection therapy following organ transplantation.,Understand issues related to organ donation,Understand the pathophysiology of transplanted organ rejection.,Recognize and manage immunosuppression and toxicity induced by anti-Â_â€êrejection therapy.,Recognize and be able to manage drug interactions with anti-Â_â€êrejection therapy.,Adjust dosages of anti-Â_â€êrejection therapy based on drug levels and therapeutic targets.,To develop an understanding of the patient perspective of receiving a transplant.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Bone Marrow Transplant,,,Jennifer Jupp,lecture,80 minutes,2016-03-22,Direct Lecture,,,,Understand the rationale for combination anti-Â_â€êrejection therapy following organ transplantation.,Understand issues related to organ donation,Understand the pathophysiology of transplanted organ rejection.,Recognize and manage immunosuppression and toxicity induced by anti-Â_â€êrejection therapy.,Recognize and be able to manage drug interactions with anti-Â_â€êrejection therapy.,Adjust dosages of anti-Â_â€êrejection therapy based on drug levels and therapeutic targets.,To develop an understanding of the patient perspective of receiving a transplant.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Course Introduction; General pathophysiology and general treatment considerations,,,Dr. Sharon Mitchell,lecture,80 minutes,2016-02-23,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,"General Pathophysiology ;Pharmacology of small molecule drugs: Cyclosporine, Tacrolimus, Sirolimus, Everolimus",,,Dr. Sharon Mitchell,lecture,80 minutes,2016-02-25,Direct Lecture,,,,Understand the mechanisms of action and effects and adverse effects of anti-Â_â€êrejection medication.,Understand the rationale for combination anti-Â_â€êrejection therapy following organ transplantation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Canadian Transplant System,,,"Canadian Blood Services Group, Kathy Yetzer",seminar,50 minutes,2016-03-14,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Islet Cell Transplant,,,Dr. Peter Senior,lecture,80 minutes,2016-03-24,Direct Lecture,,,,Understand the rationale for combination anti-Â_â€êrejection therapy following organ transplantation.,Understand issues related to organ donation,Understand the pathophysiology of transplanted organ rejection.,Recognize and manage immunosuppression and toxicity induced by anti-Â_â€êrejection therapy.,Recognize and be able to manage drug interactions with anti-Â_â€êrejection therapy.,Adjust dosages of anti-Â_â€êrejection therapy based on drug levels and therapeutic targets.,To develop an understanding of the patient perspective of receiving a transplant.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,MedChem: Anti- Arrhythmics/CCB/Statins,,MSB 231,Barakat,lecture,110 minutes,2016-01-29,Direct Lecture,,,,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Hypertension,,MSB 231,Thompson,lecture,110 minutes,2016-02-01,Direct Lecture,,,,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Hypertension,,MSB 231,Thompson,lecture,110 minutes,2016-02-05,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Hypertension,,MSB 231,Thompson,lecture,110 minutes,2016-02-08,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Dyslipidemia,,MSB 231,Pearson,lecture,110 minutes,2016-02-22,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Dyslipidemia,,MSB 231,Pearson,lecture,110 minutes,2016-02-24,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pathophys/Therap: CHD,,MSB 231,TBD,lecture,110 minutes,2016-02-26,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pathophys/Therap: CHD,,MSB 231,TBD,lecture,110 minutes,2016-02-29,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Introduction/Anatomy,,MSB 231,Seubert/Patrick,lecture,110 minutes,2016-01-04,Direct Lecture,,,,Explain the anatomy of the heart and great blood vessels.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Physiology,,Online,Seubert/Patrick,lecture,110 minutes,2016-01-06,Direct Lecture,,,,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Physiology,,Online,Seubert/Patrick,lecture,110 minutes,2016-01-08,Direct Lecture,,,,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Physiology,,Online,Seubert/Patrick,lecture,110 minutes,2016-01-11,Direct Lecture,,,,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pathophysiology,,MSB 231,Seubert,lecture,110 minutes,2016-01-13,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Patient Assessment History,,MSB 231,Koshman,lecture,110 minutes,2016-01-16,Direct Lecture,,,,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pharm: Beta-blockers/RAAS,,MSB 231,Seubert,lecture,110 minutes,2016-01-20,Direct Lecture,,,,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pharm: Lipids/Diuretics,,MSB 231,,lecture,110 minutes,2016-01-22,Direct Lecture,,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pharm: CCB/Vasodilators,,,Seubert,lecture,110 minutes,2016-01-25,Direct Lecture,,,,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pharm: Anti-Arrhythmics,,MSB 231,Light,lecture,110 minutes,2016-01-27,Direct Lecture,,,,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Patient Assessment Physical Exam,,MSB 231,Koshman,lecture,110 minutes,2016-12-05,Direct Lecture,,,,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,ASA-Podcast,,,Online,lecture,110 minutes,2016-03-02,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,"Pathophys/Therap: Acute Coronary Syndromes, MI",,MSB 231,Ackman,lecture,110 minutes,2016-03-07,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,"Pathophys/Therap: Acute Coronary Syndromes, MI",,MSB 231,Ackman,lecture,110 minutes,2016-03-09,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 1 _ Primary Prevention,,Education,TBD,seminar,110 minutes,2016-03-09,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pathophys/Therap: CHF,,MSB 231,Fradette,lecture,110 minutes,2016-03-11,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pathophys/Therap: CHF,,MSB 231,Fradette,lecture,110 minutes,2016-03-14,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,"Kinetics: Anti-Arrhythmics, Procainamide, Amiodarone, Digoxin",,MSB 231,Brocks,lecture,110 minutes,2016-03-16,Direct Lecture,,,,Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 2 - CAD,,Education,TBD,seminar,110 minutes,2016-03-16,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,"Kinetics: Anti-Arrhythmics, Procainamide, Amiodarone, Digoxin",,MSB 231,Brocks,lecture,110 minutes,2016-12-05,Direct Lecture,,,,Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pathphys/Therap: A Fib,,,George-Phillips,lecture,110 minutes,2016-03-21,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Pathphys/Therap: A Fib,,,George-Phillips,lecture,110 minutes,2016-03-23,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 3 â€“ Heart Failure,,Education,TBD,lecture,110 minutes,2016-03-23,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 4 - Arrhythmia,,MSB 231,,lecture,110 minutes,2016-03-30,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Peripheral Vascular Disease,,MSB 231,Walter,lecture,110 minutes,2016-04-04,Direct Lecture,,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drug,,,,,,,,,,,,,
PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Cardiotoxicology,,MSB 231,Seubert,lecture,110 minutes,2016-04-06,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Course Introduction Introduction to Assignments Geriatrics Pre-test Demographics,,MSB 227,Sadowski,lecture,50 minutes,2016-01-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,"Challenges of Pediatric Practice; developmental stages (communication) , presentation of illness, dosing, administration (oral, parenteral and topical), availability of medications, adherence, counseling Assessment of Newborn/Basic neonatal care Pediatric age groups; prems, newborns, infants, toddlers, children, adolescents Physiologic differences in children; Impact on PK/PD Terminology of gestation and birthweight Prematurity and birthweight- implications (dosing)",,MSB 227,Gukert,lecture,80 minutes,2016-01-19,Direct Lecture,,,,"Identify and discuss some of the challenges involved in treating the pediatric population; including communication strategies, presentation of illness and the management and administration of medications to infants and children.",Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,Discuss basic neonatal care and challenges including premature birth.,Explain how pharmacokinetic parameters are different in infants and children versus adults.,"Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants; including premature babies, and neonates",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Cultural Diversity,,MSB 227,Sadowski/Gukert/Waugh,seminar,170 minutes,2016-01-19,Direct Lecture,,,,"Describe the role that culture, religion, and ethnicity may play in health and decision making.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Gerontology Caregiving Physiologic changes with aging,,MSB 227,Sadowski,lecture,50 minutes,2016-01-06,Direct Lecture,,,,Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient.,Contrast how a geriatric syndrome is different than a disease state.,List the common geriatric syndromes.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Pharmacokinetics Pharmacodynamics High risk medications in the elderly,,MSB 227,Sadowski,lecture,80 minutes,2016-01-07,Direct Lecture,,,,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics.",Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors.,Define polypharmacy and underutilization in terms of medications in seniors.,Use tools to assess medication appropriateness and medication management in seniors.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications.,Apply knowledge and skills to establish safe and effective drug use.,Identify and be able to recommend aids to assist in medication management and administration.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Geriatrics â€“ Home care,,MSB 227,Haggarty/Featherstone,seminar,110 minutes,2016-01-08,Direct Lecture,,,,Describe the role of the pharmacist in working with home care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Medication problems in the elderly Evidence base/research,,MSB 227,Sadowski,lecture,50 minutes,2016-01-08,Direct Lecture,,,,Describe the challenges of providing care in a population with limited evidence.,Contrast the presentation of adverse events in the elderly compared to the young adult.,Utilize when available an evidence based approach to therapeutic management of pediatric and geriatric patients.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Communications â€“ Hearing impairment,,MSB 227,Cindy Gordon,lecture,50 minutes,2016-01-11,Direct Lecture,,,,Identify methods of appropriately communicating with older adults who are hard of hearing.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Adverse drug events Manifestations of toxicity in the elderly,,MSB 227,Sadowski,lecture,80 minutes,2016-01-12,Direct Lecture,,,,Define polypharmacy and underutilization in terms of medications in seniors.,Contrast the presentation of adverse events in the elderly compared to the young adult.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Geriatrics â€“ Abuse,,MSB 227,Elder Abuse Intervention Team,seminar,110 minutes,2016-01-13,Direct Lecture,,,,Categorize the types of abuse commonly suffered by seniors.,Describe the role of the pharmacist in reducing elder abuse.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Geriatric Syndromes Falls,,MSB 227,Sadowski,lecture,50 minutes,2016-01-13,Direct Lecture,,,,Describe the impact of falls on the senior population.,Identify risk factors for falls in older individuals.,Describe appropriate interventions for falls.,Contrast how a geriatric syndrome is different than a disease state.,List the common geriatric syndromes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Geriatric assessment Communication issues for older adults; Resources,,MSB 227,Sadowski,lecture,80 minutes,2016-01-14,Direct Lecture,,,,Identify methods of appropriately communicating with older adults who are hard of hearing.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,"Pediatrics Introduction Demographics and Determinants Evolution of Pediatric Practice; Current Trends and Practice/ Approach to Pediatric Care Ethical Challenges: research, caregiver issues, use of CAM",,MSB 227,Gukert,lecture,50 minutes,2016-01-15,Active Learning,,,,"Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)","Identify and discuss some of the challenges involved in treating the pediatric population; including communication strategies, presentation of illness and the management and administration of medications to infants and children.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Pediatrics Abuse,,MSB 227,Dibden,lecture,50 minutes,2016-01-22,Direct Lecture,,,,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,"Pediatric Toxicology/Medication Safety (Reyes Syndrome, Grey Baby Syndrome, Codeine, Cough and Cold remedies) Safe medication practices; - strategies for systemic safety - preventative measures to minimize poisonings",,MSB 227,Gukert,lecture,50 minutes,2016-01-20,Direct Lecture,,,,Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,Apply knowledge and skills to establish safe and effective drug use.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,"Student assignments â€“ group work, presentation preparation",,MSB 227,Sadowski/Gukert,lecture,80 minutes,2016-01-21,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Student Debates,,MSB 227,Sadowski/Gukert,seminar,110 minutes,2016-01-21,Direct Lecture,,,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,"Clinical Issues in Pediatrics (focus GI); - diarrhea/hydration/vomiting, constipation, - presentation, assessment and management Presentation in pediatrics",,MSB 227,Romanick,lecture,50 minutes,2016-01-25,Direct Lecture,,,,"Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,"Clinical Issues in Pediatrics; presentation , assessment and management - focus respiratory (croup & bronchiolitis) - fever and febrile seizures - colic",,MSB 227,Meyer,lecture,80 minutes,2016-01-26,Direct Lecture,,,,Discuss presentation and treatment for common pulmonary pediatric illnesses; Croup and Bronchiolitis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Pediatric Communications and Child Life,,MSB 227,Wolgemuth,lecture,50 minutes,2016-01-27,Direct Lecture,,,,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Autism,,MSB 227,Reynolds,seminar,110 minutes,2016-01-27,Direct Lecture,,,,Discuss the management and implications involved with a diagnosis of autism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,"Clinical Issues in Pediatrics Pediatric references; guidelines, equations, tools Review of age appropriate references for dosing, formulations and recipes",,MSB 227,Meyer,lecture,50 minutes,2016-01-29,Direct Lecture,,,,Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug related problems specific to the populations being studied.,Identify and be able to recommend aids to assist in medication management and administration.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Introductory Geriatrics ,,MSB 227,Sadowski,lecture,80 minutes,2016-01-05,Direct Lecture,,,,"Explain the demographics of aging, and how that may impact society and the healthcare system.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Hormonal Contraception conâ€™t,,MSB 227,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-03-09,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Emergency Contraception,,MSB 227,Oksana Dacko/Dr. Nese Yuksel,lecture,50 minutes,2016-03-14,Direct Lecture,,,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Menopause 2: Management of Symptoms/Hormone Therapy,,MSB 227,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-03-18,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Treatment of Infertility /Pregnancy and Ovulation Testing,,MSB 227,Dr. NesÃ© Yuksel,lecture,80 minutes,2016-03-31,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Treatment Issues in Pregnancy,,MSB 227,Dr. Peter Mitchell,lecture,80 minutes,2016-04-05,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Seminar 1: Hormonal contraception cases,,TBA,Dr. NesÃ© Yuksel,lecture,170 minutes,2016-03-16,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Seminar 3: Menopause cases,,TBA,Dr. NesÃ© Yuksel,lecture,170 minutes,2016-03-30,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Seminar 4: Mens Health,,TBA,Dr. Cheryl Sadowski,lecture,170 minutes,2016-04-06,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,"Introduction, Course Syllabus Anatomy/Physiology",,MSB 227,Dr. NesÃ© Yuksel/Dr. Susan Patrick,lecture,80 minutes,2016-03-01,Direct Lecture,,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Anatomy/Physiology,,Online,Dr Susan Patrick,lecture,50 minutes,2016-03-03,Direct Lecture,,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Hormonal Contraception,,MSB 227,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-03-07,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.","Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.","Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Hormonal Contraception conâ€™t,,MSB 227,Dr. NesÃ© Yuksel,lecture,80 minutes,2016-03-08,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.","Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Contraception Workshop: Non- Hormonal/Barrier Methods,,MSB 227,Ris Grover,lecture,110 minutes,2016-03-09,Direct Lecture,,,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Anatomy/Physiology,,Online,Dr. Susan Patrick,lecture,50 minutes,2016-03-11,Direct Lecture,,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Topics in Womenâ€™s Health: Menstrual Related Disorders/PMS/PMDD,,MSB 227,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-03-15,Direct Lecture,,,,"Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.","Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Anatomy/Physiology,,Online,Dr. Susan Patrick,lecture,50 minutes,2016-03-16,Direct Lecture,,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Menopause 1: Pathophysiology &Pharmacology of hormones,,MSB 227,Dr. NesÃ© Yuksel,lecture,80 minutes,2016-03-17,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Menopause 2: Management of Symptoms/Hormone Therapy conâ€™t,,,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-03-21,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Medicinal Chemistry,,MSB 227,Dr. Frank Wuest,lecture,50 minutes,2016-03-23,Direct Lecture,,,,Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Topics in Womenâ€™s Healt: Endometriosis/PCOS,,MSB 227,Dr. NesÃ© Yuksel,lecture,80 minutes,2016-03-24,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Topics in Mens Health: Sexual Dysfunction/Erectile Dysfunction,,MSB 227,Dr Cheryl Sadowski,lecture,80 minutes,2016-03-29,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Topics in Menâ€™s Health: Andropause/ Male Pattern Baldness,,MSB 227,Dr Cheryl Sadowski,lecture,50 minutes,2016-03-30,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Topics in Menâ€™s Health: Andropause/ Male Pattern Baldness conâ€™t,,MSB 227,Dr Cheryl Sadowski,lecture,50 minutes,2016-04-01,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Drug Principles in Pregnancy and Lactation,,MSB 227,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-04-04,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Prenatal/Postpartum Care and Postpartum Depression,,MSB 227,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-04-06,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Class Evaluations/Final Exam Review Treatment of Sexual Dysfunction in Women,,MSB 227,Dr. NesÃ© Yuksel,lecture,50 minutes,2016-04-07,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the  state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Seminar 2: FASD seminar,,TBA,Dr. Sharon Mitchell,lecture,170 minutes,2016-03-23,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 1,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-02,,,Introduction/Kinetics of Transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 2,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-07,,,Kinetics of Transport/Kinetics of iv bolus Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 3,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-08,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 4,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-09,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 5,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-12,,,Kinetics of iv bolus Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 6,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-14,,,Compartmental Concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 7,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-16,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 8,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-19,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 9,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-21,,,Kinetics of Doses after intravenous infusion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 10,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-23,,,Kinetics of Doses after 1st order Input,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 11,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-26,,,Oral absorption and bioequivalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 12,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-28,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 13,,MS 227,Dr. Brocks,lecture,50 minutes,2016-09-30,,,Kinetics after Constant Input of Drug,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 14,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-03,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 15,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-05,,,Multiple dose pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 16,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-07,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 17,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-12,,,Drug distribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 18,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-17,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 19,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-19,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 20,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-21,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,MIDTERM,,,,exam,,2016-10-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 21,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-26,,,Drug clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 22,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-28,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 23,,MS 227,Dr. Brocks,lecture,50 minutes,2016-10-31,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 24,,MS 227,Dr. Brocks,lecture,50 minutes,2016-11-02,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 25,,MS 227,Dr. Brocks,lecture,50 minutes,2016-11-14,,,Nonlinear elimination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 26,,MS 227,Dr. Brocks,lecture,50 minutes,2016-11-16,,,Nonlinear elimination / PK-PD relationship,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 27,,MS 227,Dr. Guirguis,lecture,50 minutes,2016-11-18,,,PK Drug Interactions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 28,,MS 227,Dr. Jamali,lecture,50 minutes,2016-11-21,,,Effects of age on pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 29,,MS 227,Dr. Jamali,lecture,50 minutes,2016-11-23,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 30,,MS 227,Dr. Jamali,lecture,50 minutes,2016-11-25,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 31,,MS 227,Dr. Jamali,lecture,50 minutes,2016-11-28,,,PK-Pharmacodynamic variables,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 32,,MS 227,Dr. Jamali,lecture,50 minutes,2016-11-30,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 33,,MS 227,Dr. Jamali,lecture,50 minutes,2016-12-02,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 34,,MS 227,Dr. Jamali,lecture,50 minutes,2016-12-05,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,FINAL,,,,exam,110 minutes,2016-12-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Introduction into Compounding,,CS 2 193,Dr. Lobenberg,lecture,110 minutes,2016-01-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Accuracy in Pharmaceutical Compounding,,ECHA 1498,Hashem,seminar,50 minutes,2016-01-04,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Contemporary Compounding,,CS 2 193,Dr. Lobenberg,lecture,110 minutes,2016-01-06,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Accuracy in Pharmaceutical Compounding,,ECHA 1498,Hashem,seminar,50 minutes,2016-01-06,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Accuracy in Pharmaceutical Compounding,,ECHA 1490,Hashem,seminar,50 minutes,2016-01-08,"Direct Lecture, Active Learning, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Solubility,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-08,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Pharmaceutical Solutions and Waters,,CS 2 193,Dr. Lobenberg,lecture,110 minutes,2016-01-11,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Solubility,,ECHA 1498,Osama,seminar,50 minutes,2016-01-11,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Solubility,,MSB lab,Osama,lab,110 minutes,2016-01-11,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Solubility,,MSB lab,Osama,lab,110 minutes,2016-01-13,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Solubility,,MSB lab,Osama,lab,110 minutes,2016-01-15,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,MSB lab,Muhammad,lab,110 minutes,2016-01-18,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,MSB lab,Muhammad,lab,110 minutes,2016-01-20,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,MSB lab,Muhammad,lab,110 minutes,2016-01-22,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsion,,MSB lab,Hanan,lab,110 minutes,2016-01-25,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsion,,MSB lab,Hanan,lab,110 minutes,2016-01-27,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsion,,MSB lab,Hanan,lab,110 minutes,2016-01-29,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Semisolids,,MSB lab,Hoda,lab,110 minutes,2016-02-01,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Containers,,CS 2 193,Dr. Lobenberg,lecture,110 minutes,2016-02-05,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Routes of Administration,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-02-08,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Solubility,,ECHA 1498,Osama,seminar,50 minutes,2016-01-13,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-13,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Solubility,,ECHA 1490,Osama,seminar,50 minutes,2016-01-15,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-15,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsions,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-18,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,ECHA 1498,Muhammad,seminar,50 minutes,2016-01-18,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsions,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-20,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,ECHA 1498,Muhammad,seminar,50 minutes,2016-01-20,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suspensions,,ECHA 1490,Muhammad,seminar,50 minutes,2016-01-22,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Semisolids,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-22,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsion,,ECHA 1498,Hanan,seminar,50 minutes,2016-01-25,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsion,,ECHA 1498,Hanan,seminar,50 minutes,2016-01-27,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Colloids,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-27,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Emulsion,,ECHA 1490,Hanan,seminar,50 minutes,2016-01-29,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Colloids,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-01-29,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suppositories,,CS 2 193,Dr. Lobenberg,lecture,110 minutes,2016-02-01,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Semisolids,,ECHA 1498,Hoda,seminar,50 minutes,2016-02-01,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Semisolids,,MSB lab,Hoda,lab,110 minutes,2016-02-03,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Powders and Capsules,,CS 2 193,Dr. Lobenberg,lecture,110 minutes,2016-02-03,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Semisolids,,ECHA 1498,Hoda,seminar,50 minutes,2016-02-03,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Semisolids,,MSB lab,Hoda,lab,110 minutes,2016-02-05,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Semisolids,,ECHA 1490,Hoda,seminar,50 minutes,2016-02-05,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Routes of Administration,,CS 2 193,Dr. Lavasanifar,lecture,110 minutes,2016-02-10,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Compounding review,,CS 2 193,Dr. Lobenberg,lecture,110 minutes,2016-02-12,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suppositories,,MSB lab,Igor,lab,110 minutes,2016-02-22,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suppositories,,ECHA 1498,Igor,seminar,50 minutes,2016-02-22,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suppositories,,MSB lab,Igor,lab,110 minutes,2016-02-24,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suppositories,,ECHA 1498,Igor,seminar,50 minutes,2016-02-24,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suppositories,,ECHA 1490,Igor,seminar,50 minutes,2016-02-26,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Suppositories,,MSB lab,Igor,lab,110 minutes,2016-02-26,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Powders and Capsules,,ECHA 1498,Amir,seminar,50 minutes,2016-03-01,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Powders and Capsules,,MSB lab,Amir,lab,110 minutes,2016-03-01,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Powders and Capsules,,ECHA 1498,Amir,seminar,50 minutes,2016-03-02,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Powders and Capsules,,MSB lab,Amir,lab,110 minutes,2016-03-02,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Powders and Capsules,,ECHA 1490,Amir,seminar,50 minutes,2016-03-04,"Direct Lecture, Problem Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Powders and Capsules,,MSB lab,Amir,lab,110 minutes,2016-03-04,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Course introduction / historical background,,MS 227,Shkrobot,lecture,170 minutes,2016-01-04,"Direct Lecture, Active Learning, Team Based Learning",,,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Health systems / Canadaâ€™s healthcare system / patient involvement,,MS 227,Shkrobot,lecture,170 minutes,2016-01-11,"Direct Lecture, Active Learning, Team Based Learning",,,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Healthcare resources,,MS 227,Shkrobot,lecture,170 minutes,2016-01-18,"Direct Lecture, Active Learning, Team Based Learning",,,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Provision of healthcare,,MS 227,Shkrobot,lecture,170 minutes,2016-01-25,"Direct Lecture, Active Learning, Team Based Learning",,,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Provision of healthcare,,MS 227,Shkrobot,lecture,170 minutes,2016-02-01,"Direct Lecture, Active Learning, Team Based Learning",,,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Healthcare organizations,,MS 227,Shkrobot,lecture,170 minutes,2016-02-08,"Direct Lecture, Active Learning, Team Based Learning",,,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Pharmacy frameworks,,MS 227,Shkrobot,lecture,170 minutes,2016-02-29,"Direct Lecture, Active Learning, Team Based Learning",,,,The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,The student will develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Solutions to healthcare issues,,MS 227,Shkrobot,lecture,170 minutes,2016-03-07,"Direct Lecture, Active Learning, Team Based Learning",,,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Debates,,MS 227,Shkrobot,lecture,170 minutes,2016-12-09,"Active Learning, Problem Based Learning, Team Based Learning",,,,The student will be able to identify and debate key issues and challenges facing the Canadian healthcare system.,The student will be able to develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part ofthose solutions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Debates,,MS 227,Shkrobot,lecture,170 minutes,2016-03-21,"Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Physiology and Pathophysiology of Pain,,MS 231,Susan Patrick,lecture,110 minutes,2016-01-07,Direct Lecture,,,,Describe the anatomy of central and peripheral nervous system as it relates to pain.,Describe the physiology of central and peripheral nervous system as it relates to pain.,Describe the pathophysiology of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacology of Analgesics and Anesthetics,,MS 231,Peter Smith,lecture,110 minutes,2016-01-19,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the anatomy of central and peripheral nervous system as it relates to pain.,Describe the physiology of central and peripheral nervous system as it relates to pain.,Describe the pathophysiology of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacology of Analgesics and Anesthetics,,MS 231,Peter Smith,lecture,110 minutes,2016-01-21,Direct Lecture,,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the pharmacokinetics and pharmacodynamics of analgesics and antiinflammatory drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Guest lecture: methadone,,MS 231,Serena Rix,lecture,110 minutes,2016-02-23,Direct Lecture,,,,Describe the principles of pharmacology relevant to the conditions of primary focus.,Describe the pathophysiology of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,"Describe the therapeutic approach (Clinical Practice Guidelines) incorporating nonpharmacologic and pharmacologic treatments for the treatment and management of the conditions of primary focus including the use of specific target drugs for the condition as well as alternative therapies (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity).",Describe and manage the toxicity of medications used in the management of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Medicinal Chemistry (minor analgesics),,MS 231,Carlos VelÃ¡zquez,lecture,50 minutes,2016-01-12,Direct Lecture,,,,Describe the principles of medicinal chemistry relevant to the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacology of Analgesics and Anesthetics,,MS 231,Peter Smith,lecture,50 minutes,2016-01-12,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the principles of pharmacology relevant to the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the pharmacokinetics and pharmacodynamics of analgesics and antiinflammatory drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacology of Analgesics and Anesthetics,,MS 231,Peter Smith,lecture,110 minutes,2016-01-14,Direct Lecture,,,,Describe the anatomy of central and peripheral nervous system as it relates to pain.,Describe the physiology of central and peripheral nervous system as it relates to pain.,Describe the pathophysiology of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Medicinal Chemistry (major analgesics),,MS 231,Carlos VelÃ¡zquez,lecture,110 minutes,2016-01-26,Direct Lecture,,,,Describe the principles of medicinal chemistry relevant to the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacy practice,,MS 231,Sheila Walter,lecture,110 minutes,2016-01-28,Direct Lecture,,,,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacy practice,,MS 231,Sheila Walter,lecture,110 minutes,2016-02-09,Direct Lecture,,,,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,Develop an awareness of the consequences of under-treated acute pain.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Guest lecture: management of acute pain,,MS 231,Shahileen Retmulla,lecture,110 minutes,2016-02-11,Direct Lecture,,,,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,Develop an awareness of the consequences of under-treated acute pain.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,New immediate release formulations for deterring abuse of opioids,,MS 231,John Ussher,seminar,50 minutes,2016-03-01,Direct Lecture,,,,Describe and manage the toxicity of medications used in the management of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,The inadequate treatment of pain,,MS 231,John USsher,seminar,50 minutes,2016-03-01,Direct Lecture,,,,Describe the principles of pharmacology relevant to the conditions of primary focus.,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,Develop an awareness of the consequences of under-treated acute pain.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacy practice,,MS 231,Sheila Walter,lecture,110 minutes,2016-03-03,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the principles of pharmacology relevant to the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,"Describe the therapeutic approach (Clinical Practice Guidelines) incorporating nonpharmacologic and pharmacologic treatments for the treatment and management of the conditions of primary focus including the use of specific target drugs for the condition as well as alternative therapies (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity).",Describe and manage the toxicity of medications used in the management of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Guest lecture: management of malignant pain syndromes,,MS 231,Alastair Ilich,lecture,110 minutes,2016-03-08,Direct Lecture,,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the principles of pharmacology relevant to the conditions of primary focus.,Describe the pathophysiology of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the pharmacokinetics and pharmacodynamics of analgesics and antiinflammatory drugs.,"Describe the therapeutic approach (Clinical Practice Guidelines) incorporating nonpharmacologic and pharmacologic treatments for the treatment and management of the conditions of primary focus including the use of specific target drugs for the condition as well as alternative therapies (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity).",Describe and manage the toxicity of medications used in the management of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Introduction,,MS 231,John Ussher,lecture,110 minutes,2016-01-05,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Pharmacy practice,,MS 231,Sheila Walter,lecture,110 minutes,2016-02-02,Direct Lecture,,,,"Select and monitor drug therapy for the management of the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles.",Identify the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and classify the severity of the disease.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources.,Use an evidence-based approach to synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of primary focus.,Develop an awareness of the consequences of under-treated acute pain.,"Acquire an understanding that pain is a true medical condition that requires treatment, and that respect for a patients need to access pain medications is required",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 15,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-12-02,,face to face,Medical Aid in Dying: The Legal Framework and the Role of the Pharmacist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 1,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-10-19,,face to face,Course overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 2,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-10-21,,face to face,Ethics and the pharmacy profession: Historical overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 3,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-10-24,,face to face,Medical ethics: Beneficence and nonmaleficence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 4,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-10-26,,face to face,Medical ethics: Autonomy and informed consent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 5,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-10-28,,face to face,Professional ethics: Conscientious objection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 6,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-10-31,,face to face,Professional Responsibility: The ACP Code of Ethics / The professional discipline process / Pharmacists and substance abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 7,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-02,,face to face,Introduction to the Legal System: Defining law / Sources and institutions of law,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 8,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-14,,face to face,Types of legal actions / The Alberta court system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 9,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-16,,face to face,Privacy Law: Health Information Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 10,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-18,,face to face,Privacy Law: Health Information Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,MIDTERM,,,,lecture,50 minutes,2016-11-21,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 11,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-23,,face to face,Law of Negligence: Duty and Standard of Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 12,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-25,,face to face,Law of Negligence: Causation and Damages,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 13,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-28,,face to face,Law of Negligence: Defences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 14,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-11-30,,face to face,Supported Decision-Making: Personal Directives and Powers of Attorney,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Lecture 16,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2016-12-05,,face to face,Aboriginal Peoples and health care; Group assignment due,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,FINAL,,,,lecture,50 minutes,2016-12-09,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,MIDTERM,,,,lecture,50 minutes,2016-10-11,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,FINAL,,,,lecture,50 minutes,2016-12-14,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Seminar 1,,TBA,R. Sanghera,seminar,110 minutes,2016-10-06,,face to face,Electrolyte Disorders/ Laboratory Values,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 10,,MS 628,J. Ton,lecture,80 minutes,2016-10-13,,face to face,"Acid-Base Disorders , Describe the etiology, pathophysiology, clinical presentation, and compensatory mechanism of the four acid-base disorders, Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 11,,MS 628,C. Sadowski ,lecture,80 minutes,2016-10-18,,face to face,"Lower Urinary Tract Symptoms Part I (Pharmacological Treatment), Overview of the classification, pathophysiology, signs and symptoms and diagnosis of various lower urinary tract symptoms, Management of LUTS via pharmacological treatments will be discussed in detail, Management of LUTS via non-pharmacological treatments will be discussed in detail",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 12,,MS 628,K. Hunter,lecture,80 minutes,2016-10-25,,face to face,Lower Urinary Tract Symptoms Part II (Non-pharmacological Treatment),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Seminar 2,,TBA,R. Sanghera/C. Sadowski,seminar,110 minutes,2016-10-27,,face to face,Urology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 13,,MS 628,R. Breault,lecture,80 minutes,2016-11-01,,face to face,"Acute Kidney Injury/Drug Induced Kidney Injury, Review of the definition of AKI, the pathophysiology, causes and management of AKI, Explanation of the mechanism of injury to the kidney and toxicology secondary to commonly used drugs, Explanation of the different forms of drug induced kidney injury based on presentation, history, clinical symptoms and urinary findings., Identification of renal protective strategies for various drug induced renal injuries",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 14,,MS 628,R. Breault,lecture,80 minutes,2016-11-03,,face to face,"Nephrolithiasis (Kidney Stones), Epidemiology, risk factors, pathophysiology, clinical signs and symptoms of kidney stones",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 15,,Online,R. Sanghera,lecture,80 minutes,2016-11-15,,face to face,"Introduction to Renal Replacement Therapy, Basic overview of hemodialysis, peritoneal dialysis, and continuous renal replacement therapy, Drug dosing considerations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 1,,MS 628,R. Sanghera/S. Patrick,lecture,80 minutes,2016-09-06,,face to face,Course Introduction Anatomy /Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 2,,MS 628,S. Patrick,lecture,80 minutes,2016-09-08,,face to face,"Physiology, Describe anatomy and function of the kidney, ureters, bladder and urethra, Describe physiology of the kidney, including regulation of glomerular filtration, sodium/water balance, fluid balance, acid-base balance as well as other electrolytes, tubular reabsorption and secretion., Describe physiology of the ureters, bladder and urethra including a general outline of bladder function and micturition",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 3,,MS 628,S. Patrick,lecture,80 minutes,2016-09-13,,face to face,Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 4,,MS 628,S. Patrick,lecture,80 minutes,2016-09-15,,face to face,Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 5,,MS 628,A. Tse,lecture,80 minutes,2016-09-20,,face to face,"Diuretic Pharmacology, Describe and review the various classes of diuretics, their mechanism of action and place in therapy including osmotic, loop, thiazide diuretics, carbonic anhydrase inhibitors, and potassium sparing diuretics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 6,,MS 628,R. Sanghera,lecture,80 minutes,2016-09-22,,face to face,"Fluids/Electrolytes Part I, Explain and interpret pertinent serum chemistry laboratory values, as well as specific laboratory tests used in the diagnosis and monitoring of acute kidney injury, chronic kidney disease, nephrolithiasis, and lower urinary tract symptoms (LUTS), Explain the major functions and consequences of disturbances of: sodium, potassium, magnesium, calcium, and phosphate",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 7,,MS 628,R. Sanghera,lecture,80 minutes,2016-09-27,,face to face,Fluids/Electrolytes Part II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 8,,MS 628,R. Sanghera,lecture,80 minutes,2016-09-29,,face to face,"Laboratory Values Part I, Overview of common laboratory values used in the diagnosis and monitoring of various disease states, Discussion of how lab values are accessed in practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 9,,MS 628,R. Sanghera,lecture,80 minutes,2016-10-04,,face to face,Laboratory Values Part II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 16,,MS 628,R. Breault,lecture,80 minutes,2016-11-17,,face to face,"Chronic Kidney Disease Part I Epidemiology and Pathophysiology, Epidemiology and Pathophysiology, Review of the epidemiology, etiology and pathophysiology of CKD, Management of Complications, Overview of the drug therapy used to manage the common complications of chronic kidney disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 17,,MS 628,R. Breault,lecture,80 minutes,2016-11-22,,face to face,Chronic Kidney Disease Part II Management of Complications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Smeinar 3,,MS 628,R. Sanghera,seminar,110 minutes,2016-11-24,,face to face,CKD Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 18,,MS 628,R. Breault,lecture,80 minutes,2016-11-24,,face to face,"Drug Dosing in Renal Failure and Dialysis, Review of the assessment of renal function, including calculations of creatinine clearance and estimated GFR, Review the effects of renal impairment on the absorption, distribution, metabolism and excretion of drugs, Practical approach using case-based examples of adjusting medications in patients with renal impairment.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 19,,MS 628,R. Sanghera/ J. Ton ,lecture,80 minutes,2016-11-29,,face to face,Drug Information Resources: Clinical Application ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 20,,MS 628,R. Sanghera,lecture,80 minutes,2016-12-01,,face to face,Class Wrap-up & Case Debrief,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 1,MS 227,"Dr. A Lavasanifar, Dr. R Lbenberg",Lecture,lecture,50 minutes,2017-06-01,,face to face,"General outline and objectives of course: textbooks, examinations, grading, distribution of marks, homework assignments, laboratory purpose and procedures., Introduction to the Course/Compounding of Parenterals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 2,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,"Patient monitoring and complaint system: outcome monitoring, reports, Patient or caregiver training, Maintaining product quality and control after it leaves the pharmacy: transit, in the home, Finished product release checks and tests Physical inspection Compounding accuracy checks Storage and expiration dating, Sterile drug products for home use Responsibility of the dispensing pharmacist Risk levels Low Medium high risk Quality assurance program Environmental quality control: critical site exposure Environmentally controlled workspaces Cleaning and sanitizing the workspaces Personnel and gowning Standard operation procedure, Sterility and pyrogen testing Filtration and direct transfer method Endo and exotoxins Bacterial endotoxin test, Sterilization methods Dry heat Steam under pressure Filtration Other methods, Sterility: Pharmacopeial requirements and definitions of parenteral dosage forms, Aseptic compounding techniques",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 3,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 4,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 5,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,"Pharmaceutically and physiologically acceptable ophthalmic, otic and nasal solutions, Drug delivery considerations for otic and nasal preparations, Compounding techniques, Viscosity enhancers, Antioxidants, Preservatives, Sterility of ophthalmic solutions, Define buffers, buffer capacity, isotonicity, iso-osmoticity, osmotic pressure, hypertonicity, hypotonicity., Pharmcopeia standards for opthphalmic dosage forms, Biological barrier of ophthalmic drug absorption, Anatomy and physiology of the eys and tears, Ophthalmic/Nasal/Ear Products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,ECHA 1-182,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS I, IV: Sterile products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,ECHA 1-190,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS II, III: Dissolution",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,ECHA 1-182,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS I, II: Compounding gel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,ECHA 1-190,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS III, IV: Granules/lozenges",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 6,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,Tablets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 7,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,"NHP approval process, Drug approval process, New drugs, Biowaivers, In vitro and in vivo methods to determine permeability and dissolution rate, Biopharmaceutics drug classification, In vitro in vivo correlations, Bioavailability and bioequivalence, Tablets/Biopharmaceutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 8,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,"NHP approval process, Drug approval process, New drugs, Biowaivers, In vitro and in vivo methods to determine permeability and dissolution rate, Biopharmaceutics drug classification, In vitro in vivo correlations, Bioavailability and bioequivalence, Biopharmaceutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 9,MS 227,Mr. R Marcinkoski,Lecture,lecture,50 minutes,2017-06-01,,face to face,LVP/TPN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 10,MS 227,Dr. A Lavasanifar,Lecture,lecture,50 minutes,2017-06-01,,face to face,TTS/transdermal delivery systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MS 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 11,MS 227,Dr. A Lavasanifar,Lecture,lecture,50 minutes,2017-06-01,,face to face,"Incompatibilities of drugs and ingredients., Rates and orders of degradations (apparent zero order), first order, accelerated stability analysis, Arrhenius equation, half life, shelf life, predicting shelf life, kinetics in different dosage forms, calculating expiry date., Mechanisms of degradation, effect of temperature, light., Stability & Kinetics: Sources of drug instability",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,MIDTERM,,,Exam,lecture,50 minutes,2017-06-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 12,MS 227,Dr. A Lavasanifar,Lecture,lecture,50 minutes,2017-06-01,,face to face,"Incompatibilities of drugs and ingredients., Rates and orders of degradations (apparent zero order), first order, accelerated stability analysis, Arrhenius equation, half life, shelf life, predicting shelf life, kinetics in different dosage forms, calculating expiry date., Mechanisms of degradation, effect of temperature, light., Stability & Kinetics: Sources of drug instability",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 13,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,"Innovations: gene therapy, drug targeting, protein delivery, Carriers for sustained release or target therapy: transdermal delivery systems, liposomes, microspheres, microcapsules, micelles, nanoparticles, human cells., Controlled release systems: diffusion controlled, dissolution controlled, reservoir, monolytic systems (biodegradable, nonbiodegradable), osmotic systems., Kinetics, terminology, sustained release, prolonged release versus controlled release, pulsed release., Controlled Release Delivery systems",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,ECHA 2-420,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS I, IV: Dissolution",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,ECHA 2-430,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS II, III: Sterile products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,ECHA 2-420,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS I, II: Granules/lozenges",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,ECHA 2-430,TA,Seminar,lecture,50 minutes,2017-06-01,,face to face,"GROUPS III, IV: Compounding gel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 14,MS 227,Dr. R Lbenberg,Lecture,lecture,50 minutes,2017-06-01,,face to face,Approval Process/regulatory science,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 15,MS 227,Dr. A Martin,Lecture,lecture,50 minutes,2017-06-01,,face to face,"Applications, Inhalation therapy, Manufacturing, Propellants, Dispensers, Definitions, Aerosols",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 16,MS 227,Dr. A Martin,Lecture,lecture,50 minutes,2017-06-01,,face to face,"Applications, Inhalation therapy, Manufacturing, Propellants, Dispensers, Definitions, Aerosols",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Granules/lozenges,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 17,MS 227,Dr. A Lavasanifar,Lecture,lecture,50 minutes,2017-06-01,,face to face,Nanomedicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 18,MS 227,"Dr(s) F. Jamali, R. Loebenberg, A. Lavasanifar",Lecture,lecture,50 minutes,2017-06-01,,face to face,"Example current practice topics relavant to the field of pharmaceutics, Hot topics in pharmaceutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 19,MS 227,Dr. D Wishart,Lecture,lecture,50 minutes,2017-06-01,,face to face,Protein Delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 20,MS 227,Dr. M Hitt,Lecture,lecture,50 minutes,2017-06-01,,face to face,Gene Delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,FINAL,,,,lecture,50 minutes,2017-06-01,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 1,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-10-13,,,Blood and Lymphatics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 2,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-10-18,,,Blood & Circulation - Red blood cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 3,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-10-20,,,Blood & Circulation - White blood cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 4,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-10-25,,,Blood & Circulation - Platelets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 5,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-10-27,,,Anti-platelets drugs & anticoagulants,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 6,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2016-11-01,,,Thromboembolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,MIDTERM,,ECHA L1 190,Dr. Paul Jurasz,Exam,80 minutes,2016-11-03,,,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 7,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2016-11-15,,,Anticoagulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 8,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2016-11-17,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 9,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2016-11-22,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Seminar 1,,ECHA L1 190,TBA,seminar,110 minutes,2016-11-22,,,Anticoagulation Seminar and Quiz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 10,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-11-24,,,"Iron products, Vitamin B12, Folates",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 11,,ECHA L1 190,Dr. Christine Hughs,lecture,80 minutes,2016-11-29,,,Anemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 12,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-12-01,,,"Bleeding, thrombosis, neoplastic disorders",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 13,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2016-12-06,,,Course review session,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,FINAL,,,,,160 minutes,2016-12-12,,,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 1,,,Lisa Guirguis,lecture,50 minutes,2016-09-06,,,"Orientation & Intro to Health Comm, Why Communication?, What is Good Communication""?, Explain Lecture, Lab & Speechcraft Format",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 2,,,Lisa Guirguis,lecture,140 minutes,2016-09-08,,,"Listening and Nonverbal Communication/ Lab Information , Listening, Questions and probes, Empathetic responding, Nonverbal communication",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 1,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-09-12,,,"Lab Orientation, Welcome Video Recording, Bubble Pack Activity, Write initial reflection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 3,,,Lisa Guirguis,lecture,140 minutes,2016-09-13,,,"Medication Experience Guest: Tristan, What are we listening for?, Pharmacists role in medication use: a communication perspective",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 1,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-09-14,,,"Lab Orientation, Welcome Video Recording, Bubble Pack Activity, Write initial reflection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 4,,,Lisa Guirguis,lecture,140 minutes,2016-09-15,,,"Reflection + Debrief Bubble Pack , Role of reflection in professional learning, Medication context for first year communications: ibuprofen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 2,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-09-19,,,"Time off for Medication Exp Interview/ (OPTIONAL Help Session Available), Review and provide peer feedback on the welcome video, Debrief the bubble pack assignment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 3,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-09-21,,,"Time off for Medication Exp Interview/ (OPTIONAL Help Session Available), Review and provide peer feedback on the welcome video, Debrief the bubble pack assignment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 5,,,Lisa Guirguis,lecture,140 minutes,2016-09-22,,,"Community Ed Presentation / Vital Behaviors for Patient Engagement , Review and application of communication model: _Vital Behaviours for Patient Engagement",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 6,,,Lisa Guirguis,lecture,140 minutes,2016-09-27,,,"Movie + Reflection, Reflections on Patient Experience in Health Care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 7,,,Lisa Guirguis,lecture,140 minutes,2016-09-29,,,"Focused Medication History , Review and rehearse a focused history when accepting a prescription, Gathering info and assessment & PEGGY VB #3-4 Module",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 3,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-10-03,,,"Focused Med History #1, Accepting a prescription with a Colleague, Guided peer feedback on reflection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 8,,,Lisa Guirguis,lecture,140 minutes,2016-10-04,,,"Communicating Professionally/ Health Literacy , Professionalism and communication, Recognize and apply aggressive, passive, and assertive communication strategies, Health Literacy, Define health literacy, Describe the health care experiences of low-literacy patients, Review techniques to improve communication with low-literacy patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 3,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-10-05,,,"Focused Med History #1, Accepting a prescription with a Colleague, Guided peer feedback on reflection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 9,,,Lisa Guirguis,lecture,140 minutes,2016-10-06,,,"Documentation Note/ Patient Centered Care in Pharmacy, How to Chart a course forward with a personalized plan, Clinical documentation, Write Documentation Notes for Lab 3, Patient Centered Care in Pharmacy, Define person centred care, Apply person centred care to pharmacy communications",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 4,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-10-17,,,"Focused Med History #2, Accepting a prescription with a Senior Student",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 10,,,Kelly Grindrod,lecture,50 minutes,2016-10-18,,,"Social Media, Social media in health care, Examples of effective use, Opportunities for effective communication",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 4,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-10-19,,,"Focused Med History #2, Accepting a prescription with a Senior Student",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 11,,,Lisa Guirguis,lecture,50 minutes,2016-10-25,,,"Lab Debrief and Video Review, Lab debrief /Video review, Words vs. Scripts",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 5,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-10-31,,,"Focused Med History #3, Accepting a prescription with Standardized Patient",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 12,,,Lisa Guirguis,lecture,50 minutes,2016-11-01,,,"Wrap Up & Review, Course evaluation, Wrap-up lecture, Q&A for final",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 5,,,Lisa Guirguis / Farhana Chowdhury,lab,110 minutes,2016-11-02,,,"Focused Med History #3, Accepting a prescription with Standardized Patient",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 1,,MSB 227,Dr. Susan Patrick & Dr. Nese Yuksel,lecture,110 minutes,2016-10-26,,,Introduction & Anatomy/Physiology:GI and Liver,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 2,,MSB 227,Dr. Susan Patrick,lecture,110 minutes,2016-10-28,,,Anatomy/Physiology:GI and Liver,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 3,,MSB 227,Dr. Susan Patrick & Dr. David Kelner,lecture,110 minutes,2016-10-31,,,Anatomy/Physiology:GI and Liver & Oral health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 4,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2016-11-02,,,Pharmacology/Therapeutics: Nausea and Vomiting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 5,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2016-11-14,,,Pharmacology/Therapeutics: Constipation/Diarrhea,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Seminar 1,,MSB 227,Dr. Nese Yuksel,Seminar ,110 minutes,2016-11-14,,,Seminar 1: Neausea and Vomitting Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 6,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2016-11-16,,,Pharmacology/Therapeutics: Constipation/Diarrhea & Irritable Bowel Syndrome (IBS),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Seminar 2,,MSB 227,Dr. Nese Yuksel,Seminar ,110 minutes,2016-11-16,,,Seminar 1: Neausea and Vomitting Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 7,,MSB 227,Dr. Mark Makowsky,lecture,110 minutes,2016-11-18,,,Pharmacology/Therapeutics: Dyspepsia/Gastroesophageal Disease (GERD)/Peptic Ulcer Disease (PUD),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 8,,MSB 227,Dr. Mark Makowsky & Dr. Frank Wuest,lecture,110 minutes,2016-11-21,,,Pharmacology/Therapeutics: Dyspepsia/Gastroesophageal Disease (GERD)/Peptic Ulcer Disease (PUD) & Medicinal Chemistry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,MIDTERM,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2016-11-23,,,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Seminar 3,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2016-11-25,,,Pharmacology/Therapeutics: Inflammatory Bowel Disease ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 9,,MSB 227,Dr. Nese Yuksel & Dr. Ayman El-Kadi,lecture,110 minutes,2016-11-28,,,Pharmacology/Therapeutics: Inflammatory Bowel Disease (IBD) & Toxicology: Drug Induced Liver Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Seminar 4,,MSB 227,Dr. Nese Yuksel ,Seminar,110 minutes,2016-11-28,,,Seminar 2: Inflammatory Bowel Disease Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 10,,MSB 227,Dr Deon Druteika,lecture,110 minutes,2016-11-30,,,Pathophysiology: Liver Function Tests and Liver Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Seminar 5,,MSB 227,Dr. Nese Yuksel ,Seminar,110 minutes,2016-11-30,,,Seminar 2: Inflammatory Bowel Disease Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 11,,MSB 227,Dr Deon Druteika,lecture,110 minutes,2016-12-02,,,Therapeutics: Liver Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Lecture 12,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2016-12-05,,,Class Evaluations; CAM in GI and Liver & GI Topics: Hemorrhoids/Ostomy; Final Exam Prep,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,FINAL,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2016-12-16,,,FINAL EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 1,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2016-10-20,,,Introduction to Biotechnology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 2,,MS 231,M. Doschak,Lecture,80 minutes,2016-10-24,,,Structure of Proteins and DNA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 3,,MS 231,M. Doschak,Lecture,80 minutes,2016-10-26,,,"Recombinant DNA Technology, Isolation of cloned genes, Polymerase chain reaction and applications, Protein biosynthesis and regulation of gene expression",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 4,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2016-10-27,,,Flipped-Classroom; study session 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 5,,MS 231,M. Doschak,Lecture,80 minutes,2016-10-28,,,PCR / Gene Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 6,,MS 231,W. Dixon,Lecture,80 minutes,2016-10-31,,,Transgenic Animals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 7,,MS 231,W. Dixon,Lecture,80 minutes,2016-11-02,,,"Stem Cells, Methods for ex vivo and in vivo gene delivery, Applications to diseases, Approaches and targeted diseases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 8,,MS 231,W. Dixon,Lecture,80 minutes,2016-11-03,,,Protein Pharmaceuticals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,MIDTERM,,ECHA 2-190,,Exam,50 minutes,2016-11-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 9,,MS 231,M. Doschak,Lecture,80 minutes,2016-11-14,,,"Elements of the Immune System, Acquired Immunity _specificity and memory, Clonal selection theory, Host defense responses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 10,,MS 231,M. Doschak,Lecture,80 minutes,2016-11-16,,,Aby Structure and B-cell Diversity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 11,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2016-11-17,,,Hybridoma and Phage Display Technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 12,,MS 231,M. Doschak,Lecture,80 minutes,2016-11-18,,,Immunoassays and ELISA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 13,,MS 231,H. Sunwoo,Lecture,80 minutes,2016-11-21,,,Chicken IgY Antibody Technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 19,,ECHA 2-190,G. Haggag,Lecture,80 minutes,2016-12-01,,,"Antisense Therapy, Design of antisense oligonucleotides and drug delivery systems, Applications to diseases, Inhibition of gene expression by oligonucleotides",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 14,,MS 231,M. Doschak,Lecture,80 minutes,2016-11-23,,,"Cell-mediated Immunity, Development of T lymphocytes, T cell-mediated Immunity, Antigen recognition by T lymphocytes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 15,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2016-11-24,,,"Humoral Immunity and Complement, Development of B lymphocytes, Immunity mediated by B cells and antibodies, Antibodies: structure, classes, and diversity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 16,,MS 231,M. Doschak,Lecture,80 minutes,2016-11-25,,,Bodys Defense Against Infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 17,,MS 231,M. Doschak,Lecture,80 minutes,2016-11-28,,,"Vaccines, Traditional approaches to vaccine development, Currently used vaccines - overview, Active and passive immunizations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 18,,MS 231,W. Cheng,Lecture,80 minutes,2016-11-30,,,Drug Delivery Systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 20,,MS 231,W. Cheng,Lecture,80 minutes,2016-12-02,,,"Cytokines as Therapeutics, Origin, characteristics and functions of selected cytokines, Therapeutic cytokines, General characteristics, Classification",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 21,,MS 231,M. Doschak,Lecture,80 minutes,2016-12-05,,,Immune Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Lecture 22,,MS 231,M. Doschak,Lecture,80 minutes,2016-12-07,,,Flipped-Classroom;  study session 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,FINAL,,TBA,,Exam,80 minutes,2016-12-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 2,,MSB 231,S. Patrick,lecture,80 minutes,2016-09-07,,face to face,"Anatomy and Physiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 1,,MSB 231,A. El-Kadi & S. Patrick,lecture,80 minutes,2016-09-02,,face to face,"Introduction/ Anatomy and Physiology, ANATOMY: Cell and tissue types, Autonomic nervous system, Circulatory system, Muscle",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 3,,MSB 231,S. Patrick,lecture,80 minutes,2016-09-09,,face to face,"Anatomy and Physiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 4,,MSB 231,S. Patrick,lecture,80 minutes,2016-09-12,,face to face,"Physiology, PHYSIOLOGY: Cell physiology (incl. membranes, proteins, sig. trans.), Autonomic nervous system, Muscle, Electrical properties of cells",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 5,,MSB 231,S. Patrick,lecture,80 minutes,2016-09-13,,face to face,"Physiology/ Anatomy and Physiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 6,,MSB 231,S. Patrick,lecture,80 minutes,2016-09-14,,face to face,"Anatomy and Physiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 7,,ECHA 2-190,S. Patrick & J. Seubert,lecture,80 minutes,2016-09-19,,face to face,"Anatomy and Physiology/ Pathophysiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 8,,ECHA 2-190,A. Holt,lecture,80 minutes,2016-09-21,,face to face,"Fundamentals of Pharmacology 1/ Pharmacology 2, PHARMACOLOGY: How do drugs work at their targets?, Agonists, antagonists and other drug mechanisms, Pharmacokinetics and drug metabolism, Autonomic pharmacology of the eye",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 9,,ECHA 2-190,A. Holt,lecture,80 minutes,2016-09-23,,face to face,"Fundamentals of Pharmacology 3/ Pharmacology 4, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 10,,ECHA 2-190,A. Holt,lecture,80 minutes,2016-09-26,,face to face,"Fundamentals of Pharmacology 5/ Pharmacology 6, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 11,,ECHA 2-190,S. Patrick,lecture,80 minutes,2016-09-28,,face to face,"MIDTERM/ Anatomy and Physiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 12,,ECHA 2-190,S. Patrick/ A. Siraki,lecture,80 minutes,2016-09-30,,face to face,"Anatomy and Physiology/ Pathophysiology, PATHOPHYSIOLOGY: Cell injury, death, adaptations, Inflammation, Infection, Immunologic disease, Neoplasia, Vascular disease, Environmental, nutritional, traumatic disease, Genetic, developmental disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 13,,ECHA 2-190,A. Siraki/ J. Gnarpe,lecture,80 minutes,2016-10-03,,face to face,"Pathophysiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 14,,ECHA 2-190,A. Siraki/ J. Gnarpe,lecture,80 minutes,2016-10-05,,face to face,"Pathophysiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 15,,ECHA 2-190,A. El-Kadi,lecture,80 minutes,2016-10-07,,face to face,"Introductory Toxicology 1/ Toxicology 2, TOXICOLOGY: Introduction to Toxicology, Risk Assessment in Toxicology, Forensic Toxicology, Toxicity and Safety Assessment of Natural Health Products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 16,,ECHA 2-190,A. Siraki/ S. Patrick,lecture,80 minutes,2016-10-12,,face to face,"Pathophysiology/ Anatomy, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 17,,ECHA 2-190,G. Jones,lecture,80 minutes,2016-10-14,,face to face,"Forensic Toxicology 1/ Toxicology 2, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 18,,ECHA 2-190,J. Seubert,lecture,80 minutes,2016-10-17,,face to face,"Pathophysiology, PATHOPHYSIOLOGY: Cell injury, death, adaptations, Inflammation, Infection, Immunologic disease, Neoplasia, Vascular disease, Environmental, nutritional, traumatic disease, Genetic, developmental disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 19,,ECHA 2-190,D. Birkholz,lecture,80 minutes,2016-10-19,,face to face,"Environmental Toxicology, TOXICOLOGY: Environmental Toxicology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 20,,ECHA 2-190,A. El-Kadi,lecture,80 minutes,2016-10-25,,face to face,TBA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 1,,MS231,Sherif Mahmoud Susan Patrick,lecture,80 minutes,2016-09-27,,,"Orientation; Group Assignment;Introduction; , Central nervous system; Peripheral nervous system ; Neurons;  Brain organization: cerebrum, diencephalon, brain stem, cranial nerves and cerebellum;  Sensory physiology;  Motor control;  Blood supply of the brain and ICP;  Neurotransmitters;  Higher CNS functions;  Autonomic nervous system; Basal ganglia; The vestibular system",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 2,,MS231,Susan Patrick,lecture,80 minutes,2016-09-29,,,"Anatomy/Physiology- Brain organization, protection & cerebrum, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 3,,eClass,Susan Patrick,lecture,80 minutes,2016-10-03,,,"Anatomy/Physiology - Diencephalon, brainstem, cranial nerves & cerebellum; Sensory physiology, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 4,,eClass,Susan Patrick,lecture,90 minutes,2016-10-04,,,"Anatomy/Physiology - Sensory physiology (cont); Motor control; Blood supply of the brain & ICP, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 5,,eClass,Susan Patrick,lecture,90 minutes,2016-10-06,,,"Anatomy/Physiology - Neurotransmitters; Autonomic nervous system; Higher CNS functions, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 6,,MS231,William Colmers (Faculty of Medicine) Carlos Velzquez,lecture,110 minutes,2016-10-07,,,"Pharmacology: Seizures and Epilepsy (1h) Chemistry: Seizures and Epilepsy (1h), Antiepileptic drugs : GABA-ergic; Sodium channels; Calcium channels; Other",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 7,,MS231,Sherif Mahmoud,lecture,80 minutes,2016-10-11,,,"Therapeutics: Seizures and Epilepsy 1, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 8,,MS 628,Sherif Mahmoud,lecture,110 minutes,2016-10-12,,,"Therapeutics: Seizures and Epilepsy 2, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 9,,MS231,Sherif Mahmoud,lecture,80 minutes,2016-10-13,,,"Therapeutics: Peripheral Neuropathies, Mononeuropathies; Polyneuropathies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 10,,MS 628,Tyler Moore (AHS),lecture,110 minutes,2016-10-14,,,"Therapeutics: Stroke, Classification; Acute stroke management; Primary prevention ; Secondary prevention",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Seminar 1,,ECHA 1-490 ECHA 1-498,Sherif Mahmoud Tyler Moore (AHS),seminar,170 minutes,2016-10-14,,,"Case studies - Seizures and Epilepsy; Stroke, Classification: Focal; Generalized ; Management principles ; Antiepileptic drugs ; Therapeutic Drug Monitoring",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 11,,eClass,Susan Patrick,lecture,60 minutes,2016-10-17,,,Anatomy/Physiology - Basal ganglia; Vestibular system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 12,,MS 628,Bradley Kerr (Faculty of Medicine),lecture,110 minutes,2016-10-17,,,"Pharmacology _ Multiple Sclerosis; Movement Disorders, Interferons ; Glatiramer ; Mitoxantrone ; Cyclophosphamide ; Fingolimod ; Monoclonal antibodies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Midterm Exam,,TBA,,exam,110 minutes,2016-10-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 13,,MS 628,Peter Smith (Faculty of Medicine) Carlos Velzquez,lecture,110 minutes,2016-10-19,,,Pharmacology: Headache (1h) Chemistry: Dopaminergic Neurotransmission (1h),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Seminar 2,,ECHA 1-190,Sherif Mahmoud,seminar,110 minutes,2016-10-19,,,Rare Neurologic Disorders Seminar: A day in the life of a Neurology Pharmacist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 14,,MS231,Penny Smyth(Faculty of Medicine),lecture,80 minutes,2016-10-20,,,"Therapeutics: Multiple Sclerosis, Classification/ complications ; Acute relapse management ; Disease modifying therapies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 15,,MS 628,"Sherif Mahmoud Shaun Gray (U of A, Division of Physical Medicine and Rehabilitation)",lecture,110 minutes,2016-10-21,,,"Therapeutics: Traumatic Brain InjuryAcute Management; Rehabilitation, Acute management of TBI ; Rehabilitation of TBI",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 16,,MS 628,Sherif Mahmoud,lecture,110 minutes,2016-10-24,,,"Therapeutics: Headache, Migraine ; Tension-type headache ; Cluster headache",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 17,,MS231,Cheryl Sadowski,lecture,80 minutes,2016-10-25,,,"Therapeutics: Movement Disorders 1 (Parkinson Disease), Levodopa/carbidopa  Dopamine agonists  MAO-B inhibitors  COMT inhibitors  Amantadine  Anticholinergics  Botulinum toxin, Classification: Parkinson disease, Restless legs syndrome, Dystonia, Tremor ;Leg cramps (Contrast with movement disorder); Complications: Motor,Psychiatric, Autonomic",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 18,,MS 628,Cheryl Sadowski,lecture,110 minutes,2016-10-26,,,"Therapeutics: Movement Disorders 2(Restless Legs Syndrome; Tremor; LegCramps), See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Seminar 3,,ECHA 1-190 ECHA 1-498,Cheryl Sadowski & Sherif Mahmoud,seminar,170 minutes,2016-10-26,,,"Case studies - Movement Disorders; Headache, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 19,,MS231,Sherif Mahmoud,lecture,80 minutes,2016-10-27,,,"Therapeutics: Myasthenia Gravis, Clinical features ; Symptom management ; Immunosuppressive therapy ; Myasthenia crisis management",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Lecture 20,,MS 628,Sherif Mahmoud Cheryl Sadowski,lecture,110 minutes,2016-10-28,,,"Course Feedback/Final Exam Discussion Therapeutics: Dizziness _ Vertigo, Dysequilibrium, Syncope, Lightheadedness, Vertigo ; Disequilibrium ; Presyncope ; Lightheadedness",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Final Exam,,TBA,,exam,110 minutes,2016-11-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 1,,MSB 227,Bertholet/Patrick,lecture,50 minutes,2016-09-02,,,Introduction; Anatomy; Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 2,,online,Patrick,lecture,80 minutes,2016-09-06,,,"Anatomy; Physiology, Anatomy of the lungs, Mechanics of breathing, Pulmonary volumes , capacity and ventilation, Gas Exchange, Control of breathing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 3,,MSB 227,Davies,lecture,50 minutes,2016-09-07,,,"Pharmacology, Beta agonists, Antimuscarinics, Leukotriene receptor antagonists, Steroids, Cromolyns, Ketotifen, Xanthines, Anti IgE therapies, Mucolytics, Pancreatic supplements",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 4,,,Bertholet/Patrick,lecture,80 minutes,2016-09-08,,,Online Anatomy; Physiology COPD pathophysiology(Q#1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 5,,MSB 227,Davies,lecture,50 minutes,2016-09-09,,,"Pharmacology, Structure, function, binding mode and Structure activity relationships (SAR):, Adrenoreceptors: Beta2 agonists (long acting, short acting), Glucocorticoids, Pre/antidrug concept",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 6,,MSB 227,Davies,lecture,50 minutes,2016-09-12,,,Pharmacology (Q#2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 7,,ECHA 2-190,Bharakat,lecture,80 minutes,2016-09-13,,,Medicinal Chemistry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 8,,MSB 227,Bertholet,lecture,110 minutes,2016-09-13,,,"GOLD guidelines, COPD Therapeutics /cases (Q#3), Pathophysiology of COPD (online Sept 8), Definitions, Epidemiology, risk factors for COPD, Clinical presentation: Screening & Diagnosis : including pulmonary function testing, Goals of therapy, therapeutic management (non-pharmacologic, pharmacologic) for stable COPD and acute exacerbations (AECOPD) (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity, drug interactions, precautions, contraindications), Short acting bronchodilators (SABD), Long acting bronchodilators (LABD), Anti-inflammatories, COPD Action Plan, Role of the pharmacist",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 9,,MSB 227,Bertholet,lecture,50 minutes,2016-09-14,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 10,,ECHA 2-190,Bertholet,lecture,80 minutes,2016-09-15,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Seminar 1,,MSB 227,Bertholet,seminar,50 minutes,2016-09-16,,,COPD cases - (Q#4),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,MiDTERM,,,,exam,,2016-09-19,,,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 11,,ECHA 2-190,El-Kadi,lecture,80 minutes,2016-09-20,,,"Pathophysiology of chemical/drug-induced lung disease, Primary lung responses to toxicants, Examples of chemical and drug-induced lung toxicities, Mechanisms of chemical and drug-induced lung toxicities, Treatment of chemical and drug-induced lung toxicities",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 12,,MSB 227,Bertholet,lecture,50 minutes,2016-09-20,,,Theophylline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 13,,MSB 227,Bertholet,lecture,110 minutes,2016-09-20,,,"Tobacco Cessation: e-cigarettes, water pipes, Pharmacokinetics/pharmacodynamics of nicotine, Prevalence, health benefits to cessation, Pathophysiology: nicotine & addiction, Smoking Cessation Model, Goals of therapy, therapeutic management (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity, drug interactions, precautions, contraindications), Non-pharmacologic, Nicotine replacement therapy, Prescription: varenicline, bupropion, other, Tobacco cessation in special populations: adolescents, pregnancy, hospitalization, Other tobacco delivery systems; e-cigs, water pipes, Role of the pharmacist",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 14,,MSB 227,Jesswein,lecture,50 minutes,2016-09-21,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 15,,ECHA 2-190,Bertholet,lecture,80 minutes,2016-09-22,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 16,,MSB 227,Jamali,lecture,50 minutes,2016-09-23,,,Pharmacokinetics (Q#5) Pharmacodynamics of smoking,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 17,,MSB 227,Shkrobot,lecture,50 minutes,2016-09-26,,,"Cough; Cold, Epidemiology and etiology, Pathophysiology including clinical presentation and differential diagnosis, Therapeutic approach: non-pharmacologic and pharmacologic treatments for the prevention, treatment and management of cold symptoms as well as alternative therapies (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity, drug interactions, precautions, contraindications), Rhinorrhea (first generation antihistamines), Sinus congestion (topical and systemic decongestants), Cough (cough suppressants and expectorants), Fever and pain management (analgesics), Pharmacist Role and responsibility in condition identification, management, referral and prevention, Debate of best practices to patient management (pediatric and adult patient groups)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 18,,ECHA 2-190,Shkrobot,lecture,80 minutes,2016-09-27,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 19,,MSB 227,Bertholet,lecture,50 minutes,2016-09-28,,,"Asthma pathophysiology (Q#6), Pathophysiology of asthma, Epidemiology, risk factors , Clinical presentation, diagnosis and differential diagnosis, Goals of therapy, therapeutic management for prevention and treatment of chronic and acute asthma including non-pharmacologic & pharmacologic (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity, drug interactions, precautions, contraindications), GINA guidelines, Anti-inflammatories, Short acting bronchodilators (SABD), Long acting bronchodilators (LABD), Asthma Action Plan, Asthma in special populations: pediatrics (children < 6yrs as compared to 6-12 yrs and adolescents), pregnancy, Role of the pharmacist",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 20,,ECHA 2-190,Bertholet,lecture,80 minutes,2016-09-29,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 21,,MSB 227,Bertholet,lecture,50 minutes,2016-09-30,,,Chronic asthma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 22,,MSB 227,Bertholet,lecture,50 minutes,2016-10-03,,,"Inhalers/devices, Inhalation therapy and devices, Types of devices, Factors influencing PK/PD of inhaled medications, Factors affecting optimal delivery, Valved holding chambers, Peak expiratory flow meters",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 23,,ECHA 2-190,Gukert/Smith,lecture,80 minutes,2016-10-04,,,"Cystic Fibrosis, Epidemiology, etiology, Pathophysiology, clinical presentation, symptomatology, long term health consequences, Drugs used in the management of CF including, IV and oral antibiotics, inhaled tobramycin, Nebulized hypertonic saline, Dornase alpha, Pancreatic enzymes, Vitamin supplements, Supplementary and emerging therapies, Therapeutic management including non-pharmacologic, Nutritional therapy, Chest physio, Cycling of antibiotics, Role of the pharmacist",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 24,,MSB 227,Bertholet,lecture,110 minutes,2016-10-05,,,Acute Asthma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 25,,MSB 227,Bertholet,lecture,50 minutes,2016-10-06,,,Pediatric Asthma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Lecture 26,,ECHA 2-190,Bertholet,lecture,80 minutes,2016-10-07,,,"Asthma cases (Q#7), Overview of theophylline, Place in therapy, PK and PD, How to start and monitor a patient on theophylline, Traditional, low dose, Role of Pharmacist",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,FINAL,,,,exam,,2016-10-14,,,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 1,MS231,R. Sanghera,lecture,50 minutes,2016-09-02,1969-12-31,,,Course Overview/ Introduction/Assignment Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 2,MS231,J. Bachynsky,lecture,50 minutes,2016-09-07,1969-12-31,,,Evolution of the Profession of Pharmacy ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 3,MS231,R. Sanghera,lecture,50 minutes,2016-09-09,1969-12-31,,,Defining Professionalism ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 4,MS231,R. Sanghera,lecture,50 minutes,2016-09-12,1969-12-31,,,Defining Professionalism Contd ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 5,MS231,J. Whissell,lecture,50 minutes,2016-09-14,1969-12-31,,,Alberta Pharmacists Association  ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 6,MS231,R. Sanghera,lecture,50 minutes,2016-09-16,1969-12-31,,,NO CLASS: IP Pathway Launch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 7,MS231,G. Eberhart,lecture,50 minutes,2016-09-19,1969-12-31,,,Alberta College of Pharmacists (ACP) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 8,MS231,C. Hughes,lecture,50 minutes,2016-09-21,1969-12-31,,,NO CLASS: Podcast Online Re: Patient Care Process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 9,MS231,C. Hughes,lecture,50 minutes,2016-09-23,1969-12-31,,,Introduction to the Patient Care Process ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 10,MS231,C. Hughes,lecture,50 minutes,2016-09-26,1969-12-31,,,Introduction to the Patient Care Process contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 11,MS231,R. Sanghera,lecture,50 minutes,2016-09-28,1969-12-31,,,Module Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 12,MS231,C. Mitchell,lecture,50 minutes,2016-09-30,1969-12-31,,,Overview of the Canada Health Act and Fed. Responsibilities in Health Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 13,MS231,C. Mitchell,lecture,50 minutes,2016-10-03,1969-12-31,,,Health Canada and Health Products and Foods Branch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 14,MS231,C. Mitchell,lecture,50 minutes,2016-10-05,1969-12-31,,,Prov. And Regional Health Auth. Responsibilities in Health care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 15,MS231,NO CLASS ,lecture,50 minutes,2016-10-07,1969-12-31,,,TIME OFF in lieu of IP Pathway Launch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 16,MS231,C. Mitchell,lecture,50 minutes,2016-10-12,1969-12-31,,,Health Human Resources: Who are the players in the system?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,MIDTERM,MS231,R. Sanghera,lecture,50 minutes,2016-10-14,1969-12-31,,,MIDTERM EXAM ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 17,MS231,R. Sanghera,lecture,50 minutes,2016-10-17,1969-12-31,,,Current Topics in Pharmacy Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 18,MS231,R. Sanghera,lecture,50 minutes,2016-10-19,1969-12-31,,,Current Topics in Pharmacy Practice Contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 19,MS231,F. Faruquee,lecture,50 minutes,2016-10-21,1969-12-31,,,Discussion on Prescribing/Practice Relations Within the System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 20,MS231,K. Tam,lecture,50 minutes,2016-10-24,1969-12-31,,,Invited Practitioners: Hospital Pharmacist ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 21,MS231,TBA,lecture,50 minutes,2016-10-26,1969-12-31,,,TIME OFF: Lieu of IP Pathway Launch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 22,MS231,No Pharm 322,lecture,50 minutes,2016-10-28,1969-12-31,,, (Lisa Guirguis needs this day. I have Oct 25 @ 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 23,MS231,R. Sanghera,lecture,50 minutes,2016-10-31,1969-12-31,,,Class votes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 24,MS231,R. Sanghera,lecture,50 minutes,2016-11-02,1969-12-31,,,Introduction to Current Payment Models Within the Realm of Pharmacy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 25,MS231,J. Ramji,lecture,50 minutes,2016-11-04,1969-12-31,,,Invited Practitioners: PCN Pharmacist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 26,MS231,B. Sprague,lecture,50 minutes,2016-11-14,1969-12-31,,,Public/Third Party Payers and Prescription Drug Financing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 27,MS231,R. Sanghera,lecture,50 minutes,2016-11-16,1969-12-31,,,Module Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 28,MS231,L. Guirguis,lecture,50 minutes,2016-11-18,1969-12-31,,,Health Beliefs and Behaviors (1:00-2:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 29,MS231,A. Fuller,lecture,50 minutes,2016-11-21,1969-12-31,,,Invited Practitioners: Community Pharmacist ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 30,MS231,M. Visconti,lecture,50 minutes,2016-11-23,1969-12-31,,,Determinants of Health (1:00-2:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 31,MS231,M. Visconti,lecture,50 minutes,2016-11-25,1969-12-31,,,Health Promotion (1:00-2:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 32,MS231,R. Sanghera,lecture,50 minutes,2016-11-30,1969-12-31,,,Module Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 33,MS231,R. Sanghera,lecture,50 minutes,2016-11-02,1969-12-31,,,TIME OFF: Lieu of Nov 23rd ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 34,MS231,R. Sanghera,lecture,50 minutes,2016-11-05,1969-12-31,,,TIME OFF: Lieu of Nov 25th  ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Lecture 35,MS231,J. Whissell,lecture,50 minutes,2016-12-07,1969-12-31,,,RxA Payment Models (Rescheduled Lecture),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,FINAL ,TBA,R. Sanghera,lecture,50 minutes,2016-12-16,1969-12-31,,,FINAL EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 1,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-01,,,Course Introduction ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 2,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-02,,,Overview of Infectious Diseases ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 3,,ECHA L1 190,Dr. Tyrrell,lecture,90 minutes,2016-09-06,,,Structure Bacterial Cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 4,,MSB 231,Dr. Tyrrell,lecture,60 min,2016-09-07,,,Bacterial physiology growth and reproduction ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 5,,ECHA L1 190,Dr. Tyrrell,lecture,90 minutes,2016-09-08,,,"Bacteria, growth, reproduction, Taxonomy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 6,,MSB 231,Dr. Tyrrell,lecture,60 min,2016-09-09,,,Laboratory and Clinical Lab Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 7,,MSB 231,Dr. Tyrrell,lecture,60 min,2016-09-12,,,Laboratory and Clinical Lab Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 8,,ECHA L1 190,Dr. Mitchell/Dr. Tyrrell,lecture,90 minutes,2016-09-13,,,Bacterial Pathogens - Gram + Cocci ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 9,,MSB 231,Dr. Mitchell/Dr. Tyrrell,lecture,60 min,2016-09-14,,,"Gram negative cocci, Gram negative rods",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 10,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-15,,,"Gram negative rods, Anaerobes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 11,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-16,,,"Spiral/curved organisms, Mycoplasmas",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 12,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-19,,,Problems with Antimicrobial Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 13,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-20,,,Antimicrobial Resistance ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 14,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-21,,,Antimicrobial Resistance ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 15,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-22,,,Clinical Signs of Infection and Lab tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 16,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-23,,,Penicillins,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 17,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-26,,,Penicillins,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 18,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-27,,,Penicillins/ Kinetics Adverse Effects of Penicillins ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 19,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-28,,,Penicillin Allergy Testing and Desensitization ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 20,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-29,,,Pharmacokinetics/Dynamics of Antimicrobials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 21,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-30,,,Pharmacokinetics/Dynamics of Antimicrobials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 22,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 23,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-10-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-05,,,No Class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 25,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 26,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 27,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-10-11,,,"lactamases, lactamase Inhibitors ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 28,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-12,,,Jeopardy ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,MIDTERM,,CS2-191,Dr. Mitchell,Exam,90 minutes,2016-10-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 29,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-14,,,"lactamases, lactamase Inhibitors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 30,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-19,,,Macrolides ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 31,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-10-20,,,"Macrolides, Ketolides",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 32,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-21,,,Inhibitors of Folic Acid Synthesis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 33,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-24,,,Inhibitors of Folic Acid Synthesis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 34,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-10-25,,,"Tetracyclines Glycylcyclines, Clindamycin,  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 35,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-26,,,"Metronidazole, Quinolones and Fluoroquinolones  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 36,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-10-27,,,"Quinolones and Fluoroquinolones, ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 37,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-28,,,"Fosfomycin, Aminoglycosides",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 38,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-31,,,"Aminoglycosides,",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 39,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-01,,,Upper Respiratory Tract Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-02,,,No Class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 40,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-03,,,Upper Respiratory Tract Infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 41,,MSB 231,Dr. Jamali,lecture,60 minutes,2016-11-04,,,Aminoglycoside Kinetics ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 42,,MSB 231,Dr. Jamali,lecture,60 minutes,2016-11-14,,,Aminoglycosides Kinetics ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 43,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-15,,,Lower Respiratory Tract Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 44,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-16,,,Glycopeptides                                                      ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 45,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-17,,,Glycopeptides                                                          ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 46,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-18,,,"Polymixin B, Bacitracin, Fusidic Acid, Mupiricin, Retapamulin  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 47,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-21,,,Urinary Tract Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 48,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-22,,,"Oxazolidinones, Quinupristin/Dalfopristin, Daptomycin, Chloramphenicol ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 49,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-23,,,Antitubercular agents and TB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 50,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-24,,,Antitubercular agents and TB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 51,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-25,,,Surgical Prophylaxis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 52,,MSB 232,Dr. Mitchell,lecture,60 minutes,2016-11-28,,,Meningitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 53,,MSB 233,Dr. Mitchell,lecture,90 minutes,2016-11-29,,,"Intraabdominal Infections, Endocarditis ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 54,,MSB 234,Dr. Mitchell,lecture,60 minutes,2016-11-30,,,"Endocarditis, Sepsis Syndrome & Septic Shock ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 55,,MSB 235,Dr. Mitchell,lecture,90 minutes,2016-12-01,,,"Sepsis Syndrome and Septic Shock, Skin and Soft Tissue Infections ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 56,,MSB 236,Dr. Mitchell,lecture,60 minutes,2016-12-02,,,Skin and Soft Tissue Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 57,,MSB 237,Dr. Mitchell,lecture,60 minutes,2016-12-05,,,Jeopardy ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Lecture 58,,MSB 238,Dr. Mitchell,lecture,90 minutes,2016-12-06,,,Evaluation / Review / Questions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,FINAL,,TBA,,Exam,120 minutes,2016-12-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 17,,MS 628,Rix,lecture,110 minutes,2016-09-28,,face to face,History of palliative care; Comprehensive case study spanning multiple lectures of material,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 18,,MS 628,Rix/ Gagnon,lecture,110 minutes,2016-09-30,,face to face,"Long term and end of life pain management, including oncology specific treatment options and ethics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 19,,MS 628,Gagnon,lecture,110 minutes,2016-10-03,,face to face,Palliative care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,FINAL,,ECHA L1-420,,lecture,110 minutes,2016-10-05,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 1,,MS 628,Marsh,lecture,80 minutes,2016-09-01,,face to face,Cancer basics;  Cancer statistics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 2,,MS 628,Wuest,lecture,110 minutes,2016-09-02,,face to face,Mechanisms of action of the main categories of anticancer drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 3,,MS 628,Jurasz,lecture,80 minutes,2016-09-06,,face to face,Background and use of another recent class of anticancer drugs; Side effects and patient care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 4,,MS 628,Marsh,lecture,110 minutes,2016-09-07,,face to face,"Background of disease, Incidenc, Diagnosis, Treatment options, Types of complimentary techniques and medications; Use, evidence for and against, Colorectal cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 5,,MS 628,Jurasz,lecture,80 minutes,2016-09-08,,face to face,Background and use of one of the newest classes of anticancer drugs; Side effects and patient care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 6,,MS 628,Debenham/ Marsh,lecture,50 minutes,2016-09-09,,face to face,"Predicting toxicity and screening patients prior to treatment based on DNA; Predicting response and screening patients prior to treatment based on DNA; Determining relevant treatment or dose to prevent toxicity and/or imrpove likelihood of treatment response, Use in cancer treatment; Side effects and patient care, Pharmacogenomics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 7,,MS 628,Danilak,lecture,170 minutes,2016-09-09,,face to face,"Background of disease, Incidence, Diagnosis, Treatment options",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 8,,MS 628,Baracos/Marsh,lecture,50 minutes,2016-09-12,,face to face,"Background of disease; Incidence; Diagnosis; Treatment options, Cachexia (weight loss) in cancer patients; Treatment options, Lung cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 9,,MS 628,Marsh/ Danilak,lecture,80 minutes,2016-09-13,,face to face,"Background of disease types; Incidence; Diagnosis; Treatment options, Drug Interactions",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 10,,MS 628,Leslie,lecture,110 minutes,2016-09-14,,face to face,"Background of types of disease; Incidence; Diagnosis; Treatment options, Haematological cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 11,,MS 628,Leslie,lecture,170 minutes,2016-09-14,,face to face,"How/when used in cancer treatment; Problems and side effects, Bone Marrow Transplant:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,MIDTERM,,ECHA 2-190,,lecture,110 minutes,2016-09-16,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 12,,MS 628,Rix,lecture,110 minutes,2016-09-19,,face to face,"Cause, incidence and management of one of the most common side effects of cancer therapy; Case study",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 13,,MS 628,Marsh,lecture,110 minutes,2016-09-21,,face to face,"Background of disease type, Incidence, Diagnosis, Treatment options",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 14,,ECHA L1-490,Marsh/ OvarianCanada/MyelomaFoundation,lecture,170 minutes,2016-09-21,,face to face,"Ovarian cancer survivors describe their diagnosis and treatment and issues surrounding cancer, with time for Q&A with the patients; Alberta Myeloma Foundation cancer patients and survivors discuss their experiences, with time for Q&A with the patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 15,,MS 628,Danilak,lecture,110 minutes,2016-09-23,,face to face,"Basics of drug-drug interactions with a focus on anticancer treatment options; How to identify potential interactions; How to deal with potential drug-drug interactions, Background of disease, Incidence, Diagnosis, Treatment options",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Lecture 16,,MS 628,Rix,lecture,110 minutes,2016-09-26,,face to face,"Anticancer medications causing cardiotoxicity; Diagnosis; Treatment/monitoring, Identifying febrile neutropenia; Antibiotic and antifungal treatment for secondary infections from febrile neutropenia (common side effect from cancer treatment), Cardiotoxicity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lecture 1,,MS 227,Ken Cor & TBA,lecture,50 minutes,2016-09-02,,face to face,"Introduction, Pharmacists role in answering drug information requests, Types of drug information requests, Types of drug information resources",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 1,,MSB 2-50,Trish Chatterley,seminar,50 minutes,2016-09-06,,face to face,Research Skills Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 2,,MSB 2-50,Trish Chatterley,seminar,50 minutes,2016-09-07,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 3,,MSB 2-50,Trish Chatterley,seminar,50 minutes,2016-09-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 4,,MSB 2-50,Trish Chatterley,seminar,50 minutes,2016-09-13,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 5,,MSB 2-50,Trish Chatterley,seminar,50 minutes,2016-09-14,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 6,,MSB 2-50,Trish Chatterley,seminar,50 minutes,2016-09-15,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lecture 2,,MS 227,Katherine Sorenson,lecture,50 minutes,2016-09-20,,face to face,"Drug Information Services and Resources, Role of drug information in healthcare, Drug information resources",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 1,,MS 1-15,Course TAs,lab,50 minutes,2016-09-26,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lecture 3,,MS 227,Katherine Sorenson,lecture,50 minutes,2016-09-27,,face to face,"Systematic Approach to Drug Information, Gathering requestor information, Classifying and confirming the ultimate question, Evaluating the data and composing a response, Obtaining background information, Planning and complete a literature search, Replying to the requestor, Following-up",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 2,,MS 1-15,Course TAs,lab,50 minutes,2016-09-28,,face to face,Drug Information Resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3,,MS 1-15,Course TAs,lab,50 minutes,2016-09-30,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 4,,MS 1-15,Course TAs,lab,50 minutes,2016-10-07,,face to face,Systematic Approach to Drug Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 5,,MS 1-15,Course TAs,lab,50 minutes,2016-10-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 6,,MS 1-15,Course TAs,lab,50 minutes,2016-10-14,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 7,,MS 1-15,Course TAs,lab,50 minutes,2016-10-24,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 8,,MS 1-15,Course TAs,lab,50 minutes,2016-10-26,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 9,,MS 1-15,Course TAs,lab,50 minutes,2016-10-28,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 3,,ECHA 2-190,Nekolaichuk/ Rix,seminar,110 minutes,2016-09-28,,,"Feedback Lab 1, End of Life Care, How to Communicate with a Palliative Patient ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 2,,MSB 1-15,Shkrobot,lab,170 minutes,2016-10-04,,,"Follow Up, Palliative Care and Pain Management ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 2,,MSB 1-15,Shkrobot,lab,170 minutes,2016-10-06,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 1,,ECHA L1-490,Shkrobot,seminar,170 minutes,2016-09-07,,,"Orientation, Review Scope of Practice, Patient Care Process and Documentation Workshop",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 2,,PBLrooms (TBD),Various,seminar,80 minutes,2016-09-15,,,Patient Care Plan Presentations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 1,,MSB 1-15,Shkrobot,lab,170 minutes,2016-09-20,,,"Establishing a Therapeutic Relationship, Developing Detailed Monitoring Plans, Pre-filled subcutaneous injection training, Group Documentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 1,,MSB 1-15,Shkrobot,lab,170 minutes,2016-09-22,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 4,,ECHA 2-190,Shkrobot,seminar,110 minutes,2016-10-12,,,"Feedback Lab 2, Integrated Case 1 Review",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 3,,MSB 1-15,Shkrobot,lab,170 minutes,2016-10-18,,,"OTC and Prescription Counselling on Various Therapeutic Drug Classes, Prescription Processing/ Kroll Practice Review",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 3,,MSB 1-15,Shkrobot,lab,170 minutes,2016-10-20,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 4,,MSB 1-15,Shkrobot,lab,170 minutes,2016-10-25,,,"Prescribing, Adapting and Extending Prescriptions, Therapeutic Drug Monitoring Documentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 4,,MSB 1-15,Shkrobot,lab,170 minutes,2016-10-27,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 5,,MSB 2-27,Shkrobot/ Sadowski,seminar,110 minutes,2016-11-17,,,"Feedback Lan 3&4, Cognitive Assessment, Cognitive Impairment Cases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 5,,MSB 1-15,Shkrobot,lab,170 minutes,2016-11-22,,,"Patient Assessment, Antidepressant Titration and Switching",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 5,,MSB 1-15,Shkrobot,lab,170 minutes,2016-11-24,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 6,,MSB 2-27,Shkrobot,seminar,110 minutes,2016-12-01,,,"Feedback Lab 5, Application of Alberta's Pharmacy Services Framework to the Patient Care Plan Process, Midterm information ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,MIDTERM ,,MSB 1-15,,exam,,2016-12-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 7,,MSB 2-31,Charrois,seminar,110 minutes,2017-01-12,,,"Orientation , Ethics, Interprofessional Collaboration",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 6,,MSB 1-15,Charrois,lab,170 minutes,2017-01-17,,,"Infectious Diseases, Ethical Scenarios, Communication on health-care teams, Transfer of Care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 6,,MSB 1-15,Charrois,lab,170 minutes,2017-01-19,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 8,,MSB 2-27,Charrois/Danis/Alexander,seminar,110 minutes,2017-01-25,,,"Lab 6 Feedback, Injections Overview",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 7,,MSB 1-15,Charrois/Danis/Alexander,lab,170 minutes,2017-01-31,,,Injection Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 7,,MSB 1-15,Charrois/Danis/Alexander,lab,170 minutes,2017-02-02,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 9,,MSB 2-27,Charrois,seminar,110 minutes,2017-02-06,,,"Triage and referral in Self-care, Differential diagnosis in Self-care, integrated Case #2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Other,,MS 1-15,Charrois,other,,2017-02-10,,,Injection Authorization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 8,,MSB 1-15,Charrois,lab,170 minutes,2017-02-14,,,"Minor ailments, Interprofessional Collaborations with RN's",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 8,,MSB 1-15,Charrois,lab,170 minutes,2017-02-16,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 9,,MSB 1-15,Charrois,lab,170 minutes,2017-03-07,,,Ambulatory assistive devices with PT students,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 9,,MSB 1-15,Charrois,lab,170 minutes,2017-03-09,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 10,,MSB 2-27,MacDonald/Charrois,seminar,110 minutes,2017-03-17,,,"Motivational interviewing, Chronic Disease management ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 10,,MSB 1-15,Charrois,lab,170 minutes,2017-03-21,,,"CDM, Motivational interviewing, Diabetes Management ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 10,,MSB 1-15,Charrois,lab,170 minutes,2017-03-23,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 11,,MSB 1-15,Charrois,lab,170 minutes,2017-03-28,,,"Women's Health , Patient Education",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Lab 12,,MSB 1-15,Charrois,lab,170 minutes,2017-03-30,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 11,,ECHA 2-190,Charrois,seminar,110 minutes,2017-04-04,,,"Lab 10 Feedback, IC Feedback, Practical Aspect of Scope of Practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Seminar 12,,ECHA 2-190,Charrois,seminar,110 minutes,2017-04-07,,,OSCE Preparation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,FINAL,,MSB 1-15,Charrois,exam,,2017-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 2,,MS 231,Siraki,lecture,80 minutes,2016-11-01,,face to face,Medicinal Chemistry: Antidepressants & Benzodiazepines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 3,,MS 628,Walter,lecture,80 minutes,2016-11-02,,face to face,Sleep Wake Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 4,,MS 628,Butler,lecture,110 minutes,2016-11-04,,face to face,Depressive Disorders: Part 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 5,,MS 628,Butler,lecture,110 minutes,2016-11-14,,face to face,Depressive Disorders: Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 6,,MS 628,Siraki,lecture,110 minutes,2016-11-15,,face to face,Medicinal Chemistry/Pharmacology: Drugs of Abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 7,,MS 231,Butler,lecture,80 minutes,2016-11-15,,face to face,Anxiety Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 9,,MS 628,Sadowsi,lecture,110 minutes,2016-11-16,,face to face,Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 10,,"ED 255, ED 262, ED 265, ED 276",Walter/Butler/Dacko,seminar,110 minutes,2016-11-16,,face to face,"Depression, Anxiety & Insomnia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 11,,MS 231,Sadowski,lecture,80 minutes,2016-11-17,,face to face,Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 12,,MS 628,Fuller,lecture,110 minutes,2016-11-18,,face to face,Bipolar Disorder Part 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 13,,Online,Siraki,lecture,80 minutes,2016-11-18,,face to face,Pharmacology of Anti Psychotics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 14,,MS 628,Fuller,lecture,80 minutes,2016-11-21,,face to face,Bipolar Disorder Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 15,,MS 231,Lanz,lecture,80 minutes,2016-11-22,,face to face,Schizophrenia Part 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 16,,MS 628,Lanz,lecture,110 minutes,2016-11-23,,face to face,Schizophrenia Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 18,,MS 231,St. Arnaud,lecture,80 minutes,2016-11-24,,face to face,Cognitive Behavioural Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,MIDTERM,,ECHA 2-190,,lecture,50 minutes,2016-11-28,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 19,,MS 628,Lanz,lecture,80 minutes,2016-11-29,,face to face,Substance Abuse Disorders Part 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 20,,ECHA L1-490,Walter/Baumback,lecture,110 minutes,2016-11-30,,face to face,Opioid Dependency Treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 21,,MS 628,Lanz,lecture,110 minutes,2016-11-30,,face to face,Substance Abuse Disorders Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 22,,MS 231,Walter,lecture,80 minutes,2016-12-01,,face to face,Addiction: Psychosocial Perspectives & Non-Drug Treatment Options,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 23,,MS 628,Walter,lecture,110 minutes,2016-12-02,,face to face,ADHD/Course Evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 24,,MS 628,Waler,lecture,110 minutes,2016-12-05,,face to face,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,FINAL ,,TBD,,lecture,110 minutes,2016-12-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 1,,MS 628,Walter/Siraki,lecture,110 minutes,2016-10-31,,face to face,Course Introduction; Pharmacology of Antidepressants & Antianxiety Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 8,,Online,Siraki,lecture,80 minutes,2016-11-16,,face to face,Pharmacology of Drugs Affecting Cognition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Lecture 17,,"ED 255, ED 262, ED 265, ED 276",Lanz/Walter/Dacko/Fuller,seminar,110 minutes,2016-11-23,,face to face,Bipolar Disorder & Schizophrenia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 1,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-02,,face to face,"Introduction, Review of nomenclature and numbering, Stereochemical designations, Peptide designations, Steroid Nomenclature",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 2,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-07,,face to face,"Functional Group Characteristics and Roles, Definition of a functional group, Chemical properties, Electronic effects; Inductive effects; Solubility effects; Steric effects; Binding interactions; Metabolism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 3,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-09,,face to face,Functional Group Characteristics and Roles,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 4,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 5,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-13,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 6,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-14,,face to face,"Identifying Acidic and Basic Functional Groups, Acidic/basic functional groups, Therapeutic significance of acid/base groups",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 7,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-19,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 9,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-23,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 10,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-26,,face to face,"pH and pKa - Principles and Applications, Definition of pH, Definition of pKa., The Henderson-Hasselbach equation., Solving pH and pKa problems, Calculating the pKa of a functional group., The importance of pH and pKa in drug therapy, Influence of pH and pKa on the solubility of a drug molecule, The influence on the duration of action of a drug molecule, The influence on drug binding interactions., Ionization and chemical antagonism, Drug interactions based on pH and/or pKa changes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 11,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-28,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 12,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-30,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 13,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-03,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 14,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-05,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 15,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-07,,face to face,"Salts and Solubility , Definition of salt., Application of drug molecules, Inorganic salts., Organic salts., Salts and drug interactions., Use of salts, Solubility and partition coefficient, The balance between water and lipid solubility, Strategies for optimizing drug solubility, Solubility and drug metabolism",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 16,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 17,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-14,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 18,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-17,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 19,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-19,,face to face,"Drug Binding Interactions, Covalent bonds, Non-covalent bonds., Ionic bonds., Ion-dipole and dipole-dipole interactions., Hydrogen bonds, van der Waals interactions, Hydrophobic bonding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,MIDTERM,,MSB 231,Teaching Assistant ,lecture,50 minutes,2016-10-21,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 20,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-24,,face to face,"Drug Binding Interactions, Covalent bonds, Non-covalent bonds., Ionic bonds., Ion-dipole and dipole-dipole interactions., Hydrogen bonds, van der Waals interactions, Hydrophobic bonding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 21,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-26,,face to face,Drug Binding Interactions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 22,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-28,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 23,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-10-31,,face to face,"Stereochemistry, Chirality and asymmetry., Enantiomers, Pharmacological implications of enantiomeric mixtures, Diastereomers., Geometric isomers, Pharmacological implications of diastereomeric mixtures., Conformational isomers., The active conformation., Conformational restriction  implications.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 24,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-11-02,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 25,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-11-04,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 26,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-11-14,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 8,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-09-21,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 27,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2016-11-16,,face to face,"Drug Metabolism, General concepts, Phase I metabolism, Phase II metabolism, Factors that affect drug metabolism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 29,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2016-11-21,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 30,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2016-11-23,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 31,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2016-11-25,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 28,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2016-11-28,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 32,,MSB 231,Dion Brocks,lecture,50 minutes,2016-11-28,,face to face,"Drug Transporter Proteins, Active transporters, Facilitated transporters., Organic ion transporters, Clinical considerations.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 33,,MSB 231,Dion Brocks,lecture,50 minutes,2016-11-30,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 34,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-12-02,,face to face,"Structure-activity Relationships (SAR), SARs., SAR and drug interactions and adverse drug reactions, Molecular modification, Examples of SARs., SAR and pharmacological activity., SAR and binding interactions., SARs and ADME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 35,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-12-05,,face to face,Structure-activity Relationships (SAR),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 36,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-12-07,,face to face,Concepts in Drug Design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Lecture 37,,MSB 231,Carlos A. Velzquez,lecture,50 minutes,2016-12-09,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,FINAL,,MSB 231,Teaching Assistant ,lecture,50 minutes,2016-12-19,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 9,,,Wilson Cheng,lecture,80 minutes,2016-11-24,,face to face,Isotonic Solutions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 10,,,Wilson Cheng,lecture,80 minutes,2016-11-26,,face to face,Electrolyte Solutions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 11,,,Wilson Cheng,lecture,80 minutes,2016-12-01,,face to face,Concentration and Rates of IV Fluids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 12,,,Wilson Cheng,lecture,80 minutes,2016-12-03,,face to face,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 1,,,Wilson Cheng,lecture,80 minutes,2016-10-13,,face to face,Introduction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 2,,,Wilson Cheng,lecture,80 minutes,2016-10-15,,face to face,Units and Calculation of Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 3,,,Wilson Cheng,lecture,80 minutes,2016-10-20,,face to face,"Numbers, Errors and Rounding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 4,,,Wilson Cheng,lecture,80 minutes,2016-10-22,,face to face,Least Weighable Quantities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 5,,,Wilson Cheng,lecture,80 minutes,2016-10-29,,face to face,Reducing and Enlarging Formulas,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 6,,,Wilson Cheng,lecture,80 minutes,2016-11-03,,face to face,Density and Specific Gravity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 7,,,Wilson Cheng,lecture,80 minutes,2016-11-05,,face to face,Percentage and Ratio Strengths,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Lecture 8,,,Wilson Cheng,lecture,80 minutes,2016-11-19,,face to face,Dilutions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,FINAL,,,Wilson Cheng,lecture,80 minutes,2016-12-14,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 3,,Practice Lab,Terri Charrois,Lab 3,240 min,2016-11-03,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 6,,MS 231,Terri Charrois,Seminar,120 min,2016-11-17,,,Feedback Lab 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 4,,Practice Lab,Terri Charrois,Lab 4,240 min,2016-11-29,,,Minor Ailments Assessment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 4,,Practice Lab,Terri Charrois,Lab 4,240 min,2016-12-01,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 7,,MS 227,Terri Charrois,Seminar,120 min,2016-12-05,,,Feedback Lab 4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,MIDTERM,,,,Exam,,2016-12-08,,,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 8,,MS 227,Renette Bertholet,Seminar,120 min,2017-01-11,,,Orientation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 9,,MS 227,Renette Bertholet,Seminar,120 min,2017-01-18,,,Communicating Risk and Benefit to Patients ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 10,,MS 227,Renette Bertholet,Seminar,120 min,2017-01-23,,,Feedback Lab 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 5,,MSB 1-115,Renette Bertholet,Lab 5,240 min,2017-01-24,,,Shared Decision Making and Professionalism ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 5,,MSB 1-115,Renette Bertholet,Lab 5,240 min,2017-01-26,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 7,,MSB 1-115,Renette Bertholet,Lab 7,240 min,2017-01-28,,,Review of Hospital Chart for Med Rec Preparation for Discharge Counseling ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 11,,MS 227,Renette Bertholet,Seminar,120 min,2017-02-01,,,Feedback Lab 5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 6,,MSB 1-115,Renette Bertholet,Lab 6,240 min,2017-02-07,,,Presenting Patient Problems to HCP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 6,,MSB 1-115,Renette Bertholet,Lab 6,240 min,2017-02-09,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 7,,MSB 1-115,Renette Bertholet,Lab 7,240 min,2017-03-02,,,Review of Hospital Chart for Med Rec Preparation for Discharge Counseling ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 12,,MS 227,Renette Bertholet,Seminar,120 min,2017-03-08,,,Feedback Lab 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 8,,MSB 1-115,Renette Bertholet,Lab 8,240 min,2017-03-14,,,Hospital Discharge Counseling ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 8,,MSB 1-115,Renette Bertholet,Lab 8,240 min,2017-03-16,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 13,,MS 227,Renette Bertholet,Seminar,120 min,2017-03-23,,,Feedback Lab 8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 9,,HSERC,Renette Bertholet,Lab 9,240 min,2017-03-30,,,Physiotherapy (PT) and Inhaler Teaching Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 10,,MSB 1-115,Renette Bertholet,Lab 10,240 min,2017-04-04,,,Brief Evidence Based Assessments of Research (BEARS) tool,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 10,,MSB 1-115,Renette Bertholet,Lab 10,240 min,2017-04-06,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,FINAL,,,,Exam,,2017-04-18,,,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 1,,MS 227,Terri Charrois,Seminar,120 min,2016-09-07,,,Introduction and Review of Patient Care Process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 2,,MS 227,Terri Charrois,Seminar,120 min,2016-09-14,,,Scope of Practice - Adaption,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab1,,Practice Lab,Terri Charrois,Lab 1,240 min,2016-09-27,,,Best Possible Medication History ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab1,,Practice Lab,Terri Charrois,Lab 1,240 min,2016-09-29,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 3,,MS 227,Terri Charrois,Seminar,120 min,2016-10-05,,,Feedback for Lab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 2,,Practice Lab,Terri Charrois,Lab 2,240 min,2016-10-11,,,Pulmonary Cases and Patient Counseling ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 2,,Practice Lab,Terri Charrois,Lab 2,240 min,2016-10-13,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 4,,MS 227,Terri Charrois,Seminar,120 min,2016-10-20,,,Feedback Lab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Seminar 5,,MS 227,Terri Charrois,Seminar,120 min,2016-10-25,,,Drug Reaction Assessment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Lab 3,,Practice Lab,Terri Charrois,Lab 3,240 min,2016-11-01,,,Renal Cases and Assessing Lab Values ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,"Class Introduction;Disability Presentation Introduction of Voice of Albertans with Disabilities Society (VADS) - (roles, activities, purpose) Disability â€“ definitions, meaning, impact, epidemiology, types Interventions and advocacy from VADS (e.g. MD office visit) Pharmacy teams consultation with VADS",,ECHA L1-420,Sadowski/Graham,lecture,170 minutes,2016-09-06,Direct Lecture,,,,Consider disease and functional/disability information as relevant to the specific design needs. ,Classify forms of disability and identify functional supports associated with those disabilities.,"Explain the current approach to pharmacy visits for individuals with disabilities, as completed by Alberta Committee on Citizens with Disabilities (ACCD).","Express empathy for those experiencing disabilities, impairments, or handicaps.",Listen to others with respect.,Appreciates the role of advocacy for those who are vulnerable.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Lecture (R Lederer) regarding project management;Work with groups to define project criteria and develop design outlines and goals,,Design Studio,Lederer/Rasmussen/Sadowski,lecture,170 minutes,2016-09-13,"Direct Lecture, Team Based Learning",,,,Identify aspects of design that impact patient ability to manage medications.,Consider disease and functional/disability information as relevant to the specific design needs. ,Describe features of universal design.,"Collaboration a.	Identify and employ appropriate technologies to facilitate collaboration b.	Employ appropriate team role behaviours to support team function c.	Takes action in instances where there is a lack of inclusivity, respect, or trust on the team d.	Identify opportunities to improve team outcomes  e.	Negotiate action with team members to plan and execute team tasks",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Disability project outlines developed,,ECHA L1-420,Sadowski,lecture,170 minutes,2016-09-20,"Direct Lecture, Active Learning, Team Based Learning",,,,"Identify health, medication management and safety needs for patients.",Identify aspects of design that impact patient ability to manage medications.,Consider disease and functional/disability information as relevant to the specific design needs. ,Describe features of universal design.,Classify forms of disability and identify functional supports associated with those disabilities.,"Develop design features that ensure patientsâ€™ medication access, safety, health and medication management/monitoring","Demonstrate patient/client-centered (individual, family, community group) approach in design.","Develop writing and presentation skills (oral, written) to demonstrate effectively the teamâ€™s final design in front of peers, clients, or experts in design and health services.",Actively listen and engage in negotiation with clients to effectively plan the approach for the project.,"Professional Roles a.	Share and evaluate own professional values and culture (translates knowledge to team members) b.	Articulate and share knowledge of other professional roles c.	Consult, seeks advice and confer with other professionals d.	Adapt professional role within a given context/ environment","Communication  a.	Integrate feedback into professional and team practice b.	Match level and mode of communication to the needs of team members c.	Actively listen and be receptive to the knowledge and opinions of others d.	Analyze conflict effectively and employ appropriate conflict resolution techniques/models e.	Develop presentations that consider the audience background, context, and learning needs","Collaboration a.	Identify and employ appropriate technologies to facilitate collaboration b.	Employ appropriate team role behaviours to support team function c.	Takes action in instances where there is a lack of inclusivity, respect, or trust on the team d.	Identify opportunities to improve team outcomes  e.	Negotiate action with team members to plan and execute team tasks","Reflection a.	Takes action based on reflection to improve personal and team performance  b.	Reflect on pharmacistsâ€™ contribution to the process. c.	Explore strengths and weaknesses in team composition and process","Express empathy for those experiencing disabilities, impairments, or handicaps.",Listen to others with respect.,Appreciates the role of advocacy for those who are vulnerable.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Team meetings with faculty members to discuss: Literature searches Background research Project strategies,,Design Studio,Lederer/Rasmussen/Sadowski,lecture,170 minutes,2016-09-27,"Direct Lecture, Active Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Disability project development,,ECHA L1-420,Sadowski,lecture,170 minutes,2016-10-04,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,"Identify health, medication management and safety needs for patients.",Identify aspects of design that impact patient ability to manage medications.,Consider disease and functional/disability information as relevant to the specific design needs. ,Describe features of universal design.,"Develop design features that ensure patientsâ€™ medication access, safety, health and medication management/monitoring","Demonstrate patient/client-centered (individual, family, community group) approach in design.","Develop writing and presentation skills (oral, written) to demonstrate effectively the teamâ€™s final design in front of peers, clients, or experts in design and health services.",Actively listen and engage in negotiation with clients to effectively plan the approach for the project.,"Professional Roles a.	Share and evaluate own professional values and culture (translates knowledge to team members) b.	Articulate and share knowledge of other professional roles c.	Consult, seeks advice and confer with other professionals d.	Adapt professional role within a given context/ environment","Communication  a.	Integrate feedback into professional and team practice b.	Match level and mode of communication to the needs of team members c.	Actively listen and be receptive to the knowledge and opinions of others d.	Analyze conflict effectively and employ appropriate conflict resolution techniques/models e.	Develop presentations that consider the audience background, context, and learning needs","Collaboration a.	Identify and employ appropriate technologies to facilitate collaboration b.	Employ appropriate team role behaviours to support team function c.	Takes action in instances where there is a lack of inclusivity, respect, or trust on the team d.	Identify opportunities to improve team outcomes  e.	Negotiate action with team members to plan and execute team tasks","Reflection a.	Takes action based on reflection to improve personal and team performance  b.	Reflect on pharmacistsâ€™ contribution to the process. c.	Explore strengths and weaknesses in team composition and process","Express empathy for those experiencing disabilities, impairments, or handicaps.",Listen to others with respect.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,"Team presentations:  presentation of design concept to clients, including the design concept - goals, objectives, needs, wants",,Design Studio,Lederer/Rasmussen/Sadowski,lecture,170 minutes,2016-10-11,Direct Lecture,,,,"Identify health, medication management and safety needs for patients.",Identify aspects of design that impact patient ability to manage medications.,Consider disease and functional/disability information as relevant to the specific design needs. ,Describe features of universal design.,Classify forms of disability and identify functional supports associated with those disabilities.,"Develop design features that ensure patientsâ€™ medication access, safety, health and medication management/monitoring","Demonstrate patient/client-centered (individual, family, community group) approach in design.","Develop writing and presentation skills (oral, written) to demonstrate effectively the teamâ€™s final design in front of peers, clients, or experts in design and health services.",Actively listen and engage in negotiation with clients to effectively plan the approach for the project.,"Professional Roles a.	Share and evaluate own professional values and culture (translates knowledge to team members) b.	Articulate and share knowledge of other professional roles c.	Consult, seeks advice and confer with other professionals d.	Adapt professional role within a given context/ environment","Communication  a.	Integrate feedback into professional and team practice b.	Match level and mode of communication to the needs of team members c.	Actively listen and be receptive to the knowledge and opinions of others d.	Analyze conflict effectively and employ appropriate conflict resolution techniques/models e.	Develop presentations that consider the audience background, context, and learning needs","Collaboration a.	Identify and employ appropriate technologies to facilitate collaboration b.	Employ appropriate team role behaviours to support team function c.	Takes action in instances where there is a lack of inclusivity, respect, or trust on the team d.	Identify opportunities to improve team outcomes  e.	Negotiate action with team members to plan and execute team tasks","Reflection a.	Takes action based on reflection to improve personal and team performance  b.	Reflect on pharmacistsâ€™ contribution to the process. c.	Explore strengths and weaknesses in team composition and process","Express empathy for those experiencing disabilities, impairments, or handicaps.",Listen to others with respect.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Disability project development,,ECHA L1-420,Sadowski,lecture,170 minutes,2016-10-18,"Direct Lecture, Active Learning, Team Based Learning",,,,"Identify health, medication management and safety needs for patients.",Identify aspects of design that impact patient ability to manage medications.,Consider disease and functional/disability information as relevant to the specific design needs. ,Describe features of universal design.,Classify forms of disability and identify functional supports associated with those disabilities.,"Develop design features that ensure patientsâ€™ medication access, safety, health and medication management/monitoring","Demonstrate patient/client-centered (individual, family, community group) approach in design.","Develop writing and presentation skills (oral, written) to demonstrate effectively the teamâ€™s final design in front of peers, clients, or experts in design and health services.",Actively listen and engage in negotiation with clients to effectively plan the approach for the project.,"Professional Roles a.	Share and evaluate own professional values and culture (translates knowledge to team members) b.	Articulate and share knowledge of other professional roles c.	Consult, seeks advice and confer with other professionals d.	Adapt professional role within a given context/ environment","Communication  a.	Integrate feedback into professional and team practice b.	Match level and mode of communication to the needs of team members c.	Actively listen and be receptive to the knowledge and opinions of others d.	Analyze conflict effectively and employ appropriate conflict resolution techniques/models e.	Develop presentations that consider the audience background, context, and learning needs","Collaboration a.	Identify and employ appropriate technologies to facilitate collaboration b.	Employ appropriate team role behaviours to support team function c.	Takes action in instances where there is a lack of inclusivity, respect, or trust on the team d.	Identify opportunities to improve team outcomes  e.	Negotiate action with team members to plan and execute team tasks","Reflection a.	Takes action based on reflection to improve personal and team performance  b.	Reflect on pharmacistsâ€™ contribution to the process. c.	Explore strengths and weaknesses in team composition and process","Express empathy for those experiencing disabilities, impairments, or handicaps.",Listen to others with respect.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Presentation of Design Briefs to Faculty,,Design Studio,Lederer/Rasmussen/Sadowski,lecture,170 minutes,2016-10-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Disability project presentations to VADS,,ECHA L1-420,Sadowski,lecture,170 minutes,2016-11-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,IP Group Consultation with Faculty,,Design Studio,Lederer/Rasmussen/Sadowski,lecture,170 minutes,2016-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,IP Group Consultation with Faculty,,Design Studio,Sadowski,lecture,170 minutes,2016-11-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,"IP Team Final Presentations to Clients, Faculty, Guests",,Design Studio,Lederer/Rasmussen/Sadowski,lecture,170 minutes,2016-11-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,"Feedback on Reports, assignments",,ECHA L1-420,Sadowski,lecture,170 minutes,2016-12-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Third year pharmacy student presentation,,TBD,Sadowski,lecture,170 minutes,2016-12-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Course Introduction ,,MS 231,"Cox, Cheryl",lecture,50 minutes,2016-09-08,Direct Lecture,,,,Develop an understanding of the role and expectations of experiential learning in the curriculum ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Course Expectations and  Person-Centred Care,,MS 231,"Cox, Cheryl",lecture,80 minutes,2016-10-11,Direct Lecture,,,,Develop an understanding of the role and expectations of experiential learning in the curriculum ,Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Seminar #1 ,,Medical Science Seminar Rooms,"Cox, Cheryl",seminar,80 minutes,2016-11-01,Team Based Learning,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Course Expectations and Background Information ,,MS 227,"Cox, Cheryl",lecture,80 minutes,2016-11-22,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Seminar #2,,Medical Science Seminar Rooms,"Cox, Cheryl",seminar,80 minutes,2016-11-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Overview of Reflection Assignment #3,,MS 231,"Cox, Cheryl",lecture,50 minutes,2017-01-11,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Technical Support for Assignment #3,,MS 227,"Cox, Cheryl",lecture,50 minutes,2017-01-24,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Course Evaluation/Case 9: Transplant/Case 10: Pharmacokinetics/Final Exam Discussion,,ECHA 1-498,Mahmoud/Broscheit,lecture,170 minutes,2016-12-05,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Therapeutic Decision Making,,ECHA 1-498,Mahmoud,seminar,170 minutes,2016-10-17,"Direct Lecture, Problem Based Learning",,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Therapeutic Decision Making,,ECHA 1-498,Mahmoud,seminar,170 minutes,2016-10-24,"Direct Lecture, Problem Based Learning, Team Based Learning",,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Case 1: Pediatric Asthma,,ECHA 1-498,Meyer,lecture,80 minutes,2016-10-31,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,,Case 3: Cardiology,ECHA 1-498,Hall,lecture,80 minutes,2016-11-14,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Case 4: Pediatric Critical Care,,ECHA 1-498,Chan,lecture,80 minutes,2016-11-14,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Case 6: HIV,,ECHA 1-498,Foisy,lecture,80 minutes,2016-11-21,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Case 5: Toxicology,,ECHA 1-498,Druteik,lecture,80 minutes,2016-11-21,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Case 7: Subarachnoid Hemorrhage,,ECHA 1-498,Mahmoud,lecture,80 minutes,2016-11-28,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Case 8: Infectious Diseases,,ECHA 1-498,Lau,lecture,80 minutes,2016-11-28,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Case 2: Stroke,,ECHA 1-498,Moore,lecture,50 minutes,2016-12-06,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Literature Evaluation I,,ECHA 1-498,Makowsky,lecture,170 minutes,2016-09-19,Direct Lecture,,,,Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Literature Evaluation II,,ECHA 1-498,Makowsky,lecture,170 minutes,2016-09-26,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,A Day in the Life of a Pharmacist,,ECHA 1-498,Mahmoud,lecture,170 minutes,2016-10-03,Direct Lecture,,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.",Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach., Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Course Introduction,,ECHA 1-498,Mahmoud,lecture,170 minutes,2016-09-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Healthcare organizations,,MS 227,Shkrobot,lecture,170 minutes,2017-02-13,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Pharmacy Frameworks,,MS 227,Shkrobot,lecture,170 minutes,2017-03-06,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Course introduction / historical background,,MS 227,Shkrobot,lecture,170 minutes,2017-01-09,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Debates,,MS 227,Shkrobot,lecture,170 minutes,2017-03-27,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Solutions to healthcare issues,,MS 227,Shkrobot,lecture,170 minutes,2017-03-13,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Debates,,MS 227,Shkrobot,lecture,170 minutes,2017-03-20,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Health systems / Canadas healthcare system / patient involvement,,MS 227,Shkrobot,lecture,170 minutes,2017-01-16,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Healthcare resources,,MS 227,Shkrobot,lecture,170 minutes,2017-01-23,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Provision of healthcare,,MS 227,Shkrobot,lecture,170 minutes,2017-01-30,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Provision of healthcare,,MS 227,Shkrobot,lecture,170 minutes,2017-02-06,"Direct Lecture, Active Learning, Team Based Learning",Face to Face,,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 1,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-01,,,Course Introduction ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 2,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-02,,,Overview of Infectious Diseases ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 3,,ECHA L1 190,Dr. Tyrrell,lecture,90 minutes,2016-09-06,,,Structure Bacterial Cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 4,,MSB 231,Dr. Tyrrell,lecture,60 min,2016-09-07,,,Bacterial physiology growth and reproduction ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 5,,ECHA L1 190,Dr. Tyrrell,lecture,90 minutes,2016-09-08,,,"Bacteria, growth, reproduction, Taxonomy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 6,,MSB 231,Dr. Tyrrell,lecture,60 min,2016-09-09,,,Laboratory and Clinical Lab Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 7,,MSB 231,Dr. Tyrrell,lecture,60 min,2016-09-12,,,Laboratory and Clinical Lab Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 8,,ECHA L1 190,Dr. Mitchell/Dr. Tyrrell,lecture,90 minutes,2016-09-13,,,Bacterial Pathogens - Gram + Cocci ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 9,,MSB 231,Dr. Mitchell/Dr. Tyrrell,lecture,60 min,2016-09-14,,,"Gram negative cocci, Gram negative rods",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 10,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-15,,,"Gram negative rods, Anaerobes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 11,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-16,,,"Spiral/curved organisms, Mycoplasmas",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 12,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-19,,,Problems with Antimicrobial Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 13,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-20,,,Antimicrobial Resistance ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 14,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-21,,,Antimicrobial Resistance ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 15,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-22,,,Clinical Signs of Infection and Lab tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 16,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-23,,,Penicillins,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 17,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-26,,,Penicillins,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 18,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-27,,,Penicillins/ Kinetics Adverse Effects of Penicillins ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 19,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-28,,,Penicillin Allergy Testing and Desensitization ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 20,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-09-29,,,Pharmacokinetics/Dynamics of Antimicrobials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 21,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-09-30,,,Pharmacokinetics/Dynamics of Antimicrobials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 22,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 23,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-10-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-05,,,No Class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 25,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 26,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 27,,ECHA L1 190,Dr. Mitchell,lecture,90 minutes,2016-10-11,,,"lactamases, lactamase Inhibitors ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 28,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-12,,,Jeopardy ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,MIDTERM,,CS2-191,Dr. Mitchell,Exam,90 minutes,2016-10-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 29,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-14,,,"lactamases, lactamase Inhibitors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-10-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 30,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-19,,,Macrolides ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 31,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-10-20,,,"Macrolides, Ketolides",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 32,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-21,,,Inhibitors of Folic Acid Synthesis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 33,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-24,,,Inhibitors of Folic Acid Synthesis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 34,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-10-25,,,"Tetracyclines Glycylcyclines, Clindamycin,  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 35,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-26,,,"Metronidazole, Quinolones and Fluoroquinolones  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 36,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-10-27,,,"Quinolones and Fluoroquinolones, ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 37,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-28,,,"Fosfomycin, Aminoglycosides",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 38,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-10-31,,,"Aminoglycosides,",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 39,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-01,,,Upper Respiratory Tract Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-02,,,No Class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 40,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-03,,,Upper Respiratory Tract Infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 41,,MSB 231,Dr. Jamali,lecture,60 minutes,2016-11-04,,,Aminoglycoside Kinetics ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,NO CLASS,,,,,,2016-11-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 42,,MSB 231,Dr. Jamali,lecture,60 minutes,2016-11-14,,,Aminoglycosides Kinetics ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 43,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-15,,,Lower Respiratory Tract Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 44,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-16,,,Glycopeptides                                                      ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 45,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-17,,,Glycopeptides                                                          ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 46,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-18,,,"Polymixin B, Bacitracin, Fusidic Acid, Mupiricin, Retapamulin  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 47,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-21,,,Urinary Tract Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 48,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-22,,,"Oxazolidinones, Quinupristin/Dalfopristin, Daptomycin, Chloramphenicol ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 49,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-23,,,Antitubercular agents and TB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 50,,MSB 231,Dr. Mitchell,lecture,90 minutes,2016-11-24,,,Antitubercular agents and TB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 51,,MSB 231,Dr. Mitchell,lecture,60 minutes,2016-11-25,,,Surgical Prophylaxis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 52,,MSB 232,Dr. Mitchell,lecture,60 minutes,2016-11-28,,,Meningitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 53,,MSB 233,Dr. Mitchell,lecture,90 minutes,2016-11-29,,,"Intraabdominal Infections, Endocarditis ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 54,,MSB 234,Dr. Mitchell,lecture,60 minutes,2016-11-30,,,"Endocarditis, Sepsis Syndrome & Septic Shock ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 55,,MSB 235,Dr. Mitchell,lecture,90 minutes,2016-12-01,,,"Sepsis Syndrome and Septic Shock, Skin and Soft Tissue Infections ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 56,,MSB 236,Dr. Mitchell,lecture,60 minutes,2016-12-02,,,Skin and Soft Tissue Infections ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 57,,MSB 237,Dr. Mitchell,lecture,60 minutes,2016-12-05,,,Jeopardy ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Lecture 58,,MSB 238,Dr. Mitchell,lecture,90 minutes,2016-12-06,,,Evaluation / Review / Questions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,FINAL,,TBA,,Exam,120 minutes,2016-12-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Anatomy & Joint Physiology 3,,MS 227,Patrick,lecture,80 minutes,2017-02-16,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Arthroplasty Anticoagulation Therapy,,MSB 227,Morin,lecture,80 minutes,2017-03-02,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Osteoporosis 2,,MSB 227,Yuksel,lecture,50 minutes,2017-02-15,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Fracture versus Osteomalacia,,MSB 227,Doschak,lecture,80 minutes,2017-02-09,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Bisphosphonates â€“ Med.Chem,,MSB 227,Doschak,lecture,50 minutes,2017-02-10,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Medical Imaging,,MSB 227,Jaremko,lecture,50 minutes,2017-02-10,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,OA Natural Health Products,,MSB 227,Basiuk / Necyk,lecture,50 minutes,2017-02-13,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,OsteoArthritis,,MSB 227,Aghazadeh-Habashi,lecture,80 minutes,2017-02-14,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Osteoporosis 1,,MS 227,Yuksel,lecture,80 minutes,2017-02-14,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Rheumatoid Arthritis 2,,MSB 227,Hall,lecture,50 minutes,2017-03-01,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Seminar 1 (Osteoporosis & Osteoarthritis),,"ED 276, ED 377, ED N1 128",Various,seminar,110 minutes,2017-03-01,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Drugs used with RA (Pharmacology),,MSB 227,Jamali,lecture,80 minutes,2017-03-03,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Course Introduction/Anatomy & Joint Physiology 1,,MS 227,Doschak/Patrick,lecture,50 minutes,2017-02-07,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Anatomy & Joint Physiology 2,,MS 227,Patrick,lecture,50 minutes,2017-02-07,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Biologics in Rheumatic Disease,,MSB 227,Charlton,lecture,50 minutes,2017-02-27,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Sports Medicine,,MSB 227,Robinson,lecture,50 minutes,2017-03-06,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,DMARDs - Med.Chem,,MSB 227,Barakat,lecture,80 minutes,2017-02-28,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Rheumatoid Arthritis 1,,MSB 227,Hall,lecture,80 minutes,2017-02-28,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Drugs used with OA (Pharmacology),,MSB 227,Jamali,lecture,50 minutes,2017-03-07,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Gout & Hyperuricemia,,MSB 227,Hall,lecture,80 minutes,2017-03-07,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Other Metabolic Bone Disease,,MSB 227,Doschak,lecture,50 minutes,2017-03-08,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Seminar 2 (Rheum Arth & Gout/Hyperuric),,"ED 276, ED 377, ED N1 128",Various,seminar,110 minutes,2017-03-08,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Other Rheumatic conditions,,MSB 227,Hall,lecture,80 minutes,2017-03-09,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Orthopaedic Surgery,,MSB 227,Bergman,lecture,80 minutes,2017-03-10,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Course Outline & Introduction to Pharmacoepidemiology,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-01-18,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Limitations of Drug Approval & Pre-Marketing Clinical Trials,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-01-20,Direct Lecture,,,,Identify the inherent limitations of the drug approval process and pre-Â_marketing clinical trials with regard to assessment of drug safety and effectiveness.,Define type I and type II errors and power.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Sources of Bias in Observational Studies,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-02-08,Direct Lecture,,,,Understand how specific biases may affect measures of association.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-02-10,Direct Lecture,,,,"List Sir Bradford-Â_Hillâ€™s considerations for inferring causation from observational data, and describe the difference between causal and spurious associations.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Confounding in Observational Studies,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-02-22,Direct Lecture,,,,Describe methods used to minimize the effects of confounding and other limitations in pharmacoepidemiologic studies.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Meta-Analysis â€“ Part I,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-02-24,Direct Lecture,,,,Explain the rationale for meta-Â_analyses.,Describe the major elements of a meta-Â_analysis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Meta-Analysis â€“ Part II,,MSB 231,Dr. SImpson,lecture,50 minutes,2016-02-26,Direct Lecture,,,,Explain the rationale for meta-Â_analyses.,Describe the major elements of a meta-Â_analysis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Critical Appraisal of Articles Assessing Risk / Harm,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-03-02,Direct Lecture,,,,Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,COMPUTER SKILLS LAB,,ECHA L1-250,Dr. Simpson,lab,50 minutes,2016-03-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Quality Improvement Framework â€“ Benchmarking,,MSB 231,,lecture,50 minutes,2016-03-04,Direct Lecture,,,,Explain each step involved in a continuous quality improvement process.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,COMPUTER SKILLS LAB,,MSB 250,,lecture,50 minutes,2016-03-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Changing Patterns of Drug Use (Clinician & Patient Levels),,MSB 231,Dr. Simpson,lecture,50 minutes,2016-03-07,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Pharmacy Practice Research Designs,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-02-09,Direct Lecture,,,,Describe different study designs that are commonly used in pharmacy practice research. Examples will be used to illustrate the advantages and limitations of these different study designs.,Identify the common measures used in pharmacoeconomic studies.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Consent and Ethical Considerations for Practice Research,,MSB 231,Charmaine Kabatoff,lecture,50 minutes,2016-02-11,Direct Lecture,,,,Explain how the guiding ethical principles from the Tri-Â_Council Policy Statement (TCPS) apply when conducting practice based research.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Survey Methods â€“ Parts I&2,,MSB 231,Dr. Cor,lecture,50 minutes,2016-03-14,Direct Lecture,,,,Describe the major elements of a survey.,Describe common biases that can affect the interpretation of survey data.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Pharmacy Practice Research Examples,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-12-04,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Pharmacy Practice Research Examples,,MSB 231,Dr. Charrois,lecture,50 minutes,2016-03-21,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Pharmacoeconomic Evaluations,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-03-23,Direct Lecture,,,,Identify the common measures used in pharmacoeconomic studies.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Randomized Controlled Trials & Observational Studies,,MSB 231,Dr. Eurich,lecture,50 minutes,2016-01-22,Direct Lecture,,,,Describe the various data sources used in pharmacoepidemiologic studies. Examples will be presented to highlight the advantages and limitations of each data source.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Data Sources â€“ Part I,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-01-25,Direct Lecture,,,,"When trying to detect a difference in risk, describe what can influence a study sample size.",Describe why we need adverse drug reaction reporting systems and how pharmacists can contribute to this process.,Compare type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Data Sources â€“ Part II,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-01-27,Direct Lecture,,,,"When trying to detect a difference in risk, describe what can influence a study sample size.",Describe why we need adverse drug reaction reporting systems and how pharmacists can contribute to this process.,Compare type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,Describe the various data sources used in pharmacoepidemiologic studies. Examples will be presented to highlight the advantages and limitations of each data source.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Pharmacoepidemiologic Study Designs â€“ Part I,,MSB 231,Dr. SImpsno,lecture,50 minutes,2016-01-29,Direct Lecture,,,,"Describe the major elements of cross-Â_sectional, case-Â_control, cohort, and other common designs of pharmacoepidemiologic studies that evaluate drug safety, effectiveness, and utilization patterns.",Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Pharmacoepidemiologic Study Designs â€“ Part II,,MSB 231,Dr. Simpson,lecture,50 minutes,2016-02-01,Direct Lecture,,,,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,"Interpret different measures of association reported in pharmacoepidemiologic studies (e.g. odds ratio, relative risk, hazard ratio).",Categorize and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Measurement of Association,,MSB 231,Dr. SImpson,lecture,50 minutes,2016-02-03,Direct Lecture,,,,Define confounding and how it can affect the interpretation of a measure of association.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,exam,,MS 233,John Ussher,exam,110 minutes,2017-04-13,,Face to Face,Final exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 16,,MS 232,Momen El Ghazouly,lecture,110 minutes,2017-03-14,,Face to Face,"Interactive case reports for students to gain experience on differentiating acute from chronic pain, Differentiating Acute from Chronic Pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 15,,MS 231,Alastair Ilich,lecture,110 minutes,2017-03-09,,Face to Face,"radiopharmaceuticals, bisphosphonates, dexamethasone, visceral pain, spinal cord compression, Guest lecture: management of malignant pain syndromes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 14,,MS 231,Momen El Ghazouly,lecture,110 minutes,2017-03-07,,Face to Face,"post-herpetic neuralgia, fibromyalgia, lower back pain, anticonvulsants & antidepressants, Neuropathic pain and adjuvants for chronic pain, Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 13,,MS 231,Serina Rix,lecture,110 minutes,2017-03-02,,Face to Face,"Examples of pain assessment and opioid rotations, SC administration of methadone, Methadone for cancer pain, Guest lecture: methadone",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 12,,MS 231,Momen El Ghazouly,lecture,110 minutes,2017-02-28,,Face to Face,"Multidisciplinary approach to management of chronic pain, Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,inhibitors," opioids)""",Pain in ICU,"Case reports (ankle sprain, etc.)",,,1969-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,(acetaminophen, NSAIDs, COX-2,,,,1969-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 11,,MS 231,Shahileen Retmulla,lecture,110 minutes,2017-02-16,,Face to Face,"Pain assessment, Guest lecture: management of acute pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,exam,,MS 231,John Ussher,exam,110 minutes,2017-02-14,,Face to Face,Midterm exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 10,,MS 231,Sheila Walter,lecture,110 minutes,2017-02-09,,Face to Face,"Opioid allergies, Opioid combination products, COX-2 removal from market, acute pain management (acetaminophen, NSAID, tramadol), Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 9,,MS 231,Sheila Walter,lecture,110 minutes,2017-02-07,,Face to Face,"Goals of therapy, Patient education, Pain presentation, assessment process, Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 8,,MS 231,Peter Smith,lecture,110 minutes,2017-02-02,,Face to Face,"Opioid withdrawal, Opioid addiction, Opioid agonists/antagonists, Pharmacology of morphine, Mechanism of action of opioids, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 7,,MS 231,Peter Smith,lecture,110 minutes,2017-01-31,,Face to Face,"Neuropathic pain, Local anasthetics (chemistry, mechanism of action, pharmacokinetics, toxicity), Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 6,,MS 231,Peter Smith,lecture,110 minutes,2017-01-26,,Face to Face,"Spinal processing of pain, Peripheral processing of pain, Pain perception, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 5,,MS 231,Peter Smith,lecture,110 minutes,2017-01-24,,Face to Face,"Pharmacology of acetominophen, Pharmacology of NSAIDs, Pharmacology of COX1&2, Effects of tissue injury, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 4,,MS 231,Carlos Velzquez,lecture,110 minutes,2017-01-19,,Face to Face,"Specific Opioid drugs, Opioid metabolism, Opioid receptors, Endogenous opioid peptides, Medicinal Chemistry (major analgesics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 3,,MS 231,Carlos Velzquez,lecture,110 minutes,2017-01-17,,Face to Face,"Chemical classes of nonprescription NSAIDs, Chemical classes of prescription NSAIDs, Prescription NSAIDs in Alberta, Medicinal Chemistry (minor analgesics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 2,,MS 231,Susan Patrick,lecture,110 minutes,2017-01-12,,Face to Face,"Pathophysiology of pain, Physiology of pain, Introduction to sensory systems, Overview of neural signaling, Physiology and Pathophysiology of Pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 1,,MS 231,John Ussher,lecture,110 minutes,2017-01-10,,Face to Face,"Chronic pain as a public health problem in Canada, Terms & definitions related to the study of pain, Overview of course syllabus, Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Physiology,,Online,Patrick,lecture,110 minutes,2017-01-10,Direct Lecture,Distance,,,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Physiology,,Online,Patrick,lecture,110 minutes,2017-01-13,Direct Lecture,Distance,,,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Physiology,,Online,Patrick,lecture,110 minutes,2017-01-16,Direct Lecture,Distance,,,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophysiology,,MSB 628,Seubert,lecture,110 minutes,2017-01-18,Direct Lecture,Face to Face,,,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: Beta-blockers/RAAS,,MSB 628,Seubert,lecture,110 minutes,2017-01-20,Direct Lecture,Face to Face,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: Lipids/Diuretics,,MSB 628,Seubert,lecture,110 minutes,2017-01-23,Direct Lecture,Face to Face,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: CCB/Vasodilators,,MSB 628,Seubert,lecture,110 minutes,2017-01-25,Direct Lecture,Face to Face,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,MedChem: Anti-Arrhythmics/CCB/Statins,,MSB 628,Barakat,lecture,110 minutes,2017-01-27,Direct Lecture,Face to Face,,,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: Anti-Arrhythmics,,MSB 628,Light,lecture,110 minutes,2017-01-30,Direct Lecture,Face to Face,,,Explain the effects of drugs used in the management of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Dyslipidemia,,MSB 628,Pearson,lecture,110 minutes,2017-02-01,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Anatomy,,Online,Patrick,lecture,80 minutes,2017-01-09,Direct Lecture,Distance,,,Explain the anatomy of the heart and great blood vessels.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Introduction,,MSB 628,Seubert,lecture,50 minutes,2017-01-09,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap: CHF,,MSB 628,Fradette,lecture,110 minutes,2017-03-24,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Dyslipidemia,,MSB 628,Pearson,lecture,110 minutes,2017-02-03,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Hypertension,,MSB 628,Thompson,lecture,110 minutes,2017-02-10,Direct Lecture,Face to Face,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Hypertension,,MSB 628,Thompson,lecture,110 minutes,2017-02-13,Direct Lecture,Face to Face,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Hypertension,,MSB 628,Thompson,lecture,110 minutes,2017-02-15,Direct Lecture,Face to Face,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Patient Assessment History,,MSB 628,Turgeon,lecture,110 minutes,2017-02-27,Direct Lecture,Face to Face,,,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Patient Assessment Physical Exam,,MSB 628,Turgeon,lecture,110 minutes,2017-03-01,Direct Lecture,Face to Face,,,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap: CHD,,MSB 628,Omar,lecture,110 minutes,2017-03-03,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap: CHD,,MSB 628,May,lecture,110 minutes,2017-03-06,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,ASA-Podcast,,Online,Thompson,lecture,110 minutes,2017-03-08,Direct Lecture,Distance,,,Explain the effects of drugs used in the management of the conditions of primary focus.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,"Pathophys/Therap: ACS, MI",,MSB 628,Ackman,lecture,110 minutes,2017-03-13,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,"Pathophys/Therap: ACS, MI",,MSB 628,Ackman,lecture,110 minutes,2017-03-15,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Kinetics: Anti-Arrhythmics,,MSB 628,Brocks,lecture,110 minutes,2017-03-17,Direct Lecture,Face to Face,,,Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Kinetics: Anti-Arrhythmics,,MSB 628,Brocks,lecture,110 minutes,2017-03-20,Direct Lecture,Face to Face,,,Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap: CHF,,MSB 628,Fradette,lecture,110 minutes,2017-03-22,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Cardiotoxicology,,MSB 628,Seubert,lecture,110 minutes,2017-03-27,Direct Lecture,Face to Face,,,Describe how to manage the toxicity of cardiac medications,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Peripheral Vascular Disease,,MSB 628,Walter,lecture,110 minutes,2017-03-29,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathphys/Therap: A Fib,,MSB 628,George-Phillips,lecture,110 minutes,2017-04-03,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathphys/Therap: A Fib,,MSB 628,George-Phillips,lecture,110 minutes,2017-04-05,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,TBD,,MSB 628,Seubert,lecture,110 minutes,2017-04-05,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 1,,MS 2-31,R. Sanghera,Lecture ,50 minutes ,2018-01-08,,,Course Overview ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 2,,MS 2-31,R. Sanghera,Lecture ,50 minutes ,2018-01-15,,,Jurisprudence Part 1 - F&D Act and Regulations ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 1,,ECHA L1-430,R. Sanghera,Seminar,80 minutes,2018-01-16,,,Jurisprudence Part 2: Intro to the Drug Use Process-PBL Learning Activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 3,,MS 2-31,R. Sanghera,Lecture ,50 minutes ,2018-01-17,,,Jurisprudence Part 1 & 3 - F&D Act and Regulations Contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 2,,ECHA L1-498,R. Sanghera,Seminar,80 minutes,2018-01-18,,,Jurisprudence Part 2: Intro to the Drug Use Process-PBL Learning Activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 4,,MS 2-31,R. Sanghera,Lecture ,50 minutes ,2018-01-19,,,Jurisprudence Part 3 Contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 5,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-01-22,,,"Jurisprudence Part 4  Controlled Drugs and, Substances Act",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 3,,MSB Computer Lab,R. Sanghera,seminar,80 minutes,2018-01-23,,,"Introduction to Pharmacy Software , Introduction to the Prescription Process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Leture 6,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-01-24,,,Jurisprudence Part 6  F&D Regulations; Part G and Part J,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 4,,MSB Computer Lab,R. Sanghera,seminar,80 minutes,2018-01-25,,,"Introduction to Pharmacy Software , Introduction to the Prescription Process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 7,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-01-26,,,Jurisprudence Part 6 Contd  ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 8,,MS 2-31,G. Eberhart,lecture ,110 minutes ,2018-01-29,,,Jurisprudence Part 7: Provincial Legislation ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-29,,,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-29,,,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 6,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-01-30,,,Jurisprudence Part 5  Narcotic Control Regulations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 9,,MS 2-31,D. Cooney,lecture ,50 minutes ,2018-01-31,,,Jurisprudence Part 8: Standards of Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-31,,,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-31,,,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 7,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-02-01,,,Jurisprudence Part 5  Narcotic Control Regulations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 10,,MS 2-31,D. Cooney,lecture ,50 minutes ,2018-02-02,,,Jurisprudence Part 8: Standards of Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-02,,,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-02,,,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 11,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-02-05,,,Bridging the Patient Care Process (PCC) with Jurisprudence ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-05,,,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-05,,,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 8,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-02-06,,,Federal and Provincial Drug Scheduling- PBL Learning Activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 12,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-02-07,,,Bridging the Patient Care Process (PCC) with Jurisprudence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-07,,,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-07,,,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 9,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-02-08,,,Federal and Provincial Drug Scheduling- PBL Learning Activities/Case Based,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-09,,,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-09,,,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,MIDTERM,,TBA,R. Sanghera,exam,50 minutes ,2018-02-12,,,MIDTERM EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-12,,,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-12,,,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 10,,ECHA L1-430,R. Sanghera/L. Walzac,seminar,80 minutes,2018-02-13,,,Adverse Drug Reaction Reporting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 13,,MS 2-31,D. Dolman,lecture ,50 minutes ,2018-02-13,,,Third Party Lecture (Alberta Blue Cross),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-13,,,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-13,,,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 11,,ECHA L1-498,R. Sanghera/L. Walzac,seminar,80 minutes,2018-02-14,,,Adverse Drug Reaction Reporting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 14,,MS 2-31,D. Dolman,Lecture ,50 minutes ,2018-02-14,,,Third Party Lecture (Alberta Blue Cross),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-15,,,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-15,,,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 15,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-02-26,,,Patient Safety,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-26,,,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-26,,,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 12,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-02-27,,,Drug Diversion Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 16,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-02-28,,,Patient Safety Contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-28,,,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-28,,,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 13,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-03-01,,,Drug Diversion Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 17,,MS 2-31,C. Necyk,lecture ,50 minutes ,2018-03-02,,,CAM Legislation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-02,,,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-02,,,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 18,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-03-05,,,Continued Competence (ACP),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-05,,,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-05,,,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 14,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-03-06,,,Pharmacist and Pharm. Tech Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 19,,MS 2-31,R. Sanghera,lecture ,50 minutes ,2018-03-07,,,Review Session & Class Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-07,,,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-07,,,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 15,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-03-08,,,Pharmacist and Pharm. Tech Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-09,,,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-09,,,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,FINAL EXAM,,,R. Sanghera,exam,120 minutes,2018-03-13,,,"CS 2-191: Last Names A to N, CS 2-193: Last Names O to Z",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,"Introduction, Course Syllabus;Anatomy/Physiology",,MSB 227,Yuksel/Patrick,lecture,80 minutes,2017-03-07,Direct Lecture,Face to Face,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,Online,Patrick,lecture,80 minutes,2017-03-09,Direct Lecture,Distance,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception,,MSB 231,Yuksel,lecture,50 minutes,2017-03-13,Direct Lecture,Face to Face,,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal contraception cases,,TBA,Yuksel,seminar,170 minutes,2017-03-22,"Active Learning, Problem Based Learning, Team Based Learning",Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,FASD seminar,,TBA,Mitchell,seminar,170 minutes,2017-03-29,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause cases,,TBA,Yuksel,seminar,170 minutes,2017-04-05,"Active Learning, Problem Based Learning, Team Based Learning",Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Topics in Mens Health: Andropause/ Male Pattern Baldness cont,,MSB 231,Sadowski,lecture,50 minutes,2017-04-05,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Mens Health Seminar,,MSB 227,Sadowski,lecture,80 minutes,2017-04-06,"Direct Lecture, Active Learning",Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Drug Principles in Pregnancy & Lactation,,MSB 231,Yuksel,lecture,50 minutes,2017-04-07,Direct Lecture,Face to Face,,,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Treatment Issues in Pregnancy Prenatal/Postpartum Care/Postpartum Depression,,MSB 227,Yuksel,lecture,110 minutes,2017-04-10,Direct Lecture,Face to Face,,,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Class Evaluations/Final Exam ReviewTreatment of Sexual Dysfunction in Women,,MSB 227,Yuksel,lecture,80 minutes,2017-04-11,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception cont,,MSB 227,Yuksel,lecture,80 minutes,2017-03-14,Direct Lecture,Face to Face,,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception cont,,MSB 231,Yuksel,lecture,50 minutes,2017-03-15,Direct Lecture,Face to Face,,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Contraception Workshop: Non-Hormonal/Barrier Methods,,MSB 231,Grover,seminar,110 minutes,2017-03-15,"Direct Lecture, Active Learning",Face to Face,,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,Online,Patrick,lecture,80 minutes,2017-03-17,Direct Lecture,Distance,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Emergency Contraception,,MSB 231,Yuksel,lecture,50 minutes,2017-03-20,Direct Lecture,Face to Face,,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menstrual Related Disorders/PMS/PMDD,,MSB 227,Yuksel,lecture,80 minutes,2017-03-21,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,Online,Patrick,lecture,50 minutes,2017-03-22,Direct Lecture,Distance,,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 1: Pathophysiology &Pharmacology of hormones,,MSB 227,Yuksel,lecture,80 minutes,2017-03-23,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 2: Management of Symptoms/Hormone Therapy,,MSB 231,Yuksel,lecture,50 minutes,2017-03-24,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 2: Management of Symptoms/Hormone Therapy cont,,MSB 231,Yuksel,lecture,50 minutes,2017-03-27,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Endometriosis;Polycystic Ovarian Syndrome,,MSB 227,Yuksel,lecture,80 minutes,2017-03-28,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.","Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Pregnancy and ovulation testing/Treatment of Infertility,,MSB 231,Yuksel,lecture,80 minutes,2017-03-30,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Medicinal Chemistry,,MSB 231,Wuest,lecture,50 minutes,2017-03-31,Direct Lecture,Face to Face,,,Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Topics in Mens Health: Sexual Dysfunction/Erectile Dysfunction,,MSB 231,Sadowski,lecture,50 minutes,2017-04-03,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Topics in Mens Health: Andropause/ Male Pattern Baldness,,MSB 227,Sadowski,lecture,80 minutes,2017-04-04,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Metabolic syndrome/Healthy Diet: Canadian Health Food Guide,,MS 231,Hoon Sunwoo,lecture,80 minutes,2017-01-12,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Grain and Phytochemical Nutrition: Safety and Health Benefits,,MS 231,Hoon Sunwoo,lecture,50 minutes,2017-01-16,Direct Lecture,Face to Face,,,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition and Age-Related Macular Degeneration,,MS 231,Miyoung Suh,lecture,80 minutes,2017-01-17,Direct Lecture,Face to Face,,,"Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Contemporary Nutrition in Clinical Medicine,,MS 231,Stephen Genius,lecture,80 minutes,2017-01-19,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Food and Drug Interaction,,MS 231,Raimar Loebenberg,lecture,50 minutes,2017-01-20,Direct Lecture,Face to Face,,,Explain the interaction of food and drug.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Q/A,,MS 231,Hoon Sunwoo,lecture,50 minutes,2017-01-23,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition-related Obesity,,MS 231,Blaine Colton,lecture,50 minutes,2017-01-25,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Case Studies of Obesity,,MS 231,Blaine Colton,lecture,50 minutes,2017-01-26,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Search and report on a topic of relevance to nutrition and health.,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition and Male Reproductive Health,,MS 231,Miyoung Suh,lecture,50 minutes,2017-01-27,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition and Autoimmune-Inflammation Diseases,,MS 231,Hoon Sunwoo,lecture,80 minutes,2017-01-30,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition in Celiac Disease and Non-celiac gluten sensitivity,,MS 231,Hoon Sunwoo,lecture,80 minutes,2017-01-31,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Health Effect of Branched Chain Amino Acid,,MS 231,Diana Mager,lecture,50 minutes,2017-02-02,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Health benefits of Ginseng and Omega-3,,MS 231,Jacqueline Shan,lecture,50 minutes,2017-02-03,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition and Bone Health (osteoporosis),,MS 231,Justine Turner,lecture,50 minutes,2017-02-06,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition for Sport Performance,,MS 231,Sarah Loehr,lecture,80 minutes,2017-02-07,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Basic nutritional terminology/Macro Nutrients/Energy Metabolism,,MS 231,Hoon Sunwoo,lecture,50 minutes,2017-01-09,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Search and report on a topic of relevance to nutrition and health.,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition Assessment/Micro Nutrients/DRI/Nutrition and Life Stage,,MS 231,Hoon Sunwoo,lecture,80 minutes,2017-01-10,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Search and report on a topic of relevance to nutrition and health.,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Importance of Nutrients in Parenteral/Enteral Nutrition,,MS 231,Hoon Sunwoo,lecture,50 minutes,2017-01-13,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Nutrition guidelines in Children with IBD and separately IBS,,MS 231,Jason Silverman,lecture,50 minutes,2017-02-08,Direct Lecture,Face to Face,,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Consumer Trends and Regulations in Nonprescriptionand Natural Health Products,,MS 231,Lindsay Sutton,lecture,80 minutes,2017-02-09,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Q/A,,MS 231,Hoon Sunwoo,lecture,50 minutes,2017-02-10,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,A Day in the Life of a Pharmacist II,,ECHA 2-150,Mahmoud,lecture,170 minutes,2017-02-27,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 2 Stroke (Moore),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-06,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 1 Pediatric Asthma (L .Meyer),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-06,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 4 Pediatric Critical Care (Chan),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-13,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 3 Toxicology (Druteika),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-13,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 5 Cardiology (Hall),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-20,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 6 HIV (Foisy),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-20,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 8 Infectious Diseases (Lau),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-27,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 7 Subarachnoid Hemorrhage (Mahmoud),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-03-27,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Course Evaluation and Final Exam Discussion (Mahmoud),,ECHA 2-150,Mahmoud,lecture,50 minutes,2017-04-03,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 9 Transplant (Broscheit),,ECHA 2-150,Mahmoud,lecture,50 minutes,2017-04-03,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Case 10 Pharmacokinetics (Mahmoud),,ECHA 2-150,Mahmoud,lecture,80 minutes,2017-04-03,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Course Introduction,,ECHA 2-150,Mahmoud,lecture,170 minutes,1900-01-09,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Literature Evaluation I,,ECHA 2-150,Makowsky,lecture,170 minutes,2017-01-16,Direct Lecture,Face to Face,,,"Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Literature Evaluation II,,ECHA 2-150,Makowsky,lecture,170 minutes,2017-01-23,Direct Lecture,Face to Face,,,"Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,A Day in the Life of a Pharmacist I,,ECHA 2-150,Mahmoud,lecture,170 minutes,2017-01-30,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Therapeutic Decision Making Cases: Groups 1-5,,ECHA 2-150,Mahmoud,lecture,170 minutes,2017-02-06,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Therapeutic Decision Making Cases: Groups 6-10,,ECHA 2-150,Mahmoud,lecture,170 minutes,2017-02-13,Direct Lecture,Face to Face,,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,"Course Introduction;Introduction to Assignments;Geriatrics; Pre-test, Demographics",,MSB 227,Sadowski,lecture,50 minutes,2017-01-09,Direct Lecture,Face to Face,,," Explain the demographics of aging, and how that may impact society and the healthcare system.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Introductory Geriatrics;Health care utilization;Principles of geriatric care;Psychosocial aspects of aging,,MSB 227,Sadowski,lecture,80 minutes,2017-01-10,Direct Lecture,Face to Face,,,Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Gerontology;Caregiving;Physiologic changes with aging,,MSB 227,Sadowski,lecture,50 minutes,2017-01-11,Direct Lecture,Face to Face,,,Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Pharmacokinetics;Pharmacodynamics;High risk medications in older adults,,MSB 227,Sadowski,lecture,80 minutes,2017-01-12,Direct Lecture,Face to Face,,,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics.",Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Use tools to assess medication appropriateness and medication management in seniors.,Be able to triage patients in a community setting and refer them to medical attention as appropriate.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Medication problems in the elderly;Evidence base/research,,MSB 227,Sadowski,lecture,50 minutes,2017-01-13,Direct Lecture,Face to Face,,,Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors.,Define polypharmacy and underutilization in terms of medications in seniors.,Use tools to assess medication appropriateness and medication management in seniors.,Be able to triage patients in a community setting and refer them to medical attention as appropriate.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug-related problems specific to the populations being studied.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatrics  Elder Abuse,,MSB 227,Elder Abuse Intervention Team (EPS),seminar,110 minutes,2017-01-13,,Face to Face,,,Categorize the types of abuse commonly suffered by seniors.,Describe the role of the pharmacist in reducing elder abuse,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Adverse drug events/Drug Safety;Manifestations of toxicity in the elderly,,MSB 227,Sadowski,lecture,50 minutes,2017-01-16,Direct Lecture,Face to Face,,,Discuss the role of the pharmacist in medication management of seniors.,Use tools to assess medication appropriateness and medication management in seniors.,Be able to triage patients in a community setting and refer them to medical attention as appropriate.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatric Syndromes;Falls,,MSB 227,Sadowski,lecture,80 minutes,2017-01-17,Direct Lecture,Face to Face,,,Describe the impact of falls on the senior population.,Identify risk factors for falls in older individuals.,Describe appropriate interventions for falls.,Contrast how a geriatric syndrome is different than a disease state.,List the common geriatric syndromes.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatric Assessment,,MSB 227,Sadowski,lecture,50 minutes,2017-01-18,Direct Lecture,Face to Face,,,Discuss the role of the pharmacist in medication management of seniors.,Use tools to assess medication appropriateness and medication management in seniors.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatrics  Home Care and Community; Resources,,MSB 227,"Haggarty, Featherstone",seminar,110 minutes,2017-01-18,Direct Lecture,Face to Face,,,Describe the role of the pharmacist in working with home care.,Identify appropriate home care supports for a given patient.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Communication issues for older adults;Resources,,MSB 227,Sadowski,lecture,80 minutes,2017-01-19,Direct Lecture,Face to Face,,,Identify methods of appropriately communicating with older adults who are hard of hearing.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Communication and Child Life,,MSB 227,Painter,lecture,50 minutes,2017-01-20,Direct Lecture,Face to Face,,,Identify and describe age-appropriate communication strategies.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Pediatrics (Introduction);Demographics and DeterminantsEvolution of Pediatric Practice; Current Trends and Practice;Approach to Pediatric Care;Ethical Challenge,,MSB 227,Gukert,lecture,80 minutes,2017-01-24,Direct Lecture,Face to Face,,,"Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)","Identify and discuss some of the challenges involved in treating the pediatric population, including communication strategies, presentation of illness and the management and administration of medications to infants and children.","Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Indigenous Health/Diversity in Vulnerable Populations,,MSB 227,Swidrovich,seminar,110 minutes,2017-01-24,Direct Lecture,Face to Face,,,Describe common stereotypes and biases toward aging in our western society.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Pediatric Toxicology/Medication Safety;Safe medication practices (20 mins);Pediatric age groups;Physiologic differences in children; Impact on PK/PD (30 mins),,MSB 227,"Gukert, Romanick",lecture,50 minutes,2017-01-25,Direct Lecture,Face to Face,,,"Identify and discuss some of the challenges involved in treating the pediatric population, including communication strategies, presentation of illness and the management and administration of medications to infants and children.",Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,Explain how pharmacokinetic parameters are different in infants and children versus adults.," Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants, including premature babies, and neonates",Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,"Student Assignments  Group Work, Debate preparation",,MSB 227,"Sadwoski, Gukert",seminar,80 minutes,2017-01-26,Direct Lecture,Face to Face,,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Seminar  Student Debates,,MSB 227,"Sadwoski, Gukert",seminar,80 minutes,2017-01-26,Direct Lecture,Face to Face,,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,"GI: diarrhea/hydration/vomiting, constipation, colic",,MSB 227,Romanick,lecture,50 minutes,2017-01-27,Direct Lecture,Face to Face,,,"Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,,,,,lecture,50 minutes,2017-01-15,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Pediatrics Abuse,,MSB 227,Dibden,lecture,50 minutes,2017-01-30,Direct Lecture,Face to Face,,,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assessment of Newborn/Neonatal care;Terminology of gestation and birthweight;Prematurity and birthweight implications;Teething;Topical Analgesics,,MSB 227,Dersch,lecture,80 minutes,2017-01-31,Direct Lecture,Face to Face,,,Discuss basic neonatal care and challenges including premature birth.,Identify and discuss appropriate management plans for common pediatric concerns such as teething and fevers.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,"Clinical Issues in Pediatrics (Respiratory) croup, bronchiolitis, fever and febrile seizures",,MSB 227,Dersch,lecture,50 minutes,2017-02-01,Direct Lecture,Face to Face,,,Discuss presentation and treatment for common pulmonary pediatric illnesses; croup and bronchiolitis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,"Clinical Issues in Pediatrics;Pediatric references; guidelines, equations, tools;Review of age appropriate references for dosing, formulations and recipes",,MSB 227,Dersch,seminar,110 minutes,2017-02-01,Direct Lecture,Face to Face,,,Discuss the importance of medication safety and identify measures used to ensure safe medication practices,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Autism Spectrum Disorder,,MSB 227,Gagnon,lecture,50 minutes,2017-02-03,Direct Lecture,Face to Face,,,Discuss the management and implications involved with a diagnosis of autism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Alopecia/ Hyperhidrosis,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-12,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Time off for assignment,,TBA,R. Sanghera,lecture,50 minutes,2017-04-14,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Time off for assignment,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-15,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Anatomy & Physiology of the Eye: Special Senses,,Online,S. Patrick,lecture,50 minutes,2017-03-14,,Distance,,,"Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Anatomy & Physiology of the Ear, Nose and Throat ",,Online,S. Patrick,lecture,50 minutes,2017-03-14,Direct Lecture,Distance,,,"Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Course Introduction; Assignment Introduction; Scholar Lecture; Introduction to Scholar;Counseling Self-Treating Patients Quickly and Effectively,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-14,Direct Lecture,Face to Face,,,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Allergic Rhinitis Contd,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-15,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Intro to the Ear; Be able to perform an assessment of a patient who presents with hearing loss, ear pain and ear drainage ;Have an awareness of some of the drugs that cause ototoxicity and the characteristics of the drug-induced ototoxicity ;Describe the common disorders of the auditory canal and middle ear;Differentiate between the signs and symptoms of the following otic conditions and make recommendations: o Cerumen (earwax) impaction o Otitis Externa o Otitis Media; Identify the role of the following agents in the treatment of ear disorders o Anti-infectives o Analgesics o Local anesthetics o Wax softeners o Cerumenolytics;Demonstrate the correct method: o Instilling ear drops( adults & children);Ear syringing",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-15,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Overview of Lab; How will the labs operate? o Timing o Rotations o Roles & responsibilities; What is the Patient Care Process? ;Scenario in relation to marking rubric,,ECHA 2 490,R. Sanghera,seminar,80 minutes,2017-03-17,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Allergic Rhinitis, PMCOL of Antihistamines & Decongestants;Describe the classification of allergic rhinitis;Understand the mechanism of action of antihistamines;Understand inverse agonis;Recognize potential adverse effects of antihistamine;Explain the pathophysiology of allergic rhinitis;Describe the management of allergic rhinitis (drug & nondrug);Understand the role of immunotherapy;Demonstrate how to use emergency epinephrine products",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-18,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Ophthalmology Part I o Diagnosis & Management of Eye Disease o Care for contact lenses,,CS 2-193,R. Mangat,lecture,50 minutes,2017-03-18,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Ophthalmology Part I Contd,,CS 2-193,R. Mangat,lecture,50 minutes,2017-03-18,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Allergic Rhinitis, PMCOL of Antihistamines & Decongestants; Describe the classification of allergic rhinitis;Understand the mechanism of action of antihistamines;Understand inverse agonism;Recognize potential adverse effects of antihistamines;Explain the pathophysiology of allergic rhinitis;Describe the management of allergic rhinitis (drug & nondrug);Understand the role of immunotherapy;Demonstrate how to use emergency epinephrine products",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-15,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Dermatitis/Eczema/ Seborrhea/ Psoriasis,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-04,Direct Lecture,Face to Face,,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Dermatitis/Eczema/ Seborrhea/ Psoriasis  Therapeutics Dermatologic Disease  Eczema & Psoriasis Dermatologic Therapeutics Topical Corticosteroids Systemic Corticosteroids Topical Vitamin D3 Analogues, Methotrexate, Sunscreen, Topical Hydroquinone, Topical Calcineurin Inhibitors",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-04,Direct Lecture,Face to Face,,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Dermatitis/Eczema/ Seborrhea/ Psoriasis,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-04,Direct Lecture,Face to Face,,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Drug-induced Skin Eruptions & Contact Dermatitis Contact Dermatitis & Adverse Cutaneous Drug Reactions,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-06,Direct Lecture,Face to Face,,,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Sunburn, Skin Cancer, Vitiligo & Hyperpigmentation Dermatologic Disease; Skin Cancer; Melasma; Vitiligo; Dermatologic Therapeutics; Sunscreen; Topical Hydroquinone; Topical Calcineurin Inhibitors",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-06,Direct Lecture,Face to Face,,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),,Prac Lab,R. Sanghera,lab,50 minutes,2017-04-06,Direct Lecture,Face to Face,,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Dermatological Diseases Contd,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-06,Direct Lecture,Face to Face,,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Wound Care The process of wound healing Moist wound healing theory Wound classification Basic wound care Wound care products,,CS 2-193,C. Steele,lecture,50 minutes,2017-04-08,Direct Lecture,Face to Face,,,Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),,Prac Lab,R. Sanghera,lab,50 minutes,2017-04-08,Direct Lecture,Face to Face,,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Wound Care Contd,,CS 2-193,C. Steele,lecture,50 minutes,2017-04-08,Direct Lecture,Face to Face,,,Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Corns/Calluses Class Wrap-up,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-12,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Acne/Rosacea Therapeutics, PMCOL of Retinoids; Understand retinoids are analogues of Vitamin A; Mechanism of action not well understood; Potential for adverse effects, especially with oral retinoids; Dermatologic Disease o  Acne & Rosacea Dermatologic Therapeutics o Topical Benzoyl Peroxide, o Topical Retinoids o Systemic Retinoids o Isotretinoin Topical Metronidazole",,CS 2-193,J. Carbon,lecture,50 minutes,2017-03-21,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Debrief Ear Assignment; Physiology & Anatomy- Integumentary System (Online, students will be given time off in future classes. The module will be released early)",,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-21,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Lice/Scabies: Life cycle and transmission, Epidemiology, Presenting symptoms, Treatment drug/non-drug; Antiparasitics: MOA o Indications/Contraindications/Precautions o Dose/Duration of Treatment o Adverse Effects Prevention (Role of the pharmacist)",,CS 2-193,A Hemraj,lecture,50 minutes,2017-03-21,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences., follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Acne/Rosacea Contd,,CS 2-193,J. Carbon,lecture,50 minutes,2017-03-23,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medicinal Chemistry/PMCOL: Corticosteroids Familiarize with structures of some important corticosteroids Relative potency of topical corticosteroids Understand structure-activity relationships Familiarize with few common antiproliferatives Define inflammation Identify inflammatory mediators Identify the three main strategies to treat inflammation Identify the three main classes of drugs that modulate eicosanoid pharmacology Describe the three mechanisms of action associated with anti-inflammatory drugs,,CS 2-193,C. Velasquez,lecture,50 minutes,2017-03-23,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medicinal Chemistry: Antihistamines Study histamine structure and its different chemical forms Familiarize with phamacophores for antihistamine activity Understand structure-activity relationships,,CS 2-193,C. Velasquez,lecture,50 minutes,2017-03-23,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"PCP/Case Workup Gather relevant patient-related information. Use a systematic approach to complete a patient assessment and identify drug related problems. Given a case, develop a care plan. Describe the importance of documentation and the essential components. Develop a documentation note.",J1,ED 129,R. Sanghera,seminar,80 minutes,2017-03-24,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"PCP/Case Workup Gather relevant patient-related information. Use a systematic approach to complete a patient assessment and identify drug related problems. Given a case, develop a care plan. Describe the importance of documentation and the essential components. Develop a documentation note.",J2,ED 129,R. Sanghera,seminar,80 minutes,2017-03-24,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice)",,Prac Lab,R. Sanghera,lab,50 minutes,2017-03-30,Direct Lecture,Face to Face,,, follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Assignment Introduction/TBA,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-03-30,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Ophthalmology Contd,,CS 2-193,C. Sadowski,lecture,50 minutes,2017-04-01,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Ophthalmology Pat II AMD Glaucoma Cataracts Age related eye changes,,CS 2-193,C. Sadowski,lecture,50 minutes,2017-04-01,Direct Lecture,Face to Face,,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Time off in lieu of Physiology/Anatomy,,CS 2-193,R. Sanghera,lecture,50 minutes,2017-04-01,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice) ",,Prac Lab,R. Sanghera,lab,50 minutes,2017-04-01,Direct Lecture,Face to Face,,, follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Dermatology Compounding,,CS 2-193,A Virji,lecture,50 minutes,2017-04-11,"Direct Lecture, Active Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Dermatology Compounding,,CS 2-193,A Virji,lecture,50 minutes,2017-04-11,"Direct Lecture, Active Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Practice Discussion,,CS 2-193,A Fuller,lecture,50 minutes,2017-04-11,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 1,,MS Lab 1-45,Sherif / Daniela,lab,,2018-01-16,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 21,,TBA,Amir / Lb,seminar,,2018-03-10,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 20,,TBA,Amir / Lb,seminar,,2018-03-08,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 19,,TBA,Amir / Lb,seminar,,2018-03-06,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 18,,TBA,Amina / Lb ,seminar,,2018-03-03,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 17,,TBA,Amina / Lb ,seminar,,2018-03-01,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 16,,TBA,Amina / Lb ,seminar,,2018-02-27,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 15,,TBA,Igor / Lb,seminar,,2018-02-10,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 14,,TBA,Igor / Lb,seminar,,2018-02-08,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 13,,TBA,Igor / Lb,seminar,,2018-02-06,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 12,,TBA,Hanan/ Lb,seminar,,2018-02-03,,Face to Face,Emulsion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 11,,TBA,Hanan/ Lb,seminar,,2018-02-01,,Face to Face,Emulsion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 10,,TBA,Hanan/ Lb,seminar,,2018-01-30,,Face to Face,Emulsion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 9,,TBA,Daniela / Lb,seminar,,2018-01-27,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 8,,TBA,Daniela / Lb,seminar,,2018-01-25,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 7,,TBA,Daniela / Lb,seminar,,2018-01-23,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 6,,TBA,Sherif / Lav ,seminar,,2018-01-20,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 5,,TBA,Sherif / Lav ,seminar,,2018-01-18,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 4,,TBA,Sherif / Lav ,seminar,,2018-01-16,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 3,,TBA,Doaa / Lb ,seminar,,2018-01-13,,Face to Face,Accuracy in Pharmaceutical Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 2,,TBA,Doaa / Lb ,seminar,,2018-01-11,,Face to Face,Accuracy in Pharmaceutical Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 1,,TBA,Doaa / Lb ,seminar,,2018-01-09,,Face to Face,Accuracy in Pharmaceutical Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 17,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-17,,Face to Face,Routes of Administration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 16,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-15,,Face to Face,Routes of Administration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 15,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-13,,Face to Face,Compounding review ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 14,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-10,,Face to Face,Containers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 13,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-08,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 12,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-06,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 11,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-03,,Face to Face,Colloids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 10,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-01,,Face to Face,Colloids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,EXAM,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-30,,Face to Face,Midterm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 9,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-27,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 8,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-25,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 7,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-23,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 6,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-20,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 5,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-18,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 4,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-16,,Face to Face,Pharmaceutical Solutions and Waters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 3,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-13,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 2,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-11,,Face to Face,Contemporary Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 1,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-09,,Face to Face,Introduction into Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Exam,,MS Lab 1-45,,,,2018-03-21,,,Lab exam ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 21,,MS Lab 1-45,Amir / Sherif,lab,,2018-03-10,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 20,,MS Lab 1-45,Amir / Sherif,lab,,2018-03-08,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 19,,MS Lab 1-45,Amir / Sherif,lab,,2018-03-06,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 18,,MS Lab 1-45,Asma / Amir,lab,,2018-03-03,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 17,,MS Lab 1-45,Asma / Amir,lab,,2018-03-01,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 16,,MS Lab 1-45,Asma / Amir,lab,,2018-02-27,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 15,,MS Lab 1-45,Doaa / Asma,lab,,2018-02-17,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 14,,MS Lab 1-45,Doaa / Asma,lab,,2018-02-15,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 13,,MS Lab 1-45,Doaa / Asma,lab,,2018-02-13,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 12,,MS Lab 1-45,Igor / Doaa,lab,,2018-02-10,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 11,,MS Lab 1-45,Igor / Doaa,lab,,2018-02-08,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 10,,MS Lab 1-45,Igor / Doaa,lab,,2018-02-06,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 9,,MS Lab 1-45,Hanan/ Igor,lab,,2018-02-03,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 8,,MS Lab 1-45,Hanan/ Igor,lab,,2018-02-01,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 7,,MS Lab 1-45,Hanan/ Igor,lab,,2018-01-30,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 6,,MS Lab 1-45,Daniela/Hanan,lab,,2018-01-27,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 5,,MS Lab 1-45,Daniela/Hanan,lab,,2018-01-25,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 4,,MS Lab 1-45,Daniela/Hanan,lab,,2018-01-23,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 3,,MS Lab 1-45,Sherif / Daniela,lab,,2018-01-20,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 2,,MS Lab 1-45,Sherif / Daniela,lab,,2018-01-18,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Therapeutics: HIV (case discussions),,MSB 227,Hughes,lecture,110 minutes,2017-03-06,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Mycology overview,,MSB 227,Dingle,lecture,50 minutes,2017-03-24,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Immunization of adults/travellers Vaccine storage and handling,,,Hughes,lecture,50 minutes,2017-01-25,Direct Lecture,Distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Travellerâ€™s Health Practice,,MSB 227,Kmet,lecture,50 minutes,2017-03-22,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Virology: respiratory illnesses, gastroenteritis, rash illnesses, viral hepatitis, CNS infections, herpes viruses, HPV",,MSB 227,Charlton,lecture,110 minutes,2017-01-11,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Therapeutics: HIV/opportunistic Infections - candidiasis, mycobacterium avium, PJP",,MSB 227,Hughes,lecture,110 minutes,2017-03-08,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Patient Perspective (HIV),,MSB 227,Guest,lecture,50 minutes,2017-03-08,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Introduction/Virology overview: structure, classification, replication, transmission, diagnosis",,MSB 227,Hughes/Charlton,lecture,110 minutes,2017-01-09,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Case: Herpes Zoster,,"ED B19, ED B18, ED 158",Hughes/Gray/Watson,seminar,110 minutes,2017-02-08,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Case - HIV,,"ED B19, ED B18, ED 158",Hughes/Foisy/Gray/Benson/Nickel,seminar,110 minutes,2017-03-15,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,No class - study time Review questions/cases will be posted onâ€êline,,MSB 227,Hughes,lecture,50 minutes,2017-04-07,,Distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Legal & Ethical Issues: Vaccinations,,MSB 227,Ogbogu,lecture,110 minutes,2017-01-18,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Virology: respiratory illnesses, gastroenteritis, rash illnesses, viral hepatitis, CNS infections, herpes viruses, HPV",,MSB 227,Charlton,lecture,110 minutes,2017-01-13,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Antivirals: pharmacology anti-herpes drugs, anti-HBV drugs, anti-HCV drugs, anti-influenza agents",,MSB 227,Siraki,lecture,110 minutes,2017-01-16,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Vaccine Licensure and Immunization delivery,,MSB 227,Hedley,lecture,50 minutes,2017-01-20,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Overview of vaccine types: live, killed/inactivated/subunit, vaccine failures, reactions",,Recorded Lecture,Hughes,lecture,50 minutes,2017-01-20,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Immunizations of adults/ travellers; Vaccine storage and handling; Immunization delivery ,,MSB 227,Hughes,lecture,110 minutes,2017-01-23,Direct Lecture,Distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Immunizations of children: vaccine schedules, adverse effects, illness manifestations",,MSB 227,Hedley,lecture,110 minutes,2017-01-27,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Immunization delivery (case examples) Therapeutics: Herpes Simplex 1 & 2,,MSB 227,Hughes,lecture,110 minutes,2017-01-30,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Therapeutics: Herpes Zoster,,MSB 227,Hughes,lecture,110 minutes,2017-02-01,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Hepatitis recorded lecture & case preparation,,Recorded Lecture,Hughes,lecture,110 minutes,2017-02-03,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Therapeutics: Hepatitis A&B Hepatitis C Case Discussions,,MSB 227,Hughes,lecture,110 minutes,2017-02-06,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Therapeutics: Influenza,,MSB 227,Watson,lecture,110 minutes,2017-02-10,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Midterm review - practice questions,,MSB 227,Hughes,lecture,80 minutes,2017-02-13,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Therapeutics: STIs - chlamydia, gonorrhea, syphilis, genital herpes, genital HPV",,MSB 227,Singh,lecture,50 minutes,2017-02-15,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"HIV overview (Pathophysiology, transmission, diagnosis)",,MSB 227,Hughes,lecture,110 minutes,2017-02-27,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Therapeutics: HIV Drug classes, MOA, side effects, interactions, goals of therapy",,MSB 227,Hughes,lecture,110 minutes,2017-03-03,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Antiprotozoals - pharmacology antimalarials, other antiprotozoals",,MSB 227,Ussher,lecture,80 minutes,2017-03-10,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Parasitology introduction,,MSB 227,Kowaleskaâ€êGrochowska,lecture,50 minutes,2017-03-13,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Travellerâ€™s Health - Malaria,,MSB 227,Houston,lecture,110 minutes,2017-03-17,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Therapeutics: Protozoal Diseases - toxoplasmosis, giardia lamblia, cryptosporidium, amebiasis",,MSB 227,Kowaleskaâ€êGrochowska,lecture,80 minutes,2017-03-20,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Therapeutics: Pinworms,,MSB 227,Shi/Hughes,lecture,110 minutes,2017-03-22,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Antifungals Pharmacology - polyenes, imidazoles & triazoles,echinocandins",,MSB 227,Gray,lecture,110 minutes,2017-03-27,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Bioterrorism,,MSB 227,Franc,lecture,50 minutes,2017-03-29,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,"Therapeutics: Dermatophytoses (candida, ringworm, athletes foot, jock itch, fungal nail infections)",,MSB 227,Hughes,lecture,110 minutes,2017-04-03,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Course evaluations; Final exam review,,MSB 227,Hughes,lecture,50 minutes,2017-04-03,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Case discussions - Systemic Fungal Infections,,MSB 227,Gray,lecture,110 minutes,2017-04-05,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Critical Evaluation of the Literature*,,,Mark Makowsky,lecture,50 minutes,2016-02-10,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Journal Club  Group EBM Project Presentation*,,,Jill Hall,lecture,50 minutes,2016-02-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Journal Club  Group EBM Project Presentation*,,,Jill Hall,lecture,50 minutes,2016-02-13,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Journal Club  Group EBM Project Presentation*,,,Jennifer Shiu,lecture,50 minutes,2016-02-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Journal Club  Group EBM Project Presentation*,,,Mark Makowsky,lecture,50 minutes,2016-02-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Journal Club  Group EBM Project Presentation*,,,Jennifer Shiu,lecture,50 minutes,2016-02-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Journal Club  Group EBM Project Presentation*,,,Mark Makowsky,lecture,50 minutes,2016-02-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Introduction/Overview of evidence-based clinical practice,,,Mark Makowsky,lecture,50 minutes,2016-01-10,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,What is the Best Evidence?,,,Mark Makowsky,lecture,50 minutes,2016-01-12,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Research Skills*,,,TBA,seminar,50 minutes,2016-01-16,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Practical Statistics & Weighing the Risks and Benefits,,,Mark Makowsky,lecture,50 minutes,2016-01-17,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Research Skills*,,,TBA,lecture,50 minutes,2016-01-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Critical Appraisal of a RCT  Assessing Validity ,,,Mark Makowsky,lecture,50 minutes,2016-01-19,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Research Skills*,,,TBA,lecture,50 minutes,2016-01-20,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Research Skills*,,,TBA,lecture,50 minutes,2016-01-23,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Critical Appraisal of a RCT  Assessing Validity II,,,Mark Makowsky,lecture,50 minutes,2016-01-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Research Skills*,,,TBA,lecture,50 minutes,2016-01-25,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Critical Appraisal of a RCT  Validity III & RCT - Interpreting the Results,,,Mark Makowsky,lecture,50 minutes,2016-01-26,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Research Skills*,,,TBA,lecture,50 minutes,2016-01-27,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Critical Appraisal of a RCT - Application of study results to patient care,,,Mark Makowsky,lecture,50 minutes,2016-01-31,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Critical Appraisal of a RCT - Measuring patient experiences,,,Mark Makowsky,lecture,50 minutes,2016-02-02,Direct Lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Critical Evaluation of the Literature*,,,Jill Hall,lecture,50 minutes,2016-02-06,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning, Blended Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar: Critical Evaluation of the Literature*,,,Shiu,lecture,50 minutes,2016-02-08,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Course Introduction;Anatomy and Physiology,,MS 227,Necyk/Patrick,lecture,80 minutes,2017-01-10,Direct Lecture,Face to Face,,,Identify the main anatomical components of the endocrine system.,Describe the physiological effects of endocrine hormones.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Anatomy and Physiology,,Online,Patrick,lecture,80 minutes,2017-01-12,Direct Lecture,Distance,,,Identify the main anatomical components of the endocrine system.,Describe the physiological effects of endocrine hormones.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Introduction to Diabetes,,MS 227,Simpson,lecture,80 minutes,2017-01-17,Direct Lecture,Face to Face,,,Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Pharmacology  Antidiabetic Drugs,,MS 227,Ussher,lecture,80 minutes,2017-01-19,Direct Lecture,Face to Face,,,Recognize the main structural features of drugs used to manage endocrine disorders.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Medicinal Chemistry  Antidiabetic Drugs,,MS 227,Velazquez,lecture,80 minutes,2017-01-24,Direct Lecture,Face to Face,,,Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Anatomy and Physiology,,Online,Patrick,lecture,80 minutes,2017-01-26,Direct Lecture,Distance,,,Identify the main anatomical components of the endocrine system.,Describe the physiological effects of endocrine hormones.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Type 2 Diabetes  Treatment (Part I),,MS 227,Eurich,lecture,80 minutes,2017-01-31,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Type 2 Diabetes  Treatment (Part II),,MS 227,Eurich,lecture,80 minutes,2017-02-02,Direct Lecture,Face to Face,,,Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Diabetes (Type 2) Management,,TBA,Necyk,seminar,110 minutes,2017-02-03,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",Face to Face,,,Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Insulin Use in Type 1 Diabetes,,MS 227,Yeung,lecture,80 minutes,2017-02-07,Direct Lecture,Face to Face,,,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Insulin Use in Type 2 Diabetes,,MS 227,Hodgins,lecture,80 minutes,2017-02-09,Direct Lecture,Face to Face,,,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Insulin Dosing and Management,,TBA,Necyk,seminar,110 minutes,2017-02-09,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",Face to Face,,,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Gestational Diabetes,,MS 227,Ryan,lecture,80 minutes,2017-02-16,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Long-term Complications of Diabetes ,,MS 227,Simpson,lecture,80 minutes,2017-02-28,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the adverse effects of drugs used to manage endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Current issues in Diabetes Management,,MS 227,Simpson,lecture,80 minutes,2017-03-02,Direct Lecture,Face to Face,,,Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Medicinal Chemistry  Thyroid Drugs,,MS 227,Velazquez,lecture,80 minutes,2017-03-14,Direct Lecture,Face to Face,,,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Review Material for Session 19 Case Discussions,,TBA,Necyk,seminar,110 minutes,2017-03-17,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Thyroid Disorders,,MS 227,Hughes,lecture,80 minutes,2017-03-21,Direct Lecture,Face to Face,,,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,"Vitamin D, PTH & Bone Metabolism",,MS 227,Doschak,lecture,80 minutes,2017-03-23,Direct Lecture,Face to Face,,,Describe the physiological effects of endocrine hormones.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Disorders of the Pituitary and Adrenals,,MS 227,Yeung,lecture,80 minutes,2017-03-28,Direct Lecture,Face to Face,,,Describe the physiological effects of endocrine hormones.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Complimentary & Alternative Medications for Diabetes & Thyroid,,MS 227,Zubach-Cassano/Necyk,lecture,80 minutes,2017-03-30,Direct Lecture,Face to Face,,,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Final Exam,,,,lecture,50 minutes,2017-07-10,,face to face,FINAL EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Lecture 7,,,Charrois/Bharadia,lecture,50 minutes,2017-07-03,,face to face,"Final Exam Review , Diagnostic Studies Blended Online/Classroom, Qualitative Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Seminar 5,,,Bharadia,seminar,50 minutes,2017-06-26,,face to face,Should it be an RCT? (focus: observational research),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Lecture 6,,,Bharadia,lecture,50 minutes,2017-06-26,,face to face,Observational Research: Appraisal of case control and cohort studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Seminar 4,,,Bharadia,seminar,50 minutes,2017-06-19,,face to face,Journal Club,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Lecture 5,,,Charrois/Bharadia,lecture,50 minutes,2017-06-19,,face to face,Synthesized Resources: Systematic Reviews & Meta analysis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Lecture 4,,,Simpson/Bharadia,lecture,50 minutes,2017-06-12,,face to face,Synthesized Resources: Clinical Practice Guidelines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Seminar 3,,,Bharadia,seminar,50 minutes,2017-06-12,,face to face,Are we misguided? (focus: clinical practice guidelines),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,:ecture 3,,,Bharadia,lecture,50 minutes,2017-06-05,,face to face,Articles on Therapy: Non inferiority,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Seminar 2,,,Bharadia,seminar,50 minutes,2017-06-05,,face to face,Evidence in the media (focus: articles on therapy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Lecture 2,,,Bharadia,lecture,50 minutes,2017-05-31,,face to face,Articles on Therapy: RCT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Lecture 1,,TBD,,lecture,50 minutes,2017-05-30,,face to face,"Review: Principles of Evidence-Based Clinical PracticeeLiteracy, Critical appraisal & eNumeracy, Course Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Seminar 1,,,Kung,seminar,50 minutes,2017-05-29,,face to face,Finding the Best Evidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Asthma (Pediatrics) ,,TBD,Deonne Dersch-Mills,lecture,50 minutes,2017-07-13,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Diabetes,,TBD,Rhonda Roedler ,lecture,50 minutes,2017-06-29,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Heart Failure (Geriatrics),,TBD,Ginny Cummings,lecture,50 minutes,2017-07-06,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Communication in Collaboration & Interprofessional Teams,,TBD,Teresa Paslawski/Jill Hall,seminar,50 minutes,2017-07-19,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Mental Health,,TBD,Jeff Lanz/Candace Necyk,lecture,50 minutes,2017-07-20,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Pain/Addiction,,TBD,Brett Baumback,lecture,50 minutes,2017-07-27,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Therapeutic Drug Monitoring (antibiotics),,TBD,Serena Bains,seminar,50 minutes,2017-08-02,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Infectious Diseases,,TBD,Cecilia Lau /Serena Bains,lecture,50 minutes,2017-08-03,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,TBL Practice Case; Introduction to Patient 1,,TBD,Jill Hall,lecture,50 minutes,2017-06-15,Direct Lecture,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,CV Risk Reduction,,TBD,Rene Breault/Ann Thompson,lecture,50 minutes,2017-06-22,"Direct Lecture, Active Learning, Problem Based Learning",Face to Face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,FINAL EXAM,,,,exam,,2017-07-07,,,Final Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Seminar 6,,,Sherif Mahmoud,seminar,110 minutes,2017-07-05,,Face to Face,Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lab 3,,,Renette Bertholet / Sherif Mahmoud,seminar,110 minutes,2017-06-23,,Face to Face,Patient Assessment 3 (Cardiovascular),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Seminar 5,,,Sherif Mahmoud / Jill Hall,lab,240 minutes,2017-07-05,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Facilitated Cases 5,,,Candace Necyk / Sherif Mahmoud,lecture,110 minutes,2017-06-28,,Face to Face,Mental health assessment case,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 8,,,Candace Necyk / Sherif Mahmoud,seminar,110 minutes,2017-06-28,,Face to Face,Mental health assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Seminar 4,,,Candace Necyk,lecture,110 minutes,2017-06-26,,Distance,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Facilitated Cases 4,,,Mary Gunther,lecture,110 minutes,2017-06-21,,Face to Face,Anemia assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 7,,,Mary Gunther / Sherif Mahmoud,seminar,110 minutes,2017-06-21,,Face to Face,Anemia Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lab 2,,,Ravina Sanghera / Sherif Mahmoud,lecture,110 minutes,2017-06-16,,Distance,Patient Assessment 2 (Respiratory assessment),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Seminar 3,,,Mary Gunther,lab,240 minutes,2017-06-19,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Facilitated Cases 3,,,Rene Breault,lecture,110 minutes,2017-06-14,,Face to Face,Infectious disease assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 6,,,Rene Breault / Sherif Mahmoud,seminar,110 minutes,2017-06-14,,Face to Face,Pre-lab: Strep Pharyngitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 5,,,Sherif Mahmoud,lecture,110 minutes,2017-06-12,,Distance,Pharmacokinetic Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 4,,,Rene Breault,lecture,110 minutes,2017-06-12,,Face to Face,Infectious disease assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lab 1,,,Ann Thompson/ Sherif Mahmoud,lab,240 minutes,2017-06-09,,Face to Face,Patient Assessment 1 (Skin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Seminar 2,,,Christine Hughes,lecture,110 minutes,2017-06-07,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Facilitated Cases 2,,,Christine Hughes/ Sherif Mahmoud,seminar,110 minutes,2017-06-07,,Face to Face,Liver and Kidney functions assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 3,,,Christine Hughes,lecture,110 minutes,2017-06-05,,Distance,Liver and Kidney Functions Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Seminar 1,,,Sherif Mahmoud,lecture,110 miuntes,2017-06-02,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Facilitated Cases 1,,,Sherif Mahmoud/ Jill Hall,seminar,110 minutes,2017-06-02,,Face to Face,Symptom Assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 2,,,Sherif Mahmoud,lecture,110 minutes,2017-05-31,,Face to Face,Symptom Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Lecture 1,,,Sherif Mahmoud,lecture,110 minutes,2017-05-29,,Face to Face,"Course introduction, patient assessment, documentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 13,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-12-05,,face to face,Concentration and IV Infusion Rates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 4,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-10-19,,face to face,"Pharmaceutical Measurement, Aliquots, Least Weighable Quantities",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 3,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-10-17,,face to face,Calculation of Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 7,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-11-02,,face to face,Percentage and Ratio Strength,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 5,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-10-26,,face to face,Manipulating Formulas,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 6,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-10-31,,face to face,Density and Specific Gravity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 8,,TBA,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-11-09,,face to face,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 9,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-11-21,,face to face,Dilutions and Alligation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 10,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-11-23,,face to face,Isotonic Solutions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 11,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-11-28,,face to face,Electrolyte Solutions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 12,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-11-30,,face to face,Content TBA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 14,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-12-07,,face to face,Course Review and Prep for Final,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Final,,TBA,Gillian Johnson/Ravina Sanghera,lecture,110 minutes,2018-12-11,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Lecture 2,,MS 2-27,Gillian Johnson/Ravina Sanghera,lecture,80 minutes,2017-10-12,,face to face,Systems of Measure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 3,,MS 628,Tyler Moore (AHS),lecture,110 minutes,2017-09-29,,face to face,Therapeutics: Stroke,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 4,,MS 628,Carlos Velazquez,lecture,50 minutes,2017-10-02,,face to face,Chemistry: Seizures and Epilepsy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 5,,MS231,Sherif Mahmoud,lecture,80 minutes,2017-10-03,,face to face,Therapeutics;Pharmacology: Seizures and Epilepsy 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 6,,MS231,Sherif Mahmoud,lecture,110 minutes,2017-10-04,,face to face,Therapeutics: Seizures and Epilepsy 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 7,,MS231,Sherif Mahmoud,lecture,80 minutes,2017-10-05,,face to face,Therapeutics: Seizures and Epilepsy 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Seminar 1,,ECHA 1-490 ECHA 1-498,Sherif Mahmoud Tyler Moore (AHS),seminar,170 minutes,2017-10-06,,face to face,Case studies - Seizures and Epilepsy; Stroke,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 8,,eClass,Susan Patrick,lecture,80 minutes,2017-10-10,,face to face,Anatomy/Physiology 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 2,,MS231,Susan Patrick,lecture,80 minutes,2017-09-28,,face to face,Anatomy/Physiology 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 14,,MS231,Peter Smith (Faculty of Medicine) Sherif Mahmoud,lecture,110 minutes,2017-10-18,,face to face,Pharmacology: Headache (1h) Therapeutics: Headache 1 (1h),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 15,,MS231,Sherif Mahmoud,lecture,80 minutes,2017-10-19,,face to face,Therapeutics: Headache 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Seminar 2,,ECHA 1-498,Sherif Mahmoud,seminar,170 minutes,2017-10-19,,face to face,Rare Neurologic Disorders Seminar: A day in the life of a Neurology Pharmacist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Midterm Exam,,TBA,,lecture,110 minutes,2017-10-20,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 16,,MS 628,Sherif Mahmoud Carlos Velazquez,lecture,110 minutes,2017-10-23,,face to face,Therapeutics: Traumatic Brain Injury (1h) Chemistry: Dopaminergic Neurotransmission (1h),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 20,,MS 628,Sherif Mahmoud,lecture,110 minutes,2017-10-27,,face to face,Therapeutics: Myasthenia Gravis Course Feedback/Final Exam Discussion ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Final Exam,,TBA,,lecture,110 minutes,2017-11-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 9,,MS 628,Bradley Kerr (Faculty of Medicine),lecture,110 minutes,2017-10-11,,face to face,Pharmacology _ Multiple Sclerosis; Movement Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 10,,eClass,Susan Patrick,lecture,80 minutes,2017-10-12,,face to face,Anatomy/Physiology 4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 11,,eClass,Susan Patrick,lecture,110 minutes,2017-10-13,,face to face,Anatomy/Physiology 5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 12,,MS 628,Penny Smyth(Faculty of Medicine),lecture,110 minutes,2017-10-16,,face to face,Therapeutics: Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 13,,MS231,Cheryl Sadowski,lecture,80 minutes,2017-10-17,,face to face,"Therapeutics: Dizziness _ Vertigo, Dysequilibrium, Syncope, Lightheadedness",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 17,,MS231,Cheryl Sadowski,lecture,80 minutes,2017-10-24,,face to face,Therapeutics: Movement Disorders 1 (Parkinson Disease),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 18,,MS 628,Cheryl Sadowski,lecture,110 minutes,2017-10-25,,face to face,Therapeutics: Movement Disorders 2(Restless Legs Syndrome; Tremor; LegCramps),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Seminar 3,,ECHA 1-420 ECHA 1-498,Cheryl Sadowski & Sherif Mahmoud,seminar,170 minutes,2017-10-25,,face to face,Case studies - Movement Disorders; Headache,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 19,,MS628,Sherif Mahmoud,lecture,110 minutes,2017-10-26,,face to face,Therapeutics: Peripheral Neuropathies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 1,,MS231,Sherif Mahmoud Susan Patrick,lecture,80 minutes,2017-09-26,,face to face,Introduction; Anatomy/Physiology 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 2,,MS 628,S. Patrick,lecture,80 minutes,2017-09-07,,face to face,"Physiology, Describe anatomy and function of the kidney, ureters, bladder and urethra, Describe physiology of the kidney, including regulation of glomerular filtration, sodium-water balance, fluid balance, acid-base balance as well as other electrolytes, tubular reabsorption and secretion., Describe physiology of the ureters, bladder and urethra including a general outline of bladder function and micturition",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 14,,MS 628,R. Breault,lecture,80 minutes,2017-10-31,,face to face,Chronic Kidney Disease Part II Management of Complications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 15,,MS 628,R. Breault,lecture,80 minutes,2017-11-02,,face to face,"Drug Dosing in Renal Failure and Dialysis, Review of the assessment of renal function, including calculations of creatinine clearance and estimated GFR, Review the effects of renal impairment on the absorption, distribution, metabolism and excretion of drugs, Practical approach using case-based examples of adjusting medications in patients with renal impairment.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 16,,Online,R. Sanghera,lecture,80 minutes,2017-11-07,,face to face,"Introduction to Renal Replacement Therapy, Basic overview of hemodialysis, peritoneal dialysis, and continuous renal replacement therapy, Drug dosing considerations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 17,,MS 628,R. Breault,lecture,80 minutes,2017-11-09,,face to face,"Nephrolithiasis (Kidney Stones), Epidemiology, risk factors, pathophysiology, clinical signs and symptoms of kidney stones",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,MIDTERM,,TBA,R. Sanghera,lecture,80 minutes,2017-10-19,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 13,,MS 628,R. Breault,lecture,80 minutes,2017-10-24,,face to face,"Chronic Kidney Disease Part I Epidemiology and Pathophysiology, Epidemiology and Pathophysiology, Review of the epidemiology, etiology and pathophysiology of CKD, Management of Complications, Overview of the drug therapy used to manage the common complications of chronic kidney disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 3,,MS 628,S. Patrick,lecture,80 minutes,2017-09-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 4,,MS 628,S. Patrick,lecture,80 minutes,2017-09-14,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 8,,MS 628,A. Hemraj,lecture,80 minutes,2017-09-28,,face to face,Overview of common laboratory values used in the diagnosis and monitoring of various disease states,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 9,,MS 628,J. Ton,lecture,80 minutes,2017-10-03,,face to face,Laboratory Values: Acid/Base,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 10,,MS 628,R. Breault,lecture,80 minutes,2017-10-10,,face to face,Introduction to Kidney Disease and Renal Lab Values,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 11,,MS 628,R. Breault,lecture,80 minutes,2017-10-12,,face to face,"Acute Kidney Injury-Drug Induced Kidney Injury, Review of the definition of AKI, the pathophysiology, causes and management of AKI, Explanation of the mechanism of injury to the kidney and toxicology secondary to commonly used drugs, Explanation of the different forms of drug induced kidney injury based on presentation, history, clinical symptoms and urinary findings., Identification of renal protective strategies for various drug induced renal injuries",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 1,,MS 628,R. Sanghera-S. Patrick,lecture,80 minutes,2017-09-05,,face to face,Course Introduction Anatomy -Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 5,,MS 628,A. Tse,lecture,80 minutes,2017-09-19,,face to face,"Diuretic Pharmacology, Describe and review the various classes of diuretics, their mechanism of action and place in therapy including osmotic, loop, thiazide diuretics, carbonic anhydrase inhibitors, and potassium sparing diuretics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 6,,MS 628,R. Sanghera,lecture,80 minutes,2017-09-21,,face to face,Introduction to lab values and how they are accessed in pharmacy practice. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 7,,MS 628,"A, Hemraj",lecture,80 minutes,2017-09-26,,face to face,Overview of common laboratory values used in the diagnosis and monitoring of various disease states. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Seminar 1,,TBA,R. Sanghera,seminar,110 minutes,2017-10-12,,face to face,Electrolyte Disorders- Laboratory Values,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 12,,MS 628,J. Ton and R. Sanghera,lecture,80 minutes,2017-10-17,,face to face,Drug Information Resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 18,,MS 628,N/A,lecture,80 minutes,2017-11-14,,face to face,Reading Week No Class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 19,,MS 628,R. Sanghera,lecture,80 minutes,2017-11-21,,face to face,Time off to work on practice cases as asked,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 20,,MS 628,C. Sadowski,lecture,80 minutes,2017-11-23,,face to face,"Lower Urinary Tract Symptoms Part I (Pharmacological Treatment), Overview of the classification, pathophysiology, signs and symptoms and diagnosis of various lower urinary tract symptoms",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 21,,MS 628,K. Hunter,lecture,80 minutes,2017-11-28,,face to face,"Lower Urinary Tract Symptoms Part II (Non-pharmacological Treatment), Management of LUTS via pharmacological treatments will be discussed in detail",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 22,,MS 628,R. Sanghera,lecture,80 minutes,2017-11-30,,face to face,Flex lecture time,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Seminar 2,,TBA,R. Sanghera,seminar,110 minutes,2017-11-30,,face to face,Urology-LUTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Lecture 23,,MSB 628,J. Ton-R. Sanghera,lecture,80 minutes,2017-12-05,,face to face,"Class wrap-up, Review of Drug Information Resources (contd from Oct 17)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,FINAL,,,,lecture,110 minutes,2017-12-18,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 7,,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-18,,face to face,RADIOSENSITIZATION AND PHOTOSENSITIZATION: Concepts and therapeutic advantage to combining radiation with pharmaceuticals; Mechanisms of radiation therapy and chemotherapy; The role of free radicals in mediating chemotherapeutic/toxic action; Chemical requirements for radiosensitizers; Radioprotection as a means to prevent damage to normal tissues; Photosensitization as a means to generate reactive species for photodynamic therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 8,,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-20,,face to face,ADJUNCT AGENTS FOR USE WITH DIAGNOSTIC IMAGING: Specific examples where organ imaging requires enhancement with drugs; Mechanism of action of drugs and how the image improves,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 9 (IN CLASS QUIZ),,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-22,"Direct Lecture, Active Learning",face to face,"Summary of diagnostic imaging & contrast agents AND IN-CLASS QUIZ;X-RAY, ULTRASOUND, MRI: X-ray, ultrasound, MRI; Contrast agents (iodinated; bismuth) in Xray; Paramagnetic contrast agents in MRI; ultrasonic contrast agents.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 10,,MS 227,Dr. Schirrmacher,lecture,50 minutes,2017-09-25,,face to face,RADIOPHARMACEUTICALS - PRACTICAL ASPECTS: Techniques for dispensing of radiopharmaceuticals; Tc99m generators,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 11,,MS 227,Dr. Schirrmacher,lecture,50 minutes,2017-09-27,,face to face,"RADIOPHARMACEUTICALS - PRACTICAL ASPECTS: Design, calibration and use of equipment for radionuclide assays; Purpose of using radiopharmaceuticals, routes of administration, and safe dispensing.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 12,,MS 227,Dr. Schirrmacher,lecture,50 minutes,2017-09-29,,face to face,RADIOPHARMACEUTICAL APPLICATIONS: Radiopharmaceuticals in clinical practice; Radiopharmaceuticals in bone scanning Radiopharmaceuticals in cardiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 13,,MS 227,Dr. Wuest,lecture,50 minutes,2017-10-02,,face to face,POSITRON EMISSION TOMOGRAPHY (PET): Positron Emissions-Tomography (PET): Molecular imaging and molecular; Positron Emission Tomography (PET): A general introduction; PET-Radiotracers as molecular probes for medical research and clinical routin; PET-RADIOTRACERS AS MOLECULAR PROBES FOR MEDICAL RESEARCH AND CLINICAL ROUTIN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 1,,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-05,,face to face,INTRODUCTION / RADIATION PRINCIPLES: Brief overview of what to expect from this course; Begin content of next lecture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 2,,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-06,,face to face,RADIATION PRINCIPLES: Atomic structure; concepts of nuclear stability; radioactive isotopes; radiation emissions;Types of radioactive decay associated with nuclides commonly used for medical purposes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 3 (IN-CLASS QUIZ),,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-07,"Direct Lecture, Active Learning",face to face,Continuation of Radiation Principles and IN-CLASS QUIZ  (material so far),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 4,,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-08,,face to face,"RADIATION EFFECTS ON LIVING SYSTEMS; Units of radioactivity; calculations involving radioactive decay, calculations for radiopharmaceutical dosage to allow for radioactive decay; concepts of physical, biological and effective half-life; Charged particles; electromagnetic radiation, thermal and fast neurons, physical characteristics, sources, interactions with matter, energy loss, tissue penetration (this topic presented from a health sciences viewpoint)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 5,,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-11,,face to face,"RADIATION EFFECTS ON LIVING SYSTEMS: Concepts of radiation energy in terms of transfer and absorption in biological systems; Mechanisms of radiation induced injury; Oxidative stress as a result of radiation, and biological effects; Antioxidant enzymes as deterrents to free radical induced damage.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Lecture 6,,MS 227,Dr. Siraki,lecture,50 minutes,2017-09-13,,face to face,RADIATION EFFECTS ON LIVING SYSTEMS: Other radicals that can partake in radiation induced damage; Damage of free radicals to biological targets and its consequences; Free radicals and cell death; A description of the enzymatic and nonenzymatic systems to detoxify radiation induced free radical formation; Free radicals and cell death; Signalling mechanisms that can result in death or carcinogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,MIDTERM,,ECHA 2-190,Dr. Siraki,lecture,50 minutes,2017-09-15,,face to face,"Know lectures 1-6 inclusive , MCQs based on material covered in week 1 - 3.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Functional groups (characteristics and roles),,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-06,Direct Lecture,face to face,Most common types of functional groups in drug molecules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Functional groups (characteristics and roles),,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-08,Direct Lecture,face to face,"Chemical, electronic, and stereochemical features of functional groups",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Identifying acidic and basic functional groups in drug molecules,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-11,Direct Lecture,face to face,Identifying acidic and basic groups,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Identifying acidic and basic functional groups in drug molecules,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-12,Direct Lecture,face to face,Most common types of acidic groups in drug molecules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Identifying acidic and basic functional groups in drug molecules,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-13,Direct Lecture,face to face,Most common types of basic groups in drug molecules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Identifying acidic and basic functional groups in drug molecules,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-15,,face to face,Therapeutic significance of acidic and basic groups in drug molecules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,pH and pKa problems (principles and applications),,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-18,Direct Lecture,face to face,Definitions of pH and pKa; The Henderson-Hasselbach equation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,pH and pKa problems (principles and applications),,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-20,Direct Lecture,face to face,Solving pH and pKa problems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,pH and pKa (principles and applications),,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-25,Direct Lecture,face to face,pH and pKa - Principles and Applications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,pH and pKa (principles and applications),,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-27,,face to face,The importance of pH and pKa in drug therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,pH and pKa (principles and applications),,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-29,Direct Lecture,face to face,Drug interactions based on pH and pKa changes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Salts and solubility,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-10-02,Direct Lecture,face to face,Definition of salts (organic vs inorganic); applications of salts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Salts and solubility,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-10-04,Direct Lecture,face to face,Salts in drug interactions; different uses of salts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Salts and Solubility,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-10-06,Direct Lecture,face to face,The balance between water and lipid solubility; strategies for optimizing drug solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Salts and Solubility,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-10-11,Direct Lecture,face to face,Salts and drug metabolism; routes of administration of different salts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug binding interactions,,MSB 231,Khaled Barakat,lecture,50 minutes,2017-10-13,Direct Lecture,face to face,Covalent bonds; ionic bonds; non-covalent bonds,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug binding interactions,,MSB 231,Khaled Barakat,lecture,50 minutes,2017-10-16,Direct Lecture,face to face,Ion-dipole and dipole-dipole interactions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug binding interactions,,MSB 231,Khaled Barakat,lecture,50 minutes,2017-10-18,Direct Lecture,face to face,Hydrogen bonds,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,MIDTERM EXAM,,To be announced (eClass),Carlos Velazquez / Teaching assistant,lecture,110 minutes,2017-10-23,Other,face to face,All lectures until this date,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Stereochemistry,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-10-25,Direct Lecture,face to face,Chirality and asymmetry; enantiomers and diastereomers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Stereochemistry,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-10-27,Direct Lecture,face to face,Pharmacological implications of stereoisomers; geometric isomers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Stereochemistry,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-10-30,Direct Lecture,face to face,Conformational isomers and its implications in drug therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Stereochemistry,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-11-01,,face to face,Conformational restriction and its implications in drug therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug metabolism,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2017-11-03,Direct Lecture,face to face,General concepts about drug metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug metabolism,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2017-11-06,Direct Lecture,face to face,Factors that affect drug metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug Metabolism,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2017-11-08,Direct Lecture,face to face,"Phase I metabolism (oxidation, reduction and hydrolysis)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug Metabolism,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2017-11-10,Direct Lecture,face to face,"Phase I metabolism (oxidation, reduction and hydrolysis)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug Metabolism,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2017-11-20,Direct Lecture,face to face,Phase II metabolism (conjugation),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug Metabolism,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2017-11-22,Direct Lecture,face to face,Phase II metabolism (methylation),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug Metabolism,,MSB 231,Ayman El-Kadi,lecture,50 minutes,2017-11-24,Direct Lecture,face to face,Therapeutic implications of drug metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug Transporter Proteins,,MSB 231,Dion Brocks,lecture,50 minutes,2017-11-27,Direct Lecture,face to face,"Active transporters, organic ion transporters",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug Transporter Proteins,,MSB 231,Dion Brocks,lecture,50 minutes,2017-11-29,Direct Lecture,face to face,Clinical considerations of ion transporters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Structure-activity Relationships (SAR),,MSB 231,Khaled Barakat,lecture,50 minutes,2017-12-01,Direct Lecture,face to face,Structure-activity relationships (SAR) and pharmacological activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Structure-activity Relationships (SAR),,MSB 231,Khaled Barakat,lecture,50 minutes,2017-12-04,Direct Lecture,face to face,SARs and molecular modification in drug design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Concepts in Drug Design,,MSB 231,Khaled Barakat,lecture,50 minutes,2017-12-06,Direct Lecture,face to face,Functional group replacements; isosters and bioisosters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Concepts in Drug Design,,MSB 231,Khaled Barakat,lecture,50 minutes,2017-12-08,Direct Lecture,face to face,Prodrugs and their uses drug therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,FINAL EXAM,,To be announaced,Teaching Assistant ,lecture,50 minutes,2017-12-18,Other,face to face,FINAL EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Introduction - Course outline,,MSB 231,Carlos A. Velazquez,lecture,50 minutes,2017-09-05,Direct Lecture,face to face,Introduction and course expectations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Drug binding interactions,,MSB 231,Khaled Barakat,lecture,50 minutes,2017-10-20,,face to face,van der Waals and hydrophobic interactions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 7c,,,Jill Hall; Cheryl Sadowski,lecture,110 minutes,2017-11-08,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Seminar 1,,,Sharon Marsh,seminar,110 minutes,2017-11-20,,face to face,Pharmacogenomics/Drug Metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Seminar 2,,,Sherif Mahmoud,seminar,110 minutes,2017-11-22,,face to face,TDM - anticonvulsants,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TCBL 2a,,,Jill Hall; Tara Leslie,lecture,50 minutes,2017-11-24,,face to face,Oncologic Complications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TCBL 1b,,,Jill Hall; Stan Dyjur,lecture,50 minutes,2017-10-23,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TCBL 1c,,,Jill Hall; Stan Dyjur,lecture,110 minutes,2017-10-25,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 6a,,,Jill Hall; Cathy Biggs,lecture,50 minutes,2017-10-27,,face to face,Pain and Addiction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 6b,,,Jill Hall; Cathy Biggs,lecture,170 minutes,2017-10-30,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 6c,,,Jill Hall; Cathy Biggs,lecture,110 minutes,2017-11-01,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 7a,,,Jill Hall; Cheryl Sadowski,lecture,50 minutes,2017-11-03,,face to face,Geriatrics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 7b,,,Jill Hall; Cheryl Sadowski,lecture,170 minutes,2017-11-06,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,CBL 2b,,,Jill Hall; Alice Chan,lecture,110 minutes,2017-12-04,,face to face,"See Above, (9:00-11:00)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Seminar 3,,,Jill Hall; Alice Chan,seminar,110 minutes,2017-12-06,,face to face,"TDM - antibiotics, (9:00-11:00)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TCBL 2b,,,Jill Hall; Tara Leslie,lecture,170 minutes,2017-11-27,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TCBL 2c,,,Jill Hall; Tara Leslie,lecture,110 minutes,2017-11-29,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,CBL 2a,,,Jill Hall; Alice Chan,lecture,110 minutes,2017-12-01,,face to face,"ID - Pneumonia , (8:00-10:00)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 1a,,,Jill Hall; Glen Pearson ,lecture,50 minutes,2017-09-08,,face to face,CV Risk Reduction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 1b,,,Jill Hall; Glen Pearson,lecture,170 minutes,2017-09-11,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 1c,,,Jill Hall; Glen Pearson,lecture,110 minutes,2017-09-13,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 2a,,,Jill Hall; Ricky Turgeon ,lecture,50 minutes,2017-09-15,,face to face,Heart Failure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 2b,,,Jill Hall; Ricky Turgeon,lecture,170 minutes,2017-09-18,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 2c,,,Jill Hall; Ricky Turgeon,lecture,110 minutes,2017-09-20,,face to face,See above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 3a,,,Jill Hall; Joline Vretenar ,lecture,50 minutes,2017-09-23,,face to face,Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 3b,,,Jill Hall; Joline Vretenar ,lecture,170 minutes,2017-09-26,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 3c,,,Jill Hall; Joline Vretenar ,lecture,110 minutes,2017-09-27,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 4a,,,Jill Hall; Kirsten George-Phillips,lecture,50 minutes,2017-09-29,,face to face,AFib / Stroke,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 4b,,,Jill Hall; Kirsten George-Phillips,lecture,170 minutes,2017-10-02,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 4c,,,Jill Hall; Kirsten George-Phillips,lecture,110 minutes,2017-10-04,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,CBL 1a,,,Jill Hall; Deon Druteika,lecture,110 minutes,2017-10-06,,face to face,"COPD, (8:00-10:00)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,CBL 1b,,,Jill Hall; Deon Druteika ,lecture,110 minutes,2017-10-11,,face to face,"See above, (9:00-11:00)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 5a,,,Jill Hall,lecture,50 minutes,2017-10-13,,face to face,Rheumatoid Arthritis / Osteoarthritis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 5b,,,Jill Hall,lecture,170 minutes,2017-10-16,,face to face,See above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,PBL 5c,,,Jill Hall,lecture,110 minutes,2017-10-18,,face to face,See above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TCBL 1a,,,Jill Hall; Stan Dyjur,lecture,50 minutes,2017-10-20,,face to face,Depression and Anxiety ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 16,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-16,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 17,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-18,,face to face,Drug distribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 18,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-20,,face to face,Drug distribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 2,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-08,,face to face,Kinetics of Transport/Kinetics of iv bolus Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 3,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-11,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 4,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-13,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 5,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-15,,face to face,Kinetics of iv bolus Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 6,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-18,,face to face,Compartmental Concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 29,,MS 227,Dr. Kiang,lecture,50 minutes,2017-11-27,,face to face,Effects of age on pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 30,,MS 227,Dr. Kiang,lecture,50 minutes,2017-11-29,,face to face,Effects of age on pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 31,,MS 227,Dr. Kiang,lecture,50 minutes,2017-12-01,,face to face,Drugs in pregnancy and lactation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 32,,MS 227,Dr. Kiang,lecture,50 minutes,2017-12-04,,face to face,Drugs in pregnancy and lactation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 33,,MS 227,Dr. Kiang,lecture,50 minutes,2017-12-06,,face to face,Other patient-specific changes in drug PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 34,,MS 227,Dr. Kiang,lecture,50 minutes,2017-12-08,,face to face,Other patient-specific changes in drug PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,FINAL,,,,lecture,110 minutes,2017-12-20,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 1,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-06,,face to face,Introduction/Kinetics of Transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 10,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-27,,face to face,Kinetics of Doses after 1st order Input,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,MIDTERM,,MS 227,Dr. Brocks,lecture,80 minutes,2017-10-23,Other,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 9,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-25,,face to face,Kinetics of Doses after intravenous infusion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 11,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-29,,face to face,Oral absorption and bioequivalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 12,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-02,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 13,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-04,,face to face,Kinetics after Constant Input of Drug,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 14,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-06,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 15,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-11,,face to face,Multiple dose pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 19,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-25,,face to face,Drug distribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 20,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-27,,face to face,Drug distribution/clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 21,,MS 227,Dr. Brocks,lecture,50 minutes,2017-10-30,,face to face,Drug clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 22,,MS 227,Dr. Brocks,lecture,50 minutes,2017-11-01,,face to face,Drug clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 23,,MS 227,Dr. Brocks,lecture,50 minutes,2017-11-06,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 24,,MS 227,Dr. Brocks,lecture,50 minutes,2017-11-08,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 25,,MS 227,Dr. Brocks,lecture,50 minutes,2017-11-10,,face to face,Nonlinear elimination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 26,,MS 227,Dr. Brocks,lecture,50 minutes,2017-11-20,Direct Lecture,face to face,"Nonlinear elimination, PK-PD relationship",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 27,,MS 227,Dr. Guirguis,lecture,50 minutes,2017-11-22,Direct Lecture,face to face,PK drug interactions overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 28,,MS 227,Dr. Kiang,lecture,50 minutes,2017-11-24,,face to face,Clinical variables affecting PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 7,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-20,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture 8,,MS 227,Dr. Brocks,lecture,50 minutes,2017-09-22,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 1,,MS 628,Dr. Samokhvalov,lecture,80 minutes,2017-09-05,,,"History of disease, Cancer key aspects;  Cancer statistics, Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 2,,MS 628,Dr. Wuest,lecture,110 minutes,2017-09-06,,,"Mechanisms of action of the main categories of anticancer drugs, Medicinal chemistry , Use in cancer treatment. Side effects and patient care, Radiation Oncology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 3,,MS 628,Dr. Leslie,lecture,110 minutes,2017-09-08,,,"Background, Incidence, Diagnosis and Treatment options, Haematological cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 4,,ECHA L- 490,Dr. Leslie,lecture,170 minutes,2017-09-08,,,"Safety of agents to treat haematological cancer, Haematological cancer/Med. Safety",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 5,,MS 628,Dr. Danilak,lecture,110 minutes,2017-09-11,,,"Drug-drug interactions. Mechanisms of action. Managing medications, Drug Interactions, Background of disease, Incidence, Diagnosis, Treatment options, Prostate cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 6,,MS 628,Dr. Jurasz,lecture,80 minutes,2017-09-12,,,"Background and use of another recent classof anti-cancer drugs, Anti-angiogenesis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 7,,MS 628,Dr. Romanick and Dr. Basiuk,lecture,110 minutes,2017-09-13,,,"Background of disease, Incidence, Diagnosis, Treatment options, Paediatric  Cancer, Types of complimentary medicines, evidence for and against, issues with alternative medicines, Complimentary and Alternative Medicines (CAM)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 8,,ECHA L1-490,Dr. Danilak,lecture,170 minutes,2017-09-13,,,"Background of disease, Incidence, Diagnosis, Treatment options, Breast Cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 9,,MS 628,Dr. Jurasz,lecture,80 minutes,2017-09-14,,,"Background and use one of the newest classes of anti-cancer drugs, Immunotherapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,MIDTERM,,TBD,,exam,110 minutes,2017-09-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 10,,MS 628,Dr. Rix,lecture,110 minutes,2017-09-18,,,"Anti-cancer medications causing cardiotoxicity., Diagnosos., Treatment and Monitoring, Cardiotoxicity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 11,,MS 628,Dr. Barakos,lecture,80 minutes,2017-09-19,,,"Cachexia in cancer patients., treatment options, Nutrition",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 12,,MS 628,Dr. Rix,lecture,110 minutes,2017-09-20,,,"Cause, incidence and management of gastrointestinal toxixity in cancer patients, Gastrointestinal toxicity ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 13,,ECHA L1-490,Ovarian Canada/Myeloma Foundation,lecture,170 minutes,2017-09-20,,,"Ovarian and myeloma cancer survivors discuss their experience with time for Q&A, Patient Perspectives",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 14,,MS 628,Dr. Rix,lecture,80 minutes,2017-09-21,,,"Antibiotic and antifungal treatment for secondary infections from febrile neutropenia, Managing Infection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 15,,MS 628,Dr. Rix,lecture,110 minutes,2017-09-22,,,"Long term and end of life pain management, including oncology specific treatment options and ethics, Introduction to Palliative care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 16,,MS 628,Dr. John,lecture,110  minutes,2017-09-25,,,"Background of disease, incidence, diagnosis, treatment options, Colorectal Cancer, Background of disease, incidence, diagnosis, treatment options, Lung Cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 17,,online,Dr. Marsh,lecture,110 minutes,2017-09-27,,,"Determining relevant treatment or dose to prevent toxicity and/or improve likelihood of treatment response, Predicting toxicity and screening patients prior to treatment based on DNA, Pharmacogenomics, Background of disease, incidence, diagnosis, treatment options, Pancreatic/ovarian/cervical/melanoma cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 18,,MS 628,Dr. Ha,lecture,110 minutes,2017-09-29,,,Palliative Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Lecture 19,,MS 628,Dr. Ha,lecture,140 minutes,2017-10-02,,,Palliative Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,FINAL,,CS 2-191 and CS 2-193,,exam,110 minutes,2017-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3,D5,MS 1-15,Course TAs,lab,110 minutes,2017-10-25,Active Learning,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3,D6,MS 1-15,Course TAs,lab,110 minutes,2017-10-27,Active Learning,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lecture 2,,MS 227,Katherine Sorenson,lecture,50 minutes,2017-09-26,Direct Lecture,face to face,"Drug information resources, Role of drug information in healthcare, Drug Information Services and Resources",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 1,D4,MS 1-15,Course TAs,lab,110 minutes,2017-09-25,Active Learning,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 1,E1,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-12,"Direct Lecture, Active Learning",face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Introduction to Drug Information,,MS 227,Ken Cor & TBA,lecture,50 minutes,2017-09-08,Direct Lecture,face to face,"Types of drug information resources, Types of drug information requests, Pharmacists role in answering drug information requests","""Identify categories of drug information requests."", ""List primary drug information sources required for community pharmacy practice."", ""List common drug information requesters.""",Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 1,E2,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-11,"Direct Lecture, Active Learning",face to face,Research Skills Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 1,E6,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-21,"Direct Lecture, Active Learning",face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 1,E4,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-18,"Direct Lecture, Active Learning",face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 1,E3,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-19,"Direct Lecture, Active Learning",face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Seminar 1,E5,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-20,"Direct Lecture, Active Learning",face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 1,D5,MS 1-15,Course TAs,lab,110 minutes,2017-09-27,Active Learning,face to face,Drug Information Resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 1,D6,MS 1-15,Course TAs,lab,110 minutes,2017-09-29,Active Learning,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lecture 3,,MS 227,Katherine Sorenson,lecture,110 minutes,2017-10-03,Direct Lecture,face to face,"Following-up, Replying to the requestor, Planning and complete a literature search, Obtaining background information, Evaluating the data and composing a response, Classifying and confirming the ultimate question, Gathering requestor information, Systematic Approach to Drug Information",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 2,D4,MS 1-15,Course TAs,lab,110 minutes,2017-10-06,Active Learning,face to face,Systematic Approach to Drug Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 2,D5,MS 1-15,Course TAs,lab,110 minutes,2017-10-11,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 2,D6,MS 1-15,Course TAs,lab,110 minutes,2017-10-20,Active Learning,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3,D4,MS 1-15,Course TAs,lab,110 minutes,2017-10-23,Active Learning,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Group Dynamics,2,Online,,lecture,50 minutes,2017-09-17,Other,distance,"Evaluating Group Experiences, Effective vs. Ineffective Groups",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Setting Goals and Objectives and Evaluation Plans,3,Online,,lecture,50 minutes,2017-10-01,Other,distance,"Developing an Approach to Evaluation, Critique of Learning Goals and Objectives, Goals vs. Objectives, Individual and Group Goals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Learning Styles,4,Online,,lecture,50 minutes,2017-10-15,Other,distance,"Identification of Personal Learning Styles, Familiarization with Common Learning Styles",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Learning Theory Presentations,5,Online,,lecture,50 minutes,2017-10-29,Other,distance,"Reflect on Learning Theories Prevalent in Teaching Approaches, Review Each Group's Presentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Critical Learning Theories,6,Online,,lecture,50 minutes,2017-11-19,Other,distance,"Examine Personal Perspective on Teaching and Learning, Examine Relevance of Critical Theory in Practice, Discuss Learning Styles Through a Critical Lens",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Introduction to Group Theory and Learning Theories,1,Online,,lecture,50 minutes,2017-09-05,Other,distance,"Relevance of Theory, Course Review Quiz, ""Who am I?"" Activity, Welcome Module",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 1,,ECHA 1-498,Kiang,lecture,170 minutes,2017-09-11,,face to face,Course Introduction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 2,,ECHA 1-498,Makowsky,lecture,170 minutes,2017-09-18,,face to face,"Literature Evaluation I, Searching PICO questions, Tailoring Search Strategies, Keeping Current; Databases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 3,,ECHA 1-498,Kiang,lecture,170 minutes,2017-09-25,,face to face,"A Day in the Life of a Pharmacist , Patient Care Skills Interactive Workshop, Patient Cases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 4,,ECHA 1-498,Makowsky,lecture,170 minutes,2017-10-02,,face to face,"Literature Evaluation II, Step-by-step: Journal Club Interactive Workshop",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 5,,ECHA 1-498,Kiang,lecture,170 minutes,2017-10-16,,face to face,Therapeutic Decision Making Cases: Groups 1-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 6,,ECHA 1-498,Kiang,lecture,170 minutes,2017-10-23,,face to face,Therapeutic Decision Making Cases: Groups 6-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 7,,ECHA 1-498,Kiang,lecture,170 minutes,2017-10-30,,face to face,"Case 1 Pediatric Asthma (L .Meyer), Case 2 Stroke (Moore)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 8,,ECHA 1-498,Kiang,lecture,170 minutes,2017-11-06,,face to face,"Case 4 Pediatric Critical Care (Chan), Case 3 Toxicology (Druteika)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 9,,ECHA 1-498,Kiang,lecture,170 minutes,2017-11-20,,face to face,"Case 5 Cardiology (Hall), Case 6 HIV (Foisy)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 10,,ECHA 1-498,Kiang,lecture,170 minutes,2017-11-27,,face to face,"Case 7 Subarachnoid Hemorrhage (Mahmoud), Case 8 Infectious Diseases (Lau)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Lecture 11,,ECHA 1-498,Kiang,lecture,170 minutes,2017-12-04,,face to face,"Course Evaluation, Case 9 Transplant (Broscheit), Case 10 Pharmacokinetics, Final Exam Discussion ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,FINAL EXAM,,TBA,,exam,170 minutes,1969-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 19,,ECHA 1-490,R. Breault ,lecture,50 minutes,2017-11-27,"Active Learning, Other",face to face,Symptom Assessment Presentations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 20,,ECHA 1-490,R. Breault ,lecture,110 minutes,2017-11-29,"Active Learning, Team Based Learning",face to face,Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,FINAL,,,R. Breault ,lecture,170 minutes,2017-12-13,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 1,,Online,R. Breault ,lecture,50 minutes,2017-09-04,Direct Lecture,distance,"Patient care process, patient assessment, documentation, symptom assessment ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 11,,Online ,T. Lawson,lecture,50 minutes,2017-10-16,Direct Lecture,distance,Patient Assessment: Critical Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 3,,ECHA 1-240,S. MacLennan,lab,170 minutes,2017-09-29,Active Learning,face to face,Physical Assessment: HEENT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 9,,Online,C. Hughes,lecture,50 minutes,2017-10-02,Direct Lecture,distance,Lab Values: Anemia Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 2,,ECHA 1-240,S. MacLennan,lab,170 minutes,2017-09-22,Active Learning,face to face,Physical Assessment: Skin Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 7,,Online,R. Breault ,lecture,50 minutes,2017-09-25,Direct Lecture,distance,Lab Values: Liver Chemistry Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 8,,ECHA 1-490,R. Breault ,lecture,110 minutes,2017-09-27,"Active Learning, Team Based Learning",face to face,Lab Values: Liver Chemistry Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 15,,Online,C. Necyk,lecture,50 minutes,2017-10-30,Direct Lecture,distance,Patient Assessment: Mental Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 16,,ECHA 1-490,C. Necyk,lecture,110 minutes,2017-11-01,"Active Learning, Team Based Learning",face to face,Patient Assessment: Mental Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 17,,ECHA 1-490,R. Breault,lecture,110 minutes,2017-11-08,"Active Learning, Team Based Learning",face to face,Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 2,,ECHA 1-490,R. Breault ,lecture,110 minutes,2017-09-06,"Active Learning, Team Based Learning",face to face,"Patient care process, patient assessment, documentation; Symptom Assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 3,,,R. Breault ,lecture,50 minutes,2017-09-11,Other,face to face,"Patient Care Process, Patient Assessment, documentation, Symptom Assessment ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 1,,ECHA 1-240,S. MacLennan,lab,170 minutes,2017-09-15,Active Learning,face to face,"Physical Assessment: Basic Techniques, BP & Vitals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 5,,Online,R. Breault ,lecture,50 minutes,2017-09-18,Direct Lecture,distance,Lab values  Kidney Function,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 6,,ECHA 1-490,R. Breault,lecture,110 minutes,2017-09-20,"Active Learning, Team Based Learning",face to face,Lab Values: Kidney Function ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 12,,ECHA 1-490,T. Lawson,lecture,110 minutes,2017-10-18,"Active Learning, Team Based Learning",face to face,Patient Assessment: Critical Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 5,,ECHA 1-240,S. MacLennan,lab,170 minutes,2017-10-20,Active Learning,face to face,Physical Assessment: Neuromuscular,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 13,,Online,M. Gunther,lecture,50 minutes,2017-10-23,Direct Lecture,distance,Patient Assessment: Infectious Diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 14,,ECHA 1-490,M. Gunther,lecture,110 minutes,2017-10-25,"Active Learning, Team Based Learning",face to face,Patient Assessment: Infectious Diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,MIDTERM ,,Learning Assessment Centre,R. Breault ,lecture,80 minutes,2017-10-27,Other,face to face,Midterm Exam ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 4,,ECHA 1-490,R. Breault ,lecture,110 minutes,2017-09-13,"Active Learning, Team Based Learning",face to face,"Patient Care Process, Patient Assessment, Documentation, Symptom Assessment ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 21,,ECHA 1-490,R. Breault,lecture,50 minutes,2017-12-04,Active Learning,face to face,Symptom Assessment Assignment Presentations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 22,,ECHA 1-490,R. Breault,lecture,110 minutes,2017-12-06,"Active Learning, Team Based Learning",face to face,Course Review/Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 10,,ECHA 1-490,C. Hughes,lecture,110 minutes,2017-10-04,"Active Learning, Team Based Learning",face to face,Lab Values: Anemia Assessment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 4,,ECHA 1-240,S. MacLennan,lab,170 minutes,2017-10-06,Active Learning,face to face,Physical Assessment: Cardio/Resp/PV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Lecture 1,,MS 227,Cheryl Cox,lecture,110 minutes,2017-09-07,,face to face,"Service Learning Fair ( Located in MS 1-15), Course Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Lecture 2,,MS 227,Cheryl Cox,lecture,80 minutes,2017-10-10,,face to face,Course Expectations and Person-Centred Care ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Seminar 1a,,MS PBL Rooms,Cheryl Cox,seminar,80 minutes,2017-10-24,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Seminar 1b,,MS PBL Rooms,Cheryl Cox,seminar,80 minutes,2017-10-26,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Lecture 3,,MS 227,Cheryl Cox,lecture,80 minutes,2017-11-21,,face to face,"Citizenship, Person Centred Care Assignment Information ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Seminar 2a ,,MS PBL Rooms,Cheryl Cox,seminar,80 minutes,2017-11-28,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Seminar 2b,,MS PBL Rooms,Cheryl Cox,seminar,80 minutes,2017-11-30,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 1,,MSB 231,A. El-Kadi & S. Patrick,lecture,110 minutes,2017-09-06,,face to face,"Introduction , Anatomy and Physiology- Cell physiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 2,,MSB 231,S. Patrick,lecture,110 minutes,2017-09-08,,face to face,"Anatomy and Physiology - Cell physiology, Membrane transport, Protein synthesis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 3,,MSB 231,S. Patrick,lecture,110 minutes,2017-09-11,,online,"ONLINE, Anatomy and Physiology - Signal transduction, Cell Physiology and tissue types",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 4,,MSB 231,S. Patrick,lecture,110 minutes,2017-09-12,,online,"ONLINE, Physiology - Electrical Properties of cells",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 5,,MSB 231,S. Patrick,lecture,110 minutes,2017-09-13,,face to face,"ONLINE, See Above",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 6,,MSB 231,S. Patrick,lecture,110 minutes,2017-09-15,,face to face,"ONLINE, Anatomy and Physiology - Autonomic nervous system",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 7,,MSB 231,S. Patrick & J. Seubert,lecture,110 minutes,2017-09-18,,face to face,"ONLINE, See Above, Pathophysiology-Cell injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 8,,MSB 231,S. Patrick ,lecture,110 minutes,2017-09-20,,face to face,Anatomy and Physiology - Muscle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 9,,MSB 231,A. Holt,lecture,110 minutes,2017-09-21,,face to face,Fundamentals of Pharmacology 1 & 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 10,,ECHA 2-190,A. Holt,lecture,110 minutes,2017-09-25,,face to face,Fundamentals of Pharmacology 3  & 4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 11,,ECHA 2-190,A. Holt,lecture,110 minutes,2017-09-27,,face to face,Fundamentals of Pharmacology 5 & 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,MIDTERM & Lecture 12,,ECHA 2-190,A. Siraki,exam,110 minutes,2017-09-29,,face to face,"Mid-Term Exam, Pathophysiology-Inflammation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 13,,ECHA 2-190,A. Siraki/ J. Gnarpe,lecture,110 minutes,2017-10-02,,face to face,"Pathophysiology-Inflammation, Infection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 14,,ECHA 2-190,A. Siraki/ J. Gnarpe,lecture,110 minutes,2017-10-04,,face to face,"Pathophysiology-Immunological disease, Infection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 15,,ECHA 2-190,A. El-Kadi,lecture,110 minutes,2017-10-06,,face to face,Introductory Toxicology 1 & 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 16,,ECHA 2-190,A. Siraki/ S. Patrick,lecture,110 minutes,2017-10-11,,face to face,"ONLINE, Anatomy  Circulatory System (ONLINE), Pathophysiology-Immunological disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 17,,ECHA 2-190,G. Jones,lecture,110 minutes,2017-10-13,,face to face,Forensic Toxicology 1 & 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 18,,ECHA 2-190,J. Seubert,lecture,110 minutes,2017-10-16,,face to face,"Pathophysiology-Neoplasia, Vascular disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 19,,ECHA 2-190,D. Birkholz,lecture,110 minutes,2017-10-18,,face to face,Environmental Toxicology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Lecture 20,,ECHA 2-190,A. El-Kadi,lecture,110 minutes,2017-10-24,,face to face,Toxicity and Safety Assessment of Natural Health Products,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,FINAL,,CS 1-191,,exam,110 minutes,2017-10-24,,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 1,,ECHA L1-140,Makowsky,lecture,170 minutes,2017-09-07,,face to face,"Course Introduction , 1. Review: Principles of Evidence-Based Clinical Practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 2,,ECHA L1-140,Makowsky,lecture,170 minutes,2017-09-14,,face to face,"1. Review: eLiteracy, Critical appraisal & eNumeracy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 1,,ECHA L1-140,Kung,seminar,50 minutes,2017-09-14,,face to face,Finding the Best Evidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 5,,ECHA L1-140,Loebenburg,seminar,50 minutes,2017-10-19,,face to face,SEMINAR: Bioequivalence & SEB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 7,,ONLINE,M. Guirguis/R. Loebenburg,lecture,170 minutes,2017-10-19,,face to face,Bioequivalence & Subsequent Entry Biologics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,EXAM,,ECHA L1-140,Makowsky,lecture,50 minutes,2017-10-26,,distance,ONLINE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 6,,ECHA L1-140,Makowsky,seminar,50 minutes,2017-11-02,,face to face,SEMINAR: Midterm Exam Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 8,,ECHA L1-140,Makowsky,lecture,170 minutes,2017-11-02,,face to face,5. Synthesized Resources: Systematic Reviews & Meta analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 3,,ECHA L1-140,Makowsky,lecture,170 minutes,2017-09-21,,face to face,2. Articles on Therapy  RCT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 2,,ECHA L1-140,Kung,seminar,50 minutes,2017-09-21,,face to face,SEMINAR: Finding the Best Evidence ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 3,,ECHA L1-140,Makowsky,seminar,50 minutes,2017-09-28,,face to face,Finding the Best Evidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 4,,ECHA L1-140,Makowsky,lecture,170 minutes,2017-09-28,,face to face,2. Articles on Therapy  Non inferiority,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 4,,ECHA L1-140,TA/Makowsky,seminar,50 minutes,2017-10-05,,face to face,SEMINAR: Deliberate Practice  Student identified questions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 5,,ECHA L1-140,Korownyk,lecture,170 minutes,2017-10-05,,face to face,2. Articles on Therapy - How not to get fooled again and again and again,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 6,,ONLINE,Campbell-Scherer,lecture,170 minutes,2017-10-12,,distance,"ONLINE, Diagnosis & Screening",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 9,,ECHA L1-140,Padwal/Makowsky ,lecture,170 minutes,2017-11-09,,face to face,5. Synthesized Resources: Clinical Practice Guidelines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 7,,ECHA L1-140,Makowsky,seminar,50 minutes,2017-11-09,,face to face,SEMINAR: Oral Presentations of Tools For Practice Summaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,FINAL EXAM,,ECHA L1-140,Makowsky,lecture,50 minutes,2017-12-15,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 10,,ECHA L1-140,L. Guirguis/R Bertholet,lecture,170 minutes,2017-11-23,,face to face,6. Shared Decision Making,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 8,,ECHA L1-140,Makowsky,lecture,50 minutes,2017-11-23,,face to face,SEMINAR: Oral Presentations of Tools For Practice Summaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 11,,ECHA L1-140,Eurich,lecture,170 minutes,2017-11-30,,face to face,7. Observational Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 9,,ECHA L1-140,Makowsky,seminar,50 minutes,2017-11-30,,face to face,SEMINAR: Oral Presentations of Tools For Practice Summaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 12,,ECHA L1-140,Schindel,lecture,170 minutes,2017-12-07,,face to face,8. Qualitative Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 3,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-07,Direct Lecture,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 2,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-06,Direct Lecture,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Granules/lozenges,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 9,,MS 227,Dr R LÃ¶benberg,lecture,110 minutes,2017-09-20,Direct Lecture,face to face,Biopharmaceutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 10,,MS 227,Dr R LÃ¶benberg,lecture,110 minutes,2017-09-22,Direct Lecture,face to face,Controlled Release Delivery systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 17,,MS 227,Dr A. Martin,lecture,110 minutes,2017-10-16,,face to face,Aerosols,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 18,MS 227,,Dr A Martin,lecture,110 minutes,2017-10-18,,face to face,Aerosols,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 19,MS 227,,Dr. D Wishart,lecture,110 minutes,2017-10-20,,face to face,Protein Delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,MIDTERM,,,Exam,lecture,50 minutes,2017-06-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-420,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS I, IV: Dissolution",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,FINAL,,,,lecture,50 minutes,2017-06-01,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MS 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 6,,MS 227,Mr R Marcinkoski,lecture,110 minutes,2017-09-13,Direct Lecture,face to face,Tablets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 12,,MS 227,Dr. A Lavasanifar,lecture,110 minutes,2017-09-29,Direct Lecture,face to face,"Mechanisms of degradation, effect of temperature, light., Stability & Kinetics: Sources of drug instability",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-420,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS I, II: Granules/lozenges",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-430,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS III, IV: Compounding gel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 16,MS 227,,"Drs F Jamali, Dr R Loebenberg; Dr A Lavasanifar",lecture,110 minutes,2017-10-11,Direct Lecture,face to face,Hot topics in Pharmaceutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 20,,MS 227,Dr. M Hitt,lecture,110 minutes,2017-10-23,,face to face,Gene Delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 14,,MS 227,Dr A. Lavasanifar,lecture,110 minutes,2017-10-04,,face to face,Transdermal Delivery Systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 1,MSB227,Dr. A Lavasanifar/Dr R Lobenberg,Lecture,lecture,110 minutes,2017-09-05,Direct Lecture,face to face,"General outline and objectives of course: textbooks, examinations, grading, distribution of marks, homework assignments, laboratory purpose and procedures., Introduction to the Course/Compounding of Parenterals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-39,TA,Lab,lab,140 minutes,2017-09-13,Active Learning,face to face,GROUP I: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 7,,MS 227,Dr. R Lobenberg,lecture,110 minutes,2017-09-15,Direct Lecture,face to face,Tablets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 4,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-08,Direct Lecture,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 8,,MS 227,Dr. R Lobenberg,lecture,110 minutes,2017-09-18,Direct Lecture,face to face,"In vitro and in vivo methods to determine permeability and dissolution rate, Biopharmaceutics drug classification, In vitro in vivo correlations, Bioavailability and bioequivalence, Biopharmaceutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 11,,MS 227,Dr R LÃ¶benberg,lecture,110 minutes,2017-09-25,,face to face,Approval Process/regulatory science,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-430,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS II, III: Sterile products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 15,,MS 227,Dr. A Lavasanifar,lecture,110 minutes,2017-10-06,Direct Lecture,face to face,Nanomedicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,,ECHA 1-190,TA,lecture,80 minutes,2017-09-11,,face to face,"GROUPS II, III: Dissolution",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1, ,ECHA 1-182,TA,seminar,80 minutes,2017-09-11,Direct Lecture,face to face,"GROUPS I, IV: Sterile products  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,,ECHA 1-182,TA,lecture,80 minutes,2017-09-11,,face to face,"GROUPS I, II: Compounding gel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,,ECHA 1-190,TA,seminar,80 minutes,2017-09-11,Direct Lecture,face to face,"GROUPS III, IV: Granules/lozenges",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 5,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-11,Direct Lecture,face to face,"Pharmaceutically and physiologically acceptable ophthalmic, otic and nasal solutions, Drug delivery considerations for otic and nasal preparations, Compounding techniques, Viscosity enhancers, Antioxidants, Preservatives, Sterility of ophthalmic solutions, Define buffers, buffer capacity, isotonicity, iso-osmoticity, osmotic pressure, hypertonicity, hypotonicity., Pharmcopeia standards for opthphalmic dosage forms, Biological barrier of ophthalmic drug absorption, Anatomy and physiology of the eys and tears, Ophthalmic/Nasal/Ear Products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 13,,MS 227,Dr A Lavasanifar,lecture,110 minutes,2017-10-02,,face to face,Stability & Kinetics: Shelf life calculations ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 25,,MS231,J. Whissell,lecture,50 minutes,2017-11-06,Direct Lecture,face to face,RxA Payment Models,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 26,,MS231,B. Sprague,lecture,50 minutes,2017-11-08,Direct Lecture,face to face,Public/Third Party Payers and Prescription Drug Financing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 1,,MS231,C. Faruquee,lecture,50 minutes,2017-09-06,,face to face,Course Overview/ Introduction/Assignment Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 2,,MS231,R. Sanghera,lecture,50 minutes,2017-09-08,,face to face,Defining Professionalism ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 3,,MS231,R. Sanghera,lecture,50 minutes,2017-09-11,,face to face,Defining Professionalism Contd ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 4,,MS231,J. Bachynsky ,lecture,50 minutes,2017-09-13,Direct Lecture,face to face,Evolution of the Profession of Pharmacy ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 5,,MS231,J. Whissell,lecture,50 minutes,2017-09-15,Direct Lecture,face to face,Alberta Pharmacists Association  ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 6,,MS231,C. Hughes ,lecture,50 minutes,2017-09-18,Direct Lecture,face to face,Introduction to Patient Care Process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 7,,MS231,C. Hughes,lecture,50 minutes,2017-09-20,Direct Lecture,face to face,Introduction to the Patient Care Process contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 8,,MS231,C. Faruquee,lecture,50 minutes,2017-09-22,Team Based Learning,face to face,NO CLASS: IP Pathway Launch ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 18,,MS231,C. Faruquee,lecture,50 minutes,2017-10-20,Direct Lecture,face to face,Discussion on Prescribing/Practice Relations Within the System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 19,,MS231,C. Faruquee,lecture,50 minutes,2017-10-23,Direct Lecture,face to face,Current Topics in Pharmacy Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 20,,MS231,K. Tam,lecture,50 minutes,2017-10-25,Direct Lecture,face to face,Invited Practitioners: Hospital Pharmacist ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 21,,MS231,C. Necyk,lecture,50 minutes,2017-10-27,Direct Lecture,face to face,The role of CAM provider in the health care system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 22,,MS231,C. Necyk,lecture,50 minutes,2017-10-30,Direct Lecture,face to face,The role of CAM provider in the health care system contd.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 23,,MS231,S. Simpson ,lecture,50 minutes,2017-11-01,Direct Lecture,face to face,Inducement programs in pharmacies - are they harmful?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 11,,MS231,C. Faruquee,lecture,50 minutes,2017-09-29,Direct Lecture,face to face,Module Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 12,,MS231,C. Mitchell,lecture,50 minutes,2017-10-02,Direct Lecture,face to face,Overview of the Canada Health Act and Fed. Responsibilities in Health Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 13,,MS231,C. Mitchell,lecture,50 minutes,2017-10-04,Direct Lecture,face to face,Health Canada and Health Products and Foods Branch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 14,,MS231,C. Mitchell,lecture,50 minutes,2017-10-06,Direct Lecture,face to face,Prov. And Regional Health Auth. Responsibilities in Health care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 15,,MS231,C. Mitchell,lecture,50 minutes,2017-10-11,,face to face,Health Human Resources: Who are the players in the system?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,MIDTERM,,MS231,C. Faruquee,lecture,50 minutes,2017-10-13,,face to face,MIDTERM EXAM ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 16 ,,MS231,A. Fuller,lecture,50 minutes,2017-10-16,Direct Lecture,face to face,Invited Practitioners: Community Pharmacist ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 17,,MS231,T. Leong,lecture,50 minutes,2017-10-18,Direct Lecture,face to face,Invited Practitioners: PCN Pharmacist ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 27,,MS231,L. Guirguis,lecture,110 minutes,2017-11-10,Direct Lecture,face to face,Health Beliefs and Behaviors (1:00-2:50) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 29,,MS231,M. Visconti,lecture,110 minutes,2017-11-22,Direct Lecture,face to face,Determinants of Health (1:00-2:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 30,,MS231,M. Visconti,lecture,110 minutes,2017-11-24,Direct Lecture,face to face,Health Promotion (1:00-2:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 31,,MS231,C. Faruquee,lecture,50 minutes,2017-11-27,Direct Lecture,face to face, TIME OFF in lieu of IP Pathway Launch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 32,,MS231,C. Faruquee,lecture,50 minutes,2017-11-29,Direct Lecture,face to face,Module Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 33,,MS231,C. Faruquee,lecture,50 minutes,2017-12-01,,face to face, TIME OFF in lieu of IP Pathway Launch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 34,,MS231,C. Faruquee,lecture,50 minutes,2017-12-04,,face to face,TIME OFF in lieu of Nov 10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 35,,MS231,C. Faruquee,lecture,50 minutes,2017-12-06,,face to face,TIME OFF in lieu of Nov 22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 36,,MS231,C. Faruquee,lecture,50 minutes,2017-12-08,,face to face,TIME OFF in lieu of Nov 24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,FINAL ,,TBA,C. Faruquee,lecture,50 minutes,2017-12-15,,face to face,FINAL EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 24,,MS231,C. Faruquee,lecture,50 minutes,2017-11-03,Direct Lecture,face to face,Introduction to Current Payment Models Within the Realm of Pharmacy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 28,,MS231,C. Faruquee,lecture,50 minutes,2017-11-20,Direct Lecture,face to face,Module Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 10,,MS231,C. Hughes,lecture,50 minutes,2017-09-27,Direct Lecture,face to face,Introduction to the Patient Care Process contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Lecture 9,,MS231,G. Eberhart ,lecture,50 minutes,2017-09-25,Direct Lecture,face to face,Alberta College of Pharmacists (ACP),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Module 2: Hypertension,,,Ann Thompson,lecture,80 minutes,2017-09-03,Problem Based Learning,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Module 3: CV Risk Reduction ,,,Bill Semchuk,lecture,80 minutes,2017-09-17,Problem Based Learning,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Module 5: Heart Failure ,,,Doson Chua,lecture,80 minutes,2017-10-15,Problem Based Learning,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Module 6: Pneumonia,,,Harris Iacovides,lecture,80 minutes,2017-10-29,Problem Based Learning,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Self-Study Module 1: Pharmacokinetic Basics and Approach to TDM,,,Sherif Mahmoud,lecture,80 minutes,2017-08-20,Other,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Module 4: Diabetes ,,,Ginny Cummings,lecture,80 minutes,2017-10-01,Problem Based Learning,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Module 7: Oncology Complications,,,Sarah Woodworth,lecture,80 minutes,2017-11-19,Problem Based Learning,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Module 1: VTE,,,Sarah Woodworth,lecture,80 minutes,2017-08-20,Problem Based Learning,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 7,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-03-02,,Face to Face,"Communicate or observe patients with vision or hearing loss, requiring a translator, or support behaviour change (ongoing therapy or require education on a device); Group Review 1 Videos from Lab 4 Lab Staff",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 13,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-03-02,,Face to Face,Wrap-Up and Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 12,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-02-28,,Face to Face,Risk Communication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 6,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-02-14,,Face to Face,The Emotional Patient ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 11,,MS 227,Linda Cundy,lecture,80 minutes,2017-02-14,,Face to Face,Hearing Loss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 10,,MS 227,Holly Payne,lecture,80 minutes,2017-02-09,,Face to Face,The Emotional Patient ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 5,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-02-09,,Face to Face,Conduct a Structured Medication Review; Self & Peer Assess Video from Lab 4 (in partners); Communication Challenge Exercise,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 9,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-02-07,,Face to Face,Lost in Translation & 3 Minute Empowerment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 8,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-02-02,,Face to Face,Medication Taking Behaviours,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 4,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-02-02,,Face to Face,Assess Patient's Ongoing Therapy (Refill); Prepare for the Structured Medication Review; Group Review SDM Video,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 7,,MS 227,Lisa Guirguis/Marlene Gukert,lecture,80 minutes,2017-01-31,,Face to Face,Patient Interviewing Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 6,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-26,,Face to Face,Sample Patient Interviewing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 3,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-01-26,,Face to Face,Motivational Interviewing; Shared Decision Making (Video); Group Review Patient Education Video,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 5,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-24,,Face to Face,Assessing Ongoing Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 2,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-01-19,,Face to Face,Review 314 Lab Exam Set Learning Goals; Unpack Pill Packs / Develop Patient Script; Patient Education Exercise with Devices (Video),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 4,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-19,,Face to Face,Shared Decision Making and Intro to Motivational Interviewing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 3,,MS 227,Holly Payne/Merico Tesolin,lecture,80 minutes,2017-01-17,,Face to Face,Communicating with People with Vision Loss ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 1,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-01-12,,Face to Face,Time in Lieu during PDW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 2,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-12,,Face to Face,SBAR technique and SMART Goal Setting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 1,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-10,,Face to Face,Course Overview and Education,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 8,,ECHA 1-490,T Schindel,lecture,170 minutes,2017-10-24,"Direct Lecture, Active Learning",face to face,"Collaboration and Inteprofessional Teams: Communication, Peer Teaching - Debrief",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 11,,ECHA 1-490,T Schindel; T Charrois,lecture,170 minutes,2017-11-21,"Direct Lecture, Active Learning",face to face,"Peer Teaching and Learning, â€¢	Facilitate professional learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 13,,ECHA 1-490,T Schindel; T Charrois,lecture,170 minutes,2017-12-05,"Direct Lecture, Active Learning",face to face,"Peer Teaching - Debrief, Planning, delivery, and evaluation of education: Review",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 6,,ECHA 1-490,T Schindel; T Charrois,lecture,170 minutes,2017-10-10,"Direct Lecture, Active Learning",face to face,"Planning Education - Topics for Peer Teaching, Collaboration and Inteprofessional Teams: Leadership , Peer Teaching and Learning",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 4,,ECHA 1-490,"S Walter, T Schindel",lecture,170 minutes,2017-09-26,,face to face,Preceptor Workshop,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 2,,ECHA 1-490,T Schindel,lecture,170 minutes,2017-09-12,"Direct Lecture, Active Learning",face to face,"Teaching and Learning: Education Theories, Planning, delivery, and evaluation of education (ADDIE)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 5,,ECHA 1-490,T Schindel,lecture,170 minutes,2017-10-03,"Direct Lecture, Active Learning",face to face,"Planning education/Topics in preceptorship, Collaboration and Inteprofessional Teams: Teamwork",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 7 - Tuesday and Thursday,,MSB - Practice Skills Lab,T Charrois; T Schindel,lab,170 minutes,2017-10-17,,face to face,Peer Teaching,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 10,,ECHA 1-490,T Schindel; T Paslawski,lecture,170 minutes,2017-11-07,Active Learning,face to face,"Collaboration and Inteprofessional Teams: Weaving the Fabric of Collaboration, Collaboration and Inteprofessional Teams: Workshop",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 12 - Tuesday and Thursday,,MSB - Practice Skills Lab,T Charrois; T Schindel,lab,170 minutes,2017-11-28,Active Learning,face to face,Peer Teaching,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 1,,ECHA 1-490,T Schindel; J Hall; T Charrois,lecture,170 minutes,2017-09-05,"Direct Lecture, Active Learning",face to face,"Introduction to PHARM 504, Introduction to Peer Learning, Learning in Groups",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 3,,ECHA 1-490,T Schindel; J Hall,lecture,170 minutes,2017-09-19,"Direct Lecture, Active Learning",face to face,"Critical Thinking and Learning Styles, Evaluation of educational delivery ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 9,,ECHA 1-490,T Schindel,lecture,170 minutes,2017-10-31,Active Learning,face to face,Group Presentations: Education Plans,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 8,,MSB 227,Dr. Frank Wuest,lecture,50 minutes,2017-11-08,,face to face,Medicinal Chemistry: Antiulcer Treatment (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 9,,MSB 227,Dr. Mark Makowsky,lecture,110 minutes,2017-11-10,,face to face,Pharmacology/Therapeutics: Dyspepsia/Gastroesophageal Disease (GERD)/Peptic Ulcer Disease (PUD) (09:00 -10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 10,,MSB 227,Dr. Mark Makowsky,lecture,50 minutes,2017-11-20,,face to face,Pharmacology/Therapeutics: Dyspepsia/Gastroesophageal Disease (GERD)/Peptic Ulcer Disease (PUD) con't (09:00 - 09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 1,,MSB 227,Dr. Nese Yuksel & Dr Susan Patrick,lecture,110 minutes,2017-10-25,,face to face,Introduction (09:00 - 09:10) & Anatomy/Physiology:GI and Liver (09:10 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 2,,MSB 227,Dr. Susan Patrick,lecture,110 minutes,2017-10-27,,distance,Anatomy/Physiology: GI and Liver (this will be an online session),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 4,,MSB 227,Dr. David Kelner,lecture,50 minutes,2017-10-30,,face to face,Oral Health (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 3,,MSB 227,Dr. Susan Patrick,lecture,50 minutes,2017-10-30,,distance,Anatomy/Physiology: GI and Liver (this will be an online session),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 5,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2017-11-01,,face to face,Pharmacology/Therapeutics: Nausea and Vomiting (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 6,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2017-11-06,,face to face,Pharmacology/Therapeutics: Constipation/Diarrhea (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 1A,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-06,,face to face,Seminar 1: Nausea and Vomiting Cases for 1/2 Class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 7,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-11-08,,face to face,Pharmacology/Therapeutics: Constipation/Diarrhea (09:00-09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 1B,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-08,,face to face,Seminar 1: Neausea and Vomitting Cases for 1/2 Class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 11,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-11-20,,face to face,Pharmacology/Therapeutics: Inflammatory Bowel Disease (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,MiDTERM,,TBA,Dr. Nese Yuksel,lecture,50 minutes,2017-11-22,,face to face,MIDTERM (09:00 - 09:50) - all material up Nov 10 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 12,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2017-11-24,,face to face,Pharmacology/Therapeutics: Inflammatory Bowel Disease (09:00-10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 2A,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-27,,face to face,Seminar 2: Inflammatory Bowel Disease Case for 1/2 class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 13,,MSB 227,Dr Deon Druteika,lecture,110 minutes,2017-11-27,,face to face,Pathophysiology: Liver Function Tests and Liver Disease (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 14,,MSB 227,Dr Deon Druteika,lecture,110 minutes,2017-11-29,,face to face,Therapeutics: Liver Disease and Case  (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 2B,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-29,,face to face,Seminar 2: Inflammatory Bowel Disease Case for 1/2 class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 15,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-12-01,,face to face,Pharmacology/Therapeutics: Irritable Bowel Syndrome (09:00 - 09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 16,,MSB 227,Dr. Ayman El-Kadi,lecture,50 minutes,2017-12-01,,face to face,Toxicology: Drug Induced Liver Disease (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 18,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-12-04,,face to face,"Ostomy Care, Hemorrhoids, Final Exam Overview (10:00 - 10:50)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 17,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-12-04,,face to face,Class Evaluations; CAM in GI and Liver (09:00-09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,FINAL,,TBA,Dr. Nese Yuksel,lecture,110 minutes,2017-12-11,,face to face,FINAL EXAM (10:00 - 12:00),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 1,,,C Faruquee,lecture,140 minutes,2017-09-05,Direct Lecture,face to face,Orientation & Intro to Health Comm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 2,,,C Faruquee,lecture,140 minutes,2017-09-07,Direct Lecture,face to face,Listening and Nonverbal Communication/ Lab Information ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 1,,,C Faruquee,lab,110 minutes,2017-09-11,"Active Learning, Problem Based Learning, Team Based Learning",face to face,Lab Orientation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 3,,,C Faruquee,lecture,140 minutes,2017-09-12,Direct Lecture,face to face,Medication Experience Guest: Tristan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 1,,,C Faruquee,lab,110 minutes,2017-09-13,"Active Learning, Problem Based Learning, Team Based Learning",face to face,Lab Orientation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 4,,,C Faruquee,lecture,140 minutes,2017-09-14,Direct Lecture,face to face,Reflection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 2,,,C Faruquee,lab,110 minutes,2017-09-18,"Active Learning, Problem Based Learning, Team Based Learning",face to face,"Debrief the bubble pack assignment, Time off for Medication Exp Interview",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 5,,,C Faruquee,lecture,140 minutes,2017-09-19,Direct Lecture,face to face,Movie + Reflection ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 2,,,C Faruquee,lab,110 minutes,2017-09-20,"Active Learning, Problem Based Learning, Team Based Learning",face to face,"Debrief the bubble pack assignment, Time off for Medication Exp Interview",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 6,,,C Faruquee,lecture,140 minutes,2017-09-21,Direct Lecture,face to face,Community Ed Presentation / Vital Behaviors for Patient Engagement ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 7,,,C Faruquee,lecture,140 minutes,2017-09-26,Direct Lecture,face to face,Communicating Professionally/ Health Literacy ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 8,,,C Faruquee,lecture,140 minutes,2017-09-28,Direct Lecture,face to face,Focused Medication History ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 3,,,C Faruquee,lab,110 minutes,2017-10-02,"Active Learning, Problem Based Learning, Team Based Learning",face to face,"Guided peer feedback on reflection, Focused Med History #1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 9,,,C Faruquee,lecture,140 minutes,2017-10-03,Direct Lecture,face to face,Documentation Note/ Patient Centered Care in Pharmacy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 3,,,C Faruquee,lab,110 minutes,2017-10-04,"Active Learning, Problem Based Learning, Team Based Learning",face to face,"Guided peer feedback on reflection, Focused Med History #1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 10,,,C Faruquee,lecture,140 minutes,2017-10-05,Direct Lecture,face to face,Apply person centred care to pharmacy communications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 4,,,C Faruquee,lab,110 minutes,2017-10-16,"Active Learning, Problem Based Learning, Team Based Learning",face to face,Focused Med History #2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 11,,,Kelly Grindrod,lecture,50 minutes,2017-10-17,Direct Lecture,distance,Social Media,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 4,,,C Faruquee,lab,110 minutes,2017-10-18,"Active Learning, Problem Based Learning, Team Based Learning",face to face,Focused Med History #2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 12,,,C Faruquee,lecture,50 minutes,2017-10-24,Direct Lecture,face to face,Lab Debrief and Video Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 5 (Final),,,C Faruquee,lab,110 minutes,2017-10-30,Active Learning,face to face,Focused Med History #3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lecture 13,,,C Faruquee,lecture,50 minutes,2017-10-31,Direct Lecture,face to face,Wrap Up & Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab 5 (Final),,,C Faruquee,lab,110 minutes,2017-11-01,"Active Learning, Problem Based Learning",face to face,Focused Med History #3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Final,,,C Faruquee,lecture,50 minutes,2017-11-07,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 1,,MSB 6-28,Necyk/ Tate,seminar,170 minutes,2016-09-12,,face to face,"Patient Care Process and Documentation Workshop, Review Scope of Practice, Orientation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 2,,PBL rooms (TBD),Various,seminar,80 minutes,2016-09-21,,face to face,Patient Care Plan Presentations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 1,,MSB 1-15,Necyk,lab,50 minutes,2016-09-26,,face to face,"Pre-filled subcutaneous injection training, Developing Detailed Monitoring Plans, Establishing a Therapeutic Relationship",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 1,,MSB 1-15,Necyk,lab,50 minutes,2016-09-28,,face to face,"Pre-filled subcutaneous injection training, Developing Detailed Monitoring Plans, Establishing a Therapeutic Relationship",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 3,,MSB 6-28,Nekolaichuk/ Rix,seminar,110 minutes,2016-10-04,,face to face,"How to Communicate with a Palliative Patient , End of Life Care, Feedback Lab 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 2,,MSB 1-15,Necyk,lab,50 minutes,2017-10-10,,face to face,"Drug information/EBM, Palliative Care and Pain Management , Follow Up",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 2,,MSB 1-15,Necyk,lab,50 minutes,2017-10-12,,face to face,"Drug information/EBM, Palliative Care and Pain Management , Follow Up",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 4,,MSB 6-28,Necyk,seminar,110 minutes,2017-10-18,,face to face,"Integrated Case 1 Review, Feedback Lab 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 3,,MSB 1-15,Necyk,lab,50 minutes,2017-10-24,,face to face,Mental health first aid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 3,,MSB 1-15,Necyk,lab,50 minutes,2017-10-26,,face to face,Mental health first aid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 4,,MSB 1-15,Necyk,lab,50 minutes,2017-10-31,,face to face,"Prescription processing and review, Therapeutic Drug Monitoring , Prescribing, Adapting and Extending Prescriptions",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 4,,MSB 1-15,Necyk,lab,50 minutes,2017-11-02,,face to face,"Prescription processing and review, Therapeutic Drug Monitoring , Prescribing, Adapting and Extending Prescriptions",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 8,,MSB 1-15,Charrois,lab,50 minutes,2018-02-13,,face to face,"People with disabilities, Deprescribing, Minor ailments",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 9,,MSB 1-15,Charrois,lab,110 minutes,2018-03-06,,face to face,Ambulatory assistive devices with PT students,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 9,,MSB 1-15,Charrois,lab,110 minutes,2018-03-08,,face to face,Ambulatory assistive devices with PT students,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 11,,MSB 2-27,Charrois ,seminar,110 minutes,2018-03-09,,face to face,TBA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,FINAL,,MSB 1-15,Charrois,lecture,50 minutes,2018-04-23,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 5,,MSB 6-28,Necyk/ Sadowski,seminar,110 minutes,2017-11-06,,face to face,"Cognitive Impairment Cases, Cognitive Assessment, Feedback Lan 3&4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 5,,MSB 1-15,Necyk,lab,50 minutes,2017-11-21,,face to face,"Patient education, Patient Assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 5,,MSB 1-15,Necyk,lab,50 minutes,2017-11-23,,face to face,"Patient education, Patient Assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 6,,MSB 6-28,Necyk,seminar,110 minutes,2017-11-29,,face to face,"Midterm information , Application of Alberta's Pharmacy Services Framework to the Patient Care Plan Process, Feedback Lab 5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,MIDTERM ,,MSB 1-15,Necyk,lecture,50 minutes,2017-12-18,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 7,,MSB 2-31,Charrois,seminar,110 minutes,2018-01-09,,face to face,"Transfer of care, Ethics, Orientation ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 6,,MSB 1-15,Charrois,lab,50 minutes,2018-01-16,,face to face,"Naloxone training, Addiction communication skills, Ethical Scenarios, Infectious Diseases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 6,,MSB 1-15,Charrois,lab,50 minutes,2018-01-18,,face to face,"Naloxone training, Addiction communication skills, Ethical Scenarios, Infectious Diseases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 8,,MSB 2-27,Charrois/Danis/Alexander,seminar,110 minutes,2018-01-24,,face to face,"Injections Overview, Lab 6 Feedback",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 7,,MSB 1-15,Charrois/Danis/Alexander,lab,50 minutes,2018-01-30,,face to face,Injection Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 7,,MSB 1-15,Charrois/Danis/Alexander,lab,50 minutes,2018-02-01,,face to face,Injection Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 9,,MSB 2-27,Charrois,seminar,110 minutes,2018-02-05,,face to face,"integrated Case #2, Deprescribing, Triage and referral in Self-care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Other,,MS 1-15,Charrois,lecture,50 minutes,2018-02-09,,face to face,Injection Authorization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 8,,MSB 1-15,Charrois,lab,50 minutes,2018-02-15,,face to face,"People with disabilities, Deprescribing, Minor ailments",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 10,,MSB 2-31,Charrois,seminar,110 minutes,2018-02-28,,face to face,Practical aspects of scope of practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 12,,MSB 2-27,MacDonald/Charrois,seminar,110 minutes,2018-03-13,,face to face,"Chronic Disease management , Motivational interviewing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 10,,MSB 1-15,Charrois,lab,50 minutes,2018-03-20,,face to face,"Diabetes Management , CDM, Motivational interviewing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 10,,MSB 1-15,Charrois,lab,50 minutes,2018-03-22,,face to face,"Diabetes Management , CDM, Motivational interviewing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 11,,MSB 1-15,Charrois,lab,50 minutes,2018-03-27,,face to face,"Patient Education, Women's Health ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Lab 11,,MSB 1-15,Charrois,lab,50 minutes,2018-03-29,,face to face,"Patient Education, Women's Health ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Seminar 12,,ECHA 2-190,Charrois,seminar,110 minutes,2018-04-03,,face to face,"OSCE prep, IC Feedback, Lab 10 and 11 Feedback",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 1,,ECHA 2-190,Bertholet/Patrick,lecture,80 minutes,2017-09-05,,face to face,Introduction (Dr. Bertholet); Anatomy - Physiology (Dr. Patrick) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 2,,online,Patrick,lecture,50 minutes,2017-09-06,,distance,Anatomy; Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 3,,online,Bertholet/Patrick,lecture,80 minutes,2017-09-07,,distance,"Pathophysiology of COPD (online Sept 7), Online Anatomy; Physiology COPD pathophysiology(Q#1)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session  4,,ECHA 2-490,Davies,lecture,50 minutes,2017-09-08,,face to face,Pharmacology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 5,,ECHA 2-490,Davies,lecture,50 minutes,2017-09-11,,face to face,Pharmacology (Q#2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 6,,ECHA 2-190,Bertholet ,lecture,80 minutes,2017-09-12,,face to face,COPD Therapeutics /cases (Q#3),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 7,,MSB 227,Bertholet,seminar,110 minutes,2017-09-12,,face to face,COPD Therapeutics /cases ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 8,,ECHA 2-490,Davies,lecture,50 minutes,2017-09-13,,face to face,Pharmacology ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 9,,ECHA 2-190,Bertholet,lecture,80 minutes,2017-09-14,,face to face,COPD Therapeutics/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 10,,ECHA 2-490,Bertholet,seminar,50 minutes,2017-09-15,,face to face,COPD cases - (Q#4),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,MiDTERM,,,Bertholet,lecture,50 minutes,2017-09-18,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 11,,ECHA 2-190,Barakat,lecture,80 minutes,2017-09-19,,face to face,Medicinal Chemistry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 12,,MSB 227,Bertholet,seminar,110 minutes,2017-09-19,,face to face,Tobacco Cessation therapeutics/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 13,,ECHA 2-490,Jesswein,lecture,50 minutes,2017-09-20,,face to face,"Tobacco Cessation: e-cigarettes, water pipes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 14,,ECHA 2-190,Bertholet,lecture,80 minutes,2017-09-21,,face to face,Tobacco Cessation therapeutics/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 15,,ECHA 2-490,TBA,lecture,50 minutes,2017-09-22,,face to face,Pharmacokinetics Pharmacodynamics of smoking(Q#5) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 16,,ECHA 2-490,Shkrobot,lecture,50 minutes,2017-09-25,,face to face,Cough; Cold,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 17,,ECHA 2-190,Shkrobot,lecture,80 minutes,2017-09-26,,face to face,Cough; Cold,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 18,,MB 2-27,Bertholet,lecture,110 minutes,2017-09-26,,face to face,Asthma pathophysiology/Therapeutics (Q#6),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 19,,ECHA 2-490,Bertholet,lecture,50 minutes,2017-09-27,,face to face,Asthma therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 20,,ECHA 2-190,Bertholet,lecture,80 minutes,2017-09-28,,face to face,Chronic asthma/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 21,,ECHA 2-490,Bertholet,seminar,50 minutes,2017-09-29,,face to face,Acute Asthma/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 22,,ECHA 2-490,Bertholet,lecture,50 minutes,2017-10-02,,face to face,Pediatric Asthma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 23,,ECHA 2-190,Gukert/Smith,lecture,80 minutes,2017-10-03,,face to face,Cystic Fibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 24,,ECHA 2-490,Bertholet,seminar,50 minutes,2017-10-04,,face to face,Asthma cases (Q#7),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 25,,ECHA 2-190,El-Kadi,lecture,80 minutes,2017-10-05,,face to face,Pathophysiology of chemical/drug-induced lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Lecture 26,,ECHA 2-490,Bertholet,lecture,50 minutes,2017-10-06,,distance,Inhalers/devices,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 27,,ECHA 2-490,Bertholet,lecture,50 minutes,2017-10-10,,distance,Theophylline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,FINAL,,,Bertholet,lecture,110 minutes,2017-10-13,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 1,,MS 227,Teri Charrois,lecture,110 minutes,2017-09-14,,face to face,"Introduction, Review of Patient Care Process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 2,,MS 227,Teri Charrois,lecture,110 minutes,2017-09-27,,face to face,"Scope of Practice, Best possible medication history, Medication reconciliation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab1,,Practice Lab,Teri Charrois,lab,220 minutes,2017-10-03,,face to face,"Scope of Practice - Adaption, Best possible medication history, Medication reconciliation, Clinical decision making",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab1,,Practice Lab,Teri Charrois,lab,220 minutes,2017-10-05,,face to face,"Scope of Practice - Adaption, Best possible medication history, Medication reconciliation, Clinical decision making",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 3,,MS 227,Teri Charrois,lecture,110 minutes,2017-10-11,,face to face,"Feedback for Lab 1, Documentations, Adherence assessment, Patient counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 2,,Practice Lab,Teri Charrois,lab,220 minutes,2017-10-17,,face to face,"Pulmonary Cases, Adherence assessment, Patient counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 2,,Practice Lab,Teri Charrois,lab,220 minutes,2017-10-19,,face to face,"Pulmonary Cases, Adherence assessment, Patient counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 4,,MS 227,Teri Charrois,lecture,110 minutes,2017-10-25,,face to face,"Feedback Lab 2, Monitoring and Follow-up, Documentation-Care plans, Integrated Case",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 5,,MS 227,Teri Charrois,lecture,110 minutes,2017-11-01,,face to face,"Drug Interaction Assessment, Drug allergy assessment, DI questions, Physical assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 3,,Practice Lab,Teri Charrois,lab,220 minutes,2017-11-07,,face to face,"Renal Cases, Drug allergy assessment, Drug interactions, Physical Assesment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 3,,Practice Lab,Teri Charrois,lab,220 minutes,2017-11-09,,face to face,"Renal Cases, Drug allergy assessment, Drug interactions, Physical Assesment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 6,,MS 227,Teri Charrois,lecture,110 minutes,2017-11-22,,face to face,"Feedback Lab 3, Minor ailments assessment, Self-care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 4,,Practice Lab,Teri Charrois,lab,220 minutes,2017-11-28,,face to face,"Minor Ailments Assessment, Lab value assessment, Math in patient care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 4,,Practice Lab,Teri Charrois,lab,220 minutes,2017-11-30,,face to face,"Minor Ailments Assessment, Lab value assessment, Math in patient care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 7,,MS 227,Teri Charrois,lecture,110 minutes,2017-12-04,,face to face,"Feedback Lab 4, Midterm information",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,MIDTERM,,,,lecture,50 minutes,2017-12-21,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 8,,MS 227,Renette Bertholet,lecture,110 minutes,2018-01-08,,face to face,"Orientation, Shared decision making and patient values",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 9,,MS 227,Renette Bertholet,lecture,110 minutes,2018-01-17,,face to face,"Communicating Risk and Benefit to Patients, Patient decision aids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 5,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-01-23,,face to face,"Shared Decision Making and Professionalism, Professionalism, Ethical decision making",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 5,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-01-25,,face to face,"Shared Decision Making and Professionalism, Professionalism, Ethical decision making",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 10,,MSB 1-115,Renette Bertholet,lecture,110 minutes,2018-01-31,,face to face,"Feedback Lab 5, Integrated Case, Communicating with HCP, Presenting patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 6,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-02-06,,face to face,"Presenting a patient problem to HCP, Drug information, Prescription review, Patient counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 6,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-02-08,,face to face,"Presenting a patient problem to HCP, Drug information, Prescription review, Patient counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 11,,MS 227,Renette Bertholet,lecture,110 minutes,2018-02-14,,face to face,"Feedback Lab 6, Hospital discharge, Medication reconciliation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 7,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-02-27,,face to face,"Review of hospital Chart for Med Rec Preparation for Discharge Counseling, Review of hospital orders, Prescription review, Patient counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 7,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-03-01,,face to face,"Review of hospital Chart for Med Rec Preparation for Discharge Counseling, Review of hospital orders, Prescription review, Patient counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 12,,MS 227,Renette Bertholet,lecture,110 minutes,2018-03-07,,face to face,"Feedback Lab 7, Hospital discharge, Seamless care, Integrated Case-Due",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 8,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-03-13,,face to face,"Hospital Discharge Counseling, Prescription review and counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 8,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-03-14,,face to face,"Hospital Discharge Counseling, Prescription review and counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 13,,MS 227,Renette Bertholet,lecture,110 minutes,2018-03-23,,face to face,"Feedback Lab 8, Drug therapy assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 9,,HSERC,Renette Bertholet,lab,220 minutes,2018-03-29,,face to face,Physiotherapy (PT) and Inhaler Teaching Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 10,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-04-03,,face to face,Evidence Based Assessments of Research (BEARS) tool,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Lab 10,,MSB 1-115,Renette Bertholet,lab,220 minutes,2018-04-05,,face to face,Evidence Based Assessments of Research (BEARS) tool,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Seminar 14,,MSB 1-116,Renette Bertholet,lecture,110 minutes,2018-04-10,,face to face,"Exam Information, Feedback Lab 9 and 10",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,FINAL,,,,lecture,50 minutes,2018-04-25,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 10,,TBA,Necyk,lecture,110 minutes,2017-11-10,Direct Lecture,face to face,ADHD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 9,,TBA,Siraki,lecture,80 minutes,2017-11-09,Direct Lecture,face to face,Pharmacology of Antipsychotics Pharmacology of Drugs for Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 6,,TBA,Necyk/TBA,seminar,110 minutes,2017-11-06,Active Learning,face to face,Seminar: Depression,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 1,,TBA,Necyk,lecture,110 minutes,2017-10-30,Direct Lecture,face to face,Course Introduction; Introduction to Mental Health and Public Health Perspectives   Depressive Disorders Part I-Epidemiology and Diagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 2,,TBA,Mahmoud,lecture,80 minutes,2017-11-01,Direct Lecture,face to face,"  Depressive Disorders Part 2- Medicinal Chemistry and Pharmacology (Antidepressants, anxiolytics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 3,,TBA,Necyk,lecture,80 minutes,2017-11-02,Direct Lecture,face to face,Depressive Disorders Part 3- Treatment and Special Populations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 4,,TBA,Necyk,lecture,110 minutes,2017-11-03,Direct Lecture,face to face,Depressive Disorders Part 3- Treatment and Special Populations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 19,,TBA,Necyk,lecture,110 minutes,2017-11-29,Direct Lecture,face to face,  Addiction: Psychosocial Perspectives & Non-Drug Treatment Options Introduction of â€˜The Brain Storyâ€™,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 20,,Self-study ,Necyk,seminar,80 minutes,2017-11-30,Active Learning,face to face,Opioid Dependency Guidelines Activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 21,,TBA,Necyk/Baumback/Walter,seminar,170 minutes,2017-11-30,"Team Based Learning, Other",face to face,Opioid Dependency Treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 22,,TBA,Sadowski,lecture,110 minutes,2017-12-01,Direct Lecture,face to face,Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 14,,TBA,Necyk,seminar,110 minutes,2017-11-22,Problem Based Learning,face to face,  Bipolar Disorder & Schizophrenia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 13,,TBA,Necyk,lecture,110 minutes,2017-11-22,Direct Lecture,face to face,Bipolar Disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session15,,TBA,Siraki,lecture,80 minutes,2017-11-23,Direct Lecture,face to face,Medicinal Chemistry/Pharmacology: Drugs of Abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 16,,TBA,Necyk,lecture,110 minutes,2017-11-24,Direct Lecture,face to face,"Substance Abuse Disorders  Part 1- Introduction, Recreational drugs/Alcohol",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Midterm Exam,,TBA,Necyk,lecture,110 minutes,2017-11-27,Other,face to face,Midterm Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 18,,TBA,Baumback,lecture,80 minutes,2017-11-28,Direct Lecture,face to face,  Substance Abuse Disorders Part 2- Opioids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 7,,TBA,Necyk,lecture,80 minutes,2017-11-07,Direct Lecture,face to face,Sleep Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 23,,TBA,Sadowksi,lecture,110 minutes,2017-12-04,Direct Lecture,face to face,Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Final Exam,,TBA,Necyk,lecture,110 minutes,2017-12-13,Other,face to face,Final Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 5,,TBA,Necyk,lecture,110 minutes,2017-11-06,Direct Lecture,face to face,Anxiety Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 8,,TBA,St. Arnaud/Necyk,lecture,110 minutes,2017-11-08,Direct Lecture,face to face,Cognitive Behavioral Therapy Interprofessional collaboration in mental health: psychology and pharmacy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 11,,TBA,Lewczyk,lecture,110 minutes,2017-11-20,Direct Lecture,face to face,Schizophrenia Part 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 12,,TBA,Lewczyk,lecture,80 minutes,2017-11-21,Direct Lecture,face to face,Schizophrenia Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 3,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2017-10-19,Direct Lecture,face to face,Blood & Circulation - White blood cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 11,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2017-11-28,Direct Lecture,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 12,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2017-11-30,,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 6,,ECHA L1 190,Dr. Christine Hughes,lecture,80 minutes,2017-10-31,Direct Lecture,face to face,Anemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Seminar,,"ECHA L1-430, L1-230, 1-498, 2-150",,seminar,110 minutes,2017-12-05,,face to face,Anticoagulation quiz and seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 1,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2017-10-12,Direct Lecture,face to face,Blood and Lymphatics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 2,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2017-10-17,Direct Lecture,face to face,Blood & Circulation - Red blood cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 4,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2017-10-24,Direct Lecture,face to face,Blood & Circulation - Platelets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 5,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2017-10-26,Direct Lecture,face to face,"Iron products, Vitamin B12, Folates",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,MIDTERM,,ECHA L1 190,Dr. Paul Jurasz,lecture,50 minutes,2017-11-02,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 7,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2017-11-07,Direct Lecture,face to face,Pharmacology of Anti-platelet Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 8,,ECHA L1 190,Dr. Paul Jurasz,lecture,80 minutes,2017-11-09,Direct Lecture,face to face,Pharmacology of Anticoagulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 9,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2017-11-21,Direct Lecture,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 10,,ECHA L1 190,Dr. Tammy Bungard,lecture,80 minutes,2017-11-23,,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 13,,ECHA L1-190,Dr. Paul Jurasz,lecture,80 minutes,2017-12-05,,face to face,"Bleeding, Thrombosis, Neoplastic disorders",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 2,,MS 231,J. Shkrobot,lecture,170 minutes,2017-09-11,,face to face,Strategic planning; Developing and planning patient care services; Implementing and evaluating patient care services,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 3,,MS 231,J. Shkrobot,lecture,170 minutes,2017-09-18,,face to face,Financial management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 4,,MS 231,J. Shkrobot,lecture,170 minutes,2017-09-19,,face to face,Payment for prescriptions in the retail sector; Pharmacy operations; Information management systems; Technology in practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 5,,MS 231,J. Shkrobot,lecture,170 minutes,2017-09-25,,face to face,Marketing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 6,,MS 231,J. Shkrobot,lecture,170 minutes,2017-10-02,,face to face,Inventory management; Human resource management; Recruitment and hiring strategies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,MIDTERM,,TBD,,lecture,110 minutes,2017-10-16,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 7,,MS 231,J. Shkrobot,lecture,170 minutes,2017-10-23,,face to face,Performance management; Desirable workplaces; Managing conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 8,,MS 231,,lecture,170 minutes,2017-10-30,,face to face,BUSINESS PLAN PRESENTATIONS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 9,,MS 227,,lecture,170 minutes,2017-11-07,,face to face,BUSINESS PLAN PRESENTATIONS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 10,,MS 231,J. Shkrobot,lecture,170 minutes,2017-11-20,,face to face,Leadership and management; Management essentials; Managing change,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 11,,MS 231,J. Shkrobot,lecture,170 minutes,2017-11-27,,face to face,Quality assurance and improvement; Managing risk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 12,,MS 231,J. Shkrobot,lecture,170 minutes,2017-12-04,,face to face,Legal requirements; Ethical considerations; Final exam preparation / course evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,FINAL,,TBD,,lecture,110 minutes,2017-12-11,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 1,,MS 231,J. Shkrobot,lecture,170 minutes,2017-09-07,,face to face,Course introduction; Canadian pharmacy business environment; Pharmacy business planning; Market analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,FINAL,,TBA,,Exam,80 minutes,2017-12-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 23,,MS 231,M. Doschak,Lecture,80 minutes,2017-12-08,,,Flipped-Classroom study session 5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 22,,MS 231,M. Doschak,Lecture,80 minutes,2017-12-06,,,Immune Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 21,,MS 231,M. Doschak,Lecture,80 minutes,2017-12-04,,,Vaccines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 20,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2017-12-01,,,Bodys Defense Against Infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 19,,MS 231,M. Doschak,Lecture,80 minutes,2017-11-30,,,Flipped-Classroom  study session 4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 18,,MS 231,M. Doschak,Lecture,80 minutes,2017-11-29,,,Humoral Immunity and Complement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 17,,MS 231,M. Doschak,Lecture,80 minutes,2017-11-27,,,Cell-mediated Immunity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 16,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2017-11-24,,,Immunoassays and ELISA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 15,,MS 231,M. Doschak,Lecture,80 minutes,2017-11-23,,,Hybridoma and Phage Display Technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 14,,MS 231,M. Doschak,Lecture,80 minutes,2017-11-22,,,Aby Structure and B-cell Diversity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 13,,MS 231,M. Doschak,Lecture,80 minutes,2017-11-20,,,Elements of the Immune System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 12,,ECHA 2-190,W. Asghar,Lecture,80 minutes,2017-11-10,,,Cytokines as Therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 11,,,,,,2017-11-09,,,No class  study session 3 (self-study),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 10,,MS 231,W. Dixon,Lecture,80 minutes,2017-11-08,,,Stem Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 9,,MS 231,D. Wishart,Lecture,80 minutes,2017-11-06,,,Protein Pharmaceuticals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,MIDTERM,,,,Exam,,2017-11-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 8,,,,,,2017-11-02,,,No class  study session 2 (self-study),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 7,,MS 231,W. Asgar,Lecture,80 minutes,2017-11-01,,,Drug Delivery Systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 6,,MS 231,W. Dixon,Lecture,80 minutes,2017-10-30,,,Transgenic Animals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 5,,MS 231,G. Haggag,Lecture,80 minutes,2017-10-27,,,Antisense Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 4,,MS 231,M. Doschak,Lecture,80 minutes,2017-10-26,,,Flipped-Classroom; study session 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 3,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2017-10-25,,,PCR / Gene Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 2,,MS 231,M. Doschak,Lecture,80 minutes,2017-10-23,,,"Protein biosynthesis and regulation of gene expression, Polymerase chain reaction and applications, Isolation of cloned genes, Recombinant DNA Technology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Lecture 1,,ECHA 2-190,M. Doschak,Lecture,80 minutes,2017-10-19,,,Introduction to Biotechnology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,FINAL,,,,lecture,50 minutes,2017-12-15,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 16,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-12-04,,face to face,Aboriginal Peoples and health care; Group assignment due,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 15,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-12-01,,face to face,Medical Aid in Dying: The Legal Framework and the Role of the Pharmacist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 14,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-29,,face to face,Supported Decision-Making: Personal Directives and Powers of Attorney,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 13,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-27,,face to face,Law of Negligence: Defences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 12,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-24,,face to face,Law of Negligence: Causation and Damages,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 11,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-23,,face to face,Law of Negligence: Duty and Standard of Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,MIDTERM,,,,lecture,50 minutes,2017-11-22,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 10,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-21,,face to face,Privacy Law: Health Information Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 9,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-20,,face to face,Privacy Law: Health Information Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 8,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-10,,face to face,Types of legal actions / The Alberta court system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 7,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-11-01,,face to face,Introduction to the Legal System: Defining law / Sources and institutions of law,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 6,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-10-31,,face to face,Professional Responsibility: The ACP Code of Ethics / The professional discipline process / Pharmacists and substance abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 5,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-10-27,,face to face,Professional ethics: Conscientious objection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 4,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-10-25,,face to face,Medical ethics: Autonomy and informed consent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 3,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-10-23,,face to face,Medical ethics: Beneficence and nonmaleficence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 2,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-10-20,,face to face,Ethics and the pharmacy profession: Historical overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 1,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2017-10-18,,face to face,Course overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lecture 1,,MS 227,Ken Cor & TBA,lecture,50 minutes,2017-09-08,,face to face,"Types of drug information resources, Types of drug information requests, Pharmacists role in answering drug information requests, Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Seminar 1,E8,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-11,,face to face,Research Skills Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Seminar 1,E7,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Seminar 1,E10,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-18,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Seminar 1,E9,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-19,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Seminar 1,E11,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-20,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Seminar 1,E12,MSB 2-50,Janice Kung,seminar,50 minutes,2017-09-21,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 1,D4,MS 1-15,Course TAs,lab,110 minutes,2017-09-25,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lecture 2,,MS 227,Katherine Sorenson,lecture,50 minutes,2017-09-26,,face to face,"Drug information resources, Role of drug information in healthcare, Drug Information Services and Resources",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 1,D5,MS 1-15,Course TAs,lab,110 minutes,2017-09-27,,face to face,Drug Information Resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 1,D6,MS 1-15,Course TAs,lab,110 minutes,2017-09-29,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lecture 3,,MS 227,Katherine Sorenson,lecture,110 minutes,2017-10-03,,face to face,"Following-up, Replying to the requestor, Planning and complete a literature search, Obtaining background information, Evaluating the data and composing a response, Classifying and confirming the ultimate question, Gathering requestor information, Systematic Approach to Drug Information",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 2,D4,MS 1-15,Course TAs,lab,110 minutes,2017-10-06,,face to face,Systematic Approach to Drug Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 2,D5,MS 1-15,Course TAs,lab,110 minutes,2017-10-11,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 2,D6,MS 1-15,Course TAs,lab,110 minutes,2017-10-20,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 3,D4,MS 1-15,Course TAs,lab,110 minutes,2017-10-23,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 3,D5,MS 1-15,Course TAs,lab,110 minutes,2017-10-25,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 3,D6,MS 1-15,Course TAs,lab,110 minutes,2017-10-27,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 5,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-01,,face to face,Data Sources  Part II: Secondary Analyses & Population-Based Surveys,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 6,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-03,,face to face,Pharmacoepidemiologic Study Designs  Part I: Cross-Sectional Studies and Case-Control Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 7,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-06,,face to face,Pharmacoepidemiologic Study Designs  Part II: Cohort Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 8,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-08,,face to face,Measurement of Association,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 9,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-10,,face to face,Bradford-Hill Considerations for Causal Inference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 10,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-13,,face to face,Bias in Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 11,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-15,,face to face,Confounding in Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 22,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-24,,face to face,Pharmacy Practice Research Examples,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 23,,6-28 MSB,T. Charrois,lecture,50 minutes,2018-03-27,,face to face,Pharmacy Practice Research Examples,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 24,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-29,,face to face,Pharmacoeconomic Evaluations & Course Evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 18,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-15,,face to face,Pharmacy Practice Research Design Issues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 19,,6-28 MSB,C. Kabatoff,lecture,50 minutes,2018-03-17,,face to face,Consent and Ethical Considerations in Pharmacy Practice Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 20,,6-28 MSB,Dr. Cor,lecture,50 minutes,2018-03-20,,face to face,Survey Methods  Part I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 21,,6-28 MSB,Dr. Cor,lecture,50 minutes,2018-03-22,,face to face,Survey Methods  Part II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 1,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-01-23,,face to face,Course Outline & Introduction to Pharmacoepidemiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 2,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-01-25,,face to face,Limitations of Drug Approval & Pre-Marketing Clinical Trials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 3,,6-28 MSB,Dr. Eurich,lecture,50 minutes,2018-01-27,,face to face,Randomized Controlled Trials & Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 4,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-01-30,,face to face,Data Sources  Part I: ADR Reports & Health Care Databases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 12,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-27,,face to face,Meta-Analysis  Part I: Search and Selection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 13,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-01,,face to face,Meta-Analysis  Part II: Data Synthesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 14,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-03,,face to face,JAMA Users Guides approach to critically appraising observational studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 15,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-06,,face to face,Open Topics in Pharmacoepidemiology  Questions from the Class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Midterm,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-08,,face to face,Midterm exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Seminar,,2-50 MSB,UofA Librarian,seminar,50 minutes,2018-03-09,,face to face,LITERATURE SEARCH SKILLS SEMINAR (50-minutes/group),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 16,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-10,,face to face,Quality Improvement Framework,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Seminar,,2-50 MSB,UofA Librarian,seminar,50 minutes,2018-03-10,,face to face,LITERATURE SEARCH SKILLS SEMINAR (50-minutes/group),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Lecture 17,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-13,,face to face,Knowledge Translation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,Lecture 4,,Edmonton: ECHA ; Calgary: TBD (PLC 1148 OR SHC 410030),Sheila Walter Tara Leslie,lecture,50 minutes,2017-03-02,,face to face,"Apply active listening strategies to give full attention to manage the interaction with the audience and provide constructive responses to questions, Create effective visual aids to support presentation topics, Apply EBM skills to determine the validity and applicability of a piece of evidence to practice, Summarize relevant background information to frame the PICO question, Demonstrate effective use of verbal & nonverbal presentation skills, Develop learning objectives for the audience, Identify the learning needs of the audience, Comprehensive Presentation Orientation, Career Services Presentation, Informative Presentation (Group B presenting)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,Lecture 3,,Edmonton: ECHA; Calgary: SHC 410030,Sheila Walter Tara Leslie,lecture,50 minutes,2017-02-15,,face to face,"Speaks using an organized process and appropriate tone and vocabulary, Determine a course of action based on reflection, Uses feedback to inform reflection, Explores own strengths and weaknesses as a pharmacist/professional, Reflection, Informative Presentation (Group A presenting)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,Lecture 2,,,,lecture,50 minutes,2017-11-15,,face to face,"Provide effective feedback, Assess peer performance against as standard, Peer review session",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,Lecture 1 ,,ECHA 1-490,Sheila Walter Tara Leslie,lecture,50 minutes,2016-05-12,,face to face,"Describe the expectations for Delivering Effective Feedback Assignment and the Informative seminar, Set expectations for delivering peer feedback, Review the roles and responsibilities of the student, Provide overview of seminar schedule all seminar components, Orientation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,FINAL EXAM,,MSB 227,Dr. Nes Yuksel,exam,,2018-04-18,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Class Evaluations/Final Exam Review Treatment of Sexual Dysfunction in Women,,MSB 227,Dr. Nes Yuksel,lecture,80 minutes,2018-04-12,,Face to Face,Class Evaluations/Final Exam Review Treatment of Sexual Dysfunction in Women,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Care of Transgender Patients,,MSB 227,Carla Grant,lecture,50 minutes,2018-04-11,,Face to Face,Care of Transgender Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Drugs in Pregnancy and Lactation Treatment Issues in Pregnancy,,MSB 227,Dr. Nes Yuksel,lecture,80 minutes,2018-04-10,,Face to Face,"Postpartum Care/Postpartum Depression, Drugs in Pregnancy and Lactation Treatment Issues in Pregnancy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 4: FASD Seminar,,MSB 227,Dr Sharon Mitchell,seminar,170 minutes,2018-04-11,,Distance,Seminar 4: FASD Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Pregnancy and Ovulation Testing/ Physiologic Changes in Pregnancy,,MSB 227,Dr. Nes Yuksel,lecture,50 minutes,2018-04-09,,Face to Face,Pregnancy and Ovulation Testing/ Physiologic Changes in Pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Treatment of Infertility,,MSB 227,Dr. Nes Yuksel,lecture,50 minutes,2018-04-06,,Face to Face,Treatment of Infertility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Medicinal Chemistry,,MSB 227,Dr. Frank Wuest,lecture,50 minutes,2018-04-04,,Face to Face,Medicinal Chemistry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Erectile Dysfunction,,MSB 227,Tasneem Siyam,lecture,80 minutes,2018-04-03,,Face to Face,Erectile Dysfunction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 3: Menopause Cases,,MSB 227,Dr. Nes Yuksel,seminar,170 minutes,2018-04-04,,Distance,Seminar 3: Menopause Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,"Andropause, Male Pattern Baldness",,MSB 227,Dr. Nathan Beahm,,80 minutes,2018-03-29,,Face to Face,"Andropause, Male Pattern Baldness",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,MIDTERM EXAM,,MSB 227,Dr. Nes Yuksel,exam,50 minutes,2018-03-28,,Face to Face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Endometriosis Polcystic Ovarian Syndrome,,MSB 227,Dr. Nes Yuksel,lecture,80 minutes,2018-03-27,,Face to Face,Endometriosis Polcystic Ovarian Syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 2: Management of symptoms/Role of Hormone Therapy,,MSB 227,Dr. Nes Yuksel,lecture,50 minutes,2018-03-26,,Face to Face,Menopause 2: Management of symptoms/Role of Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 2: Management of symptoms/Role of Hormone Therapy,,MSB 227,Dr. Nes Yuksel,lecture,50 minutes,2018-03-23,,Face to Face,Menopause 2: Management of symptoms/Role of Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 1: Pathophysiology and Pharmacology of Hormones,,MSB 227,Dr. Nes Yuksel,lecture,80 minutes,2018-03-22,,Distance,Menopause 1: Pathophysiology and Pharmacology of Hormones,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 2: Non-hormonal contraception session,,MSB 227,Kathleen McPherson/ Dr Nes Yuksel,seminar,170 minutes,2018-03-28,,Face to Face,Seminar 2: Non-hormonal contraception session,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Emergency Contraception,,MSB 227,Dr. Nes Yuksel,lecture,50 minutes,2018-03-21,,Face to Face,Emergency Contraception,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menstrual Related Disorders/PMS/PMDD,,MSB 227,Dr. Nes Yuksel,lecture,80 minutes,2018-03-20,,Face to Face,Menstrual Related Disorders/PMS/PMDD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,MSB 227,Dr. Susan Patrick,lecture,50 minutes,2018-03-16,,Distance,"This will be an online session, Anatomy/Physiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception cont,,MSB 227,Dr. Nes Yuksel,lecture,80 minutes,2018-03-15,,Face to Face,Hormonal Contraception cont,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 1: Hormonal contraception cases,,MSB 227,Dr. Nes Yuksel,seminar,170 minutes,2018-03-21,,Face to Face,Seminar 1: Hormonal contraception cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception cont,,MSB 227,Dr. Nes Yuksel,lecture,50 minutes,2018-03-14,,Face to Face,Hormonal Contraception cont,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,MSB 227,Dr. Nes Yuksel,lecture,50 minutes,2018-03-12,,Face to Face,Hormonal Contraception,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,MSB 227,Dr. Susan Patrick,lecture,50 minutes,2018-03-08,,Distance,"This will be an online session, Anatomy/Physiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,"Introduction, Course Syllabus Anatomy/Physiology",,MSB 227,Dr. Nes Yuksel/ Dr. Susan Patrick,lecture,80 minutes,2018-03-06,,Face to Face,"Introduction, Course Syllabus Anatomy/Physiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Final project presentations ,,ECHA 2-150,Dr. Makhinova ,lecture,170 minutes,2018-05-18,,face to face,Final project presentations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 2,,ECHA 2-150,Dr. Makhinova,lecture,170 minutes,2018-05-02,,face to face,Leading self; Personality inventory Leadership styles,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 3,,ECHA 2-150,TBA,lecture,170 minutes,2018-05-04,,face to face,Communication; Listening well; Giving feedback; Decision making; Problem-solving;,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 5,,ECHA 2-150,Dr. Makhinova ,lecture,170 minutes,2018-05-09,,face to face,"Effective teams, mission, vision, values; Team-building; ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 6,,ECHA 2-150,Dr. Makhinova,lecture,170 minutes,2018-05-11,,face to face,Self-awareness; Emotional intelligence; Why people fail? Passion and motivation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 7,,ECHA 2-150,TBA,lecture,170 minutes,2018-05-14,,face to face,Collaboration; Interprofessionalism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 8,,ECHA 2-150,Dr. Makhinova,lecture,170 minutes,2018-05-16,,face to face,Professional development; Mentorship; Life-long learning; Learning styles,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 1,,ECHA 2-150,Dr. Makhinova,lecture,170 minutes,2018-04-30,,face to face,"Introduction, Leadership; Leadership vs Management; Leadership and followership; Leading change",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Module 4,,ECHA 2-150,Dr. Makhinova,lecture,170 minutes,2018-05-07,,face to face,Conflict management; Informal power; Consensus; ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 6 - Critical Care Assessment ,,Online,Dr. Catherine Sych,lecture,50 minutes,2018-02-11,Other,distance,Critical Care Assessment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 6 - Midterm Exam,,Online,Dr. Rene Breault,lecture,50 minutes,2018-02-15,Other,distance,Midterm Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 3 - Assessment of Liver Chemistry Tests,,Online,Dr. Rene Breault,lecture,50 minutes,2018-01-21,Other,distance,Assessment of Liver Chemistry Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 7 - Reading Week Break,,,,lecture,50 minutes,2018-02-18,,distance,Reading Week Break,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 8 - Infectious Disease Assessment ,,Online,Dr. Bruce Dalton,lecture,50 minutes,2018-02-25,Other,distance,Infectious Disease Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 9 - Physical Assessment ,,Online ,Stewart McLennan,lecture,50 minutes,2018-03-04,Other,distance,Basic Techniques and Vital Signs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 10 - Physical Assessment ,,Online,Dr. Ravina Sanghera,lecture,50 minutes,2018-03-11,Other,distance,Skin Assessment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 11 - Physical Assessment ,,Online,Stewart McLennan,lecture,50 minutes,2018-03-18,Other,distance,HEENT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 12 - Physical Assessment ,,Online,Stewart McLennan,lecture,50 minutes,2018-03-25,Other,distance,Cardio/Respiratory/Peripheral Vascular,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 13 - Physical Assessment ,,Online,Stewart McLennan,lecture,50 minutes,2018-04-01,Other,distance,Neuromuscular,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 14 - Final Exam ,,Online ,Dr. Rene Breault,lecture,50 minutes,2018-04-12,Other,distance,Final Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 1 - Patient Assessment ,,Online,Dr. Rene Breault,lecture,50 minutes,2018-01-07,Other,distance,Patient Assessment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 2 - Assessment of Renal Function ,,Online,Dr. Rene Breault,lecture,50 minutes,2018-01-14,Other,distance,Assessment of Renal Function ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 4 - Anemia,,Online,Dr. Christine Hughes,lecture,50 minutes,2018-01-28,Other,distance,Assessment of Anemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Week 5 - Mental Health Assessment,,Online,Professor Candace Necyk,lecture,50 minutes,2018-02-05,Other,distance,Mental Health Assessment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Exam,,MS Lab 1-45,,,,2018-03-20,,,Lab exam ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 21,,MS Lab 1-45,Amir / Sherif,lab,,2018-03-16,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 20,,MS Lab 1-45,Amir / Sherif,lab,,2018-03-14,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 19,,MS Lab 1-45,Amir / Sherif,lab,,2018-03-12,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 18,,MS Lab 1-45,Asma / Amir,lab,,2018-03-09,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 17,,MS Lab 1-45,Asma / Amir,lab,,2018-03-07,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 16,,MS Lab 1-45,Asma / Amir,lab,,2018-03-05,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 15,,MS Lab 1-45,Doaa / Asma,lab,,2018-03-02,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 14,,MS Lab 1-45,Doaa / Asma,lab,,2018-02-28,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 13,,MS Lab 1-45,Doaa / Asma,lab,,2018-02-26,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 12,,MS Lab 1-45,Igor / Doaa,lab,,2018-02-16,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 11,,MS Lab 1-45,Igor / Doaa,lab,,2018-02-14,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 10,,MS Lab 1-45,Igor / Doaa,lab,,2018-02-12,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 9,,MS Lab 1-45,Hanan/ Igor,lab,,2018-02-09,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 8,,MS Lab 1-45,Hanan/ Igor,lab,,2018-02-07,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 7,,MS Lab 1-45,Hanan/ Igor,lab,,2018-02-05,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 6,,MS Lab 1-45,Daniela/Hanan,lab,,2018-02-02,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 5,,MS Lab 1-45,Daniela/Hanan,lab,,2018-01-31,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 4,,MS Lab 1-45,Daniela/Hanan,lab,,2018-01-29,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 3,,MS Lab 1-45,Sherif / Daniela,lab,,2018-01-26,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 2,,MS Lab 1-45,Sherif / Daniela,lab,,2018-01-24,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab 1,,MS Lab 1-45,Sherif / Daniela,lab,,2018-01-22,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 21,,TBA,Amir / Lb,seminar,,2018-03-16,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 20,,TBA,Amir / Lb,seminar,,2018-03-14,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 19,,TBA,Amir / Lb,seminar,,2018-03-12,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 18,,TBA,Amina / Lb ,seminar,,2018-03-09,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 17,,TBA,Amina / Lb ,seminar,,2018-03-07,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 16,,TBA,Amina / Lb ,seminar,,2018-03-05,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 15,,TBA,Igor / Lb,seminar,,2018-02-16,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 14,,TBA,Igor / Lb,seminar,,2018-02-14,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 13,,TBA,Igor / Lb,seminar,,2018-02-12,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 12,,TBA,Hanan/ Lb,seminar,,2018-02-09,,Face to Face,Emulsion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 11,,TBA,Hanan/ Lb,seminar,,2018-02-07,,Face to Face,Emulsion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 10,,TBA,Hanan/ Lb,seminar,,2018-02-05,,Face to Face,Emulsion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 9,,TBA,Daniela / Lb,seminar,,2018-02-02,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 8,,TBA,Daniela / Lb,seminar,,2018-01-31,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 7,,TBA,Daniela / Lb,seminar,,2018-01-29,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 6,,TBA,Sherif / Lav ,seminar,,2018-01-26,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 5,,TBA,Sherif / Lav ,seminar,,2018-01-24,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 4,,TBA,Sherif / Lav ,seminar,,2018-01-22,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 3,,TBA,Doaa / Lb ,seminar,,2018-01-19,,Face to Face,Accuracy in Pharmaceutical Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 2,,TBA,Doaa / Lb ,seminar,,2018-01-17,,Face to Face,Accuracy in Pharmaceutical Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Seminar 1,,TBA,Doaa / Lb ,seminar,,2018-01-15,,Face to Face,Accuracy in Pharmaceutical Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 17,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-28,,Face to Face,Routes of Administration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 16,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-26,,Face to Face,Routes of Administration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 15,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-16,,Face to Face,Compounding review ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 14,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-14,,Face to Face,Containers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 13,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-12,,Face to Face,Powders and Capsules,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 12,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-09,,Face to Face,Suppositories,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 11,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-07,,Face to Face,Colloids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 10,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-05,,Face to Face,Colloids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,EXAM,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-02-02,,Face to Face,Midterm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 9,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-31,,Face to Face,Semisolids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 8,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-29,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 7,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-26,,Face to Face,Emulsions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 6,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-24,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 5,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-22,,Face to Face,Suspensions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 4,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-19,,Face to Face,Pharmaceutical Solutions and Waters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 3,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-17,,Face to Face,Solubility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 2,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-15,,Face to Face,Contemporary Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lecture 1,,MS 231,Dr. Lbenberg,lecture,120 minutes,2018-01-08,,Face to Face,Introduction into Compounding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 3,,MS 628,Shkrobot,lecture,170 minutes,2018-01-22,"Direct Lecture, Active Learning, Team Based Learning",face to face,Healthcare reources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 9,,MS 628,Shkrobot,lecture,170 minutes,2018-03-19,"Direct Lecture, Active Learning, Team Based Learning",face to face,Debates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 10,,MS 628,Shkrobot,lecture,170 minutes,2018-03-26,"Direct Lecture, Active Learning, Team Based Learning",face to face,Debates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 7,,MS 628,"Shkrobot, Makhinova",lecture,170 minutes,2018-03-05,"Direct Lecture, Active Learning, Team Based Learning",face to face,"Pharmacoeconomics, Pharmacy Service Frameworks",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 2,,MS 628,Shkrobot,lecture,170 minutes,2018-01-15,"Direct Lecture, Active Learning",face to face,"Health systems, Canada's healthcare system",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 5,,MS 628,Shkrobot,lecture,170 minutes,2018-02-05,"Direct Lecture, Active Learning, Team Based Learning",face to face,Provision of healthcare services,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 8,,MS 628,Shkrobot,lecture,170 minutes,2018-03-12,"Direct Lecture, Active Learning, Team Based Learning",face to face,Solutions to healthcare issues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 1,,MS 628,Shkrobot,lecture,170 minutes,2018-01-08,"Direct Lecture, Active Learning",face to face,Historical background,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 4,,MS 628,Shkrobot,lecture,170 minutes,2018-01-29,"Direct Lecture, Active Learning, Team Based Learning",face to face,Provision of healthcare services,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Session 6,,MS 628,Shkrobot,lecture,170 minutes,2018-02-12,"Direct Lecture, Active Learning, Team Based Learning",face to face,Healthcare organizations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 1,,MS 227,R. Sanghera,Lecture,170 minutes,2018-03-14,,,"Course Introduction, Assignment Introduction, SCHOLAR Lecture",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 2,,ONLINE,S. Patrick,Lecture,170 minutes,2018-03-15,,,"Anatomy &amp; Physiology of the Ear, Nose, and Throat (Additional Nose, and Throat modules will be released (EYE) as deemed appropriate)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 1,,ECHA 2-190,R. Sanghera,Semiar,80 minutes,2018-03-16,,,Orientation to PCP Lab Activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 3,,ECHA 2-190,C. Velasquez/ S. Patrick,Lecture,110 minutes,2018-03-19,,,"Med Chem &amp; PMCOL of Corticosteroids (1300-1450) , Anatomy &amp; Physiology Eye (ONLINE: 1000-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 4,,MS 227,R. Sanghera,Lecture,110 minutes,2018-03-21,,,"PMCOL of Antihistamines (0900- 0930) , Allergic Rhinitis (0930-1130) , Take Home Ear Assignment Introduction (1130-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 2,,TBA,R. Sanghera,Semiar,80 minutes,2018-03-22,,,PCP/Case Workup,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 3,,TBA,R. Sanghera,Semiar,80 minutes,2018-03-22,,,PCP/Case Workup,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 5,,MS 227,R. Sanghera/ J. Ton,Lecture,170 minutes,2018-03-23,,,"Anatomy &amp; Physiology Eye (ONLINE: 1000-1150), Anatomy &amp; Physiology Eye (ONLINE: 1000-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 6,,MS 227,C. Sadowski/ S. Patrick,Lecture,170 minutes,2018-03-26,,,"Ophthalmology Part 2 (0900-1050), Anatomy &amp; Physiology of the Integumentary System (ONLINE: 1100-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,MIDERM,,MS 227,R. Sanghera,EXAM,110 minutes,2018-03-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 7,,MS 227,C. Velasquez/ R. Sanghera,Lecture,50 minutes,2018-03-27,,,"Med Chem of Antihistamines &amp; Decongestants (0900-1050), Time off for Anatomy &amp; Physiology of Integumentary System (ONLINE: 1100-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 1,,Practice Lab,R. Sanghera,Lab,,2018-03-28,,,"Lab # 1 Patient Care Process (Eye, Ear and Allergic Rhinitis)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 8,,MS 227,R. Sanghera,Lecture,170 minutes,2018-03-29,,,"Acne &amp; Rosacea Therapeutics (0900- 1050), Lice and Scabies (1100-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 9,,MS 227,R. Sanghera,Lecture,170 minutes,2018-04-03,,,Dermatitis/Eczema/ Seborrhea/ Psoriasis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 10,,MS 227,P. Grewal,Lecture,170 minutes,2018-04-04,,,"Sunburn, Skin Cancer, Vitiligo &amp; Hyperpigmentation (0900-1050), Drug-induced Skin Eruptions &amp; Contact Dermatitis (podcast: 1100- 1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 11,,MS 227,R. Sanghera,Lecture,170 minutes,2018-04-05,,,"Bacterial Skin Infections (0900-0950), Alopecia/ Hyperhidrosis (1000-1050), Corns/Calluses (1100-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 2,,Practice Lab,R. Sanghera,Lab,,2018-04-06,,,Lab # 2: Patient Care Process (Dermatologic Conditions),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 12,,MS 227,C. Steele/ R. Sanghera,Lecture,170 minutes,2018-04-09,,,"Wound Care (0900-1050), Class Wrap-up (1100-1150)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,FINAL,,TBA,,EXAM,,2018-04-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Small group learning activities (virology and pharmacology),,PBL rooms,,lecture,50 minutes,2018-01-22,"Active Learning, Problem Based Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Patient Perspective (HIV),,MSB 227,Guest,lecture,50 minutes,2018-03-12,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Small group learning activities - viral hepatitis, STIs, HIV, influenza",,PBL rooms,,lecture,110 minutes,2018-03-14,"Active Learning, Problem Based Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: HIV/opportunistic Infections - candidiasis, mycobacterium avium, PJP",,MSB 227,Hughes,lecture,50 minutes,2018-03-12,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Course evaluations; Final exam review,,MSB 227,Hughes,lecture,50 minutes,2018-04-13,Active Learning,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Pinworms,,MSB 227,Hughes,lecture,110 minutes,2018-03-16,Direct Lecture,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Mycology overview,,MSB 227,Dingle,lecture,110 minutes,2018-03-21,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Antifungals Pharmacology - polyenes, imidazoles & triazoles,echinocandins",,MSB 227,Gray,lecture,110 minutes,2018-03-23,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: Systemic Fungal Infections (Candidiasis, Aspergillus)",,MSB 227,Gray,lecture,110 minutes,2018-03-26,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Parasitology introduction,,MSB 227,Kowaleskaâ€êGrochowska,lecture,50 minutes,2018-03-28,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Bioterrorism,,MSB 227,Franc,lecture,50 minutes,2018-03-28,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: Dermatophytoses (candida, ringworm, athletes foot, jock itch, fungal nail infections)",,MSB 227,Hughes,lecture,110 minutes,2018-04-04,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Antiprotozoals - pharmacology antimalarials, other antiprotozoals",,MSB 227,Ussher,lecture,80 minutes,2018-04-06,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: Protozoal Diseases - toxoplasmosis, giardia lamblia, cryptosporidium, amebiasis",,MSB 227,Kowaleskaâ€êGrochowska,lecture,80 minutes,2018-04-09,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Travellerâ€™s Health - Malaria,,MSB 227,Houston,lecture,110 minutes,2018-04-11,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Travellerâ€™s Health Practice,,MSB 227,Kmet,lecture,50 minutes,2018-04-13,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Virology: respiratory illnesses, gastroenteritis, rash illnesses, viral hepatitis, CNS infections, herpes viruses, HPV",,MSB 227,Hughes/TBD,lecture,110 minutes,2018-01-17,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Antivirals: pharmacology anti-herpes drugs, anti-HBV drugs, anti-HCV drugs, anti-influenza agents",,MSB 227,Siraki,lecture,110 minutes,2018-01-19,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Herpes Simplex 1 & 2,,MSB 227,Hughes,lecture,110 minutes,2018-01-24,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Herpes Zoster,,MSB 227,Hughes,lecture,110 minutes,2018-01-26,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Vaccine Licensure and Immunization delivery,,MSB 227,Hedley,lecture,50 minutes,2018-01-29,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Overview of vaccine types: live, killed/inactivated/subunit, vaccine failures, reactions",,MSB 227,Hughes,lecture,50 minutes,2018-01-29,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Immunizations of children: vaccine schedules, adverse effects, illness manifestations",,MSB 227,Hedley,lecture,110 minutes,2018-01-31,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Legal & Ethical Issues: Vaccinations,,MSB 227,Ogbogu,lecture,110 minutes,2018-02-02,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Immunizations of adults/ travellers; Vaccine storage and handling; Immunization delivery ,,MSB 227,Hughes,lecture,110 minutes,2018-02-05,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Small group learning activities: vaccines,,PBL rooms,Hughes,lecture,110 minutes,2018-02-07,"Active Learning, Problem Based Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Vaccine hesistancy and strategies,,MSB 227,Hughes,lecture,110 minutes,2018-02-12,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: STIs - chlamydia, gonorrhea, syphilis, genital herpes, genital HPV",,MSB 227,Singh,lecture,110 minutes,2018-02-14,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Influenza,,MSB 227,Watson,lecture,110 minutes,2018-02-16,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Hepatitis recorded lecture & case preparation,,Recorded Lecture,Hughes,lecture,110 minutes,2018-02-26,Direct Lecture,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Hepatitis A&B Hepatitis C Case Discussions,,MSB 227,Hughes,lecture,110 minutes,2018-03-02,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"HIV overview (Pathophysiology, transmission, diagnosis)",,MSB 227,Hughes,lecture,110 minutes,2018-03-05,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: HIV Drug classes, MOA, side effects, interactions, goals of therapy",,MSB 227,Hughes,lecture,110 minutes,2018-03-07,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: HIV (case discussions),,MSB 227,Hughes,lecture,110 minutes,2018-03-09,Active Learning,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Introduction/Virology overview: structure, classification, replication, transmission, diagnosis",,MSB 227,Hughes/TBD,lecture,110 minutes,2018-01-08,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Virology: respiratory illnesses, gastroenteritis, rash illnesses, viral hepatitis, CNS infections, herpes viruses, HPV",,MSB 227,Hughes/TBD,lecture,110 minutes,2018-01-15,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Course Introduction; Anatomy and Physiology (Part I),,MS 227,Simpson/Patrick,lecture,80 minutes,2018-01-09,,face to face,"Negative feedback regulation, General function of the endocrine system, Overview of the endocrine glands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Anatomy and Physiology (Part II),,Online,Patrick,lecture,80 minutes,2018-01-16,,distance,"Glucose homeostasis, Introduction to dysfunction of endocrine system",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Medicinal Chemistry - Antidiabetic Drugs,,MS 227,Velazquez,lecture,80 minutes,2018-01-18,,face to face,"Insulin biosynthesis and activation, Chemical features of different oral antidiabetic drugs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Introduction to Diabetes & Treatment of Type 1 Diabetes,,MS 227,Yeung,lecture,80 minutes,2018-01-23,,face to face,"Discuss the practical management of insulin use with diet considerations (i.e. carbohydrates, Review insulin pumps and their role in Type 1 diabetes, as well as how to dose insulin accurately, Initiation and titration of insulin in the context of Type 1 diabetes, Review of insulin formulations, Treatment goals for diabetes, Risk factors for type 1 diabetes, Prevalence of diabetes, Definition and diagnostic criteria for prediabetes and diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Pharmacology - Antidiabetic Drugs,,MS 227,Ussher,lecture,80 minutes,2018-01-25,,face to face,"Highlight important differences between agents within the same pharmacologic class, Mechanisms of action for antidiabetic drugs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Type 2 Diabetes  Treatment (Part I),,MS 227,Eurich,lecture,80 minutes,2018-01-30,,face to face,"Describe treatment goals and pharmacologic options for patients with type 2 diabetes, Review pathophysiologic mechanisms contributing to development of type 2 diabetes, Describe the burden of diabetes and unmet needs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Type 2 Diabetes  Treatment (Part II),,MS 227,Eurich,lecture,80 minutes,2018-02-01,,face to face,Describe treatment goals and pharmacologic options for patients with type 2 diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Preparation time for Thyroid Case Discussions,,N/A,,seminar,110 minutes,2018-02-02,,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Type 2 Diabetes Management Flowchart & Insulin Use in Type 2 Diabetes,,MS 227,Simpson/Hodgins,lecture,80 minutes,2018-02-06,,face to face,"Discuss the role of concurrent use of insulin and antidiabetic drugs, Initiation and titration of insulin in the context of Type 2 diabetes, Review the Diabetes Canada treatment algorithm for type 2 diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Seminar: Insulin Dosing and Management,,TBA,Simpson,seminar,110 minutes,2018-02-08,,face to face,"In groups of 5-6, students will work through two patient cases which will contain guided questions and varying scenarios covering common issues and themes related to insulin use and management (i.e. dosing, sick day management, hypoglycemia, travel). Groups will be randomly selected to present and discuss their answers to the cases., Students will engage in assigned pre-readings and review lecture material prior to the seminar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Overview of Diabetes Management - Pragmatic Topics,,MS 227,TBA,lecture,80 minutes,2018-02-08,,face to face,"i.e. travel, storage, driving, acute illness management, Review practical considerations and patient education tips for patients living with diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Gestational Diabetes,,MS 227,Ryan,lecture,80 minutes,2018-02-13,,face to face,"Strategies to manage gestational diabetes, Detection, risk factors, and prevention of gestational diabetes, Implications of gestational diabetes to the mother and baby",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Long-term Complications of Diabetes ,,MS 227,Simpson,lecture,80 minutes,2018-02-27,,face to face,"Outline management strategies for complications  the A-B-Cs of Diabetes Care, Describe important considerations of diabetes-related complications, Define the metabolic syndrome and what information this provides for patient management, Review key points from lifestyle intervention studies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Seminar: Type 2 Diabetes Management,,TBA,Simpson,seminar,110 minutes,2018-03-01,,face to face,"In groups of 5-6, students will work up and discuss a series of mini-cases related to common issues with diabetes management. Each group will be responsible for presenting and leading a small discussion with the rest of the class on the case they were assigned to., Students will prepare a brief care plan (Type 2 diabetic patient) on a posted case to bring to seminar for discussion with their peers and facilitator. Risk factors and the patient care process will be discussed to identify drug-related problems and prepare an appropriate treatment plan for the patient., Students will engage in assigned pre-readings and review of lecture material prior to the seminar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Current issues in Diabetes Management,,MS 227,Simpson,lecture,80 minutes,2018-03-01,,face to face,"Describe point-of-care testing devices used for management of diabetes and its complications, Discuss current literature, evidence and considerations surrounding antidiabetic drugs, insulin and diabetes management",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Anatomy and Physiology (Part III),,Online,Patrick,lecture,80 minutes,2018-03-13,,distance,"Introduction to secretion disorders (defining primary and secondary hyper- and hyposecretion), Endocrine function of the kidney, pineal gland, and heart, Endocrine function of the Hypothalamus-Pituitary-Adrenal axis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Medicinal Chemistry - Thyroid Drugs,,MS 227,Velazquez,lecture,80 minutes,2018-03-15,,face to face,"Recognize the main structural features of thyroid peroxidase enzyme inhibitors, Recognize the main structural features of thyroid hormones and analogs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Thyroid Disorders,,MS 227,Hughes,lecture,80 minutes,2018-03-20,,face to face,"Identify drugs which may interact with levothyroxine replacement, Provide appropriate counseling information, Develop a plan to monitor pharmacotherapy, Develop an appropriate patient-specific treatment plan, Describe the signs and symptoms, and goals of therapy, Identify drugs which may cause thyroid disease, Interpret laboratory tests in a patient diagnosed with hypothyroidism or hyperthyroidism",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,"Vitamin D, PTH & Bone Metabolism",,MS 227,Doschak,lecture,80 minutes,2018-03-22,,face to face,"Treatment options & strategies, Disorders of calcium homeostasis, Bone metabolism, Calcium physiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Disorders of the Pituitary and Adrenals,,MS 227,Yeung,lecture,80 minutes,2018-03-27,,face to face,"Adrenal gland disorders (pheochromocytoma, Cushings, Addisons), Pituitary gland disorders (hypersecretion & hyposecretion)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Complimentary & Alternative Medications for Diabetes & Thyroid,,MS 227,Zubach-Cassano/Necyk,lecture,80 minutes,2018-03-29,,face to face,"Discuss the estimated prevalence of natural health products (NHP) use in diabetes, Discuss the role of the pharmacist in patient safety surrounding NHP use, Understand risks of drug interactions associated with NHPs, Discuss NHPs available for diabetes & thyroid disorders",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Introduction/Pathophysiology,,ECHA 2-490,John Seubert,lecture,110 minutes,2018-01-08,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Anatomy/Physiology,,Online,Susan Patrick,lecture,110 minutes,2018-01-15,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Physiology,,Online,Susan Patrick,lecture,110 minutes,2018-01-17,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Physiology,,Online,Susan Patrick,lecture,110 minutes,2018-01-19,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: Beta-blockers/RAAS,,ECHA 2-490,John Seubert,lecture,110 minutes,2018-01-22,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: Lipds/Diuretics,,ECHA 2-490,John Seubert,lecture,110 minutes,2018-01-24,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: CCB/Vasodilators,,ECHA 2-490,John Seubert,lecture,110 minutes,2018-01-26,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,MedChem: Anti-Arrhythmics/CCB/Statins,,ECHA 2-490,Khaled Barakat,lecture,110 minutes,2018-01-29,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Hypertension,,ECHA 2-490,Ann Thompson,lecture,110 minutes,2018-01-31,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Hypertension,,ECHA 2-490,Ann Thompson,lecture,110 minutes,2018-02-02,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Hypertension,,ECHA 2-490,Ann Thompson,lecture,110 minutes,2018-02-05,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Dyslipidemia,,ECHA 2-490,Glen Pearson,lecture,110 minutes,2018-02-07,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Dyslipidemia,,ECHA 2-490,Glen Pearson,lecture,110 minutes,2018-02-09,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,ASA-Podcast,,Online,Ann Thompson,lecture,110 minutes,2018-02-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Patient Assessment History,,ECHA 2-490,Ricky Turgeon,lecture,110 minutes,2018-02-26,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Patient Assessment History,,ECHA 2-490,Ricky Turgeon,lecture,110 minutes,2018-02-28,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap: CHD,,ECHA 2-490,Mohamed Omar,lecture,110 minutes,2018-03-02,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap: CHD,,ECHA 2-490,Taryn May,lecture,110 minutes,2018-03-05,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Cardiotoxicology,,ECHA 2-490,John Seubert,lecture,110 minutes,2018-03-07,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharmacogenomics,,ECHA 2-490,John Seubert,lecture,110 minutes,2018-03-09,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,"Pathophys/Therap:  Acute Coronary Syndromes, MI",,ECHA 2-490,Margaret Ackman,lecture,110 minutes,2018-03-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,"Pathophys/Therap:  Acute Coronary Syndromes, MI",,ECHA 2-490,Margaret Ackman,lecture,110 minutes,2018-03-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap:  CHF,,ECHA 2-490,Miriam Fradette,lecture,110 minutes,2018-03-16,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathophys/Therap:  CHF,,ECHA 2-490,Miriam Fradette,lecture,110 minutes,2018-03-19,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pharm: Anti-Arrhythmics,,ECHA 2-490,Peter Light,lecture,110 minutes,2018-03-21,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,"Kinetics:  Anti-Arrhythmics,  Procainamide, Amiodarone, Digoxin",,ECHA 2-490,Dion Brocks,lecture,110 minutes,2018-03-23,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,"Kinetics:  Anti-Arrhythmics,  Procainamide, Amiodarone, Digoxin",,ECHA 2-490,Dion Brocks,lecture,110 minutes,2018-03-26,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Peripheral Vascular Disease,,ECHA 2-490,Sheila Walter,lecture,110 minutes,2018-03-28,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathphys/Therap:  A Fib,,ECHA 2-490,Kristen George-Phillips,lecture,110 minutes,2018-04-04,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Pathphys/Therap:  A Fib,,ECHA 2-490,Kristen George-Phillips,lecture,110 minutes,2018-04-06,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Self-Study Module,Pharmacogenomics/Drug Metabolism,,Dr. Sharon Marsh,lecture,50 minutes,2018-01-07,Other,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Major Depressive Disorder,,,Dr. Melanie McLeod,lecture,50 minutes,2018-01-07,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,COPD,,,Dr. Maryam Yazdanshenas      ,lecture,50 minutes,2018-01-21,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Substance Use Disorders,,,Dr. Melanie McLeod,lecture,50 minutes,2018-02-04,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Seizure Disorders,,,"Dr. Sherif Mahmoud	",lecture,50 minutes,2018-03-11,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Pain Management,,,Monica Lawrence,lecture,50 minutes,2018-03-25,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Geriatrics,,,Dr. Melanie McLeod,lecture,50 minutes,2018-04-08,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Chronic Kidney Disease,,,Dr. Katie Haubrich,lecture,50 minutes,2017-02-28,"Direct Lecture, Active Learning, Problem Based Learning, Team Based Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,,,,,lecture,50 minutes,2017-11-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Introduction,LECB1,MS-231,Pat Mayo,Lecture ,80 min,2018-02-27,,Face-to-Face,"Introduction, Transplantation Epidemiology, Risk-Benefit of immunosuppression",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Pharmacology of small molecule drugs,LECB1,MS-231,Pat Mayo,Lecture ,80 min,2018-03-01,,Face-to-Face,"Azathioprine, Cyclophosphamide, and Corticosteroids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Living Donation and Renal Transplant ,SEMJ1,MS-231,Steven Defer,Seminar ,170 min,2018-03-05,,Face-to-Face,Discussions with a Living Donor and Recipient,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Pharmacology of small molecule drugs,LECB1,MS-231,Pat Mayo,Lecture ,80 min,2018-03-06,,Face-to-Face,"Cyclosporine, Tacrolimus, Sirolimus, and Everolimus, Mycophenolate mofetil, Mycophenolate sodium",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Pharmacology large molecule drugs,LECB1,MS-231,Pat Mayo,Lecture ,80 min,2018-03-08,,Face-to-Face,"Polyclonal antibodies (ATG[horses/rabbits]), and Monoclonal antibodies (anti?CD3, anti?CD52, anti?CD20, and anti?CD25), costimulatory CD80/86 belatacept",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Candian Transplant System and Therapeutic Issues,SEMJ1,MS-231,Kathy Yetzer,Seminar ,170 min,2018-03-12,,Face-to-Face,Candian Transplant System and Therapeutic Issues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Clinical pharmacokinetics-pharmacodynamics (PKPD),LECB1,MS-231,Pat Mayo,Lecture ,80 min,2018-03-13,,Face-to-Face,Clinical pharmacokinetics-pharmacodynamics (PKPD) of immunosuppressive drugs ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Midterm Exam,LECB1,TBA,Pat Mayo,Exam,80 min,2018-03-15,,Face-to-Face,Midterm Exam 40% Multiple Choice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Renal Transplant,SEMJ1,MS-231,Jenny Wichart  ,Seminar ,170 min,2018-03-19,,Face-to-Face,Renal Transplant & Cases ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Renal Transplant,LECB1,MS-231,Jenny Wichart,Lecture,80 min,2018-03-20,,Face-to-Face,Renal Transplant & Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Bone Marrow Transplant,LECB1,MS-231,Jennifer Jupp,Lecture,80 min,2018-03-22,,Face-to-Face,Bone Marrow Transplant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Bioethics of Transplantation: Special Cases,SEMJ1,MS-231,Dr. Brendan Leier  ,Seminar ,170 min,2018-03-26,,Face-to-Face,Bioethics of Transplantation: Special Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Opportunistic Infections,LECB1,MS-231,Cecilia Lau,Lecture,80 min,2018-03-27,,Face-to-Face,Opportunistic Infections in Transplant ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Liver Transplant,LECB1,MS-231,Dr. Norman Kneteman ,Lecture,80 min,2018-03-29,,Face-to-Face,Liver Transplant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Final Exam,LECB1,TBA,Pat Mayo,Final Exam ,120 min,2018-04-18,,Face-to-Face,Final Exam 60% Multiple Choice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Session 3,,ECHA L1-131,S. Walter,seminar,170 minutes,2018-05-08,Active Learning,face to face,,,Discuss topics related to the preceptorship of pharmacy students.,Facilitate professional learning. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Session 4,,ECHA L1-420 & L1-430,,seminar,170 minutes,2018-05-09,Active Learning,face to face,,,Critically examine issues in professional and workplace learning.,Facilitate professional learning. ,Demonstrate respect for diversity of views and experiences. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Session 1,,ECHA L1-230,M. Danilak,seminar,170 minutes,2018-05-07,Direct Lecture,face to face,,,Relate core beliefs about teaching and learning to educational experiences.,"Develop education plans using principles of needs assessment, planning, development, and evaluation for diverse audiences, including professionals, public, patients, and groups of patients.",Apply critical thinking skills. ,Demonstrate respect for diversity of views and experiences. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Session 2,,ECHA L1-131,M. Danilak,seminar,170 minutes,2018-05-08,Direct Lecture,face to face,,,Discuss topics related to the preceptorship of pharmacy students.,Critically examine issues in professional and workplace learning.,Demonstrate respect for diversity of views and experiences. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Session 5,,ECHA L-140,,seminar,170 minutes,2018-05-10,Active Learning,face to face,,,"Develop education plans using principles of needs assessment, planning, development, and evaluation for diverse audiences, including professionals, public, patients, and groups of patients.",Facilitate professional learning. ,Demonstrate collaboration in learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 5,,ECHA 1-490,Dr. R. Breault ,lecture,110 minutes,2018-09-19,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 2,,ECHA 1-240,Prof. S. MacLennan,lecture,110 minutes,2018-09-21,,face to face,Physical Assessment Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 6,,Online,Dr. R. Breault ,lecture,50 minutes,2018-09-24,,distance,Lab Values: Assessing Liver Chemistry Tests,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 1,,Online,Dr. R. Breault ,lecture,50 minutes,2018-09-03,,distance,"Patient care process, patient assessment, documentation, symptom assessment ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 2,,ECHA 1-490,Dr. R. Breault ,lecture,110 minutes,2018-09-05,,face to face,"Patient care process, patient assessment, documentation; Symptom Assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 3,,ECHA 1-490,Dr. R. Breault ,lecture,110 minutes,2018-09-12,,face to face,"Patient Care Process, Patient Assessment, documentation, Symptom Assessment ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 1,,ECHA 1-240,Prof. S. MacLennan,lecture,170 minutes,2018-09-14,,face to face,Physical Assessment Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 7,,ECHA 1-490,Dr. R. Breault ,lecture,110 minutes,2018-09-26,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 3,,ECHA 1-240,Prof. S. MacLennan,lecture,110 minutes,2018-09-28,,face to face,Physical Assessment Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 8,,TBD,Student Presentations,lecture,170 minutes,2018-10-01,,distance,Symptom Assessment Presentations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 4,,Online,Dr. R. Breault ,lecture,50 minutes,2018-09-17,,distance,Lab Values: Assessing Kidney Function,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 18,,ECHA 1-490,Dr. R. Breault ,lecture,110 minutes,2018-11-21,,face to face,Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 19,,ECHA 1-490,Dr. R. Breault ,lecture,110 minutes,2018-11-28,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 20,,ECHA 1-490,Dr. R. Breault,lecture,110 minutes,2018-12-05,,face to face,Course Evaluation and Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Final,,MSB 1-15 and LAC,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 4,,ECHA 1-240,Prof. S. MacLennan,lecture,110 minutes,2018-10-05,,face to face,Physical Assessment Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lab 5,,ECHA 1-240,Prof. S. MacLennan,lecture,110 minutes,2018-10-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 10,,Online,Dr. Christine Hughes,lecture,50 minutes,2018-10-15,,face to face,Lab Values: Assessing Anemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 11,,ECHA 1-490,Dr. Christine Hughes,lecture,110 minutes,2018-10-17,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 12,,Online,Dr. Tracey Lawson,lecture,50 minutes,2018-10-22,,face to face,Patient Assessment: Critical Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 13,,ECHA 1-490,Dr. Tracey Lawson,lecture,110 minutes,2018-10-24,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Midterm ,,LAC,Dr. R. Breault ,lecture,110 minutes,2018-10-26,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 14,,Online,Candace Neck,lecture,50 minutes,2018-10-29,,face to face,Patient Assessment: Mental Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 15,,ECHA 1-490,Candace Neck,lecture,110 minutes,2018-10-31,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 20,,ECHA 1-490,Dr. R. Breault ,lecture,110 minutes,2018-11-05,,face to face,Course Evaluation and Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 16 ,,Online,Mary Gunther,lecture,50 minutes,2018-11-05,,face to face,Patient Assessment: Infectious Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Lecture 17,,ECHA 1-490,Mary Gunther,lecture,110 minutes,2018-11-07,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Introduction to Interprofessional Collaboration,1,,,lecture,50 minutes,2018-01-07,Active Learning,distance,"Definition and models of interprofessional collaboration, Attitudes towards healthcare teams, Selection of groups for case study facilitation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Case Study 1: Teamwork,2,,,lecture,50 minutes,2018-01-21,Team Based Learning,distance,Group A facilitates case study about teamwork,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Case Study 2: Leadership,3,,,lecture,50 minutes,2018-02-04,Team Based Learning,distance,Group B facilitates case study about leadership,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Case Study 3: Communication,4,,,lecture,50 minutes,2018-02-25,Team Based Learning,distance,Group C facilitates case study about communication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Professional Workplace Learning Issues,5,,,lecture,50 minutes,2018-03-11,Active Learning,distance,"Collaboration framework summary, Interprofessional socialization, Public perception of pharmacists",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,TBL Practice Case; Introduction to Patient 1,,ECHA 2-190,Rene Breault,lecture,170 minutes,2018-06-14,Team Based Learning,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Heart Failure (Geriatrics),,ECHA 2-190,Rick Turgeon,lecture,170 minutes,2018-07-05,Team Based Learning,face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Asthma (Pediatrics) ,,ECHA 2-190,Sacha Romanchuk,lecture,170 minutes,2018-07-12,Team Based Learning,face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Communication in Collaboration & Interprofessional Teams,,MS 1-15,Terri Schindel/Jill Hall,seminar,140 minutes,2018-07-18,"Active Learning, Team Based Learning",face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Mental Health,,ECHA 2-190,Jeff Lanz/Candace Necyk,lecture,170 minutes,2018-07-19,Team Based Learning,face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Pain/Addiction,,ECHA 2-190,Brett Baumback,lecture,170 minutes,2018-07-26,Team Based Learning,face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Therapeutic Drug Monitoring (antibiotics),,ECHA 2-190,Cecilia Lau,seminar,110 minutes,2018-08-01,"Direct Lecture, Active Learning, Problem Based Learning",face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Infectious Diseases,,ECHA 2-190,Cecilia Lau ,lecture,170 minutes,2018-08-02,Team Based Learning,face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,CV Risk Reduction,,ECHA 2-1909,Rene Breault/Ann Thompson,lecture,170 minutes,2018-06-21,Team Based Learning,face to face,,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Diabetes,,ECHA 2-190,Rhonda Roedler ,lecture,170 minutes,2018-06-28,Team Based Learning,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 1,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-08,,face to face,Course Overview ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 2,,ECHA L1-498,R. Sanghera,lecture,80 minutes,2018-01-18,,face to face,Jurisprudence Part 2: Intro to the Drug Use Process-PBL Learning Activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 3,,MSB Computer Lab,R. Sanghera,seminar,80 minutes,2018-01-23,,face to face,"Introduction to Pharmacy Software , Introduction to the Prescription Process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 3,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-17,,face to face,Jurisprudence Part 1 & 3 - F&D Act and Regulations Contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 4,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-19,,face to face,Jurisprudence Part 3 Contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 8,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-29,,face to face,Bridging Jurisprudence with the Patient Care Process (Part 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-07,,face to face,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-07,,face to face,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 9,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-02-08,,face to face,Federal and Provincial Drug Scheduling- PBL Learning Activities/Case Based,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-09,,face to face,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-09,,face to face,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-12,,face to face,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-12,,face to face,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,MIDTERM,,TBA,R. Sanghera,lecture,50 minutes,2018-02-12,,face to face,MIDTERM EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 14,,MS 2-31,D. Dolman,lecture,50 minutes,2018-02-14,,face to face,Third Party Lecture (Alberta Blue Cross),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-16,,face to face,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-16,,face to face,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 15,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-02-26,,face to face,Patient Safety,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-26,,face to face,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-28,,face to face,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 13,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-03-01,,face to face,Drug Diversion Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-02,,face to face,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-02,,face to face,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-02,,face to face,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-02,,face to face,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 10,,MS 2-31,G. Eberhart,lecture,110 minutes,2018-02-02,,face to face,Overview of Health Profession's Act and Pharmacy and Drug Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-05,,face to face,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-05,,face to face,Lab 1: Accept/Input/Check,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 11,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-02-05,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 8,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-02-06,,face to face,Federal and Provincial Drug Scheduling- PBL Learning Activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 12,,MS 2-31,R. Sanghera,lecture,110 minutes,2018-02-07,,face to face,Jurisprudence 8: SOPs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 1,,ECHA L1-430,R. Sanghera,lecture,80 minutes,2018-01-16,,face to face,Jurisprudence Part 2: Intro to the Drug Use Process-PBL Learning Activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 5,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-22,,face to face,"Jurisprudence Part 4  Controlled Drugs and, Substances Act",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-26,,face to face,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 12,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-02-27,,face to face,Drug Diversion Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 6,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-01-30,,face to face,Jurisprudence Part 5  Narcotic Control Regulations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 9,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-31,,face to face,Bridging Jurisprudence with the Patient Care Process (Part 2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-31,,face to face,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-31,,face to face,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 7,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-02-01,,face to face,Jurisprudence Part 5  Narcotic Control Regulations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Leture 6,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-24,,face to face,Jurisprudence Part 6  F&D Regulations; Part G and Part J,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 4,,MSB Computer Lab,R. Sanghera,seminar,80 minutes,2018-01-25,,face to face,"Introduction to Pharmacy Software , Introduction to the Prescription Process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 7,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-26,,face to face,Jurisprudence Part 6 Contd  ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-29,,face to face,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-01-29,,face to face,Open lab for practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 10,,ECHA L1-430,R. Sanghera/L. Walzac,seminar,80 minutes,2018-02-13,,face to face,Adverse Drug Reaction Reporting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-14,,face to face,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-14,,face to face,Lab 2: Input/Check/Consult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 17,,MS 2-31,C. Necyk,lecture,50 minutes,2018-03-02,,face to face,CAM Legislation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-05,,face to face,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-05,,face to face,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 18,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-03-05,,face to face,Continued Competence (ACP),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 14,,ECHA L1-430,R. Sanghera,seminar,80 minutes,2018-03-06,,face to face,Pharmacist and Pharm. Tech Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 19,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-03-07,,face to face,Review Session & Class Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-07,,face to face,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-07,,face to face,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 15,,ECHA L1-498,R. Sanghera,seminar,80 minutes,2018-03-08,,face to face,Pharmacist and Pharm. Tech Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 2,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-01-15,,face to face,Jurisprudence Part 1 - F&D Act and Regulations ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab B,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-09,,face to face,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-03-09,,face to face,LAB 4: TPP/Review of all concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,FINAL EXAM,,,R. Sanghera,lecture,50 minutes,2018-03-13,,face to face,"CS 2-191: Last Names A to N, CS 2-193: Last Names O to Z",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Seminar 11,,ECHA L1-498,R. Sanghera/L. Walzac,seminar,80 minutes,2018-02-15,,face to face,Adverse Drug Reaction Reporting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 13,,MS 2-31,D. Dolman,lecture,50 minutes,2018-02-16,,face to face,Third Party Lecture (Alberta Blue Cross),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lecture 16,,MS 2-31,R. Sanghera,lecture,50 minutes,2018-02-28,,face to face,Patient Safety Contd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab A,,MS 1-15,R. Sanghera,lab,110 minutes,2018-02-28,,face to face,Lab 3: Prescription Processing and Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 3,,ECHA 2-490,Dr. Eurich,lecture,50 minutes,2018-01-26,,face to face,Randomized Controlled Trials & Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 6,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2018-02-02,,face to face,Pharmacoepidemiologic Study Designs  Part I: Cross-Sectional Studies and Case-Control Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 9,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2018-02-09,,face to face,Bradford-Hill Considerations for Causal Inference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 11,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2018-02-14,,face to face,Confounding in Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 12,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-26,,face to face,Meta-Analysis  Part I: Search and Selection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 16,,6-28 MSB,Dr. Makhinova,lecture,50 minutes,2018-03-09,,face to face,Quality Improvement Framework,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Seminar,,2-50 MSB,UofA Librarian,seminar,50 minutes,2018-03-09,,face to face,LITERATURE SEARCH SKILLS SEMINAR (50-minutes/group),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 17,,6-28 MSB,Dr. Makhinova,lecture,50 minutes,2018-03-12,,face to face,Knowledge Translation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 18,,6-28 MSB,Dr. Makhinova,lecture,50 minutes,2018-03-14,,face to face,Pharmacy Practice Research Design Issues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 19,,6-28 MSB,Charmaine Kabatoff,lecture,50 minutes,2018-03-16,,face to face,Consent and Ethical Considerations in Pharmacy Practice Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 20,,6-28 MSB,Dr. Ken Cor,lecture,50 minutes,2018-03-19,,face to face,Survey Methods  Part I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 21,,6-28 MSB,Dr. Ken Cor,lecture,50 minutes,2018-03-21,,face to face,Survey Methods  Part II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 1,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2018-01-22,,face to face,Course Outline & Introduction to Pharmacoepidemiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 2,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2018-01-24,,face to face,Limitations of Drug Approval & Pre-Marketing Clinical Trials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 4,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2018-01-29,,face to face,Data Sources  Part I: ADR Reports & Health Care Databases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 5,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2018-01-31,,face to face,Data Sources  Part II: Secondary Analyses & Population-Based Surveys,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 7,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2018-02-05,,face to face,Pharmacoepidemiologic Study Designs  Part II: Cohort Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 8,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2018-02-07,,face to face,Measurement of Association,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 10,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2018-02-12,,face to face,Bias in Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 13,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-02-28,,face to face,Meta-Analysis  Part II: Data Synthesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 14,,6-28 MSB,Dr. Simpson,lecture,50 minutes,2018-03-02,,face to face,JAMA Users Guides approach to critically appraising observational studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 15,,6-28 MSB,Dr. Makhinova,lecture,50 minutes,2018-03-05,,face to face,Open Topics in Pharmacoepidemiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Midterm,,6-28 MSB,Dr. Makhinova,lecture,50 minutes,2018-03-07,,face to face,Midterm exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Seminar,,2-50 MSB,UofA Librarian,seminar,50 minutes,2018-03-08,,face to face,LITERATURE SEARCH SKILLS SEMINAR (50-minutes/group),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 22,,6-28 MSB,Dr. Makhinova,lecture,50 minutes,2018-03-23,,face to face,Pharmacy Practice Research Examples,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 23,,6-28 MSB,Theresa Charrois,lecture,50 minutes,2018-03-26,,face to face,Pharmacy Practice Research Examples,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 24,,6-28 MSB,Dr. Makhinova,lecture,50 minutes,2018-03-28,,face to face,Pharmacoeconomic Evaluations & Course Evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,FINAL EXAM,,,,,,2018-07-05,,,Final Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Seminar 7,,,Sherif Mahmoud,,110 minutes,2018-07-04,,,Course Evaluation Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Seminar 6,,,Sherif Mahmoud,seminar,110 minutes,2018-07-04,,Face to Face,Integrated Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lab 3,,,Ann Thompson/Sherif Mahmoud,seminar,110 minutes,2018-06-29,,Face to Face,Patient Assessment 3 (Cardiovascular),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Seminar 5,,,Candace Necyk,lab,240 minutes,2018-06-27,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Facilitated Cases 5,,,Candace Necyk/Sherif Mahmoud,lecture,110 minutes,2018-06-27,,Face to Face,Mental health assessment case,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 8,,,Candace Necyk,seminar,110 minutes,2018-06-25,,Face to Face,Mental health assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Seminar 4,,,Candace Necyk,lecture,110 minutes,2018-06-20,,Distance,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Facilitated Cases 4,,,Christine Hughes,lecture,110 minutes,2018-06-20,,Face to Face,Anemia assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 7,,,Christine Hughes,seminar,110 minutes,2018-06-18,,Face to Face,Anemia Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lab 2,,,Christine Hughes,lecture,110 minutes,2018-06-15,,Distance,Patient Assessment 2 (Respiratory assessment),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Seminar 3,,,Renette Bertholet/Sherif Mahmoud,lab,240 minutes,2018-06-13,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Facilitated Cases 3,,,Mary Gunther,lecture,110 minutes,2018-06-13,,Face to Face,Infectious disease assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 6,,,Mary Gunther / Sherif Mahmoud,seminar,110 minutes,2018-06-12,,Face to Face,Pre-lab: Strep Pharyngitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 5,,,Sherif Mahmoud,lecture,110 minutes,2018-06-11,,Distance,Pharmacokinetic Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 4,,,Mary Gunther,lecture,110 minutes,2018-06-11,,Face to Face,Infectious disease assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lab 1,,,Ravina Sanghera/Sherif Mahmoud,lab,240 minutes,2018-06-07,,Face to Face,Patient Assessment 1 (Skin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Seminar 2,,,Sherif Mahmoud,lecture,110 minutes,2018-06-06,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Facilitated Cases 2,,,Rene Breault/ Sherif Mahmoud,seminar,110 minutes,2018-06-06,,Face to Face,Liver and Kidney functions assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 3,,,Rene Breault,lecture,110 minutes,2018-06-04,,Distance,Liver and Kidney Functions Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Seminar 1,,,Sherif Mahmoud,lecture,110 miuntes,2018-06-01,,Face to Face,Clinical Pearls/Debriefing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Facilitated Cases 1,,,Sherif Mahmoud,seminar,110 minutes,2018-06-01,,Face to Face,Symptom Assessment (Cases),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 2,,,Sherif Mahmoud,lecture,110 minutes,2018-05-30,,Face to Face,Symptom Assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Lecture 1,,,Sherif Mahmoud,lecture,110 minutes,2018-05-28,,Face to Face,"Course introduction, patient assessment, documentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Diabetes in Pregnancy,,MS 227,Yeung,lecture,80 minutes,2019-02-12,,face to face,"Implications of gestational diabetes to the mother and baby, Detection, risk factors, and prevention of gestational diabetes, Strategies to manage gestational diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Complimentary & Alternative Medications for Diabetes & Thyroid,,MS 227,Zubach-Cassano,lecture,80 minutes,2019-04-02,,face to face,"Discuss the estimated prevalence of natural health products (NHP) use in diabetes, Discuss NHPs available for diabetes & thyroid disorders, Understand risks of drug interactions associated with NHPs, Discuss the role of the pharmacist in patient safety surrounding NHP use",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Disorders of the Pituitary and Adrenals,,MS 227,Simpson,lecture,80 minutes,2019-03-28,,face to face,"Pituitary gland disorders (hypersecretion & hyposecretion), Adrenal gland disorders (pheochromocytoma, Cushings, Addisons)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,"PTH, Vitamin D, & Bone Metabolism",,MS 227,Doschak,lecture,80 minutes,2019-03-26,,face to face,"Calcium physiology, Bone metabolism, Disorders of calcium homeostasis, Treatment options & strategies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Thyroid Disorders,,MS 227,Hughes,lecture,80 minutes,2019-03-21,,face to face,"Interpret laboratory tests in a patient diagnosed with hypothyroidism or hyperthyroidism, Identify drugs which may cause thyroid disease, Describe the signs and symptoms, and goals of therapy, Develop an appropriate patient-specific treatment plan, Develop a plan to monitor pharmacotherapy, Provide appropriate counseling information, Identify drugs which may interact with levothyroxine replacement",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Medicinal Chemistry - Thyroid Drugs,,MS 227,Velazquez,lecture,80 minutes,2019-03-19,,face to face,"Recognize the main structural features of thyroid hormones and analogs, Recognize the main structural features of thyroid peroxidase enzyme inhibitors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Anatomy and Physiology (Part III),,Online,Patrick,lecture,80 minutes,2019-03-12,,distance,"Endocrine function of the Hypothalamus-Pituitary-Adrenal axis, Endocrine function of the kidney, pineal gland, and heart, Introduction to secretion disorders (defining primary and secondary hyper- and hyposecretion)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Current issues in Diabetes Management,,MS 227,Simpson,lecture,80 minutes,2019-02-28,,face to face,"Discuss current literature, evidence and considerations surrounding antidiabetic drugs, insulin and diabetes management, Describe point-of-care testing devices used for management of diabetes and its complications",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Seminar: Type 2 Diabetes Management,,TBA,Simpson,seminar,110 minutes,2019-02-07,,face to face,"Students will engage in assigned pre-readings and review of lecture material prior to the seminar., Students will prepare a brief care plan (Type 2 diabetic patient) on a posted case to bring to seminar for discussion with their peers and facilitator. Risk factors and the patient care process will be discussed to identify drug-related problems and prepare an appropriate treatment plan for the patient., In groups of 5-6, students will work up and discuss a series of mini-cases related to common issues with diabetes management. Each group will be responsible for presenting and leading a small discussion with the rest of the class on the case they were assigned to.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Long-term Complications of Diabetes ,,MS 227,Simpson,lecture,80 minutes,2019-02-26,,face to face,"Review key points from lifestyle intervention studies, Define the metabolic syndrome and what information this provides for patient management, Describe important considerations of diabetes-related complications, Outline management strategies for complications  the A-B-Cs of Diabetes Care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Seminar: Insulin Dosing and Management,,TBA,Simpson,seminar,110 minutes,2019-02-01,,face to face,"Students will engage in assigned pre-readings and review lecture material prior to the seminar., In groups of 5-6, students will work through two patient cases which will contain guided questions and varying scenarios covering common issues and themes related to insulin use and management (i.e. dosing, sick day management, hypoglycemia, travel). Groups will be randomly selected to present and discuss their answers to the cases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Overview of Diabetes Management - Pragmatic Topics,,MS 227,Leoni/Birdi,lecture,80 minutes,2019-02-07,,face to face,"Review practical considerations and patient education tips for patients living with diabetes, i.e. travel, storage, driving, acute illness management",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Type 2 Diabetes Management Flowchart & Insulin Use in Type 2 Diabetes,,MS 227,Simpson/Hodgins,lecture,80 minutes,2019-01-31,,face to face,"Review the Diabetes Canada treatment algorithm for type 2 diabetes, Initiation and titration of insulin in the context of Type 2 diabetes, Discuss the role of concurrent use of insulin and antidiabetic drugs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Preparation time for Thyroid Case Discussions,,N/A,,seminar,110 minutes,2019-03-15,,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Type 2 Diabetes  Treatment (Part II),,MS 227,Eurich,lecture,80 minutes,2019-01-29,,face to face,Describe treatment goals and pharmacologic options for patients with type 2 diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Type 2 Diabetes  Treatment (Part I),,MS 227,Eurich,lecture,80 minutes,2019-01-24,,face to face,"Describe the burden of diabetes and unmet needs, Review pathophysiologic mechanisms contributing to development of type 2 diabetes, Describe treatment goals and pharmacologic options for patients with type 2 diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Pharmacology - Antidiabetic Drugs,,MS 227,Simpson,lecture,80 minutes,2019-01-17,,face to face,"Mechanisms of action for antidiabetic drugs, Highlight important differences between agents within the same pharmacologic class",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Introduction to Diabetes & Treatment of Type 1 Diabetes,,MS 227,Simpson,lecture,80 minutes,2019-01-22,,face to face,"Definition and diagnostic criteria for prediabetes and diabetes, Prevalence of diabetes, Risk factors for type 1 diabetes, Treatment goals for diabetes, Review of insulin formulations, Initiation and titration of insulin in the context of Type 1 diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Medicinal Chemistry - Antidiabetic Drugs,,MS 227,Velazquez,lecture,80 minutes,2019-01-15,,face to face,"Chemical features of different oral antidiabetic drugs, Insulin biosynthesis and activation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Anatomy and Physiology (Part II),,Online,Patrick,lecture,80 minutes,2019-01-10,,distance,"Introduction to dysfunction of endocrine system, Glucose homeostasis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Course Introduction; Anatomy and Physiology (Part I),,MS 227,Simpson/Patrick,lecture,80 minutes,2019-01-08,Direct Lecture,face to face,"Overview of the endocrine glands, General function of the endocrine system, Negative feedback regulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 1,,,Mark Makowsky,lecture,50 minutes,2018-01-08,,face to face,Introduction/Overview of evidence-based clinical practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 2,,,Mark Makowsky,lecture,50 minutes,2018-01-09,,face to face,What is the Best Evidence?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 1,,,Janice Kung,seminar,110 minutes,2018-01-15,,face to face,Seminar: Research Skills*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 3,,,Mark Makowsky,lecture,50 minutes,2018-01-16,,face to face,Practical Statistics & Weighing the Risks and Benefits,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 1,,,Janice Kung,seminar,110 minutes,2018-01-17,,face to face,Seminar: Research Skills*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 4,,,Mark Makowsky,lecture,50 minutes,2018-01-18,,face to face,Critical Appraisal of a RCT  Assessing Validity ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 1,,,Janice Kung,seminar,110 minutes,2018-01-19,,face to face,Seminar: Research Skills*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 1,,,Janice Kung,seminar,110 minutes,2018-01-22,,face to face,Seminar: Research Skills*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 5,,,Mark Makowsky,lecture,50 minutes,2018-01-23,,face to face,Critical Appraisal of a RCT  Assessing Validity II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 1,,,Janice Kung,seminar,110 minutes,2018-01-24,,face to face,Seminar: Research Skills*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 6,,,Mark Makowsky,lecture,50 minutes,2018-01-25,,face to face,Critical Appraisal of a RCT  Validity III & RCT - Interpreting the Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 1,,,Janice Kung,seminar,110 minutes,2018-01-26,,face to face,Seminar: Research Skills*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 7,,,Mark Makowsky,lecture,50 minutes,2018-01-30,,face to face,Critical Appraisal of a RCT - Application of study results to patient care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Lecture 8,,,Mark Makowsky,lecture,50 minutes,2018-02-01,,face to face,Critical Appraisal of a RCT - Measuring patient experiences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 2,,,Mark Makowsky,seminar,110 minutes,2018-02-05,,face to face,Seminar: Critical Evaluation of the Literature*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 2,,,Jennifer Shiu,seminar,110 minutes,2018-02-07,,face to face,Seminar: Critical Evaluation of the Literature*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 2,,,Nathan Beahm,seminar,110 minutes,2018-02-09,,face to face,Seminar: Critical Evaluation of the Literature*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 3,,,Mark Makowsky,seminar,110 minutes,2018-02-12,,face to face,Seminar: Journal Club  Group EBM Project Presentation*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 3,,,Mark Makowsky,seminar,110 minutes,2018-02-12,,face to face,Seminar: Journal Club  Group EBM Project Presentation*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 3,,,Jennifer Shiu,seminar,110 minutes,2018-02-14,,face to face,Seminar: Journal Club  Group EBM Project Presentation*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 3,,,Jennifer Shiu,seminar,110 minutes,2018-02-14,,face to face,Seminar: Journal Club  Group EBM Project Presentation*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 3,,,Nathan Beahm,seminar,110 minutes,2018-02-16,,face to face,Seminar: Journal Club  Group EBM Project Presentation*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar 3,,,Nathan Beahm,seminar,110 minutes,2018-02-16,,face to face,Seminar: Journal Club  Group EBM Project Presentation*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Seminar,,"ECHA L1-430, L1-220, L1-140, 2-150",,seminar,110 minutes,2018-12-04,,face to face,Anticoagulation quiz and seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 1,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-10-11,Direct Lecture,face to face,Blood and Lymphatics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 2,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-10-16,Direct Lecture,face to face,Blood & Circulation - Red blood cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 3,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-10-18,Direct Lecture,face to face,Blood & Circulation - White blood cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 5,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-10-25,Direct Lecture,face to face,"Iron products, Vitamin B12, Folates",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 4,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-10-23,Direct Lecture,face to face,Blood & Circulation - Platelets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 6,,MS628,Dr. Christine Hughes,lecture,80 minutes,2018-10-30,Direct Lecture,face to face,Anemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,MIDTERM,,MS628,Dr. Paul Jurasz,lecture,50 minutes,2018-11-01,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 7,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-11-06,Direct Lecture,face to face,Pharmacology of Anti-platelet Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 8,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-11-08,Direct Lecture,face to face,Pharmacology of Anticoagulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 9,,MS628,Dr. Tammy Bungard,lecture,80 minutes,2018-11-20,Direct Lecture,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 10,,MS628,Dr. Tammy Bungard,lecture,80 minutes,2018-11-22,,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 11,,MS628,Dr. Tammy Bungard,lecture,80 minutes,2018-11-27,Direct Lecture,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 12,,MS628,Dr. Tammy Bungard,lecture,80 minutes,2018-11-29,,face to face,"Thromboembolism, Anticoagulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Lecture 13,,MS628,Dr. Paul Jurasz,lecture,80 minutes,2018-12-04,,face to face,"Bleeding, Thrombosis, Neoplastic disorders",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 21,,MS 231,Hoon Sunwoo,lecture,50 minutes,2018-02-10,,Face to Face,Q/A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 20,,MS 231,Lindsay Sutton,lecture,80 minutes,2018-02-09,,Face to Face,Consumer Trends and Regulations in Nonprescriptionand Natural Health Products,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 19,,MS 231,Jason Silverman,lecture,50 minutes,2018-02-08,,Face to Face,Nutrition guidelines in Children with IBD and separately IBS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 18,,MS 231,Sarah Loehr,lecture,80 minutes,2018-02-07,,Face to Face,Nutrition for Sport Performance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 17,,MS 231,Justine Turner,lecture,50 minutes,2018-02-06,,Face to Face,Nutrition and Bone Health (osteoporosis),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 16,,MS 231,Jacqueline Shan,lecture,50 minutes,2018-02-03,,Face to Face,Health benefits of Ginseng and Omega-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 15,,MS 231,Diana Mager,lecture,50 minutes,2018-02-02,,Face to Face,Health Effect of Branched Chain Amino Acid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 14,,MS 231,Hoon Sunwoo,lecture,80 minutes,2018-01-31,,Face to Face,Nutrition in Celiac Disease and Non-celiac gluten sensitivity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 13,,MS 231,Hoon Sunwoo,lecture,80 minutes,2018-01-30,,Face to Face,Nutrition and Autoimmune-Inflammation Diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 12,,MS 231,Miyoung Suh,lecture,50 minutes,2018-01-27,,Face to Face,Nutrition and Male Reproductive Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 11,,MS 231,Blaine Colton,lecture,50 minutes,2018-01-26,,Face to Face,Case Studies of Obesity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 10,,MS 231,Blaine Colton,lecture,50 minutes,2018-01-25,,Face to Face,Nutrition-related Obesity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 9,,MS 231,Hoon Sunwoo,lecture,50 minutes,2018-01-23,,Face to Face,Q/A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 8,,MS 231,Raimar Loebenberg,lecture,50 minutes,2018-01-20,,Face to Face,Food and Drug Interaction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 7,,MS 231,Stephen Genius,lecture,80 minutes,2018-01-19,,Face to Face,Contemporary Nutrition in Clinical Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 6,,MS 231,Miyoung Suh,lecture,80 minutes,2018-01-17,,Face to Face,Nutrition and Age-Related Macular Degeneration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 5,,MS 231,Hoon Sunwoo,lecture,50 minutes,2018-01-16,,Face to Face,Grain and Phytochemical Nutrition: Safety and Health Benefits,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 4,,MS 231,Hoon Sunwoo,lecture,50 minutes,2018-01-13,,Face to Face,Importance of Nutrients in Parenteral/Enteral Nutrition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 3,,MS 231,Hoon Sunwoo,lecture,80 minutes,2018-01-12,,Face to Face,Metabolic syndrome/Healthy Diet: Canadian Health Food Guide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 2,,MS 231,Hoon Sunwoo,lecture,80 minutes,2018-01-10,,Face to Face,Nutrition Assessment/Micro Nutrients/DRI/Nutrition and Life Stage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Lecture 1,,MS 231,Hoon Sunwoo,lecture,50 minutes,2018-01-09,,Face to Face,Basic nutritional terminology/Macro Nutrients/Energy Metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cardiology: Cardiac cycle; ECG,,Online,Susan Patrick,lecture,50 minutes,2018-11-05,,face to face,"Cardiac arrhythmias, Basic concepts: Leads; waves, intervals, segments, ECG:, Cardiac cycle",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Seminar: Neurology: Stroke case study,,ECHA 1-125 or ECHA 1-131,Susan Patrick,lecture,50 minutes,2018-11-05,,face to face,Neurology: Stroke case study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cardiology: Electrical activity of the heart,,Online,Susan Patrick,lecture,50 minutes,2018-11-02,,face to face,"Excitation-contraction coupling, Electrical activity of contractile cells, Electrical activity of pacemaker cells, Conduction system",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cardiology: Anatomy of the heart,,Online,Susan Patrick,lecture,50 minutes,2018-10-31,,face to face,"Blood flow through the heart , Heart anatomy, Pulmonary and systemic circuits; parallel vs. series flow",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology: Higher CNS function; Basal ganglia,,TBA,Susan Patrick,lecture,50 minutes,2018-10-29,,face to face,"Parkinsons: Symptoms; Basal ganglia function; Pharmacological and surgical treatments as examples to reinforce concepts regarding the physiological function of the CNS, and points of pharmaceutical intervention at the synapse, Basic functioning of healthy basal ganglia, Anatomy, Basal ganglia:, Limbic system, Sleep, Language, Learning and memory, Higher CNS function:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology Neurotransmitters,,Online,Susan Patrick,lecture,50 minutes,2018-10-26,,face to face,"Alzheimers, myasthenia gravis, depression, Synthesis, receptors, reuptake and/or metabolism of select neurotransmitters; major roles, ACh, biogenic amines, amino acid neurotransmitters; also: neuropeptides, purines, others",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology: Motor Control (cont); Blood supply; Cerebral perfusion pressure and blood flow,,Online,Susan Patrick,lecture,50 minutes,2018-10-24,,face to face,"Descending pathways Blood supply to the brain Intracranial pressure, cerebral perfusion pressure, cerebral blood flow, Motor cortices: 1 motor, pre-motor, supplementary motor area (SMA), Motor control:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology: Sensory physiology (cont); Motor control,,Online,Susan Patrick,lecture,50 minutes,2018-10-22,,face to face,"Coding intensity, modality, and location of a sensory stimulus, Proprioceptors, local feedback, spinal reflexes, Cerebellar damage, Feedback control, Hierarchical control, Alpha-motor neurons as the final common pathway, Motor control:, Somatic sensation: Receptors, pathways, 1 somatosensory cortex, Sensory physiology:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology: Diencephalon (cont); Brainstem; Cranial Nerves; Sensory physiology,,Online,Susan Patrick,lecture,50 minutes,2018-10-19,,face to face,"Receptive field, receptor potential, adaptation, Receptor modalities, sensory receptors, afferent-receptor configurations, Sensory information, sensation, perception, Sensory physiology:, Numbers, names, basic major functions, Cranial nerves:, Motor learning, Organization and functions, Cerebellum:, Functions of the brainstem, Brainstem: Anatomy: Midbrain, pons, medulla oblongata; cerebral aqueduct, cerebral peduncles, superior and inferior colliculi, Diencephalon (cont)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology: Cerebrum; Diencephalon,,Online,Susan Patrick,lecture,50 minutes,2018-10-17,,face to face,"Diencephalon: Anatomy and function of the epithalamus, thalamus, hypothalamus, Lateralization of function, unilateral neglect , White matter: Association, projection (internal capsule), and commissural fibres, Cortical function: 1 and higher-level cortices; association cortices, Gross anatomy, Cerebrum and cerebral cortex:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology: Brain organization and protection,,Online,Susan Patrick,lecture,50 minutes,2018-10-15,,face to face,Brain organization and protection (cont),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurology: Basic anatomy,,Online,Susan Patrick,lecture,50 minutes,2018-10-12,,face to face,"Blood-brain barrier, Ventricles; Production and flow of cerebrospinal fluid, Meninges, Brain protection:, Cerebrum, diencephalon, brainstem, cerebellum, Brain organization:, Spinal cord anatomy , Peripheral nerve anatomy, Glia of PNS, Basic anatomy:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Midterm,,ECHA L1-190,Susan Patrick,lecture,50 minutes,2018-10-10,,face to face,Cell to Pain inclusive ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",, Muscle: Skeletal muscle: Mechanics; Fibre types; Smooth muscle,,Online,Susan Patrick,lecture,50 minutes,2018-10-05,,face to face,"Glia of CNS, Neuron morphology, Contraction Neurology Basic anatomy:, Anatomy, Muscle fibre types, Mechanics of contraction, Skeletal muscle:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Muscle: Skeletal muscle: Contraction ,,Online,Susan Patrick,lecture,50 minutes,2018-10-03,,face to face,Skeletal muscle: Contraction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Pain: Pathophysiology of pain;  Muscle: Skeletal muscle: Anatomy and motor units,,Online,Susan Patrick,lecture,50 minutes,2018-10-01,,face to face,"Muscle fibre , Neuromuscular junction, Motor units, Anatomy, Types of muscle Skeletal muscle:, Pathological pain ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Course introduction; Cell: Review of cell components; Cytoskeleton; Cell membrane,,MSB 628,Susan Patrick,lecture,50 minutes,2018-09-05,,face to face,"Other components; integral vs. peripheral membrane proteins, Phospholipids, Intracellular transport Plasma membrane:, Cilia and flagella, Cell migration, Components (microfilaments, intermediate filaments, microtubules) and roles, Nucleus, cytoplasm vs. cytosol; rough vs. smooth endoplasmic reticulum; Golgi body; mitochondria; lysosomes vs. peroxisomes; vaults Cytoskeleton:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cell: Cell adhesion; Membrane transport,,MSB 628,Susan Patrick,lecture,50 minutes,2018-09-07,,face to face,"Osmosis, osmolarity, tonicity, Endocytosis, exocytosis, Active, passive, carrier-mediated transport, Electrochemical gradient, Cell junctions: Gap junction; tight junction; anchoring junctions Membrane transport:, Spatiotemporal distribution, Cell Adhesion Molecules, Cell adhesion:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cell: Membrane transport (cont); Review of protein synthesis,,MSB 628,Susan Patrick,lecture,50 minutes,2018-09-07,,face to face,"Roles of ribosomes, endoplasmic reticulum, Golgi body, Translation, transcription, Membrane transport (cont)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cell: Signal transduction; Mitosis,,Online,Susan Patrick,lecture,50 minutes,2018-09-10,,face to face,"DNA replication and mitosis, cGMP, Ca2+, G proteins (Gs, Gi, Gq) and associated second messengers and pathways, Tyrosine kinases, Receptors: intracellular, membrane-bound",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Tissues,,Online,Susan Patrick,lecture,50 minutes,2018-09-12,,face to face,"Brief introduction to other tissue types (fluid connective, muscle and neural), Supporting connective tissues, Connective tissue proper, Epithelial tissue",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurons: Introduction to the nervous system; Electrical signaling and membrane potential,,Online,Susan Patrick,lecture,50 minutes,2018-09-17,,face to face,"Membrane potential, Equilibrium potential, Ion channels, Reflex arc Electrical signaling and membrane potential:, Distribution of neurons, Basic anatomy and function of a neuron, Central vs. Peripheral nervous system, Introduction to the nervous system:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurons: Action potential,,Online,Susan Patrick,lecture,50 minutes,2018-09-19,,face to face,Action potential,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Neurons: Graded potentials; Synaptic transmission,,Online,Susan Patrick,lecture,50 minutes,2018-09-21,,face to face,"Synaptic transmission, Graded potentials",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Autonomic nervous system (ANS): Basic anatomy and function,,Online,Susan Patrick,lecture,50 minutes,2018-09-21,,face to face,"Basic functions, Dual innervation, Adrenal medulla, Sympathetic and parasympathetic ganglia, Pre- and post-ganglionic neurons, Spinal cord cross-section",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,ANS: Neurotransmitters,,Online,Susan Patrick,lecture,50 minutes,2018-09-24,,face to face,"Neuroeffector junctions in ANS, Cholinergic and adrenergic receptors, and application to pharmacy, Concept of non-adrenergic-non-cholinergic (NANC), Adrenal medulla: adrenaline, noradrenaline, dopamine, Neurotransmitters of pre- and post-ganglionic neurons: Acetylcholine, noradrenaline: Synthesis and Mechanisms of action",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,ANS: Regulation; Case study,,Online,Susan Patrick,lecture,50 minutes,2018-09-26,,face to face,"Case study: Insecticide poisoning, ANS regulation of body temperature, Pupillary light reflex and regulation of pupil size, Baroreceptors reflex regulation of blood pressure, Hypothalamus, brainstem, and visceral reflexes, Regulation:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Pain: Introduction to sensory physiology; Physiology of pain,,Online,Susan Patrick,lecture,50 minutes,2018-09-28,,face to face,"Descending inhibition, Afferent regulation, Neurotransmitters, Withdrawal reflex with crossed extension, Referred pain, Anterolateral pathway for fibre types, First and second pain, Fibre types, Nociceptors, Purpose and types of pain, Physiology of pain:, Introduction to sensory physiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Pain: Physiology of Pain (cont),,Online,Susan Patrick,lecture,50 minutes,2018-09-28,,face to face,"Central sensitization: Long term potentiation (LTP), Peripheral sensitization: Inflammatory soup, Inflammatory pain:, Physiology of pain (cont) Pathophysiology of pain:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cardiology: Cardiac output (CO),,Online,Susan Patrick,lecture,50 minutes,2018-11-07,,face to face,"Regulation of SV by afterload, Regulation of SV by end-diastolic volume (EDV) (Frank-Starling law); factors that affect EDV, ANS regulation of heart rate and stroke volume (SV), Regulation of CO:, Definition of CO",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cardiology: Major systemic arteries and veins; Haemodynamics,,Online,Susan Patrick,lecture,50 minutes,2018-11-09,,face to face,"Blood flow through arteries, arterioles, Total peripheral resistance (TPR), Flow of blood, pressure gradients, and resistance to flow, Anatomy of blood vessels, Haemodynamics:, Major systemic arteries and veins",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cardiology: Haemodynamics (cont),,Online,Susan Patrick,lecture,50 minutes,2018-11-19,,face to face,"Venomotor tone, Blood flow through veins; venous pressure and venous return, Blood flow through capillaries, Extrinsic mechanisms: neuroendocrine, Regulation of arteriolar resistance: Intrinsic mechanisms: local factors;, Haemodynamics:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Cardiology: Regulation of mean arterial pressure (MAP); Lymphatic system; Hematology: Hematocrit; Plasma and plasma proteins,,Online,Susan Patrick,lecture,50 minutes,2018-11-21,,face to face,"Antidiuretic hormone Lymphatic system Hematocrit Plasma and plasma proteins, Angiotensin II, Haemostasis: Vascular spasm; Platelet plug formation; Blood clot formation; Blood clot inhibition and dissolution, MAP = SV _ HR _ TPR, Regulation of mean arterial pressure (MAP):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Hematology: Leukocytes; Erythrocytes,,Online,Susan Patrick,lecture,50 minutes,2018-11-23,,face to face,"Blood groups, Life cycle of erythrocytes: Haematopoiesis and RBC removal, Carbon monoxide, Fetal Hb, Hb-O2 dissociation curve, and effects of H+, CO2, temperature, 2,3-BPG, Transport of  O2 and CO2 in the blood, Hemoglobin (Hb), Morphology, Erythrocytes:, Agranulocytes (monocytes, lymphocytes), Granulocytes (neutrophils, eosinophils, basophils), Leukocytes:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Hematology: Erythrocytes (cont); Platelets and haemostasis,,Online,Susan Patrick,lecture,50 minutes,2018-11-26,,face to face,"Haemostasis: Vascular spasm; Platelet plug formation; Blood clot formation; Blood clot inhibition and dissolution, Platelet production, Platelets and haemostasis:, Erythrocytes (cont)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Hematology: Platelets and haemostasis (cont); Pulmonary: Introduction and anatomy,,Online,Susan Patrick,lecture,50 minutes,2018-11-28,,face to face,"Airway branching, Purpose and organization of the respiratory system, Pulmonary:, Platelets and haemostasis (cont)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Pulmonary: Anatomy of the lungs,,Online,Susan Patrick,lecture,50 minutes,2018-11-30,,face to face,"Alveoli and the respiratory membrane, Protective mechanisms, Gross anatomy of the lungs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Pulmonary: Mechanics of breathing,,Online,Susan Patrick,lecture,50 minutes,2018-12-03,,face to face,"Airway resistance, Compliance, Air flow into and out of the lungs, Pleural sac, intrapleural pressure",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Pulmonary: Pulmonary volumes and capacities; Ventilation; Gas exchange,,Online,Susan Patrick,lecture,50 minutes,2018-12-05,,face to face,"Gas exchange at the lungs and tissues, Transport of O2 and CO2 in the blood, Ventilation-perfusion matching, Partial pressures, determinants of alveolar partial pressures, Gas exchange:, Alveolar ventilation, Minute ventilation, Ventilation:, Pulmonary volumes and capacities",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Pulmonary: Control of breathing,,Online,Susan Patrick,lecture,50 minutes,2018-12-07,,face to face,"Non-CO2 acids, Feedback control by partial pressures of O2 and CO2, Chemoreceptors, Feedback control:, Central control",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Final,,TBA,Susan Patrick,lecture,110 minutes,2018-12-17,,face to face,"Muscle to Pulmonary, inclusive",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 1,MSB227,Dr. A Lavasanifar/Dr R Lobenberg,Lecture,lecture,110 minutes,2017-09-05,Direct Lecture,face to face,"General outline and objectives of course: textbooks, examinations, grading, distribution of marks, homework assignments, laboratory purpose and procedures., Introduction to the Course/Compounding of Parenterals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 2,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-06,Direct Lecture,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 3,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-07,Direct Lecture,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 4,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-08,Direct Lecture,face to face,Aseptic compounding techniques,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 5,MS 227,Dr. R Lobenberg,Lecture,lecture,110 minutes,2017-09-11,Direct Lecture,face to face,"Pharmaceutically and physiologically acceptable ophthalmic, otic and nasal solutions, Drug delivery considerations for otic and nasal preparations, Compounding techniques, Viscosity enhancers, Antioxidants, Preservatives, Sterility of ophthalmic solutions, Define buffers, buffer capacity, isotonicity, iso-osmoticity, osmotic pressure, hypertonicity, hypotonicity., Pharmcopeia standards for opthphalmic dosage forms, Biological barrier of ophthalmic drug absorption, Anatomy and physiology of the eys and tears, Ophthalmic/Nasal/Ear Products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1, ,ECHA 1-182,TA,seminar,80 minutes,2017-09-11,Direct Lecture,face to face,"GROUPS I, IV: Sterile products  ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,,ECHA 1-190,TA,lecture,80 minutes,2017-09-11,,face to face,"GROUPS II, III: Dissolution",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,,ECHA 1-182,TA,lecture,80 minutes,2017-09-11,,face to face,"GROUPS I, II: Compounding gel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 1,,ECHA 1-190,TA,seminar,80 minutes,2017-09-11,Direct Lecture,face to face,"GROUPS III, IV: Granules/lozenges",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 6,,MS 227,Mr R Marcinkoski,lecture,110 minutes,2017-09-13,Direct Lecture,face to face,Tablets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 7,,MS 227,Dr. R Lobenberg,lecture,110 minutes,2017-09-15,Direct Lecture,face to face,Tablets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 8,,MS 227,Dr. R Lobenberg,lecture,110 minutes,2017-09-18,Direct Lecture,face to face,"In vitro and in vivo methods to determine permeability and dissolution rate, Biopharmaceutics drug classification, In vitro in vivo correlations, Bioavailability and bioequivalence, Biopharmaceutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-39,TA,Lab,lab,140 minutes,2017-09-13,Active Learning,face to face,GROUP I: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 9,,MS 227,Dr R LÃ¶benberg,lecture,110 minutes,2017-09-20,Direct Lecture,face to face,Biopharmaceutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 10,,MS 227,Dr R LÃ¶benberg,lecture,110 minutes,2017-09-22,Direct Lecture,face to face,Controlled Release Delivery systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MS 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 1,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 11,,MS 227,Dr R LÃ¶benberg,lecture,110 minutes,2017-09-25,,face to face,Approval Process/regulatory science,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,MIDTERM,,,Exam,lecture,50 minutes,2017-06-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 2,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 12,,MS 227,Dr. A Lavasanifar,lecture,110 minutes,2017-09-29,Direct Lecture,face to face,"Mechanisms of degradation, effect of temperature, light., Stability & Kinetics: Sources of drug instability",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 13,,MS 227,Dr A Lavasanifar,lecture,110 minutes,2017-10-02,,face to face,Stability & Kinetics: Shelf life calculations ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-420,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS I, IV: Dissolution",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-430,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS II, III: Sterile products",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-420,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS I, II: Granules/lozenges",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Seminar 2,,ECHA 2-430,TA,lecture,80 minutes,2017-10-02,,face to face,"GROUPS III, IV: Compounding gel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 14,,MS 227,Dr A. Lavasanifar,lecture,110 minutes,2017-10-04,,face to face,Transdermal Delivery Systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 15,,MS 227,Dr. A Lavasanifar,lecture,110 minutes,2017-10-06,Direct Lecture,face to face,Nanomedicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 16,MS 227,,"Drs F Jamali, Dr R Loebenberg; Dr A Lavasanifar",lecture,110 minutes,2017-10-11,Direct Lecture,face to face,Hot topics in Pharmaceutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Granules/lozenges,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 17,,MS 227,Dr A. Martin,lecture,110 minutes,2017-10-16,,face to face,Aerosols,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 3,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 18,MS 227,,Dr A Martin,lecture,110 minutes,2017-10-18,,face to face,Aerosols,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP I: Granules/lozenges ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 19,MS 227,,Dr. D Wishart,lecture,110 minutes,2017-10-20,,face to face,Protein Delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-39,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP II: Sterile Products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lecture 20,,MS 227,Dr. M Hitt,lecture,110 minutes,2017-10-23,,face to face,Gene Delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-35,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP III: Compounding-gels ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab 4,MSB 1-50,TA,Lab,lecture,50 minutes,2017-06-01,,face to face,GROUP IV: Dissolution ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,FINAL,,,,lecture,50 minutes,2017-06-01,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 21,,MSB-231,Necyk,lecture,80 minutes,2018-11-29,,face to face,TBA/Self-Study period for Opioid Dependency Quiz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 12,,MSB-231,Lewczyk,lecture,80 minutes,2018-11-20,,face to face,Schizophrenia Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 6,,ECHA 2-490,Necyk,seminar,110 minutes,2018-11-05,,face to face,Seminar: Depression and Anxiety Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 1,,MSB-231,Necyk,lecture,110 minutes,2018-10-29,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 2,,MSB-231,Mahmoud,lecture,80 minutes,2018-10-30,,face to face,"  Depressive Disorders Part 2- Medicinal Chemistry and Pharmacology (Antidepressants, anxiolytics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 3,,MSB-231,Necyk,lecture,80 minutes,2018-11-01,,face to face,Depressive Disorders Part 3- Treatment and Special Populations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 4,,MSB-231,Necyk,lecture,110 minutes,2018-11-02,,face to face,Depressive Disorders Part 3- Treatment and Special Populations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 5,,MSB-231,Necyk,lecture,110 minutes,2018-11-05,,face to face,Anxiety Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 7,,MSB-231,Necyk,lecture,80 minutes,2018-11-06,,face to face,Sleep Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 8,,MSB-231,Sadowski,lecture,110 minutes,2018-11-07,,face to face,Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 9,,TBA,Mahmoud,lecture,80 minutes,2018-11-08,,face to face,Pharmacology of Antipsychotics Pharmacology of Drugs for Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 10,,MSB-231,Sadowksi,lecture,110 minutes,2018-11-09,,face to face,Cognitive Impairment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 11,,MSB-231,Lewczyk,lecture,110 minutes,2018-11-19,,face to face,Schizophrenia Part 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 13,,MSB-231,Necyk,lecture,110 minutes,2018-11-21,,face to face,Bipolar Disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 14,,ECHA 2-490,Necyk,seminar,110 minutes,2018-11-21,,face to face,  Bipolar Disorder & Schizophrenia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session15,,MSB-231,Mahmoud,lecture,80 minutes,2018-11-22,,face to face,Medicinal Chemistry/Pharmacology: Drugs of Abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Midterm Exam,,TBA,Necyk,lecture,110 minutes,2018-11-23,,face to face,Midterm Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 17,,MSB-231,Necyk,lecture,110 minutes,2018-11-26,,face to face,ADHD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 18,,MSB-231,Necyk,lecture,80 minutes,2018-11-27,,face to face,Introduction to Substance Use Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 19,,MSB-231,Baumback,lecture,110 minutes,2018-11-28,,face to face,Substance Use Disorder: Opioids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 20,,MSB 2-31,Necyk/Baumback,seminar,110 minutes,2018-11-29,,face to face,Opioid Dependency Treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 22,,MSB-231,Necyk,lecture,110 minutes,2018-11-30,,face to face,"Substance Use Disorders: Alcohol, Cannabis, Others",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Session 23,,MSB-231,St. Arnaud/Necyk,lecture,110 minutes,2018-12-03,,face to face,Cognitive Behavioral Therapy Interprofessional collaboration in mental health: psychology and pharmacy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 1,,MS 227,Charrois,lecture,110 minutes,2018-09-13,,face to face,"Review of the Patient care process, Introduction to Ph 330",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 2,,MS 227,Charrois/Tate,lecture,110 minutes,2018-09-26,,face to face,"Patient Counselling, Profile Review,  Best Possible Medication History and Medication Reconciliation, Standards of practice and scope of practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 1,,Practice Lab,Charrois,lecture,,2018-10-02,,face to face,"Patient Counselling, Scope of practice and adaptation, BPMH",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 3,,MS 227,Charrois,lecture,110 minutes,2018-10-10,,face to face,"Introduction to physical exam, Documentation - DAP notes, care plans, consults, Clinical Decision Making, Process for Identifying DRPs, Feedback Lab 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 2,,Practice Lab,Charrois,lecture,,2018-10-16,,face to face,"Patient counselling, Clinical decision-making, Pulmonary assessment and physical exam",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 4,,MS 227,Charrois,lecture,110 minutes,2018-10-24,,face to face,"Release Integrated Case, Documentation - Care Plans, Monitoring and Follow-up, Feedback Lab 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 5,,MS 227,Charrois,lecture,110 minutes,2018-10-31,,face to face,"Prescription checking, Vital signs and physical exam, Process of answering drug information requests, Allergy Assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 3,,Practice Lab,Charrois,lecture,,2018-11-06,,face to face,"Vital signs and physical assessment, Assessing lab values, Renal Cases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 6,,MS 227,Charrois,lecture,110 minutes,2018-11-21,,face to face,"Assessing drug interactions, DI requests, Minor ailments assessment, Feedback Lab 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 4,,Practice Lab,Charrois,lecture,,2018-11-27,,face to face,"Answer Drug information question, Pharmaceutical math, Assess Drug interactions, Gastrointestinal Cases, Minor ailment assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 7,,MS 227,Charrois,lecture,110 minutes,2018-12-03,,face to face,"Semester wrap-up, Midterm information, Feedback Lab 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 8,,MS 6-28,Bertholet,lecture,80 minutes,2019-01-07,,face to face,"Shared decision making, patient values, Orientation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 9,,MS 231,Bertholet,lecture,110 minutes,2019-01-16,,face to face,"Communicating risk and benefit to patients, patient decision aids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 5,,Practice Lab,Bertholet,lecture,,2019-01-21,,face to face,"Shared decision making Professionalism, ethical decision making",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 10,,MS 231,Bertholet,lecture,110 minutes,2019-01-30,,face to face,"Presenting patient to the team, Communicating to other HCP, Release Integrated Case (IC) #2, Feedback Lab 5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 6,,Practice Lab,Bertholet,lecture,,2019-02-04,,face to face,"Prescription review and counselling, Drug information, Presenting a patient problem to HCP",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 11,,MS 231,Bertholet,lecture,110 minutes,2019-02-13,,face to face,"IC: delegation and time lines due, Hospital Discharge - med rec for discharge counselling, Feedback Lab 6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 7,,Practice Lab,Bertholet,lecture,,2019-02-25,,face to face,"Prescription review and counselling, Review of hospital orders, Review of hospital chart for med rec in preparation for discharge counseling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 12,,MS 231,Bertholet,lecture,110 minutes,2019-03-06,,face to face,"IC Draft Due, Hospital discharge - seamless care, Feedback Lab 7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 8,,Practice Lab,Bertholet,lecture,,2019-03-08,,face to face,"Prescription review and counseling, Hospital Discharge counseling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 13,,TBD,Bertholet,lecture,110 minutes,2019-03-14,,face to face,"Integrated case activity, Drug therapy assessment, Feedback Lab 8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 9,,Practice Lab,Bertholet,lecture,,2019-03-21,,face to face,"Integrated case activity, Prescription review and counselling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab 10,,Practice Lab,Bertholet,lecture,,2019-04-01,,face to face,"Assessments of Research for clinical practice, Evidence-Based",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Seminar 14,,MS 231,Bertholet,lecture,110 minutes,2019-04-09,,face to face,"Exam information, Feedback Lab 9 & 10",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,exam,,MS 233,John Ussher,exam,110 minutes,2018-04-20,,Face to Face,Final exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 16,,MS 232,TBA,lecture,110 minutes,2018-04-06,,Face to Face,Case Report on Chronic Pain Management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 15,,MS 231,TBA,lecture,110 minutes,2018-03-16,,Face to Face,Case Report on Acute Pain Management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 14,,MS 231,Momen El Ghazouly,lecture,110 minutes,2018-03-06,,Face to Face,"post-herpetic neuralgia, fibromyalgia, lower back pain, anticonvulsants & antidepressants, Neuropathic pain and adjuvants for chronic pain, Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 13,,MS 231,Momen El Ghazouly,lecture,110 minutes,2018-03-01,,Face to Face,"Examples of pain assessment and opioid rotations, SC administration of methadone, Methadone for cancer pain, Guest lecture: methadone",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 12,,MS 231,Pat Mayo,lecture,110 minutes,2018-02-27,,Face to Face,"Multidisciplinary approach to management of chronic pain, Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,inhibitors," opioids)""",Pain in ICU,"Case reports (ankle sprain, etc.)",,,1969-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,(acetaminophen, NSAIDs, COX-2,,,,1969-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 11,,MS 231,Serina Rix,lecture,110 minutes,2018-02-15,,Face to Face,"Pain assessment, Guest lecture: management of acute pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,exam,,MS 231,Shahileen Remtulla,exam,110 minutes,2018-02-13,,Face to Face,Midterm exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 10,,MS 231,Sheila Walter,lecture,110 minutes,2018-02-08,,Face to Face,"Opioid allergies, Opioid combination products, COX-2 removal from market, acute pain management (acetaminophen, NSAID, tramadol), Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 9,,MS 231,John Ussher,lecture,110 minutes,2018-02-06,,Face to Face,"Goals of therapy, Patient education, Pain presentation, assessment process, Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 8,,MS 231,Sheila Walter,lecture,110 minutes,2018-02-01,,Face to Face,"Opioid withdrawal, Opioid addiction, Opioid agonists/antagonists, Pharmacology of morphine, Mechanism of action of opioids, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 7,,MS 231,Peter Smith,lecture,110 minutes,2018-01-30,,Face to Face,"Neuropathic pain, Local anasthetics (chemistry, mechanism of action, pharmacokinetics, toxicity), Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 6,,MS 231,Peter Smith,lecture,110 minutes,2018-01-25,,Face to Face,"Spinal processing of pain, Peripheral processing of pain, Pain perception, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 5,,MS 231,Peter Smith,lecture,110 minutes,2018-01-23,,Face to Face,"Pharmacology of acetominophen, Pharmacology of NSAIDs, Pharmacology of COX1&2, Effects of tissue injury, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 4,,MS 231,Carlos Velzquez,lecture,110 minutes,2018-01-18,,Face to Face,"Specific Opioid drugs, Opioid metabolism, Opioid receptors, Endogenous opioid peptides, Medicinal Chemistry (major analgesics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 3,,MS 231,Carlos Velzquez,lecture,110 minutes,2018-01-16,,Face to Face,"Chemical classes of nonprescription NSAIDs, Chemical classes of prescription NSAIDs, Prescription NSAIDs in Alberta, Medicinal Chemistry (minor analgesics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 2,,MS 231,Susan Patrick,lecture,110 minutes,2018-01-11,,Face to Face,"Pathophysiology of pain, Physiology of pain, Introduction to sensory systems, Overview of neural signaling, Physiology and Pathophysiology of Pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Lecture 1,,MS 231,John Ussher,lecture,110 minutes,2018-01-09,,Face to Face,"Chronic pain as a public health problem in Canada, Terms & definitions related to the study of pain, Overview of course syllabus, Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 16,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-17,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,MIDTERM,,MS 227,Dr. Brocks,lecture,80 minutes,2018-10-22,Other,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 18,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-24,,face to face,Drug distribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 14,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-10,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 6,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-17,,face to face,Compartmental Concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 7,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-19,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 8,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-21,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 9,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-24,,face to face,Kinetics of Doses after intravenous infusion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 19,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-26,,face to face,Drug distribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 11,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-28,,face to face,Oral absorption and bioequivalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 22,,MS 227,Dr. Brocks,lecture,50 minutes,2018-11-05,,face to face,Drug clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 23,,MS 227,Dr. Brocks,lecture,50 minutes,2018-11-07,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 24,,MS 227,Dr. Brocks,lecture,50 minutes,2018-11-09,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 25,,MS 227,Dr. Brocks,lecture,50 minutes,2018-11-19,,face to face,Nonlinear elimination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 27,,MS 227,Dr. Guirguis,lecture,50 minutes,2018-11-23,Direct Lecture,face to face,PK drug interactions overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 28,,MS 227,Dr. Kiang,lecture,50 minutes,2018-11-26,,face to face,Clinical variables affecting PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 30,,MS 227,Dr. Kiang,lecture,50 minutes,2018-11-30,,face to face,Effects of age on pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 31,,MS 227,Dr. Kiang,lecture,50 minutes,2018-12-03,,face to face,Drugs in pregnancy and lactation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 32,,MS 227,Dr. Kiang,lecture,50 minutes,2018-12-05,,face to face,Drugs in pregnancy and lactation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 1,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-05,,face to face,Introduction/Kinetics of Transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 2,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-07,,face to face,Kinetics of Transport/Kinetics of iv bolus Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 3,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-10,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 4,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-12,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 12,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-01,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 13,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-03,,face to face,Kinetics after Constant Input of Drug,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 33,,MS 227,Dr. Kiang,lecture,110 minutes,2018-12-07,,face to face,Other patient-specific changes in drug PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,FINAL,,,,lecture,110 minutes,2018-12-19,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 5,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-14,,face to face,Kinetics of iv bolus Doses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 10,,MS 227,Dr. Brocks,lecture,50 minutes,2018-09-26,,face to face,Kinetics of Doses after 1st order Input,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 15,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-15,,face to face,Multiple dose pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 17,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-19,,face to face,Drug distribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 20,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-29,,face to face,Drug distribution/clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 21,,MS 227,Dr. Brocks,lecture,50 minutes,2018-10-31,,face to face,Drug clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 26,,MS 227,Dr. Brocks,lecture,50 minutes,2018-11-21,Direct Lecture,face to face,"PK-PD relationship, Nonlinear elimination",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture 29,,MS 227,Dr. Kiang,lecture,50 minutes,2018-11-28,,face to face,Effects of age on pharmacokinetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2018 LEC B1 SEM J1),PHARM 437 Wi18 - BONE AND JOINT Combined LEC SEM Wi18,Cross Listed Courses,,to be assigned,,Rheumatoid Arthritis 1,,,,lecture,110 minutes,2018-05-30,"Direct Lecture, Active Learning",face to face,"disease clasification, epidemiology, etiology, pathophysiology, clinical presentation, prognosis, diagnosis, patient assessment, goals of therapy, approach to treatment, clinical trial evidence, DMARDs - conventional synthetic","""Explain the basic pathophysiology of RA"", ""Describe the clinical presentation, diagnostic criteria, and monitoring tools utilized for RA"", ""Describe the approach to the treatment of RA and the role of the various medications used to achieve the goals of therapy"", ""Consider the 4 Pillars: Indication, Efficacy, Safety, Cost/Compliance""","Outline the epidemiology, etiology and pathophysiology of the reproductive & sexual health and musculoskeletal/joint conditions covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered. ","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), adverse effects & drug interactions for the medication classes covered.","Describe the therapeutic approach to managing the conditions covered, including:","a. guideline recommendations and clinical targets,","b. pharmacological (dose, duration of therapy, monitoring parameters),","Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and drug therapy in order to provide patient care.",Utilize independent and collaborative approaches to learning.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Appreciate the need for lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2018 LEC B1 SEM J1),PHARM 437 Wi18 - BONE AND JOINT Combined LEC SEM Wi18,Cross Listed Courses,,to be assigned,,,,,,lecture,50 minutes,2018-05-30,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 1,,MS 231,"M. Doschak, S. Patrick",lecture,80 minutes,2018-09-04,,face to face,Course Introduction Anatomy -Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 2,,MS 231,S. Patrick,lecture,80 minutes,2018-09-06,,face to face,"Describe physiology of the ureters, bladder and urethra including a general outline of bladder function and micturition, Describe physiology of the kidney, including regulation of glomerular filtration, sodium-water balance, fluid balance, acid-base balance as well as other electrolytes, tubular reabsorption and secretion., Describe anatomy and function of the kidney, ureters, bladder and urethra, Physiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 3,,MS 231,S. Patrick,lecture,80 minutes,2018-09-11,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 4,,MS 231,S. Patrick,lecture,80 minutes,2018-09-13,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 5,,MS 231,A. Tse,lecture,80 minutes,2018-09-18,,face to face,"Describe and review the various classes of diuretics, their mechanism of action and place in therapy including osmotic, loop, thiazide diuretics, carbonic anhydrase inhibitors, and potassium sparing diuretics, Diuretic Pharmacology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 6,,MS 231,R. Sanghera,lecture,80 minutes,2018-09-20,,face to face,Introduction to lab values and how they are accessed in pharmacy practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 7,,MS 231,A. Hemraj,lecture,80 minutes,2018-09-25,,face to face,Overview of common laboratory values used in the diagnosis and monitoring of various disease states.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 8,,MS 231,A. Hemraj,lecture,80 minutes,2018-09-27,,face to face,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 9,,MS 231,A. Ton,lecture,80 minutes,2018-10-02,,face to face,Laboratory Values: Acid/Base,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 10,,MS 231,A. Hemraj,lecture,80 minutes,2018-10-04,,face to face,Introduction to Kidney Disease and Renal Lab Values,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Seminar 1,,TBA,R. Sanghera,seminar,110 minutes,2018-10-09,,face to face,Electrolyte Disorders-Laboratory Values,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 11,,MS 231,A. Hemraj,lecture,80 minutes,2018-10-09,,face to face,"Identification of renal protective strategies for various drug induced renal injuries, Explanation of the different forms of drug induced kidney injury based on presentation, history, clinical symptoms and urinary findings., Explanation of the mechanism of injury to the kidney and toxicology secondary to commonly used drugs, Review of the definition of AKI, the pathophysiology, causes and management of AKI, Acute Kidney Injury-Drug Induced Kidney Injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 12,,MS 231,J. Ton and R. Sanghera,lecture,80 minutes,2018-10-11,,face to face,Drug Information Resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 13,,MS 231,M. Doschak,lecture,80 minutes,2018-10-16,,face to face,Review Session,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,MIDTERM,,MS 231,M. Doschak,lecture,80 minutes,2018-10-18,,face to face,MIDTERM ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 14,,MS 231,R. Breault,lecture,80 minutes,2018-10-23,,face to face,"Overview of the drug therapy used to manage the common complications of chronic kidney disease, Management of Complications, Review of the epidemiology, etiology and pathophysiology of CKD, Epidemiology and Pathophysiology, Chronic Kidney Disease Part I Epidemiology and Pathophysiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 15,,MS 231,R. Breault,lecture,80 minutes,2018-10-25,,face to face,Chronic Kidney Disease Part II Management of Complications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 16,,MS 231,R. Breault,lecture,80 minutes,2018-10-30,,face to face,"Practical approach using case-based examples of adjusting medications in patients with renal impairment., Review the effects of renal impairment on the absorption, distribution, metabolism and excretion of drugs, Review of the assessment of renal function, including calculations of creatinine clearance and estimated GFR, Drug Dosing in Renal Failure and Dialysis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 17,,MS 231,R. Sanghera,lecture,80 minutes,2018-11-01,,face to face,"Drug dosing considerations, Basic overview of hemodialysis, peritoneal dialysis, and continuous renal replacement therapy, Introduction to Renal Replacement Therapy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 18,,MS 231,R. Breault,lecture,80 minutes,2018-11-06,,face to face,"Epidemiology, risk factors, pathophysiology, clinical signs and symptoms of kidney stones, Nephrolithiasis (Kidney Stones)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 19,,MS 231,C. Sadowski,lecture,80 minutes,2018-11-08,,face to face,"Overview of the classification, pathophysiology, signs and symptoms and diagnosis of various lower urinary tract symptoms, Lower Urinary Tract Symptoms Part I (Pharmacological Treatment)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 20,,MS 231,K. Hunter,lecture,80 minutes,2018-11-20,,face to face,"Management of LUTS via pharmacological treatments will be discussed in detail, Lower Urinary Tract, Symptoms Part II (Non-pharmacological Treatment)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Seminar 2,,TBA,R. Sanghera,lecture,80 minutes,2018-11-22,,face to face,Urology-LUTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 21,,MS 231,R. Sanghera,lecture,80 minutes,2018-11-27,,face to face,Time off to work on practice cases as asked,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 22,,MS 231,R. Sanghera,seminar,110 minutes,2018-11-29,,face to face,Flex lecture time,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Lecture 23,,MS 231,J. Ton and R. Sanghera,lecture,80 minutes,2018-12-04,,face to face,"Review of Drug Information Resources (contd from Oct 17), Class wrap-up",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,FINAL,,MS 231,,lecture,110 minutes,2018-12-17,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Course Introduction;Introduction to Assignments;Pediatrics; Pre-test; Demographics,,MSB 628,Schindel; Romanick,lecture,50 minutes,2018-01-08,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Physiologic differences in children; Pharmacokinetics; Pharmacodynamics; GI,,MSB 227,Schindel; Romanick,lecture,80 minutes,2018-01-09,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Prevention of medication errors in children,,MSB 227,Schindel; Dersch; Romanick,seminar,110 minutes,2018-01-19,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Autism Spectrum Disorder; Medication challenges,,MSB 227,Schindel; Gagon,lecture,50 minutes,2018-01-22,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Pediatric Toxicology/common poisonings; Pediatric abuse,,MSB 227,Gukert; Dibden,lecture,80 minutes,2018-01-23,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatrics; Pre-test; Demographics; Pharmacists' role,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-01-26,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,GI; Diarrhea; Hydration; Vomiting; Constipation; Colic,,MSB 227,Schindel; Romanick,lecture,50 minutes,2018-01-15,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Pain; Fever; Teething; Sprains/fractures; Febrile seizures; Normal newborn/Neonatal care,,MSB 227,Schindel; Dersch,lecture,80 minutes,2018-01-16,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Challenges and Controversies; Immunization; Alternate Therapies; Ethical,,MSB 227,Schindel; Dersch; Romanick,seminar,110 minutes,2018-01-17,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Respiratory; Croup; Bronchitis; Pneumonia,,MSB 227,Schindel; Dersch,lecture,50 minutes,2018-01-17,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Clinical issues in pediatrics; Pediatrice references; Physiologial differences; Dosing formulations; Administrative challenges,,MSB 227,Schindel; Dersch; Romanick,lecture,80 minutes,2018-01-18,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Commuication challenges in pediatrics,,MSB 227,Schindel; ChildLife,lecture,50 minutes,2018-01-19,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatrics home care; community resources,,MSB 227,Haggarty; Featherstone,seminar,110 minutes,2018-02-06,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Deprescribing,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-02-07,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Indigenous Health/Diversity in Vulnerable Populations,,MSB 231,Schindel; Swirovich,seminar,170 minutes,2018-01-23,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Introductory Geriatrics; Health care utilization; Principles of geriatric care; Psychosocial aspects of aging,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-01-29,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Physiologic changes with aging; Pharmacokinetics; Pharmacodynamics; High risk medications in older adults,,MSB 227,Schindel; Mayo,lecture,80 minutes,2018-01-30,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatric elder abuse,,MSB 227,Power,seminar,110 minutes,2018-01-31,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Adverse drug events/Drug Safety; Manifestations of toxicity in the elderly,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-01-31,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatric Syndromes; Falls; Frail elderly,,MSB 227,Schindel; Mayo,lecture,80 minutes,2018-02-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Medication problems in the elderly; evidence based research,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-02-02,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Geriatric Assessment,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-02-05,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,End of life care; MAID,,MSB 227,Schindel; Mayo,lecture,80 minutes,2018-02-06,"Direct Lecture, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 1,,,Makowsky,lecture,80 minutes,2018-09-06,,face to face,"Review: Principles of Evidence-Based Clinical Practice, Course Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 1,,,Makowsky,seminar,50 minutes,2018-09-11,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 2,,,Makowsky,lecture,80 minutes,2018-09-13,,face to face,"Review: eLiteracy, Critical appraisal & eNumeracy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 2,,,Kung,seminar,50 minutes,2018-09-18,,face to face,Finding the Best Evidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 3,,,Makowsky,lecture,80 minutes,2018-09-20,,face to face,Articles on Therapy  RCT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 3,,,Kung,seminar,50 minutes,2018-09-25,,face to face,Finding the Best Evidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 4,,,Makowsky,lecture,80 minutes,2018-09-27,,face to face,Articles on Therapy  Non inferiority,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 4,,,Makowsky,seminar,50 minutes,2018-10-02,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 5,,,Korownyk,lecture,80 minutes,2018-10-04,,face to face,Articles on Therapy - How not to get fooled again and again and again,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 5,,,Makowsky,seminar,50 minutes,2018-10-09,,face to face,Deliberate Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 6,,,Campbell-Scherer,lecture,80 minutes,2018-10-11,,face to face,Diagnosis & Screening Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 6,,,Makowsky,seminar,50 minutes,2018-10-16,,face to face,Deliberate Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Midterm,,,Makowsky,Exam,180 minutes,2018-10-18,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 7,,,Makowsky,seminar,50 minutes,2018-10-23,,face to face,Deliberate Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 7,,,Eurich,lecture,80 minutes,2018-10-25,,face to face,Observational Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 8,,,Makowsky,seminar,50 minutes,2018-10-30,,face to face,Midterm Exam Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 8,,,Makowsky,lecture,80 minutes,2018-11-01,,face to face,Synthesized Resources: Systematic Reviews & Meta analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 9,,,Makowsky,seminar,50 minutes,2018-11-06,,face to face,Deliberate Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 9,,,Makowsky/ Ton,lecture,80 minutes,2018-11-08,,face to face,Synthesized Resources: Clinical Practice Guidelines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 10,,,Makowsky,seminar,50 minutes,2018-11-20,,face to face,Oral Presentations of Tools For Practice Summaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 10,,,L. Guirguis/ R Bertholet,lecture,80 minutes,2018-11-22,,face to face,Shared Decision Making,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 11,,,Makowsky,seminar,50 minutes,2018-11-17,,face to face,Oral Presentations of Tools For Practice Summaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 11,,,L. Bresee,lecture,80 minutes,2018-11-29,,face to face,Pharmacoeconomics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Seminar 12,,,Makowsky,seminar,50 minutes,2018-12-04,,face to face,Oral Presentations of Tools For Practice Summaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Lecture 12,,,Schindel,lecture,80 minutes,2018-12-06,,face to face,Qualitative Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Final,,,Makowsky,Exam,50 minutes,2018-12-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Orientation,,ECHA 2-190,,lecture,110 minutes,2018-08-01,Direct Lecture,face to face,"activities and assignments, peer feedback, roles and responsibilities, schedule",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Clinical Coffee - Tools for Practice,,Adobe Connect,,lecture,80 minutes,2018-09-17,Active Learning,distance,"clinical bottom line, summarizing evidence, clinical questions, course of action, professional strengths and weaknesses",,Apply clinical judgment and critical thinking skills,Develop a tool for practice based consideration of a clinical question and review of literature,Communicate effectively in writing,Demonstrate effective verbal and nonverbal communication skills ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Success in experiential education & Giving and receiving feedback,,Adobe Connect,,lecture,80 minutes,2018-09-03,Active Learning,distance,"personal factors in feedback processes, effective feedback, feedback vs. evaluation, strategies to maximize learning, role of learner, expectations",,Deliver effective feedback,Communicate effectively in writing,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Learning Plan Peer Review,,Asynchronous,,lecture,80 minutes,2018-10-17,Other,distance,"implementing feedback, goal-referenced feedback, SMART LOs",,Deliver effective feedback,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Tools for practice presentation,,Adobe Connect,,lecture,80 minutes,2018-11-05,Active Learning,distance,,,Deliver effective feedback,Apply clinical judgment and critical thinking skills,Develop a tool for practice based consideration of a clinical question and review of literature,Demonstrate effective verbal and nonverbal communication skills ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Clinical Coffee - Interprofessional Practice,,Adobe Connect,,lecture,80 minutes,2018-11-26,Active Learning,distance,"reflection, communication, collaboration, role clarification",,Envision oneâ€™s future role in pharmacy practice,Deliver effective feedback,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Clinical Coffee - Patient-centred vs. Disease centred care,,Adobe Connect,,lecture,80 minutes,2019-01-14,Active Learning,distance,"pros and cons of patient centred care, barriers and facilitators, patient experience, patient centred care",,Envision oneâ€™s future role in pharmacy practice,Deliver effective feedback,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Clinical Coffee - Practice development preparation for prescribing,,Adobe Connect,,lecture,80 minutes,2019-01-28,Active Learning,distance,"self-assessment, APA process, resources and support",,Envision oneâ€™s future role in pharmacy practice,Deliver effective feedback,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,APA Patient Case and Narrative,,not applicable,,lecture,80 minutes,2019-02-18,Other,distance,"key activites of pharmacist practice, case checklist",,Envision oneâ€™s future role in pharmacy practice,Deliver effective feedback,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Clinical Coffee - Preceptor development,,Adobe Connect,,lecture,80 minutes,2019-03-18,Active Learning,distance,"preceptor development resources, preceptor competencies, value of precepting",,Envision oneâ€™s future role in pharmacy practice,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Continuing Competence Program - Implementing Learning,,not applicable,,lecture,80 minutes,2019-04-08,Other,distance,"implementation objectives, resources and support",,Envision oneâ€™s future role in pharmacy practice,Deliver effective feedback,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,General Principle of Drug Action,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-04,,,"Receptors, Specificity, Drug-Receptor Interactions (Agonists, Antagonists, Partial Agonists, Efficacy, Inverse Agonists, Allosteric Modulation)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Drug targets and Cellular Aspects of Drug Action,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-06,,,"Receptors, Ion Channels, Enzymes, Transport Proteins; Excitation, Contraction, Secretion, Proliferation/Apoptosis, Defense",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Chemical Mediators ,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-11,,,"Acetylcholine, Muscarinic/Nicotinic Action, Cholinergic Autonomic Transmission",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Chemical Mediators,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-13,,,"Catecholamines: Adrenoceptors, Noradrenergic Autonomic Transmission",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Chemical Mediators,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-18,,,"Amino Acid-based Peptides/Proteins - 5-HT, Bradykinin, Neuropeptides, Cytokines and Chemokines",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Chemical Mediators,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-20,,,"Purines, Histamine, Eicosanoids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Chemical Mediators,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-25,,,"Nitric Oxide, H2S, & Cannabinoids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-09-27,,,"Amino acids and other neurotransmitters - glutamate, aspartate, dopamine, GABA, glycine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-02,,,General and Local Anaesthetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Midterm,,,,Exam,50 minutes,2018-10-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-09,,,Analgesics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-11,,,Anxiolytic and Hypnotic Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-16,,,Antiepileptic Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-18,,,Antipsychotic Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-23,,,Antidepressant Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-25,,,"Neurodegenerative Diseases and their Pharmacology - Parkinson's, Alzheimer's, Huntington's",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,CNS Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-10-30,,,"Stimulants, Psychomimetics, and Other Drugs of Abuse",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2018-11-01,,,"Antidysrhythmic Drugs - Class I (Na channel Blockers), Class II (b-Adrenoceptor Antagonists), Class III (K Channel Blockers), Class IV (Ca Channel Blockers)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2018-11-06,,,"Antidysrhythmic Drugs - Class I (Na channel Blockers), Class II (b-Adrenoceptor Antagonists), Class III (K Channel Blockers), Class IV (Ca Channel Blockers)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2018-11-08,,,Drugs that Increase Cardiac Contractility and Anti-Anginal Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-11-20,,,"Vascular Function, Vasoactive Drugs (Vasoconstrictors and Vasodilators)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-11-22,,,Drugs for Treating Hypertension and Heart Failure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-11-27,,,"Drugs for Treating Peripheral Artery Disease, Pulmonary Hypertension, Shock and Hypotensive States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-11-29,,,Atherosclerosis and Lipid-Lowering Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-12-04,,,Anti-Platelet Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cardiovascular Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2018-12-06,,,Anticoagulants,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Final,,,,Exam,120 minutes,2018-12-14,,,Material encompassed within lectures 1 - 25 inclusive,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Anemia Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-01-08,,,Hematinic Agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Respiratory Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-10,,,"Drugs for COPD, Drugs for  Asthma: Bronchodilators &amp; Antiinflammatories",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,GI Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-15,,,Agents for Neutralizing Gastric Acid Secretion and Antiemetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,GI Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-17,,,"Agents that Modulate Gastric Motility, Antidiarrhoeal Agents and Agents for Chronic Bowel Disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Obesity Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-22,,,"Non-Pharmacological Approaches, Central Acting Agents and Gut Hormone- Based Agents",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Skin Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-24,,,Antiinflammatories &amp; Other Agents for Skin Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Reproductive Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-29,,,"Oral Contraceptives, Agents that Act on the Uterus and Agents for Erectile Dysfunction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Endocrine Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-31,,,Type 1 Diabetes (Insulin and Insulin Analogues) &amp; Gestational Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Endocrine Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-05,,,"Type 2 Diabetes (Metformin, Sulfonylureas, Incretin Based Therapies and SGLT2 Inhibitors)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Midterm,,,,Exam,50 minutes,2019-02-07,,,Material encompassed within lectures 26 - 34 inclusive,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Endocrine Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-12,,,"Other Endocrine Disorders (Agents for Addison&#39;s Disease, Cushing Syndrome, Thyroid Disorders) and Hormone Replacement Therapy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Hematopoietic and Bone Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-14,,,Agents for Osteoporosis and Osteoarthritis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Hematopoietic and Bone Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-26,,,"Agents for Rheumatoid Arthritis, Gout and Hyperuricemia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Renal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-28,,,Diuretics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Renal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-05,,,Agents for Renal Failure and Urinary Tract Infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cancer Chemotherapy,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-03-07,,,"Alkylating Agents, Antimetabolites and Cytotoxic Antibiotics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cancer Chemotherapy,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-03-12,,,"Plant Derivatives, Hormone- Based Agents and Protein Kinase Inhibitors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Cancer Chemotherapy,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-03-14,,,"Immune Therapies for Cancer, Immunosuppressants, and Other Immunotherapies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Antimicrobial Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-19,,,"Sulfonamides, Beta-Lactam Antibiotics, Glycopeptides, Polymixins, Tetracyclines, and Aminoglycosides",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Antimicrobial Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-21,,,"Antimycobacterials and Other Antibacterial Agents; Antifungal Antibiotics, Synthetic Antifungals and Other Antifungal Agents",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Antiprotozoal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-26,,,Antimalarial Agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Antiprotozoal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-28,,,"Agents for Other Protozoal Infections (Trypanosomiasis, Leishmaniasis, Trichomoniasis, Giardiasis and Toxoplasmosis)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Antiviral Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-02,,,"Agents for Herpes and Related Viruses, Agents for Influenza Viruses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Antiviral Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-04,,,Agents for Hepatitis Viruses and HIV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Miscellaneous Topics in Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-09,,,"Lifestyle Drugs, Drugs in Sport &amp; Gene/Cell-Based Therapies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Miscellaneous Topics in Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-11,,,Drug Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Final,,,,Exam,120 minutes,2019-04-16,,,Material encompassed within lectures 26 - 50 inclusive,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 7,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-03-02,,Face to Face,"Communicate or observe patients with vision or hearing loss, requiring a translator, or support behaviour change (ongoing therapy or require education on a device); Group Review 1 Videos from Lab 4 Lab Staff",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 13,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-03-02,,Face to Face,Wrap-Up and Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 12,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-02-28,,Face to Face,Risk Communication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 6,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-02-14,,Face to Face,The Emotional Patient ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 11,,MS 227,Linda Cundy,lecture,80 minutes,2017-02-14,,Face to Face,Hearing Loss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 10,,MS 227,Holly Payne,lecture,80 minutes,2017-02-09,,Face to Face,The Emotional Patient ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 5,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-02-09,,Face to Face,Conduct a Structured Medication Review; Self & Peer Assess Video from Lab 4 (in partners); Communication Challenge Exercise,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 9,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-02-07,,Face to Face,Lost in Translation & 3 Minute Empowerment ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 8,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-02-02,,Face to Face,Medication Taking Behaviours,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 4,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-02-02,,Face to Face,Assess Patient's Ongoing Therapy (Refill); Prepare for the Structured Medication Review; Group Review SDM Video,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 7,,MS 227,Lisa Guirguis/Marlene Gukert,lecture,80 minutes,2017-01-31,,Face to Face,Patient Interviewing Part 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 6,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-26,,Face to Face,Sample Patient Interviewing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 3,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-01-26,,Face to Face,Motivational Interviewing; Shared Decision Making (Video); Group Review Patient Education Video,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 5,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-24,,Face to Face,Assessing Ongoing Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 2,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-01-19,,Face to Face,Review 314 Lab Exam Set Learning Goals; Unpack Pill Packs / Develop Patient Script; Patient Education Exercise with Devices (Video),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 4,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-19,,Face to Face,Shared Decision Making and Intro to Motivational Interviewing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 3,,MS 227,Holly Payne/Merico Tesolin,lecture,80 minutes,2017-01-17,,Face to Face,Communicating with People with Vision Loss ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 1,,MS Lab,Lisa Guirguis,lab,140 minutes,2017-01-12,,Face to Face,Time in Lieu during PDW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 2,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-12,,Face to Face,SBAR technique and SMART Goal Setting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lecture 1,,MS 227,Lisa Guirguis,lecture,80 minutes,2017-01-10,,Face to Face,Course Overview and Education,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,FINAL EXAM ,,ED B 27,,exam,,2018-05-22,,face to face,Final Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 9,,ED B 26,P. Mayo / Helen Marin,lecture,,2018-05-18,,face to face,"9.2 PGx and Oncology, 9.1 PGx and Psychiatric Health, Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 8,,ED B 25,P. Mayo,lecture,,2018-05-16,,face to face,"8.3 PAIN as a Clinical Phenotype, 8.2 COPD as a Clinical Phenotype, 8.1 Project Presentations, Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 7,,ED B 24,P. Mayo,lecture,,2018-05-14,,face to face,"7.3 Evaluating Molecular, Cellular, and Clinical Phenotypes, 7.2 Lessons from Drug Development: How to use all those studies in the drug product monograph?, 7.1 PGx Basis for Drug-Drug Interactions & Drug-Disease, Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 6,,ED B 23,P. Mayo / T. Kiang,lecture,,2018-05-11,,face to face,"6.2 Human PKPD Polymorphisms: Other Critical Drugs, 6.1 Human PKPD Polymorphisms: Warfarin, Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 5,,ED B 23,P. Mayo / Dr. Deborah James,lecture,,2018-05-09,,face to face,"5.2 Point of Care Testing, 5.1 Ethical Issues/ Medical-LegalHealth Policy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,MIDTERM,,ED B 22,,exam,,2018-05-09,,face to face,Midterm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 4,,ED B 21,P. Mayo / M. Guirguis,lecture,,2018-05-07,,face to face,"4.4 PGx Testing Considerations, 4.3 Clinical Pharmacology and PGx, 4.2 Implementation Consortium (CPIC), 4.1 Introduction of PharmGKB & Clinical Pharmacogenetics, Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 3,,ED B 20,P. Mayo,lecture,,2018-05-04,,face to face,"3.3Nof1 and other Trials, 3.2 Reconciliation with Evidence Based Medicine, 3.1 Clinical Basis for PGx: Outcomes, Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 2,,ED B 19,P. Mayo,lecture,,2018-05-02,,face to face,"2.3 Non-Classical PGx, 2.2 Classical PGx, 2.1 PGt, PGx 101 (Continued from Intro), Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Lecture 1,,ED B 18,P. Mayo / Kate Bush MSc. Spartan,lecture,,2018-04-30,,face to face,"Q&A session, CYP2C19 System, Technology/Current Applications Demonstration of the Spartan RX, Overview of the Spartan RX CYP2C19, Example of Point of Care Device, 1.3 The Basis for Precision Medicine, 1.2 PK-PD-PG: The Right Dose for Every Patient!, 1.1 Introduction Pharmacogenomics (PGx), Debrief on Pre-Class Quiz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Seminar 6,,On-line,Sheila Walter/ Tara Leslie,Seminar,,2018-06-28,,,Comprehensive Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Seminar 5,,On-line,Sheila Walter/ Tara Leslie,Seminar,,2018-06-21,,,Comprehensive Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Seminar 4,,On-line,Sheila Walter/ Tara Leslie,Seminar,,2018-06-14,,,Comprehensive Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Seminar 3,,On-line,Sheila Walter/ Tara Leslie,Seminar,,2018-06-07,,,Comprehensive Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Seminar 2,,On-line,Sheila Walter/ Tara Leslie,Seminar,,2018-05-31,,,Comprehensive Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Seminar 1,,On-line,Sheila Walter/ Tara Leslie,Seminar,,2018-05-17,,,Comprehensive Seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Lecture 1 ,,On-line,Sheila Walter,lecture,,1969-12-31,,,Orientation  recorded in e-class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,exam,,,,exam,,2017-07-10,,Face to Face,FINAL EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Lecture 7,,,Charrois/Bharadia,lecture,,2017-07-03,,Face to Face,"Final Exam Review , Diagnostic Studies Blended Online/Classroom, Qualitative Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Seminar 5,,,Bharadia,seminar,,2017-06-26,,Face to Face,Should it be an RCT? (focus: observational research),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Lecture 6,,,Bharadia,lecture,,2017-06-26,,Face to Face,Observational Research: Appraisal of case control and cohort studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Seminar 4,,,Bharadia,seminar,,2017-06-19,,Face to Face,Journal Club,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Lecture 5,,,Charrois/Bharadia,lecture,,2017-06-19,,Face to Face,Synthesized Resources: Systematic Reviews & Meta analysis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Seminar 3,,,Bharadia,seminar,,2017-06-12,,Face to Face,Are we misguided? (focus: clinical practice guidelines),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Lecture 4,,,Simpson/Bharadia,lecture,,2017-06-12,,Face to Face,Synthesized Resources: Clinical Practice Guidelines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Seminar 2,,,Bharadia,seminar,,2017-06-05,,Face to Face,Evidence in the media (focus: articles on therapy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,:ecture 3,,,Bharadia,lecture,,2017-06-05,,Face to Face,Articles on Therapy: Non inferiority,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Lecture 2,,,Bharadia,lecture,,2017-05-31,,Face to Face,Articles on Therapy: RCT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Seminar 1,,,Kung,seminar,,2017-05-29,,Face to Face,Finding the Best Evidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Lecture 1,,TBD,,lecture,,2017-05-29,,Face to Face,"Review: Principles of Evidence-Based Clinical PracticeeLiteracy, Critical appraisal & eNumeracy, Course Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Course Introduction / Business Environment,,MS 231,J. Shkrobot,lecture,170 minutes,2018-09-05,,face to face,Course introduction; Canadian pharmacy business environment; Pharmacy business planning; Market analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Developing and Planning Services,,MS 231,J. Shkrobot,lecture,170 minutes,2018-09-10,,face to face,Strategic planning; Developing and planning patient care services; Implementing and evaluating patient care services,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Financial Management,,MS 231,J. Shkrobot,lecture,170 minutes,2018-09-17,,face to face,Financial management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Pharmacy Operations,,MS 231,J. Shkrobot,lecture,170 minutes,2018-09-24,,face to face,Payment for prescriptions in the retail sector; Pharmacy operations; Information management systems; Technology in practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Marketing,,MS 231,J. Shkrobot,lecture,170 minutes,2018-09-26,,face to face,Marketing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Human Resource Management,,MS 231,J. Shkrobot,lecture,170 minutes,2018-10-01,,face to face,Inventory management; Human resource management; Recruitment and hiring strategies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,MIDTERM,,TBD,,lecture,110 minutes,2018-10-15,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Performance Management,,MS 231,J. Shkrobot,lecture,170 minutes,2018-10-22,,face to face,Performance management; Desirable workplaces; Managing conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Business Plan Presentations (1),,MS 231,,lecture,170 minutes,2018-10-29,,face to face,BUSINESS PLAN PRESENTATIONS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Business Plan Presentations (2),,MS 227,,lecture,170 minutes,2018-11-06,,face to face,BUSINESS PLAN PRESENTATIONS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Leadership and Management,,MS 231,J. Shkrobot,lecture,170 minutes,2018-11-19,,face to face,Leadership and management; Management essentials; Managing change,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quality and Risk Management,,MS 231,J. Shkrobot,lecture,170 minutes,2018-11-26,,face to face,Quality assurance and improvement; Managing risk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Legal and Ethical Considerations,,MS 231,J. Shkrobot,lecture,170 minutes,2018-12-03,,face to face,Legal requirements; Ethical considerations; Final exam preparation / course evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,FINAL,,TBD,,lecture,110 minutes,2018-12-11,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 1,,ECHA 1-490,T Schindel; J Hall; T Charrois,lecture,,2018-09-04,,distance,"Learning in Groups, Introduction to Peer Learning, Introduction to PHARM 504",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 2,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-09-11,,face to face,"Planning, delivery, and evaluation of education (ADDIE), Teaching and Learning: Education Theories",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 2 B,,TBA,T Charrois,lecture,90 minutes,2018-09-12,,face to face,Lab Facilitator Orientation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 3,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-09-18,,face to face,"Assignment Due: Groups/Topic (Sept 21), Design effective education: Planning, delivery, and evaluation of education (ADDIE) ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 4,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-09-25,,face to face,"Assignment Due: Reflective Paper (Sept 25), Critical Thinking/Learning Styles",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 5,,ECHA 1-490,S Walter; T Schindel,lecture,180 minutes,2018-10-02,,face to face,Preceptor Workshop,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 6,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-10-09,,face to face,Collaboration topic: Teamwork,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 7 - Tuesday and Thursday,,MSB - Practice Skills Lab,T Charrois; T Schindel,lab,180 minutes,2018-10-16,,face to face,Peer Teaching and Learning  Facilitation Tuesday,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 8,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-10-23,,face to face,Collaboration topic: Leadership,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 9,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-10-30,,face to face,"Assignment Due: Education Plan handout, slides (Oct 29), Presenting Education Plans - Group presentations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 10,,ECHA 1-490,T Schindel; T Paslawski,lecture,180 minutes,2018-11-06,,face to face,"Collaboration: Communication Workshop, Collaboration topic: Communication",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 11,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-11-20,,face to face,Collaboration topic: Weaving the fabric of collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 12 - Tuesday and Thursday,,MSB - Practice Skills Lab,T Charrois; T Schindel,lab,180 minutes,2018-11-27,,face to face,Peer Teaching and Learning  Facilitation Tuesday,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Week 13,,ECHA 1-490,T Schindel,lecture,180 minutes,2018-12-04,,face to face,"Assignment Due: Final Paper, Peer Teaching and Learning (Debrief)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 1,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-05,,,History and evolution of Medicinal Chemistry in clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 10,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-24,,,pH and pKa: principles and applications in clinical practice; using the Henderson-Hasselbach equation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 11,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-26,,,Importance of pH and pKa in drug therapy; influence of pH and pKa on the solubility of a drug molecule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 12,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-28,,,Relationship between pH and pKa on the duration of action of drug molecules; influence of pH and pKa on drug binding interactions (drug potency).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 13,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-01,,,Predicting chemical antagonism between drug molecules using their pKa values.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 14,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-03,,,Drug interactions based on pH and their pKa values.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 15,,MSB 628,Carlos Velazquez,Exam,50 minutes,2018-10-05,,,Midterm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 16,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-10,,,Salts and solubility of drug molecules; definition of salt; formation of salts from acid and basic drug molecules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 17,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-12,,,Inorganic salts; organic salts; salts and their influence on drug-drug and drug-food interactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 2,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-07,,,Definition of a functional group; relevant functional groups in drug molecules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 3,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-10,,,Physical chemical properties associated to functional groups in drug molecules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 4,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-10,,,Electronic and inductive effects.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 5,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-12,,,Steric effects; solubility effects; binding interactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 6,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-14,,,Most common types of acidic and basic functional groups in drug molecules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 7,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-17,,,Physiologically relevant acidic and basic functional groups.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 8,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-17,,,Therapeutic significance of acidic and basic groups.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 9,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-09-19,,,Correlating the presence (or absence) of acidic / basic groups to therapeutic effects.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 18,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-15,,,Solubility of salts and their partition coefficient; therapeutic use of salts based on their water solubility; the balance between water and lipid solubility.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 19,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-17,,,Strategies for optimizing drug solubility; relationship between solubility and drug metabolism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 20,,MSB 628,Khaled Barakat,Lecture,50 minutes,2018-10-19,,,Drug binding interactions and their relationship with potency.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 21,,MSB 628,Khaled Barakat,Lecture,50 minutes,2018-10-22,,,Covalent bonds; non-covalent bonds; ionic bonds.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 22,,MSB 628,Khaled Barakat,Lecture,50 minutes,2018-10-24,,,Ion-dipole and dipole-dipole; interactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 23,,MSB 628,Khaled Barakat,Lecture,50 minutes,2018-10-26,,,Hydrogen bonds; van der Waals interactions; hydrophobic bonding.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 24,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-29,,,Stereochemistry: chirality and asymmetry; enantiomers.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 25,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-10-31,,,Pharmacological implications of enantiomeric mixtures; diastereomers.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 26,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-11-02,,,Geometric isomers; pharmacological implications of diastereomeric mixtures.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 27,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-11-05,,,Conformational isomers; definition of the active conformation in drug; molecules; conformational restriction.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 28,,MSB 628,Ayman El-Kadi,Lecture,50 minutes,2018-11-07,,,Drug metabolism: General concepts.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 29,,MSB 628,Ayman El-Kadi,Lecture,50 minutes,2018-11-09,,,Factors affecting drug metabolism; Phase I and Phase II metabolism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 30,,MSB 628,Ayman El-Kadi,Lecture,50 minutes,2018-11-19,,,Oxidation reactions by the cytochrome P450 (CYP450) family of enzymes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 31,,MSB 628,Ayman El-Kadi,Lecture,50 minutes,2018-11-21,,,Oxidation reactions by the cytochrome P450 (CYP450) family of enzymes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 32,,MSB 628,Ayman El-Kadi,Lecture,50 minutes,2018-11-23,,,Reduction reactions by the cytochrome P450 (CYP450) family of enzymes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 33,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-11-26,,,Hydrolysis reactions; conjugation reactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 34,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-11-28,,,Relationship between drug metabolism and pharmacological activity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 35,,MSB 628,Khaled Barakat,Lecture,50 minutes,2018-11-30,,,Structure-Activity Relationships (SAR): general description; examples of SARs; SAR and pharmacological activity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 36,,MSB 628,Khaled Barakat,Lecture,50 minutes,2018-12-03,,,"SAR and binding interactions; SARs and the absorption, distribution, metabolism and excretion (ADME) process.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 37,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-12-05,,,"SAR, drug interactions and adverse; drug reactions; molecular modification; conformational restriction; variation of functional groups.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 38,,MSB 628,Carlos Velazquez,Lecture,50 minutes,2018-12-07,,,Isosters and bioisosteres; homologation; chain branching; prodrugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Lecture 39,,MSB 628,Carlos Velazquez,Lecture,50 minutes,1969-12-31,,,Final review of the course.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Orientation,,ECHA 2-190,,lecture,110 minutes,2018-08-01,Direct Lecture,face to face,"activities and assignments, peer feedback, roles and responsibilities, schedule",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Success in experiential education & Giving and receiving feedback,,Adobe Connect,,lecture,80 minutes,2018-09-03,Active Learning,distance,"personal factors in feedback processes, effective feedback, feedback vs. evaluation, strategies to maximize learning, role of learner, expectations",,Demonstrate a process to develop and maintain professional competence,Demonstrate effective verbal and nonverbal communication skills ,Communicate effectively in writing,Deliver effective feedback,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Clinical Coffee - Tools for Practice,,Adobe Connect,,lecture,80 minutes,2018-09-17,Active Learning,distance,"clinical bottom line, summarizing evidence, clinical questions, course of action, professional strengths and weaknesses",,Demonstrate effective verbal and nonverbal communication skills ,Communicate effectively in writing,Develop a tool for practice based consideration of a clinical question and review of literature,Apply clinical judgment and critical thinking skills,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Learning Plan Peer Review,,Asynchronous,,lecture,80 minutes,2018-10-17,Other,distance,"implementing feedback, goal-referenced feedback, SMART LOs",,Demonstrate a process to develop and maintain professional competence,Communicate effectively in writing,Deliver effective feedback,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Tools for practice presentation,,Adobe Connect,,lecture,80 minutes,2018-11-05,Active Learning,distance,,,Demonstrate effective verbal and nonverbal communication skills ,Develop a tool for practice based consideration of a clinical question and review of literature,Apply clinical judgment and critical thinking skills,Deliver effective feedback,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Clinical Coffee - Interprofessional Practice,,Adobe Connect,,lecture,80 minutes,2018-11-26,Active Learning,distance,"reflection, communication, collaboration, role clarification",,Demonstrate a process to develop and maintain professional competence,Demonstrate effective verbal and nonverbal communication skills ,Deliver effective feedback,Envision oneâ€™s future role in pharmacy practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Clinical Coffee - Patient-centred vs. Disease centred care,,Adobe Connect,,lecture,80 minutes,2019-01-14,Active Learning,distance,"pros and cons of patient centred care, barriers and facilitators, patient experience, patient centred care",,Demonstrate a process to develop and maintain professional competence,Demonstrate effective verbal and nonverbal communication skills ,Communicate effectively in writing,Apply clinical judgment and critical thinking skills,Deliver effective feedback,Envision oneâ€™s future role in pharmacy practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Clinical Coffee - Practice development preparation for prescribing,,Adobe Connect,,lecture,80 minutes,2019-01-28,Active Learning,distance,"self-assessment, APA process, resources and support",,Demonstrate a process to develop and maintain professional competence,Demonstrate effective verbal and nonverbal communication skills ,Deliver effective feedback,Envision oneâ€™s future role in pharmacy practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,APA Patient Case and Narrative,,not applicable,,lecture,80 minutes,2019-02-18,Other,distance,"key activites of pharmacist practice, case checklist",,Demonstrate a process to develop and maintain professional competence,Communicate effectively in writing,Apply clinical judgment and critical thinking skills,Deliver effective feedback,Envision oneâ€™s future role in pharmacy practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Clinical Coffee - Preceptor development,,Adobe Connect,,lecture,80 minutes,2019-03-18,Active Learning,distance,"preceptor development resources, preceptor competencies, value of precepting",,Demonstrate a process to develop and maintain professional competence,Demonstrate effective verbal and nonverbal communication skills ,Envision oneâ€™s future role in pharmacy practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Continuing Competence Program - Implementing Learning,,not applicable,,lecture,80 minutes,2019-04-08,Other,distance,"implementation objectives, resources and support",,Demonstrate a process to develop and maintain professional competence,Demonstrate effective verbal and nonverbal communication skills ,Communicate effectively in writing,Apply clinical judgment and critical thinking skills,Deliver effective feedback,Envision oneâ€™s future role in pharmacy practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 1,,ECHA 2-190,Bertholet/Patrick,lecture,80 minutes,2018-09-04,,face to face,Introduction Anatomy; Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 2,,online,Patrick,lecture,50 minutes,2018-09-05,,distance,Online  (chat room open 2:30- 3:30)  Anatomy; Physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 3,,online,Bertholet/Patrick,lecture,80 minutes,2018-09-06,,distance,Online Anatomy; Physiology  COPD pathophysiology (Q#1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session  4,,ECHA 2-490,Davies,lecture,50 minutes,2018-09-07,,face to face,Pharmacology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 5,,ECHA 2-490,Davies,lecture,50 minutes,2018-09-10,,face to face,Pharmacology (Q#2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 6,,ECHA 2-190,Bertholet ,lecture,80 minutes,2018-09-11,,face to face,COPD Therapeutics /cases ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 7,,MSB 227,Bertholet,seminar,110 minutes,2018-09-11,,face to face,COPD Therapeutics (Q#3) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 8,,ECHA 2-490,Davies,lecture,50 minutes,2018-09-12,,face to face,Pharmacology ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 9,,ECHA 2-190,Bertholet,lecture,80 minutes,2018-09-13,,face to face,COPD Therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 10,,ECHA 2-490,Bertholet,seminar,50 minutes,2018-09-14,,face to face,COPD cases - (Q#4),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,MIDTERM,,,Bertholet,lecture,50 minutes,2018-09-17,,face to face,MIDTERM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 11,,MSB 227,Bertholet,seminar,110 minutes,2018-09-18,,face to face,Medicinal Chemistry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 12,,ECHA 2-190,Barakat,lecture,80 minutes,2018-09-18,,face to face,Tobacco Cessation/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 13,,ECHA 2-490,Mayo/Bertholet,lecture,50 minutes,2018-09-19,,face to face,"Tobacco Cessation: e-cigarettes, water pipes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 14,,ECHA 2-190,Bertholet,lecture,80 minutes,2018-09-20,,face to face,Tobacco Cessation/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 15,,ECHA 2-490,Brocks,lecture,50 minutes,2018-09-21,,face to face,Pharmacokinetics Pharmacodynamics of smoking(Q#5) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 16,,ECHA 2-490,Shkrobot,lecture,50 minutes,2018-09-24,,face to face,Cough; Cold,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 17,,ECHA 2-190,Shkrobot,lecture,80 minutes,2018-09-25,,face to face,Cough; Cold,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 18,,MB 2-27,Bertholet,lecture,110 minutes,2018-09-25,,face to face,Asthma pathophysiology (Q#6),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 19,,ECHA 2-490,Bertholet,lecture,50 minutes,2018-09-26,,face to face,Asthma therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 20,,ECHA 2-190,Bertholet,lecture,80 minutes,2018-09-27,,face to face,Acute Asthma/cases Inhalers/devices ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 21,,ECHA 2-490,Bertholet,seminar,50 minutes,2018-09-28,,face to face,Chronic asthma/cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 22,,ECHA 2-490,Bertholet,lecture,50 minutes,2018-10-01,,face to face,Pediatric Asthma ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 23,,ECHA 2-190,Gukert/Smith,lecture,80 minutes,2018-10-02,,face to face,Cystic Fibrosis   ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 24,,ECHA 2-490,Bertholet,seminar,50 minutes,2018-10-03,,face to face,Asthma cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 25,,ECHA 2-190,El-Kadi,lecture,80 minutes,2018-10-04,,face to face,Pathophysiology of chemical/drug induced lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Session 26,,ECHA 2-490,Bertholet,lecture,50 minutes,2018-10-09,,face to face,Theophylline (Q#7),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,FINAL,,,Bertholet,lecture,110 minutes,2018-10-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,CKD/Renal Disorders,,,Dr. Katie Haubrich,lecture,50 minutes,2019-04-20,"Team Based Learning, Problem Based Learning, Active Learning, Direct Lecture",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Seizure Disorders,,,Dr. Sherif Mahmoud,lecture,50 minutes,2019-04-06,"Team Based Learning, Problem Based Learning, Active Learning, Direct Lecture",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,COPD,,,Dr Sarah Woodworth,lecture,50 minutes,2019-03-23,"Team Based Learning, Problem Based Learning, Active Learning, Direct Lecture",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Substance Use Disorders,,,Dr. Melanie McLeod,lecture,50 minutes,2019-03-09,"Team Based Learning, Problem Based Learning, Active Learning, Direct Lecture",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Major Depressive Disorder,,,Dr. Melanie McLeod,lecture,50 minutes,2019-02-16,"Team Based Learning, Problem Based Learning, Active Learning, Direct Lecture",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Pain Management,,,Dr. Pat Mayo,lecture,50 minutes,2019-02-02,"Team Based Learning, Problem Based Learning, Active Learning, Direct Lecture",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Oncology Complications,,,Prof. Tara Leslie,lecture,50 minutes,2019-01-19,"Team Based Learning, Problem Based Learning, Active Learning, Direct Lecture",distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Self-Study Module,Pharmacogenomics/Drug Metabolism,,Dr. Sharon Marsh,lecture,50 minutes,2019-04-06,"Problem Based Learning, Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Seminar 6,,,R. Sanghera,lecture,110 minutes,2018-12-04,,face to face,"Discuss pharmacists ethical obligations (case studies presented), Ethics (Behavioral):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 31,,,L. Guirguis,lecture,50 minutes,2018-11-21,,face to face,"Health Behavioral Theory -Interpersonal: Social Cognitive Theory, Communication Accommodation Theory, Facework and Politeness Theory, Social Pharmacy(Social): ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 29,,,L. Guirguis,lecture,50 minutes,2018-11-09,,face to face,"Health Behavioral Theory -Individual: Health Belief, Theory of Planned Behavior, Stages of Change, Self-Regulation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 25,,,L. Guirguis,lecture,50 minutes,2018-10-31,,face to face,"Intro to Sociology -biomedical vs psychosocial perspectives in health care, Social Pharmacy (Social):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 19,,,TBA,lecture,50 minutes,2018-10-15,,face to face,Systematic Approach to Answering (Drug Information) Questions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 18,,,TBA,lecture,50 minutes,2018-10-12,,face to face,Defining Information Resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 17,,,TBA,lecture,50 minutes,2018-10-10,,face to face,Asking Clinical Questions (Background and Foreground Questions),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 16,,,TBA,lecture,50 minutes,2018-10-05,,face to face,Overview of Evidence Based Clinical Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 15,,,TBA,lecture,50 minutes,2018-10-04,,face to face,"Overview of BASE Evidence Curriculum, (Evidence Based Clinical Practice, Drug Information, & Health Informatics, EBM 1 (Evidence-Based):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 14,,,R. Sanghera,lecture,50 minutes,2018-10-03,,face to face,"Prescription pricing model and third-party coverage principles., Medication Use Process (Administrative)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Seminar 2,,,R. Sanghera,lecture,110 minutes,2018-10-02,,face to face,"TBD (PCP/Jurisprudence Cases), Medication Use Process (Administrative):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 13,,,R. Sanghera,lecture,50 minutes,2018-10-01,,face to face,Assessing a prescription for completeness and authenticity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 12,,,R. Sanghera,lecture,50 minutes,2018-09-28,,face to face,"Gathering, documenting and providing information in the context of the medication dispensing process.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 11,,,R. Sanghera,lecture,50 minutes,2018-09-26,,face to face,Identify how the medication dispensing process intersects with the patient centered care model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 10,,,R. Sanghera,lecture,50 minutes,2018-09-24,,face to face,Identify how the medication dispensing process intersects with the patient centered care model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 9,,,R. Sanghera,lecture,50 minutes,2018-09-21,,face to face,"Introduction to prescription terminology, drug use process and patient care process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 8,,,R. Sanghera,lecture,50 minutes,2018-09-19,,face to face,"Introduction to the legislative framework that governs pharmacy practice, Medication Use Process (Administrative)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Seminar 1,,,R. Sanghera,lecture,110 minutes,2018-09-18,,face to face,"Current Pharmacy Topics, Pharmacists Role (Administrative)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 7,,,R. Sanghera,lecture,50 minutes,2018-09-17,,face to face,"Introduction to the legislative framework that governs pharmacy practice, Medication Use Process (Administrative):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 6,,,R. Sanghera,lecture,50 minutes,2018-09-14,,face to face,Current pharmacy and health care system landscape,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 4,,,R. Sanghera,lecture,50 minutes,2018-09-12,,face to face,"Attributes/tenets of professionalism, Why pharmacy is considered a profession , Role of Pharmacy (Administrative):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 3,,,N. Davies,lecture,50 minutes,2018-09-10,,face to face,Pharmacist contributions to society and the world,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 2,,,N. Davies,lecture,50 minutes,2018-09-07,,face to face,History of Pharmacy (Social); History of the Faculty of FoPPs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 1,,,All,lecture,50 minutes,2018-09-05,,face to face,Course introduction & orientation; Define BASE Elements and Framework,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 5,,,R. Sanghera,lecture,50 minutes,2018-11-28,,face to face,"Professional learning skills: Introduction to self-reflection, Attributes/tenets of professionalism Contd, Why pharmacy is considered a profession Contd",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Seminar 3,,,TBA,lecture,110 minutes,2018-10-16,,face to face,"TBD (Introduction to Drug Information Resources), EBM 1 (Evidence-Based):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 20,,,L. Guirguis,lecture,50 minutes,2018-10-17,,face to face,"Core communication skills: Listening, empathy, question asking, agenda setting, non-verbal communication, probes; Intro Med Experience Interview, Communications (Behavioral):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 21,,,L. Guirguis,lecture,50 minutes,2018-10-19,,face to face,"Gathering a Focused Patient History: connection, creating a flexible structure",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 22,,,L. Guirguis,lecture,50 minutes,2018-10-22,,face to face,"Gathering a Comprehensive Patient History: identifying goals, patient centered interviewing, gather patient perspectives, transitions, signposts",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 23,,,L. Guirguis,lecture,50 minutes,2018-10-24,,face to face,Apply the SBAR interprofessional communication technique to a community pharmacy context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Midterm,,,,lecture,50 minutes,2018-10-26,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 24,,,L. Guirguis,lecture,50 minutes,2018-10-29,,face to face,"Communicating with Emotional Patients, Communications (Behavioral):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Seminar 4,,,TBA,lecture,110 minutes,2018-10-30,,face to face,"TBD (PCP/Jurisprudence Cases), Medication Use Process (Administrative):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 26,,,L. Guirguis,lecture,50 minutes,2018-11-02,,face to face,Psychosocial perspectives on medication use: The Patients Medication Experience,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 27,,,L. Guirguis,lecture,50 minutes,2018-11-05,,face to face,"Medication Taking Behaviors: Theory of Adherence vs. Compliance, Intelligent Noncompliance, Necessity-Concerns Framework",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 28,,,L. Guirguis,lecture,50 minutes,2018-11-07,,face to face,Intro Social Determinants of Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 30,,,L. Guirguis,lecture,50 minutes,2018-11-19,,face to face,Cont,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Seminar 5,,,L. Guirguis,lecture,110 minutes,2018-11-20,,face to face,"Determinants of Health Case Study, Social Pharmacy (Social): ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 32,,,TBA,lecture,50 minutes,2018-11-23,,face to face,"Answering Therapy Related Questions, EBM 2 (Evidence-Based):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 33,,,TBA,lecture,50 minutes,2018-11-26,,face to face,What is the Best Evidence? Hierarchy of Research Design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 34,,,TBA,lecture,50 minutes,2018-11-28,,face to face,Introduction to Summary Resources: Systematic Reviews/Meta-Analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 35,,,TBA,lecture,50 minutes,2018-11-30,,face to face,Introduction to Summary Resources: Clinical Practice Guidelines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 36,,,R. Sanghera,lecture,50 minutes,2018-12-03,,face to face,"Historical overview of medical/pharmacy ethics, Ethics (Behavioral):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 37,,,R. Sanghera,lecture,50 minutes,2018-12-05,,face to face,Define common terms/principles in medical ethics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Lecture 38,,,R. Sanghera,lecture,50 minutes,2018-12-07,,face to face,Class Wrap-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Final,,,,lecture,110 minutes,2018-12-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 13 - Final Exam Preparation,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-12-06,,face to face,Final exam orientation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 13 - Emotional Patients,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-12-06,,face to face,Patient care process with an emotional (angry) patient,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 12 - Inter/Intra-professional Communication,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-11-29,,face to face,"Debrief lab 11, patient centred communication, scope of practice (pharmacists and pharmacy technicians), NOD / SBAR",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 11 - Pharmacy Math Review,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-11-22,,face to face,Debrief lab 10 and pharmacy calculations review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 11 - Prescription Preparation / Verification,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-11-22,,face to face,"Patient care process (accept / assess / document), prescription preparation and checking, drug information request from a healthcare professional",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 10 - Drug Information Inquiry,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-11-08,,face to face,"Drug information inquiry (receipt of request), written and verbal responses to answer a drug information inquiry from a patient",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 10 - Drug Information Resources,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-11-08,,face to face,Debrief lab 9 and drug information seminar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 9 - Best Possible Medication History,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-11-01,,face to face,"Best possible medication history, communication skills (empathy), prescriber telephone prescription order, unfilled prescriptions",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 8 - Midterm Exam,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-10-25,,face to face,Midterm exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 8 - Midterm Exam Preparation,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-10-25,,face to face,Midterm exam preparation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 7 - Focused Patient History,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-10-18,,face to face,"Patient care process (refill medication), Netcare orientation, focused patient history, information only prescriptions",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 7 - Patient Centred Communication,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-10-18,,face to face,"Debrief lab 6, patient centred communication, pharmacy math review",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 6 - Assessing Prescription Appropriateness,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-10-11,,face to face,"Patient care process (assessing indication, effectiveness, safety, adherence), prescription processing / preparation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 6 - Drug Information Resources,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-10-11,,face to face,"Debrief lab 5, drug information resources when assessing a prescription",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 5 - Assessment with Receipt of a Prescription,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-10-04,,face to face,"Debrief lab 4, receipt of a prescription",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 5 - Legal Assessment of a Prescription,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-10-04,,face to face,"Patient care process (gathering and documenting information), receipt of a prescription, assessment of prescription (legal), pricing and billing, reflection review",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 4 - Personal Reflection,,MS 2-27,"J. Shkrobot, L. Guirguis",seminar,50 minutes,2018-09-27,,face to face,"Prepare for patient interview, personal reflection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 4 - Documenting information / Receipt of a prescription,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-09-27,,face to face,"Patient care process (gathering and documenting information), receipt of a prescription, reflection",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 3 - Patient Interview / Kroll training,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-09-20,,face to face,"Patient interview, training on information management system (Kroll)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 3 - Information management system,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-09-20,,face to face,Debrief lab 2. Introduction to information management system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 2 - Patient care process - Gathering information,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-09-13,,face to face,"Patient care process (gathering information), peer feedback, patient experience","""Operate the Practice Lab video system."", ""Recognize challenges that patients may experience when taking their medications."", ""Apply the CORBS feedback tool to provide feedback to a simulation scenario."", ""Apply the patient care process in the initial assessment of a patient."", ""Interpret abbreviations used in prescriptions and medication orders."", ""Apply rounding, significant figures, and estimating in pharmacy calculations."", ""Define the terms that identify the anatomical locations in the human body."", ""Define and and spell medical terms related to the organization of the body."", ""Define common medical abbreviations related to the organization of the body and medical documentation.""",Demonstrate development as a professional.,Function as a team member and leader of an intraprofessional team during laboratory group activities.,Engage in self-assessment and self-directed learning.,Apply pharmaceutical calculations to meet a patients medication related needs with topics reviewed in Practice Skills 1.,"Demonstrate effective verbal communication skills, for example, when interacting with pharmacy colleagues and other health care professionals in the community pharmacy setting.",Explain the purpose of peer-assessment and providing feedback.,Define and describe basic medical terminology and medical abbreviations.,Explain how the patient care process is used as a tool for providing patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 2 - Peer feedback process,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-09-13,,face to face,"Patient care process, peer feedback process, abbreviations in practice",,"Demonstrate effective written communication skills, for example, when communicating with patients, caregivers and other health care professionals in the community pharmacy setting including appropriate grammar and punctuation.","Demonstrate effective verbal communication skills, for example, when interacting with pharmacy colleagues and other health care professionals in the community pharmacy setting.",Explain the purpose of peer-assessment and providing feedback.,Define and describe basic medical terminology and medical abbreviations.,Explain how the patient care process is used as a tool for providing patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 1 - Orientation,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-09-06,,face to face,"Lab orientation, team orientation, community pharmacy orientation","""Locate and describe the functional areas of the Practice Lab."", ""Establish an introductory professional relationship with colleagues."", ""Establish team rules pertaining to professionalism and the ongoing management of your team."", ""Simulate medication taking behaviours."", ""Apply the fundamentals of word structure as it applies to medical terminology."", ""Identify common suffixes and prefixes relating to the diagnosis, treatment or care of patients."", ""Describe where pharmaceutical calculations are used within pharmacy practice."", ""Identify components of prescriptions and medication orders."", ""Interpret commonly used abbreviations used in prescriptions and medication orders.""","Exemplify professionalism throughout all course activities by adhering to the professionalism standards outlined in the course, the Alberta College of Pharmacists and University policies.",Demonstrate development as a professional.,Function as a team member and leader of an intraprofessional team during laboratory group activities.,Apply pharmaceutical calculations to meet a patients medication related needs with topics reviewed in Practice Skills 1.,"Demonstrate effective verbal communication skills, for example, when interacting with pharmacy colleagues and other health care professionals in the community pharmacy setting.",Define and describe basic medical terminology and medical abbreviations.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 1- Introduction,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-09-06,,face to face,"Course introduction / expectations, professionalism, patient care process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab 12 - Patient Cues,,MS 1-15,J. Shkrobot,lab,170 minutes,2018-11-29,,face to face,"Patient care process (responding to cues, probe and prompt, issues with health literacy - language barrier), transfer of a prescription",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Sem 9 - Midpoint Skills Assessment Debrief,,MS 2-27,J. Shkrobot,seminar,50 minutes,2018-11-01,,face to face,Debrief lab 7 and midpoint skills assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 1,,MS 2-31,Dr. Siraki,lecture,50 minutes,2018-09-04,Direct Lecture,face to face,INTRODUCTION / RADIATION PRINCIPLES: Brief overview of what to expect from this course; Begin content of next lecture,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 2,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-05,Direct Lecture,face to face,RADIATION PRINCIPLES: Atomic structure; concepts of nuclear stability; radioactive isotopes; radiation emissions;Types of radioactive decay associated with nuclides commonly used for medical purposes.,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 3 (IN-CLASS QUIZ),,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-07,"Direct Lecture, Active Learning",face to face,Continuation of Radiation Principles and IN-CLASS QUIZ (material so far),,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 4,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-10,Direct Lecture,face to face,"RADIATION EFFECTS ON LIVING SYSTEMS; Units of radioactivity; calculations involving radioactive decay, calculations for radiopharmaceutical dosage to allow for radioactive decay; concepts of physical, biological and effective half-life; Charged particles; electromagnetic radiation, thermal and fast neurons, physical characteristics, sources, interactions with matter, energy loss, tissue penetration (this topic presented from a health sciences viewpoint)",,To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 5,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-11,Direct Lecture,face to face,"RADIATION EFFECTS ON LIVING SYSTEMS: Concepts of radiation energy in terms of transfer and absorption in biological systems; Mechanisms of radiation induced injury; Oxidative stress as a result of radiation, and biological effects; Antioxidant enzymes as deterrents to free radical induced damage.",,To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 6,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-12,Direct Lecture,face to face,RADIATION EFFECTS ON LIVING SYSTEMS: Other radicals that can partake in radiation induced damage; Damage of free radicals to biological targets and its consequences; Free radicals and cell death; A description of the enzymatic and nonenzymatic systems to detoxify radiation induced free radical formation; Free radicals and cell death; Signalling mechanisms that can result in death or carcinogenesis,,To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,MIDTERM,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-14,,face to face,Material covered: Lectures 1-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 7,,MS 2-27,Dr. Schirrmacher,lecture,50 minutes,2018-09-17,Direct Lecture,face to face,,,To illustrate the rationale for the use of radioactive drugs and contrast agents for diagnosis by discussing: the various agents presently available from commercial suppliers; the physiological basis of their utility and clinical applications; their formulation and manufacture; methods of quality control and dispensing and inventory control. The use of radioactive drugs for therapy will be examined.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 8,,MS 2-27,Dr. Schirrmacher,lecture,50 minutes,2018-09-19,Direct Lecture,face to face,"RADIOPHARMACEUTICALS - PRACTICAL ASPECTS: Design, calibration and use of equipment for radionuclide assays; Purpose of using radiopharmaceuticals, routes of administration, and safe dispensing.",,To illustrate the rationale for the use of radioactive drugs and contrast agents for diagnosis by discussing: the various agents presently available from commercial suppliers; the physiological basis of their utility and clinical applications; their formulation and manufacture; methods of quality control and dispensing and inventory control. The use of radioactive drugs for therapy will be examined.,"To illustrate ""radiopharmaceutical kits"", and radionuclide generators for daily preparation of short-lived radiopharmaceuticals in a hospital.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 9,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-21,"Direct Lecture, Active Learning",face to face,RADIOSENSITIZATION AND PHOTOSENSITIZATION: Concepts and therapeutic advantage to combining radiation with pharmaceuticals;,,To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 10,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-24,Direct Lecture,face to face,ADJUNCT AGENTS FOR USE WITH DIAGNOSTIC IMAGING: Specific examples where organ imaging requires enhancement with drugs; Mechanism of action of drugs and how the image improves,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 11,,MS 2-27,Dr. Siraki,lecture,50 minutes,2018-09-26,Direct Lecture,face to face,"RADIOPHARMACEUTICALS - PRACTICAL ASPECTS: Design, calibration and use of equipment for radionuclide assays; Purpose of using radiopharmaceuticals, routes of administration, and safe dispensing.",,"This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk â€“ benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Lecture 12,,MS 2-27,Dr. Wuest,lecture,50 minutes,2018-09-28,Direct Lecture,face to face,POSITRON EMISSION TOMOGRAPHY (PET): Positron Emissions-Tomography (PET): Molecular imaging and molecular; Positron Emission Tomography (PET): A general introduction; PET-Radiotracers as molecular probes for medical research and clinical routin; PET-RADIOTRACERS AS MOLECULAR PROBES FOR MEDICAL RESEARCH AND CLINICAL ROUTIN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,FINAL,,,,exam,50 minutes,2018-11-14,,face to face,FINAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 17,,MSB 228,Ubaka Ogbogu,lecture,51 minutes,2018-12-03,,face to face,Medical Aid in Dying: The Legal Framework and the Role of the Pharmacist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 16,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-30,,face to face,Indigenous Peoples and health care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 15,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-28,,face to face,Supported Decision-Making: Personal Directives and Powers of Attorney,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 14,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-26,,face to face,Law of Negligence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 13,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-23,,face to face,Self-directed reading  no class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 12,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-21,,face to face,Law of Negligence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 11,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-19,,face to face,Law of Negligence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,MIDTERM,,,,lecture,50 minutes,2018-11-09,,face to face,MIDTERM EXAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 10,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-07,,face to face,Law of Negligence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 9,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-11-05,,face to face,Privacy Law: Health Information Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 8,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-30,,face to face,Privacy Law: Health Information Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 7,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-30,,face to face,Types of legal actions The Alberta court system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 6,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-29,,face to face,Professional ethics: Conscientious objection / Introduction to the Legal System: Defining law; Sources and institutions of law,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 5,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-26,,face to face,"Professional responsibility: The ACP Code of Ethics, the professional discipline process and the problem of substance abuse",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 4,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-24,,face to face,Medical ethics: Autonomy and informed consent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 3,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-22,,face to face,Medical ethics: Beneficence and nonmaleficence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 2,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-19,,face to face,Ethics and the pharmacy profession: Historical overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Lecture 1,,MSB 227,Ubaka Ogbogu,lecture,50 minutes,2018-10-17,,face to face,Course overview,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 1,,MSB 227,Dr. Nese Yuksel & Dr Susan Patrick,lecture,110 minutes,2017-10-25,,face to face,Introduction (09:00 - 09:10) & Anatomy/Physiology:GI and Liver (09:10 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 2,,MSB 227,Dr. Susan Patrick,lecture,110 minutes,2017-10-27,,distance,Anatomy/Physiology: GI and Liver (this will be an online session),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 3,,MSB 227,Dr. Susan Patrick,lecture,50 minutes,2017-10-30,,distance,Anatomy/Physiology: GI and Liver (this will be an online session),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 4,,MSB 227,Dr. David Kelner,lecture,50 minutes,2017-10-30,,face to face,Oral Health (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 5,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2017-11-01,,face to face,Pharmacology/Therapeutics: Nausea and Vomiting (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 6,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2017-11-06,,face to face,Pharmacology/Therapeutics: Constipation/Diarrhea (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 1A,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-06,,face to face,Seminar 1: Nausea and Vomiting Cases for 1/2 Class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 7,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-11-08,,face to face,Pharmacology/Therapeutics: Constipation/Diarrhea (09:00-09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 1B,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-08,,face to face,Seminar 1: Neausea and Vomitting Cases for 1/2 Class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 8,,MSB 227,Dr. Frank Wuest,lecture,50 minutes,2017-11-08,,face to face,Medicinal Chemistry: Antiulcer Treatment (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 9,,MSB 227,Dr. Mark Makowsky,lecture,110 minutes,2017-11-10,,face to face,Pharmacology/Therapeutics: Dyspepsia/Gastroesophageal Disease (GERD)/Peptic Ulcer Disease (PUD) (09:00 -10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 10,,MSB 227,Dr. Mark Makowsky,lecture,50 minutes,2017-11-20,,face to face,Pharmacology/Therapeutics: Dyspepsia/Gastroesophageal Disease (GERD)/Peptic Ulcer Disease (PUD) con't (09:00 - 09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 11,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-11-20,,face to face,Pharmacology/Therapeutics: Inflammatory Bowel Disease (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,MiDTERM,,TBA,Dr. Nese Yuksel,lecture,50 minutes,2017-11-22,,face to face,MIDTERM (09:00 - 09:50) - all material up Nov 10 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 12,,MSB 227,Dr. Nese Yuksel,lecture,110 minutes,2017-11-24,,face to face,Pharmacology/Therapeutics: Inflammatory Bowel Disease (09:00-10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 2A,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-27,,face to face,Seminar 2: Inflammatory Bowel Disease Case for 1/2 class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 13,,MSB 227,Dr Deon Druteika,lecture,110 minutes,2017-11-27,,face to face,Pathophysiology: Liver Function Tests and Liver Disease (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 2B,,MSB 227,Dr. Nese Yuksel,seminar,110 minutes,2017-11-29,,face to face,Seminar 2: Inflammatory Bowel Disease Case for 1/2 class (14:00 - 15:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 14,,MSB 227,Dr Deon Druteika,lecture,110 minutes,2017-11-29,,face to face,Therapeutics: Liver Disease and Case  (09:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 15,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-12-01,,face to face,Pharmacology/Therapeutics: Irritable Bowel Syndrome (09:00 - 09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 16,,MSB 227,Dr. Ayman El-Kadi,lecture,50 minutes,2017-12-01,,face to face,Toxicology: Drug Induced Liver Disease (10:00 - 10:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 17,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-12-04,,face to face,Class Evaluations; CAM in GI and Liver (09:00-09:50),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Lecture 18,,MSB 227,Dr. Nese Yuksel,lecture,50 minutes,2017-12-04,,face to face,"Ostomy Care, Hemorrhoids, Final Exam Overview (10:00 - 10:50)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,FINAL,,TBA,Dr. Nese Yuksel,lecture,110 minutes,2017-12-11,,face to face,FINAL EXAM (10:00 - 12:00),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 1,,MS231,Sherif Mahmoud Susan Patrick,lecture,80 minutes,2017-09-26,,face to face,Introduction; Anatomy/Physiology 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 2,,MS231,Susan Patrick,lecture,80 minutes,2017-09-28,,face to face,Anatomy/Physiology 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 3,,MS 628,Tyler Moore (AHS),lecture,110 minutes,2017-09-29,,face to face,Therapeutics: Stroke,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 4,,MS 628,Carlos Velazquez,lecture,50 minutes,2017-10-02,,face to face,Chemistry: Seizures and Epilepsy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 5,,MS231,Sherif Mahmoud,lecture,80 minutes,2017-10-03,,face to face,Therapeutics;Pharmacology: Seizures and Epilepsy 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 6,,MS231,Sherif Mahmoud,lecture,110 minutes,2017-10-04,,face to face,Therapeutics: Seizures and Epilepsy 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 7,,MS231,Sherif Mahmoud,lecture,80 minutes,2017-10-05,,face to face,Therapeutics: Seizures and Epilepsy 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Seminar 1,,ECHA 1-490 ECHA 1-498,Sherif Mahmoud Tyler Moore (AHS),seminar,170 minutes,2017-10-06,,face to face,Case studies - Seizures and Epilepsy; Stroke,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 8,,eClass,Susan Patrick,lecture,80 minutes,2017-10-10,,face to face,Anatomy/Physiology 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 9,,MS 628,Bradley Kerr (Faculty of Medicine),lecture,110 minutes,2017-10-11,,face to face,Pharmacology _ Multiple Sclerosis; Movement Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 10,,eClass,Susan Patrick,lecture,80 minutes,2017-10-12,,face to face,Anatomy/Physiology 4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 11,,eClass,Susan Patrick,lecture,110 minutes,2017-10-13,,face to face,Anatomy/Physiology 5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 12,,MS 628,Penny Smyth(Faculty of Medicine),lecture,110 minutes,2017-10-16,,face to face,Therapeutics: Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 13,,MS231,Cheryl Sadowski,lecture,80 minutes,2017-10-17,,face to face,"Therapeutics: Dizziness _ Vertigo, Dysequilibrium, Syncope, Lightheadedness",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 14,,MS231,Peter Smith (Faculty of Medicine) Sherif Mahmoud,lecture,110 minutes,2017-10-18,,face to face,Pharmacology: Headache (1h) Therapeutics: Headache 1 (1h),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 15,,MS231,Sherif Mahmoud,lecture,80 minutes,2017-10-19,,face to face,Therapeutics: Headache 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Seminar 2,,ECHA 1-498,Sherif Mahmoud,seminar,170 minutes,2017-10-19,,face to face,Rare Neurologic Disorders Seminar: A day in the life of a Neurology Pharmacist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Midterm Exam,,TBA,,lecture,110 minutes,2017-10-20,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 16,,MS 628,Sherif Mahmoud Carlos Velazquez,lecture,110 minutes,2017-10-23,,face to face,Therapeutics: Traumatic Brain Injury (1h) Chemistry: Dopaminergic Neurotransmission (1h),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 17,,MS231,Cheryl Sadowski,lecture,80 minutes,2017-10-24,,face to face,Therapeutics: Movement Disorders 1 (Parkinson Disease),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 18,,MS 628,Cheryl Sadowski,lecture,110 minutes,2017-10-25,,face to face,Therapeutics: Movement Disorders 2(Restless Legs Syndrome; Tremor; LegCramps),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Seminar 3,,ECHA 1-420 ECHA 1-498,Cheryl Sadowski & Sherif Mahmoud,seminar,170 minutes,2017-10-25,,face to face,Case studies - Movement Disorders; Headache,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 19,,MS628,Sherif Mahmoud,lecture,110 minutes,2017-10-26,,face to face,Therapeutics: Peripheral Neuropathies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Lecture 20,,MS 628,Sherif Mahmoud,lecture,110 minutes,2017-10-27,,face to face,Therapeutics: Myasthenia Gravis Course Feedback/Final Exam Discussion ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Final Exam,,TBA,,lecture,110 minutes,2017-11-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,CAPhO Oncology Basics,,MS 2-31,Canadian Association of Pharmacy in Oncology,lecture,50 minutes,2018-09-09,,face to face,Self Study Program followed by eClass quiz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Radiotherapy,,MS 2-31,Dr. Debenham,lecture,50 minutes,2018-09-10,,face to face,"Introduction to antineoplastic toxicities, Oncology protocol concepts: strategies and rationale of antineoplastic drug selection, combination, dosing, and scheduling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Intro to oncology part 2,,MS 2-31,Prof. Leslie,lecture,50 minutes,2018-09-10,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Solid tumor #1 (CRC),,MS 2-31,Prof Leslie,lecture,80 minutes,2018-09-11,,face to face,Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Oncology Practice Issues (1 and 2),,MS 2-31,Prof Leslie,lecture,170 minutes,2018-09-12,,face to face,"Safe handling of antineoplastic agents, Oncology drug interaction assessment and management",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Solid tumor #2 (Lung Ca),,MS 2-31,Prof Leslie,lecture,110 minutes,2018-09-12,,face to face,Lung Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Solid tumor #3 (Prostate Ca),,MS 2-31,Prof Dorish,lecture,80 minutes,2018-09-13,,face to face,Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Solid Tumor #4 (Breast Ca),,MS 2-31,Prof Danilak,lecture,110 minutes,2018-09-14,,face to face,Breast Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,MIDTERM,,TBA,,lecture,110 minutes,2018-09-17,,face to face,Content includes everything up to and including oncology practice issues #1 and #2 (Sept 4  12),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Hematologic Malignancy: Part 1,,MS 2-31,Prof Leslie,lecture,80 minutes,2018-09-18,,face to face,"Chronic Leukemias, Lymphoma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Hematologic Malignancy: Part 2,,MS 2-31,Prof Leslie,lecture,50 minutes,2018-09-19,,face to face,"Stem Cell Transplant, Multiple Myeloma, Acute Leukemia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Oncology Practice Issues 3 and 4,,MS 2-31,Prof Leslie,lecture,50 minutes,2018-09-19,,face to face,"Empathy and understanding the patient cancer experience, Prevention of oncology medication errors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Supportive Care #1 (AIVN),,MS 2-31,Prof Leslie,lecture,80 minutes,2018-09-20,,face to face,Antineoplastic induced nausea and vomiting (AINV) prevention and management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Supportive Care #2 (Misc toxicities),,MS 2-31,Prof Leslie,lecture,110 minutes,2018-09-21,,face to face,"Unique targeted therapy toxicities, Infusion reactions, Secondary malignancy, Hand/foot, Cutaneous reactions/toxicities, Constipation/Diarrhea, Mucositis, Cardiotoxicity, Review and discussion of development/prevention/management of the following:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Supportive Care #3 (Palliative Care),,MS 2-31,Prof Ha,lecture,110 minutes,2018-09-24,,face to face,Palliative Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Supportive Care #4 (FN/Onc Emerg),,MS 2-31,Prof Leslie,lecture,110 minutes,2018-09-26,,face to face,"Oncologic Emergencies, Febrile Neutropenia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Supportive Care #5 (Nutrition),,MS 2-31,Prof Ha,lecture,50 minutes,2018-09-28,,face to face,"Anorexia/Cachexia, Nutritional Issues in Oncology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Intro to Oncology: Part 1,,MS 2-31,Prof Leslie,lecture,80 minutes,2018-09-04,,face to face,"Introductory overview of types of antineoplastic agents and treatment strategies, Key definitions in malignancy type/grade/stage, cancer treatment type/approach /modality/goals, and disease response, Cancer pathophysiology and characteristics of malignancy, Cancer incidence/statistics, Course Overview",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Medicinal Chemistry,,MS 2-31,Dr. Wuest,lecture,110 minutes,2018-09-05,,face to face,Medicinal Chemistry of cytotoxic antineoplastic agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Pharmacology: Part 1,,MS 2-31,Dr. Jurasz,lecture,80 minutes,2018-09-06,,face to face,Pharmacology of Angiogenesis Inhibitors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Pharmacology: Part 2,,MS 2-31,Dr. Jurasz,lecture,110 minutes,2018-09-07,,face to face,Pharmacology of Immunotherapy agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Supportive Care #6 (Immuno-therapy toxicity management),,MS 2-31,Prof Leslie,lecture,50 minutes,2018-09-28,,face to face,Immunotherapy toxicity management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,"Special Topics in Oncology Peds, Survivorship, CAM",,MS 2-31,Prof Diachinsky,lecture,110 minutes,2018-10-01,,face to face,Pediatric Oncology and Survivorship,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 1,,MSB 6-28,Necyk,seminar,110 minutes,2018-09-11,,face to face,"Review Scope of Practice, Orientation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 2,,MASB 2-31,Necyk/ Tate,seminar,110 minutes,2018-09-20,,face to face,"Documentation Workshop, Monitoring and Follow up into Process, Patient Care Process: Integrating",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 1,,MSB 1-15,Necyk,Lab,230 minutes,2018-09-25,,face to face,"Patient Case Presentations , Monitoring Plan, Patient Care Process: Developing a Detailed, Establishing a Therapeutic Relationship",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 3,,MSB 2-31,Necyk/ TBA,seminar,110 minutes,2018-10-03,,face to face,"How to Communicate with a Palliative Patient, End of Life Care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 2,,MSB 1-15,Necyk,Lab,230 minutes,2018-10-09,,face to face,"Pharmacy Math, Patient Education, Palliative Care and Pain Management , Patient Care Process: Follow up",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 4,,MSB 2-31,Necyk,seminar,110 minutes,2018-10-17,,face to face,"Framework to the Patient Care Plan Process, Application of Albertas Pharmacy Services, Feedback Labs 1&2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 3,,TBA,University of Alberta Community Social Work Team/ Necyk,Lab,230 minutes,2018-10-23,,face to face,"-QPR Suicide Prevention Certification, -Helping Skills, Mental Health First Aid",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 4,,MSB 1-15,Breault,Lab,230 minutes,2018-10-30,,face to face,"Prescription Processing / Review Appropriateness of Prescriptions, Therapeutic Drug Monitoring, Prescribing, Adapting and Extending Prescriptions",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Semianr 5,,MSB 2-31,Breault /Sadowski,seminar,110 minutes,2018-11-07,,face to face,"Cognitive Assessment, Feedback Lab 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 5,,MSB 1-15,Breault/ Necyk,Lab,230 minutes,2018-11-20,,face to face,"Assess Appropriateness of Prescriptions, Patient Education, Patient Care Process: Patient Assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 6,,MSB 2-31,Breault,seminar,110 minutes,2018-11-28,,face to face,"Midterm Information, Integrated Case 1 Review, Feedback Lab 5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Midterm,,,,exam,,2018-12-17,,face to face,Midterm OSCE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 7,,MSB 1-15,Charrois,seminar,110 minutes,2019-01-08,,face to face,"Introduction to Naloxone training, Ethics, Orientation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 6,,MSB 2-31,Charrois,Lab,230 minutes,2019-01-15,,face to face,"Ethical Scenarios, Naloxone training, Shared-decision making, Communicating with Individuals living with substance use disorder",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Semianr 8,,MSB 1-15,Charrois Danis Alexander,seminar,110 minutes,2019-01-23,,face to face,"Injections Overview, Lab 6 Feedback",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 7,,MSB 2-31,Charrois Danis Alexander,Lab,230 minutes,2019-01-29,,face to face,Injection Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 9,,MSB 1-15,Charrois,seminar,110 minutes,2019-02-04,,face to face,"Integrated Case #2, Self care assessment and referral, Deprescribing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Other,,MSB 2-31,Charrois,Lab,230 minutes,2019-02-08,,face to face,Injection Authorization ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 8,,MSB 1-15,Charrois,Lab,230 minutes,2019-02-12,,face to face,"Communicating with persons with disabilities, Deprescribing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 10,,MSB 2-31,Charrois,seminar,110 minutes,2019-02-27,,face to face,"Preparing for applying for APA, Practical aspects of Scope of Practice ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 9,,MSB 1-15,Charrois,Lab,230 minutes,2019-03-05,,face to face,"Pharmacy Math, Ambulatory assistive devices with PT students",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 11,,MSB 2-31,Charrois,seminar,110 minutes,2019-03-08,,face to face,"Communicating with other HCPs, Presenting formal and informal patient cases",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar 12,,MSB 2-31,Charrois/ MacDonald,seminar,110 minutes,2019-03-12,,face to face,"Chronic disease management, Motivational interviewing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 10,,MSB 1-15,Charrois,Lab,230 minutes,2019-03-19,,face to face,"Diabetes management, CDM , Motivational interviewing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab 11,,MSB 1-15,Charrois,Lab,230 minutes,2019-03-26,,face to face,"Patient education, Womens health",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Seminar13,,MSB 2-31,Charrois,seminar,110 minutes,2019-04-08,,face to face,"OSCE prep, Semester wrap-up, IC Feedback, Lab 10 Feedback ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Final ,,,Charrois,exam,,2019-04-25,,face to face,FINAL - OSCE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Course Introduction, Overview of Infectious Diseases",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Bacterial Cell Structure,,,Dr. L. Stein,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Principles (and Problems) of Antimicrobial Therapy,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Bacterial Physiology, Growth, and Reproduction",,,Dr. L. Stein,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Bacteria-Host Interactions,,,Dr. L. Stein,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Laboratory and Clinical Lab Tests,,,Dr. T. Dingle,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Bacterial Pathogens: Anaerobes, Spiral/Curved organisms",,,Dr. N. Zelyas,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Bacterial Pathogens: Mycoplasmas, Chlamydiae, Mycobacteria",,,Dr. N. Zelyas,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Antimicrobial Resistance,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Antimicrobial Resistance,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Penicillins,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Penicillins,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cephalosporins,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Cephalosporins, Carbapenems, Monobactams",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Tetracyclines, Glycylcyclines",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class  Oncology Exam,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class - Thanksgiving,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Inhibitors of Folic Acid Synthesis,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Exam Review,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,PHARM 407 Midterm Exam,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Fosfomycin, Metronidazole",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Clinical Signs of Infection and Lab Tests,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Upper Respiratory Tract Infections,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Upper Respiratory Tract Infections,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cases: URTI,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Aminoglycosides,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Aminoglycoside Pharmacokinetics,,,Dr. P. Mayo,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cases: Aminoglycoside Pharmacokinetics,,,Dr. P. Mayo,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Vancomycin Pharmacokinetics,,,Dr. P. Mayo,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Antitubercular Agents and Tuberculosis ,,,D. Chua,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class  Fall Break,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class  Fall Break,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Intraabdominal Infections,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cases: SSTI and Intraabdominal Infections,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Meningitis,,,M. Gunther,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cases: Meningitis,,,M. Gunther,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Surgical Prophylaxis,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Seminar: UTI,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cases: Bone/Joint Infections,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Endocarditis,,,M. Gray,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Evaluation/Review/Questions,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Exam Review,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Sepsis Syndrome and Septic Shock,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cases: Endocarditis,,,M. Gray,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Bone/Joint Infections ,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class  Fall Break,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class  Fall Break,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class  Fall Break,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Antitubercular Agents and Tuberculosis,,,D. Chua,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Urinary Tract Infections ,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cases: Vancomycin Pharmacokinetics,,,Dr. P. Mayo,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,No Class  Neurology Exam,,,,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Skin and Soft Tissue Infections,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Oxazolidinones, Quinupristin/Dalfopristin, Daptomycin, Chloramphenicol",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Seminar: LRTI,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Polymixin B, Bacitracin, Fusidic Acid, Mupirocin",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Clostridium difficile Infection,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Glycopeptides,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Lower Respiratory Tract Infections,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Nitrofurans, Fluoroquinolones",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Pharmacokinetics/dynamics of Antibacterials,,,Dr. P. Mayo,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Macrolides, Ketolides, Clindamycin",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Î_-lactam Allergies and Desensitization,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Î_-lactamases, Î_-lactamase Inhibitors",,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Cephalosporins,,,Dr. N. Beahm,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Bacterial Pathogens: Gram  Cocci, Gram  Rods",,,Dr. K. Kowalewska-Grochowska,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,"Bacterial Pathogens: Gram + Cocci, Gram + Rods",,,Dr. H. Zhou,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Laboratory and Clinical Lab Tests,,,Dr. T. Dingle,lecture,50 minutes,2018-12-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 1,,MS 231,L. Guirguis,Lecture,50 minutes,2019-01-07,,,"Health Literacy (Behavioural): , Health care experiences of low-literacy patients., Techniques to improve communication with low-literacy patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 2,,MS 231,L. Guirguis,Lecture,50 minutes,2019-01-09,,,"One-on-One Education (Behavioural):, Strategies for educating individuals, Guidelines on legibility and readability of written materials",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 3,,MS 231,L. Guirguis,Lecture,50 minutes,2019-01-11,,,"Risk Communication (Behavioural):, Written and verbal  strategies for effectively communicating risk, Visual methods to effectively communication risk",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 4,,MS 231,L. Guirguis,Lecture,50 minutes,2019-01-14,,,"Medication Monitoring Questions (Behavioural):, Supportive communication techniques to assess patients medication taking behaviors, Barriers to patients medication taking behaviors using supportive probing techniques",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 5,,MS 231,L. Guirguis,Lecture,50 minutes,2019-01-16,,,"Motivational Interviewing (Behavioural):, Core principles and key skills of motivational interviewing, Practical approaches to assessing readiness, increasing motivation, and overcoming barriers to change",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 6,,MS 231,R. Sanghera,Lecture,50 minutes,2019-01-18,,,"Jurisprudence Part I (Federal) (Administrative):, Overview of the Food and Drug Act and its Regulations, Part C",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 7,,MS 231,R. Sanghera,Lecture,50 minutes,2019-01-21,,,"Jurisprudence Part II (Federal) (Administrative):, Overview of the Controlled Drugs and Substances Act & Regulations , BZD and TS Regs, Precursor, Narcotic Regs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Seminar 1,,CS 2-191,R. Sanghera,Seminar,110 minutes,2019-01-22,,,"Jurisprudence (Administration), Topic TBD",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 8,,MS 231,R. Sanghera,Lecture,50 minutes,2019-01-23,,,"Jurisprudence Part III (Federal & Provincial) (Administrative):, Overview of Part G & J of F & D Act, Overview of Triplicate Prescription Program",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 9,,MS 231,R. Sanghera,Lecture,50 minutes,2019-01-25,,,"Jurisprudence Part IV (Provincial) (Administrative):, Overview of HPA & Pharmacy Drug Act, Pharmacists and Pharmacy Technicians Profession Regulation, Pharmacy & Drug Regulations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 10,,MS 231,R. Sanghera,Lecture,50 minutes,2019-01-28,,,"Jurisprudence Part IV (Provincial) (Administrative):, Principles of Drug Scheduling",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 11,,MS 231,R. Sanghera,Lecture,50 minutes,2019-01-30,,,"Jurisprudence Part IV (Provincial) (Administrative):, Regulations pertaining to other HCPs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 12,,MS 231,R. Sanghera,Lecture,50 minutes,2019-02-01,,,"Jurisprudence Part IV (Provincial)(Administrative):, Overview of FOIPP and Health Information Act",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 13,,MS 231,R. Sanghera,Lecture,50 minutes,2019-02-04,,,"Jurisprudence Part V (Administrative):, Health Canada Vigilance Program and ADR Reporting",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Seminar 2,,CS 2-191,R. Sanghera,Seminar,110 minutes,2019-02-05,,,"Jurisprudence (Administrative):, Topic TBD",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 14,,MS 231,R. Sanghera,Lecture,50 minutes,2019-02-06,,,"Identifying Drug Diversion and Robbery Prevention Techniques (Administration), Identify techniques for drug diversion, Discuss robbery preventions and management",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 15,,MS 231,R. Sanghera,Lecture,50 minutes,2019-02-08,,,"Fostering a Culture of Patient Safety (Administrative):, Patient, safety as a discipline, Define culture of patient safety terms , Critical actions in the medication use process that contribute to error reduction and patient safety, Quality Assurance Process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 16,,MS 231,R. Sanghera,Lecture,50 minutes,2019-02-11,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 17,,MS 231,R. Sanghera,Lecture,50 minutes,2019-02-13,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 18,,MS 231,L. Guirguis,Lecture,50 minutes,2019-02-15,,,"Decision Making Theory and Cognitive Bias (Social):, Relationship between thoughts and the decision making process, Interplay of thoughts and emotions in decision making",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 19,,MS 231,L. Guirguis,Lecture,50 minutes,2019-02-25,,,"Clinical Reasoning (Social):, Pharmacists clinical reasoning approaches, Expert and novice pharmacist clinical reasoning approaches",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Seminar 3,,CS 2-191,L. Guirguis,Seminar,110 minutes,2019-02-26,,,"Health Literacy (Behavioural):, Patient education materials and risk communication techniques",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 20,,MS 231,L. Guirguis,Lecture,50 minutes,2019-02-27,,,"Clinical Reasoning (Social):, Contd",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 21,,MS 231,ALL,Exam,50 minutes,2019-03-01,,,Midterm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 22,,MS 231,T. Schindel,Lecture,50 minutes,2019-03-04,,,"Professional Learning (Behavioral):, Theoretical foundations for professional learning (academic, workplace)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 23,,MS 231,T. Schindel,Lecture,50 minutes,2019-03-06,,,"Professional Learning (Behavioral):, Continuing professional development process (CPD): , How to plan learning (introduce: plan, act, evaluate, reflect, document); provide examples; introduce requirements of Alberta College of Pharmacists",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 24,,MS 231,T. Schindel,Lecture,50 minutes,2019-03-08,,,"Professional Learning (Behavioral):, Overview of Critical Thinking; relate to CPD process; emphasis on reflection as a method of evaluation; introduce a critical thinking reflection guide",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 25,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-11,,,"Evidence Literacy (Evidence Based):, Reading a trial, Synopsis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Seminar 4,,CS 2-191,M. Makowsky,Seminar,110 minutes,2019-03-12,,,"Evidence Literacy (Evidence Based):, Finding Studies & Synopses (Library/Lab 324)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 26,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-13,,,"Trial Designs (Evidence Based):, Overview of experimental and observational designs. , Introduction to RCTs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 27,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-15,,,"Study Results (Evidence Based):, Understanding & Interpreting Study Results ARR, RR, RRR, NNT, NNH, OR",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 28,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-18,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 29,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-20,,,See Above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 30,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-22,,,Continuous Data (Evidence Based),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 31,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-25,,,"Hazard Ratios (Evidence Based):, Understanding Hazard Ratios  Time to Event & Survival Analysis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Seminar 5,,CS 2-191,M. Makowsky,Seminar,110 minutes,2019-03-26,,,"Evidence Based Medicine, Evidence Literacy Seminar ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 32,,MS 231,M. Makowsky,Lecture,50 minutes,2019-03-27,,,"Understanding Incidence Rates & NNT in Systematic Reviews, Incidence Rates (Evidence Based):",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 33,,MS 231,T. Makhinova,Lecture,50 minutes,2019-03-29,,,"Personal Management (Administration):, Introduction to Leadership; Leadership vs Management",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 33,,MS 231,T. Makhinova,Lecture,50 minutes,2019-04-01,,,"Personal Management (Administration):, raits, roles and behaviours of leaders, leadership styles",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 34,,MS 231,T. Makhinova,Lecture,50 minutes,2019-04-03,,,"Personal Management (Administration):, Self-awareness; Emotional intelligence",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 35,,MS 231,T. Makhinova,Lecture,50 minutes,2019-04-05,,,"Personal Management (Administration):, Conflict management; Informal power; Consensus;",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 37,,MS 231,TBA,Lecture,50 minutes,2019-04-08,,,"Cultural Safety (Social):, Indigenous",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Seminar 6,,CS 2-191,T. Makhinova,Seminar,110 minutes,2019-04-09,,,"Personal Management (Administration):, Leading self: personality inventories (Strength Finder and Conflict management)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 38,,MS 231,TBA,Lecture,50 minutes,2019-04-10,,,"Cultural Safety (Social):, Indigenous",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Lecture 39,,MS 231,TBA,Lecture,50 minutes,2019-04-12,,,"Cultural Safety (Social):, Indigenous, OR CLASS WRAP-UP",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 4,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,"GI: Absorption of vitamins, inorganic ions, water; Regulation of GI activity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 5,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,GI: Regulation of GI activity; The liver; Integumentary: Skin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 6,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Integumentary: Skin; Accessory structures; Glucocorticoids; ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 1,,MSB 628,Susan Patrick,In-class lecture,50 minutes,1969-12-31,,,Course Introduction; Gastrointestinal (GI): Introduction; Wall of GI tract; Motility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 2,,MSB 628,Susan Patrick,In-class lecture,50 minutes,1969-12-31,,,GI: Journey through the GI tract,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 3,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,"GI: Accessory organs; Digestion and absorption of carbohydrates, proteins, lipids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 7,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Eye: Gross anatomy; Optics; Accommodation; Retina; Photoreceptors; Phototransduction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 8,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Eye: Beyond photoreceptors; Accessory structures,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 9,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Ear: Sound and audition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 10,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Ear: Vestibular system; Nose & Throat; Endocrine: Basic concepts,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 11,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Endocrine: Hormones; Feedback loops; Energy metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 12,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Endocrine: Energy metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 13,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Endocrine: Hypothalamus-pituitary axis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 14,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Endocrine: Thyroid hormones; Growth hormone; Adrenal cortex; Other endocrine organs; Introduction to secretion disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 15,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Skeletal: Introduction; Cartilage histology and growth; Bone histology and structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 16,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Skeletal: Bone development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 17,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Skeletal: Bone remodeling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 18,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Skeletal: Bone remodeling; Definition and classification of joints; Synovial joints and accessory structures,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 19,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Renal: Organization of renal system; Anatomy; Basic renal processes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 20,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Renal: Renal corpuscle; Glomerular filtration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 21,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Renal: Concepts of tubular reabsorption and secretion; Renal clearance; Journey through the nephron,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 22,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,MIDTERM EXAM (GI to Endocrine inclusive),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 23,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Renal: Journey through the nephron; Regulation of Na+ by the kidneys,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Semiar 1,,TBA,Susan Patrick,In-person seminar,50 minutes,1969-12-31,,,TBA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 24,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,"Renal: Regulation of Na+, H2O, and K+ by the kidneys",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 25,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Renal: Regulation of H+ and Ca2+ by the kidneys; Micturition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 26,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Reproductive: Introduction; Male system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 27,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Reproductive: Male system; Female system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 28,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Reproductive: Female system; Menstrual cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 29,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Reproductive: Menstrual cycle; Sexual response; Long-term hormonal changes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 30,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,"Reproductive: Fertilization, implantation, and pregnancy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 31,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Reproductive: Embryogenesis and fetal development; Parturition; Lactation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 32,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Elements of the Immune System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 33,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Aby Structure and B-cell Diversity ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 34,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Immunoassays and ELISA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 35,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Cell-mediated Immunity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 36,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Humoral Immunity and Complement ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 37,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Bodys Defense Against Infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 38,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Immune Response to Vaccines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Lecture 39,,Online,Susan Patrick,Online lecture,50 minutes,1969-12-31,,,Immunology: Immune Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Antimicrobial Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-19,,,"Sulfonamides, Beta-Lactam Antibiotics, Glycopeptides, Polymixins, Tetracyclines, and Aminoglycosides",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Anemia Pharmacology,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-01-08,,,Hematinic Agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Respiratory Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-10,,,"Drugs for COPD, Drugs for Asthma: Bronchodilators & Antiinflammatories",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,GI Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-15,,,Agents for Neutralizing Gastric Acid Secretion and Antiemetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,GI Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-17,,,"Agents that Modulate Gastric Motility, Antidiarrhoeal Agents and Agents for Chronic Bowel Disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Obesity Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-22,,,"Non-Pharmacological Approaches, Central Acting Agents and Gut Hormone-Based Agents",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Skin Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-24,,,Antiinflammatories & Other Agents for Skin Disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Reproductive Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-29,,,"Oral Contraceptives, Agents that Act on the Uterus and Agents for Erectile Dysfunction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Endocrine Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-01-31,,,Type 1 Diabetes (Insulin and Insulin Analogues) & Gestational Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Endocrine Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-05,,,"Type 2 Diabetes (Metformin, Sulfonylureas, Incretin Based Therapies & SGLT2 Inhibitors)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Endocrine Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-12,,,"Other Endocrine Disorders (Agents for Addison's Disease, Cushing Syndrome, Thyroid Disorders) and Hormone Replacement Therapy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Hematopoietic & Bone Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-14,,,Agents for Osteoporosis and Osteoarthritis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Hematopoietic & Bone Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-26,,,"Agents for Rheumatoid Arthritis, Gout and Hyperuricemia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Renal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-02-28,,,Diuretics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Renal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-05,,,Agents for Renal Failure and Urinary Tract Infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Cancer Chemotherapy,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-03-07,,,"Alkylating Agents, Antimetabolites and Cytotoxic Antibiotics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Cancer Chemotherapy,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-03-12,,,"Plant Derivatives, Hormone-Based Agents and Protein Kinase Inhibitors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Cancer Chemotherapy,,MSB 628,Dr. Paul Jurasz,In-class lecture,50 minutes,2019-03-14,,,"Immune Therapies for Cancer, Immunosuppressants, and Other Immunotherapies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Antimicrobial Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-21,,,"Antimycobacterials and Other Antibacterial Agents; Antifungal Antibiotics, Synthetic Antifungals and Other Antifungal Agents",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Antiprotozoal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-26,,,Antimalarial Agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Antiprotozoal Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-03-28,,,"Agents for Other Protozoal Infections (Trypanosomiasis, Leishmaniasis, Trichomoniasis, Giardiasis and Toxoplasmosis)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Antiviral Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-02,,,"Agents for Herpes and Related Viruses, Agents for Influenza Viruses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Antiviral Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-04,,,Agents for Hepatitis Viruses and HIV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Miscellaneous Topics in Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-09,,,"Lifestyle Drugs, Drugs in Sport & Gene/Cell-Based Therapies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Miscellaneous Topics in Pharmacology,,MSB 628,Dr. John Ussher,In-class lecture,50 minutes,2019-04-11,,,Drug Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 1,,MS 628,Shkrobot,lecture,170 minutes,2019-01-07,"Active Learning, Direct Lecture",face to face,Historical background,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 2,,MS 628,Shkrobot,lecture,170 minutes,2019-01-14,"Active Learning, Direct Lecture",face to face,"Canada's healthcare system, Health systems",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 10,,MS 628,Shkrobot,lecture,170 minutes,2019-03-25,"Team Based Learning, Active Learning, Direct Lecture",face to face,Debates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 9,,MS 628,Shkrobot,lecture,170 minutes,2019-03-18,"Team Based Learning, Active Learning, Direct Lecture",face to face,Debates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 8,,MS 628,Shkrobot,lecture,170 minutes,2019-03-11,"Team Based Learning, Active Learning, Direct Lecture",face to face,Solutions to healthcare issues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 7,,MS 628,"Shkrobot, Makhinova",lecture,170 minutes,2019-03-04,"Team Based Learning, Active Learning, Direct Lecture",face to face,"Pharmacy Service Frameworks, Pharmacoeconomics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 6,,MS 628,Shkrobot,lecture,170 minutes,2019-02-11,"Team Based Learning, Active Learning, Direct Lecture",face to face,Healthcare organizations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 5,,MS 628,Shkrobot,lecture,170 minutes,2019-02-04,"Team Based Learning, Active Learning, Direct Lecture",face to face,Provision of healthcare services,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 4,,MS 628,Shkrobot,lecture,170 minutes,2019-01-28,"Team Based Learning, Active Learning, Direct Lecture",face to face,Provision of healthcare services,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Session 3,,MS 628,Shkrobot,lecture,170 minutes,2019-01-21,"Team Based Learning, Active Learning, Direct Lecture",face to face,Healthcare reources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-04-04,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-04-02,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-03-29,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-03-28,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-03-22,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-03-12,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-03-05,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-03-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-02-28,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-02-15,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Blood Pressure Clinics,,Mazankowski Heart Institute,,lab,110 minutes,2019-02-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pharmacogenomics,,ECHA 2-490,John Seubert,lecture,110 minutes,2019-04-11,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Cardiotoxicology,,ECHA 2-490,John Seubert,lecture,110 minutes,2019-04-08,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Peripheral Vascular Disease,,ECHA 2-490,Sheila Walter,lecture,110 minutes,2019-04-05,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Seminar 4 - Arrhythmia,"1, 2, 3, 4","ED213, ED255, ED262, ED277","Jennifer Vu, Sheila Walter, Hazal Babadagli, June Chen",seminar,110 minutes,2019-04-03,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pathphys/Therap:  A Fib,,ECHA 2-490,Kristen George-Phillips,lecture,110 minutes,2019-04-03,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pathphys/Therap:  A Fib,,ECHA 2-490,Kristen George-Phillips,lecture,110 minutes,2019-04-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Seminar 3 - Heart Failure,"1, 2, 3, 4","ED213, ED255, ED262, ED277","Jennifer Vu, Sheila Walter, Hazal Babadagli, June Chen",seminar,110 minutes,2019-03-27,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,"Kinetics:  Anti-Arrhythmics,  Procainamide, Amiodarone, Digoxin",,ECHA 2-490,Dion Brocks,lecture,110 minutes,2019-03-25,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,"Kinetics:  Anti-Arrhythmics,  Procainamide, Amiodarone, Digoxin",,ECHA 2-490,Dion Brocks,lecture,110 minutes,2019-03-22,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Seminar 2 - CAD,"1, 2, 3, 4","ED213, ED255, ED262, ED277","Jennifer Vu, Sheila Walter, Hazal Babadagli, June Chen",seminar,110 minutes,2019-03-20,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pharm: Anti-Arrhythmics,,ECHA 2-490,Peter Light,lecture,110 minutes,2019-03-20,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pathophys/Therap:  CHF,,ECHA 2-490,Miriam Fradette,lecture,110 minutes,2019-03-18,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pathophys/Therap:  CHF,,ECHA 2-490,Miriam Fradette,lecture,110 minutes,2019-03-15,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,"Pathophys/Therap:  Acute Coronary Syndromes, MI",,ECHA 2-490,Margaret Ackman,lecture,110 minutes,2019-03-13,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Seminar 1 - Primary Prevention/Risk Assessment,"1,2,3,4","ED213, ED255, ED262, ED277","Jennifer Vu, Sheila Walter, Hazal Babadagli, June Chen",seminar,110 minutes,2019-03-13,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,"Pathophys/Therap:  Acute Coronary Syndromes, MI",,ECHA 2-490,Margaret Ackman,lecture,110 minutes,2019-03-11,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pathophys/Therap: CHD,,ECHA 2-490,Taryn May,lecture,110 minutes,2019-03-04,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pathophys/Therap: CHD,,ECHA 2-490,Mohamed Omar,lecture,110 minutes,2019-03-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Dyslipidemia,,MSB 2-27,Glen Pearson,lecture,110 minutes,2019-02-27,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Dyslipidemia,,ECHA 2-490,Glen Pearson,lecture,110 minutes,2019-02-25,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Hypertension,,ECHA 2-490,Ann Thompson,lecture,110 minutes,2019-02-08,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Hypertension,,ECHA 2-490,Ann Thompson,lecture,110 minutes,2019-02-06,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Hypertension,,ECHA 2-490,Ann Thompson,lecture,110 minutes,2019-02-04,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Hypertension,,ECHA 2-490,Ann Thompson,lecture,110 minutes,2019-02-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,MedChem: Anti-Arrhythmics/CCB/Statins,,ECHA 2-490,Khaled Barakat,lecture,110 minutes,2019-01-30,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pharm: CCB/Vasodilators,,ECHA 2-490,John Seubert,lecture,110 minutes,2019-01-28,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pharm: Diuretics,,ECHA 2-490,John Seubert,lecture,110 minutes,2019-01-25,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pharm: Lipds,,ECHA 2-490,John Seubert,lecture,110 minutes,2019-01-23,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Pharm: Beta-blockers/RAAS,,ECHA 2-490,John Seubert,lecture,110 minutes,2019-01-21,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Patient Assessment History,,ECHA 2-490,Sheri Koshman,lecture,110 minutes,2019-01-18,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Patient Assessment History,,ECHA 2-490,Sheri Koshman,lecture,110 minutes,2019-01-16,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Physiology,,Online,Susan Patrick,lecture,110 minutes,2019-01-14,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Physiology,,Online,Susan Patrick,lecture,110 minutes,2019-01-11,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Anatomy/Physiology,,Online,Susan Patrick,lecture,110 minutes,2019-01-09,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Introduction/Pathophysiology,,ECHA 2-490,John Seubert,lecture,110 minutes,2019-01-07,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 24,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-27,,face to face,Pharmacoeconomic Evaluations & Course Evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 23,,ECHA 2-490,Theresa Charrois,lecture,50 minutes,2019-03-25,,face to face,Pharmacy Practice Research Examples,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 22,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-22,,face to face,Pharmacy Practice Research Examples,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 21,,ECHA 2-490,Dr. Ken Cor,lecture,50 minutes,2019-03-20,,face to face,Survey Methods  Part II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 20,,ECHA 2-490,Dr. Ken Cor,lecture,50 minutes,2019-03-18,,face to face,Survey Methods  Part I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 19,,ECHA 2-490,Charmaine Kabatoff,lecture,50 minutes,2019-03-15,,face to face,Consent and Ethical Considerations in Pharmacy Practice Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 18,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-13,,face to face,Pharmacy Practice Research Design Issues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 17,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-11,,face to face,Knowledge Translation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 16,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-08,,face to face,Quality Improvement Framework,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Seminar,,2-50 MSB,UofA Librarian,seminar,50 minutes,2019-03-07,,face to face,LITERATURE SEARCH SKILLS SEMINAR (50-minutes/group),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Midterm,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-06,,face to face,Midterm exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 15,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-04,,face to face,Open Topics in Pharmacoepidemiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 14,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-03-01,,face to face,JAMA Users Guides approach to critically appraising observational studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 13,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2019-02-27,,face to face,Meta-Analysis  Part II: Data Synthesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 12,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2019-02-25,,face to face,Meta-Analysis  Part I: Search and Selection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 11,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2019-02-13,,face to face,Confounding in Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 10,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2019-02-11,,face to face,Bias in Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 9,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2019-02-08,,face to face,Bradford-Hill Considerations for Causal Inference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 8,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2019-02-06,,face to face,Measurement of Association,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 7,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-02-04,,face to face,Pharmacoepidemiologic Study Designs  Part II: Cohort Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 6,,ECHA 2-490,Dr. Simpson,lecture,50 minutes,2019-02-01,,face to face,Pharmacoepidemiologic Study Designs  Part I: Cross-Sectional Studies and Case-Control Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 5,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-01-30,,face to face,Data Sources  Part II: Secondary Analyses & Population-Based Surveys,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 4,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-01-28,,face to face,Data Sources  Part I: ADR Reports & Health Care Databases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 3,,ECHA 2-490,Dr. Eurich,lecture,50 minutes,2019-01-25,,face to face,Randomized Controlled Trials & Observational Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 2,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-01-23,,face to face,Limitations of Drug Approval & Pre-Marketing Clinical Trials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Lecture 1,,ECHA 2-490,Dr. Makhinova,lecture,50 minutes,2019-01-21,,face to face,Course Outline & Introduction to Pharmacoepidemiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,FINAL,,MS 231,,exam,,2019-02-16,,,Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 20,,MS 231,Todd Canada,lecture,,2019-02-13,,Face to Face,Parenteral Nutrition 2 (Online Keynote Lecture),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 19,,MS 231,Anna Lam,lecture,,2019-02-12,,Face to Face,Case Studies of Nutrition in Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 18,,MS 231,Jo-Ann Dawkins,lecture,,2019-02-09,,Face to Face,Managing Nutrition in Patients with Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 17,,MS 231,John Ussher,lecture,,2019-02-08,,Face to Face,Other Fad Diets for Weight Loss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 16,,MS 231,Rhonda Bell,lecture,,2019-02-07,,Face to Face,Nutrition & Pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 15,,MS 231,John Ussher,lecture,,2019-02-06,,Face to Face,Branched Chain Amino Acid Supplements,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 14,,MS 231,Carla Prado,lecture,,2019-02-05,,Face to Face,Nutrition & Body Composition & Drug Kinectics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 13,,MS 231,John Ussher,lecture,,2019-02-02,,Face to Face,Carnitine in Health and Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 12,,MS 231,Rene Jacobs,lecture,,2019-02-01,,Face to Face,Micronutrients (Choline & Folate) in Health and Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 11,,MS 231,Camila Pinto,lecture,,2019-01-30,,Face to Face,Nutrition & Supplements in Sports Performance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 10,,MS 231,John Ussher,lecture,,2019-01-29,,Face to Face,The Ketogenic Diet,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,MIDTERM,,MS 231,John Ussher,exam,,2019-01-26,,Face to Face,Exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 9,,MS 231,Blaine Colton,lecture,,2019-01-25,,Face to Face,Case Studies of Nutrition & Obesity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 8,,MS 231,Blaine Colton,lecture,,2019-01-23,,Face to Face,Nutrition & its Relation to Obesity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 7,,MS 231,Raimar Loebenberg,lecture,,2019-01-22,,Face to Face,Food & Drug Interaction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 6,,MS 231,Bodil Larsen,lecture,,2019-01-19,,Face to Face,Nutrition in Pediatrics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 5,,MS 231,Leanne Mulesa,lecture,,2019-01-18,,Face to Face,Parenteral Nutrition 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 4,,MS 231,Leanne Mulesa,lecture,,2019-01-16,,Face to Face,Enteral Nutrition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 3,,MS 231,Carla Prado,lecture,,2019-01-15,,Face to Face,"Nutrition Screening & Assessment, Dietary Reference Intakes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 2,,MS 231,John Ussher,lecture,,2019-01-09,,Face to Face,"Nutrient Metabolism: Carbohydrates, Lipids & Proteins",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,"of the Pharmacist in Nutrition""",,,,,,1969-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Lecture 1,,MS 231,John Ussher,lecture,,2019-01-08,,Face to Face,Course Introduction: The Importance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Final Exam,,TBA,Pat Mayo/ Alysha Hemraj,lecture,170 minutes,2019-04-25,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 38: Final Review,,MS-231,Pat Mayo/ Alysha Hemraj,lecture,50 minutes,2019-04-10,Direct Lecture,face to face,Course review/Final review:,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 37: Tobacco Cessation,,MS-231,Pat Mayo,lecture,50 minutes,2019-04-08,Direct Lecture,face to face,"Tobacco cessation; e-cigs, hookas, shishas",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Seminar 6: COPD Cases,,PBL Rooms/CS 2 191,Pat Mayo,seminar,50 minutes,2019-04-02,"Problem Based Learning, Active Learning",face to face,COPD Cases ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 34: COPD Exacerbations,,MS-231,Renette Bertholet,lecture,50 minutes,2019-04-01,Direct Lecture,face to face,"COPD: Exacerbations, anti-inflammatories COPD action plan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 33: COPD Bronchodilators,,MS-231,Renette Bertholet,lecture,50 minutes,2019-03-29,Direct Lecture,face to face,"COPD: Stable COPD, bronchodilators",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 32: COPD Assessment,,MS-231,Renette Bertholet,lecture,50 minutes,2019-03-27,Direct Lecture,face to face,"COPD: Assessment, diagnosis, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 31: COPD Epidemiology,,MS-231,Renette Bertholet,lecture,50 minutes,2019-03-25,Direct Lecture,face to face,"COPD: epidemiology, risk factors, screening",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 30: Asthma Pediatric,,MS-231,Pat Mayo,lecture,50 minutes,2019-03-22,Direct Lecture,face to face,Asthma/pediatrics - therapeutic approaches,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 29: Asthma Pediatric,,MS-231,Pat Mayo,lecture,50 minutes,2019-03-20,Direct Lecture,face to face,Asthma/pediatric/special populations - assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Seminar 5: Asthma Cases,,PBL Rooms/CS 2 191,Pat Mayo,seminar,50 minutes,2019-03-19,"Problem Based Learning, Active Learning",face to face,Asthma Cases and Excercises,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 28: Asthma Therapeutic,,MS-231,Pat Mayo,lecture,50 minutes,2019-03-18,Direct Lecture,face to face,Asthma; therapeutic approach ASTHMA action plans,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 27: Asthma: Acute,,MS-231,Pat Mayo,lecture,50 minutes,2019-03-15,Direct Lecture,face to face,Asthma; Assessment (acute),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 26: Asthma Therapeutics,,MS-231,Pat Mayo,lecture,50 minutes,2019-03-13,Direct Lecture,face to face,Asthma; therapeutic approach; corticosteroids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 25: Asthma Assessment,,ED 129,Pat Mayo,lecture,50 minutes,2019-03-12,Direct Lecture,face to face,"Asthma: Assessment, therapeutic approach:",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 24: Asthma Clinical,,MS-231,Pat Mayo,lecture,50 minutes,2019-03-11,Direct Lecture,face to face,Asthma: Clinical presentation assessment (chronic),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 23: Asthma Epidemiology,,MS-231,Pat Mayo,lecture,50 minutes,2019-03-08,Direct Lecture,face to face,"Asthma: epidemiology, risk factors, pathophysiology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 22: Seasonal Allergy,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-03-06,Direct Lecture,face to face,"Seasonal Allergies: assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 35: Tobacco Cessation,,MS-231,Pat Mayo,lecture,50 minutes,2019-04-03,Direct Lecture,face to face,Tobacco cessation: assessment; NRT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 36: Tobacco Cessation,,MS-231,Pat Mayo,lecture,50 minutes,2019-04-05,Direct Lecture,face to face,Tobacco cessation; Prescription therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Seminar 4: Cough Cold,,PBL Rooms/CS 2 191,Alysha Hemraj,seminar,50 minutes,2019-03-05,"Team Based Learning, Problem Based Learning, Active Learning",face to face,Seminar Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 21: Seasonal Allergy,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-03-04,Direct Lecture,face to face,"Seasonal Allergies: pathophysiology, epidemiology, clinical presentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 20: Cough Cold,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-03-01,Direct Lecture,face to face,Cough and Cold,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 19: Cough Cold,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-02-27,Direct Lecture,face to face,Cough and Cold,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 17: Acute Pain,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-02-15,Direct Lecture,face to face,"Acute Pain, Tension-Type, Headache, Sports Injuries, Low back pain: therapeutic approach, pharmacists role",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 18: Acute Pain,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-02-25,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 16: Sun Care/Heat-Related Illnesses,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-02-13,Direct Lecture,face to face,"Sun Care, Heat-Related Illnesses, Skin Cancer Surveillance, Perspiration: clinical presentation , assessment, therapeutic approach, pharmacists role",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Seminar 3: Dermatology Cases,,MS-231,Alysha Hemraj/ Ravina Sanghera,seminar,50 minutes,2019-02-12,"Team Based Learning, Problem Based Learning, Active Learning",face to face,Seminar Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 15: Wounds/Burns/Bites,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-02-08,Direct Lecture,face to face,"Burn Care, Basic Wound , Insect Bites/Stings: clinical presentation, assessment, therapeutic approach, pharmacists role",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 14: Skin Conditions,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-02-06,Direct Lecture,face to face,"Dandruff/Seborrhea, Warts/Corns/Calluses/ Bunions: pathophysiology, epidemiology, clinical presentation, assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 13: Acne,,MS-231,Ravina Sanghera,lecture,50 minutes,2019-02-04,Direct Lecture,face to face,"Acne: pathophysiology, epidemiology, clinical presentation, assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 12: Dermatology,,MS-231,Ravina Sanghera,lecture,50 minutes,2019-02-01,Direct Lecture,face to face,"Dermatitis, Diaper Rash, Xerosis: assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 11: Dermatology,,MS-231,Ravina Sanghera,lecture,50 minutes,2019-01-30,Direct Lecture,face to face,"Dermatitis, Diaper Rash, Xerosis: pathophysiology, epidemiology, clinical presentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Seminar 2: Eye/Ear/GI,,PBL Rooms/CS 2 191,Alysha Hemraj,seminar,50 minutes,2019-01-29,"Team Based Learning, Problem Based Learning, Active Learning",face to face,Eye/Ear/GI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 10: Lice/Scabies,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-01-28,Direct Lecture,face to face,"Lice and Scabies: pathophysiology, epidemiology, clinical presentation, assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 9: GI,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-01-25,Direct Lecture,face to face,"Hemorrhoids, gastrointestinal gas: pathophysiology, epidemiology, clinical presentation, assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 8: Dental Conditions,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-01-23,Direct Lecture,face to face,"Dental Care, Canker Sores, Dry Mouth, Halitosis: pathophysiology, epidemiology, clinical presentation, assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 7: Ear Conditions,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-01-21,Direct Lecture,face to face,"Ear Conditions (impacted ear wax, otitis externa, minor ear pain): pathophysiology, epidemiology, clinical presentation, assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Midterm Exam,,CAB 331,Alysha Hemraj/Pat Mayo,lecture,50 minutes,2019-02-11,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 6: Eye Conditions,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-01-18,Direct Lecture,face to face,"Eye Conditions (dry eye, contact lens care): pathophysiology, epidemiology, clinical presentation, assessment, therapeutic approach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 5: CAM Role of Pharmacist,,MS-231,Candace Necyk,lecture,50 minutes,2019-01-16,Direct Lecture,face to face,CAM Role of pharmacist in recommendations/referrals and collaboration.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Seminar 1: CAM,,PBL Rooms/CS 2 191,Candace Necyk,seminar,50 minutes,2019-01-15,"Team Based Learning, Problem Based Learning, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 4: CAM Drug Info,,MS-231,Candace Necyk,lecture,50 minutes,2019-01-14,Direct Lecture,face to face,CAM: Resources for drug information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 3: CAM Modalities,,MS-231,Candace Necyk,lecture,50 minutes,2019-01-11,Direct Lecture,face to face,"Modalities & Provider,  Complementary and Alternative Medicine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 2: Patient Care Process,,MS-231,Alysha Hemraj,lecture,50 minutes,2019-01-09,Direct Lecture,face to face,Review of Patient Care Process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Lecture 1: Introduction,,MS-231,Alysha Hemraj/Pat Mayo,lecture,50 minutes,2019-01-07,Direct Lecture,face to face,"Self-Care, Introduction to Course",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Travellerâ€™s Health - Malaria,,MSB 227,Houston,lecture,110 minutes,2019-04-03,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Small group learning activities - Fungal infections,,PBL rooms,Hughes,lecture,110 minutes,2019-03-29,"Problem Based Learning, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Antiprotozoals - pharmacology antimalarials, other antiprotozoals",,MSB 227,Ussher,lecture,80 minutes,2019-03-27,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: Dermatophytoses (candida, ringworm, athletes foot, jock itch, fungal nail infections)",,MSB 227,Hughes,lecture,110 minutes,2019-03-25,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: Systemic Fungal Infections (Candidiasis, Aspergillus)",,MSB 227,Gray,lecture,110 minutes,2019-03-22,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Small group learning activities - viral hepatitis, HIV, PrEP and PEP",,PBL rooms,,lecture,110 minutes,2019-03-08,"Problem Based Learning, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: HIV (case discussions),,MSB 227,Hughes,lecture,110 minutes,2019-03-04,Active Learning,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: HIV Drug classes, MOA, side effects, interactions, goals of therapy",,MSB 227,Hughes,lecture,110 minutes,2019-03-01,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"HIV overview (Pathophysiology, transmission, diagnosis)",,MSB 227,Hughes,lecture,110 minutes,2019-02-25,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Small group learning activities: vaccines and influenza,,PBL rooms,Hughes,lecture,110 minutes,2019-02-06,"Problem Based Learning, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Legal & Ethical Issues: Vaccinations,,MSB 227,Ogbogu,lecture,110 minutes,2019-01-28,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Vaccine Licensure and Immunization delivery,,MSB 227,Hedley,lecture,50 minutes,2019-01-23,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Small group learning activities (virology and pharmacology),,PBL rooms,Hughes,lecture,110 minutes,2019-01-16,"Problem Based Learning, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Small group learning activities - Travel medicine,,PBL rooms/MSB 227,Hughes/Kmet,lecture,110 minutes,2019-04-05,Active Learning,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: Protozoal Diseases - toxoplasmosis, giardia lamblia, cryptosporidium, amebiasis",,MSB 227,Hughes,lecture,110 minutes,2019-04-01,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: HIV/opportunistic Infections - candidiasis, mycobacterium avium, PJP",,MSB 227,Hughes,lecture,50 minutes,2019-03-06,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Small group learning activities - sexually transmitted infections,,PBL rooms,Hughes,lecture,110 minutes,2019-02-15,"Problem Based Learning, Active Learning",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Patient Perspective (HIV),,MSB 227,Guest,lecture,50 minutes,2019-03-06,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Immunization delivery,,MSB 227,Hughes,lecture,50 minutes,2019-02-01,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Introduction/Virology overview: structure, classification, replication, transmission, diagnosis",,MSB 227,Carmen Charlton,lecture,110 minutes,2019-01-07,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Virology: respiratory illnesses, gastroenteritis, rash illnesses, viral hepatitis, CNS infections, herpes viruses, HPV",,MSB 227,Carmen Charlton,lecture,110 minutes,2019-01-09,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Virology: respiratory illnesses, gastroenteritis, rash illnesses, viral hepatitis, CNS infections, herpes viruses, HPV",,MSB 227,Carmen Charlton,lecture,110 minutes,2019-01-11,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Antivirals: pharmacology anti-herpes drugs, anti-HBV drugs, anti-HCV drugs, anti-influenza agents",,MSB 227,Siraki,lecture,110 minutes,2019-01-14,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Overview of vaccine types: live, killed/inactivated/subunit, vaccine failures, reactions",,MSB 227,Hughes,lecture,50 minutes,2019-01-23,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Immunizations of children: vaccine schedules, adverse effects, illness manifestations",,MSB 227,Hedley,lecture,110 minutes,2019-01-25,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Immunizations of adults/ travellers; Vaccine storage and handling; Immunization delivery ,,MSB 227,Hughes,lecture,110 minutes,2019-01-30,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Herpes Simplex 1 & 2,,MSB 227,Hughes,lecture,110 minutes,2019-01-18,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Herpes Zoster,,MSB 227,Hughes,lecture,110 minutes,2019-01-21,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Influenza,,MSB 227,Watson,lecture,50 minutes,2019-02-01,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Hepatitis recorded lecture & case preparation,,Recorded Lecture,Hughes,lecture,110 minutes,2019-02-08,Direct Lecture,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Hepatitis A&B Hepatitis C Case Discussions,,MSB 227,Hughes,lecture,110 minutes,2019-02-11,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Therapeutics: STIs - chlamydia, gonorrhea, syphilis, genital herpes, genital HPV",,MSB 227,Singh,lecture,110 minutes,2019-02-04,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Mycology overview,,MSB 227,Dingle,lecture,110 minutes,2019-03-11,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,"Antifungals Pharmacology - polyenes, imidazoles & triazoles,echinocandins",,MSB 227,Gray,lecture,110 minutes,2019-03-18,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Bioterrorism,,MSB 227,Franc,lecture,50 minutes,2019-03-20,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Parasitology introduction,,MSB 227,Hughes,lecture,50 minutes,2019-03-20,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Therapeutics: Pinworms,,MSB 227,Hughes,lecture,110 minutes,2019-03-15,Direct Lecture,distance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Final Exam,,ECHA L1 350  & ECHA L1 270,Patrick Mayo,lecture,50 minutes,2019-03-29,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Seminar 2: Acute-Chronic Conversion,,TBA,TBA,lecture,110 minutes,2019-03-14,Active Learning,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Seminar 1: Acute Pain,,,TBA,seminar,110 minutes,2019-03-12,Active Learning,face to face,#NAME?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 12: Guest Lecture: Methadone,,MS 231,Serena Rix,lecture,110 minutes,2019-02-14,"Active Learning, Direct Lecture",face to face,#NAME?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 11: Guest lecture: Management of Acute Pain,,MS 231,Shahileen Remtulla,lecture,110 minutes,2019-02-12,Direct Lecture,face to face,"-Case reports (ankle sprain, etc.), -Pain in ICU, -Pain assessment (acetaminophen, NSAIDs, COX-2 inhibitors, opioids) ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 10: Pharmacy Practice: Management,,MS 231,Patrick Mayo,lecture,110 minutes,2019-02-07,"Active Learning, Direct Lecture",face to face,"Opioid allergies, Opioid combination products, COX-2 removal from market, acute pain management (acetaminophen, NSAID, tramadol), Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Midterm Exam,,MS 231,Patrick Mayo,lecture,110 minutes,2019-02-05,,face to face,"Goals of therapy, Patient education, Pain presentation, assessment process, Pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 8: Pharmacy Practice: Assessment,,MS 231,Patrick Mayo,lecture,110 minutes,2019-01-31,"Active Learning, Direct Lecture",face to face,"Opioid withdrawal, Opioid addiction, Opioid agonists/antagonists, Pharmacology of morphine, Mechanism of action of opioids, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 7: Pharmacology of Analgesics and Anaesthetics,,MS 231,Patrick Mayo,lecture,110 minutes,2019-01-29,Direct Lecture,face to face,"Neuropathic pain, Local anasthetics (chemistry, mechanism of action, pharmacokinetics, toxicity), Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 15: Pharmacy Practice: Neuropathic Pain,,MS 231,Momen El Ghazouly,lecture,110 minutes,2019-03-05,Direct Lecture,face to face,"-post-herpetic neuralgia, fibromyalgia, lower back pain, -anticonvulsants & antidepressants, -Neuropathic pain and adjuvants for chronic pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 14: Pharmacy Practice Multidisciplinary Approach,,MS 231,Momen El Ghazouly,lecture,110 minutes,2019-02-28,Direct Lecture,face to face,#NAME?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 13: Pharmacology & Use of Cannabinoids,,MS 231,Patrick Mayo,lecture,110 minutes,2019-02-26,Direct Lecture,face to face,"-Cannabinoids in pain management, -Pharmacology of cannabinoids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 6: Pharmacology of Analgesics and Anaesthetics,,MS 231,Patrick Mayo,lecture,110 minutes,2019-01-24,Direct Lecture,face to face,"Spinal processing of pain, Peripheral processing of pain, Pain perception, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 5: Pharmacology of Analgesics and Anaesthetics,,MS 231,Patrick Mayo,lecture,110 minutes,2019-01-22,Direct Lecture,face to face,"Pharmacology of acetominophen, Pharmacology of NSAIDs, Pharmacology of COX1&2, Effects of tissue injury, Pharmacology of Analgesics and Anesthetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 4: Medicinal Chemistry  (Major Analgesics),,MS 231,Carlos Velzquez,lecture,110 minutes,2019-01-17,Direct Lecture,face to face,"Specific Opioid drugs, Opioid metabolism, Opioid receptors, Endogenous opioid peptides, Medicinal Chemistry (major analgesics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 3: Medicinal Chemistry  (Minor Analgesics),,MS 231,Carlos Velzquez,lecture,110 minutes,2019-01-15,Direct Lecture,face to face,"Chemical classes of nonprescription NSAIDs, Chemical classes of prescription NSAIDs, Prescription NSAIDs in Alberta, Medicinal Chemistry (minor analgesics)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 2: Physiology and Pathophysiology of Pain,,MS 231,Susan Patrick,lecture,110 minutes,2019-01-10,Direct Lecture,distance,"Pathophysiology of pain, Physiology of pain, Introduction to sensory systems, Overview of neural signaling, Physiology and Pathophysiology of Pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Lecture 1: Course Introductions and Overview,,MS 231,"Pat Mayo, Susan Patrick",lecture,110 minutes,2019-01-08,Direct Lecture,face to face,"Chronic pain as a public health problem in Canada, Terms & definitions related to the study of pain, Overview of course syllabus, Introduction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Final Exam,LEC B1 SEM J1,TBA,Dr. Tony Kiang,lecture,110 minutes,2019-04-12,,face to face,final exam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Liver transplant & islet cell transplant,SEMJ1,MS 2-31,Dr. Norman Kneteman,seminar,170 minutes,2019-03-04,Direct Lecture,face to face,Liver transplant & islet cell transplant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Midterm Exam,LEC B1 SEM J1,ECHA L1-350 & ECHA L1-270,Dr. Tony Kiang,lecture,80 minutes,2019-03-14,Other,face to face,Midterm Exam 40% Multiple Choice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Clinical pharmacokinetics-pharmacodynamics (PKPD) of select immunosuppressive drugs ,LECB1,MS-231,Dr. Tony Kiang,lecture,80 minutes,2019-03-12,Direct Lecture,face to face,Clinical pharmacokinetics-pharmacodynamics (PKPD) of immunosuppressive drugs ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Candian Transplant System and Therapeutic Issues,SEMJ1,MS-231,Kathy Yetzer,seminar,170 minutes,2019-03-11,Active Learning,face to face,Candian Transplant System and Therapeutic Issues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Pharmacology large molecule drugs,LECB1,MS-231,Dr. Pat Mayo,lecture,80 minutes,2019-03-07,Direct Lecture,face to face,"Pharmacology large molecule drugs: polyclonal antibodies (ATG[horses/rabbits]), and monoclonal antibodies (antiâ€êCD3, antiâ€êCD52, antiâ€êCD20, and antiâ€êCD25), costimulatory CD80/86 belatacept.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Pharmacology of small molecule drugs part II,LECB1,MS-231,Dr. Tony Kiang,lecture,80 minutes,2019-03-05,Direct Lecture,face to face,"cyclosporine, tacrolimus, sirolimus, everolimus, mycophenolic acid",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Living Donation and Renal Transplant ,SEMJ1,MS-231,Steven Defer,lecture,80 minutes,2019-03-28,Direct Lecture,face to face,Living Donation and Renal Transplant ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Pharmacology of small molecule drugs part I,LECB1,MS-231,Dr. Pat Mayo,lecture,80 minutes,2019-02-28,Direct Lecture,face to face,"Azathioprine, Cyclophosphamide, and Corticosteroids",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Opportunistic Infections,LECB1,MS-231,Cecilia Lau,lecture,80 minutes,2019-03-19,Direct Lecture,face to face,Opportunistic Infections in Transplant ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Bioethics of Transplantation: Special Cases,SEMJ1,MS-231,Dr. Brendan Leier  ,seminar,170 minutes,2019-03-18,Active Learning,face to face,Bioethics of Transplantation: Special Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Bone Marrow Transplant,LECB1,MS-231,Jennifer Jupp,lecture,80 minutes,2019-03-21,Direct Lecture,face to face,Bone Marrow Transplant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Renal Transplant,LECB1,MS-231,Jenny Wichart,lecture,80 minutes,2019-03-26,Active Learning,face to face,Renal Transplant & Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Renal Transplant,SEMJ1,MS-231,Jenny Wichart  ,seminar,170 minutes,2019-03-25,Active Learning,face to face,Renal Transplant & Cases ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Introduction,LECB1,MS-231,Dr. Tony Kiang,lecture,80 minutes,2019-02-26,Direct Lecture,face to face,"Introduction, Transplantation Epidemiology, Risk-Benefit of immunosuppression",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 1: Pathophysiology and Pharmacology of Hormones,,MSB 227,Yuksel,lecture,50 minutes,2019-03-20,Direct Lecture,face to face,"Hormones, Menopause",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Final Exam,,TBA,Yuksel,lecture,110 minutes,2019-04-15,Other,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 2: Non-hormonal Contraception Workshop,,TBA,McPherson/Yuksel,seminar,110 minutes,2019-03-27,"Active Learning, Direct Lecture",face to face,Non-hormonal Contraceptives,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Sexual Dysfunction in Women. Final Exam Review,,MSB 227,Yuksel,lecture,50 minutes,2019-04-10,Direct Lecture,face to face,Female Sexual Dysfunction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,"Class Evaluation, Postpartum Care/Postpartum Depression",,MSB 227,Yuksel,lecture,110 minutes,2019-04-09,Direct Lecture,face to face,"Postpartum Depression, Postpartum Care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Treatment Issues in Pregnancy con't,,MSB 227,Yuksel,lecture,50 minutes,2019-04-08,Direct Lecture,face to face,"Treatment Issues in Pregnancy (Gestational Hypertension, VTE, etc)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Physiologic Changes in Pregnancy/Treatment Issues in Pregnancy,,MSB 227,Yuksel,lecture,50 minutes,2019-04-05,Direct Lecture,face to face,"Treatment Issues in Pregnancy (Gestational Hypertension, VTE etc), Physiologic Changes in Pregnancy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Pregnancy and Ovulation Testing/Treatment of Infertility,,MSB 227,Yuksel,lecture,110 minutes,2019-04-02,Direct Lecture,face to face,"Infertility, Pregnancy and Ovulation Testing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Drugs in Pregnancy and Lactation,,MSB 227,Yuksel,lecture,50 minutes,2019-04-03,Direct Lecture,face to face,Drugs in Pregnancy and Lactation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Medicinal Chemistry,,MSB 227,Wuest,lecture,50 minutes,2019-04-01,Direct Lecture,face to face,Medicinal Chemistry of Hormones,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,Online,Patrick,lecture,50 minutes,2019-03-29,Direct Lecture,distance,Anatomy/Physiology of Pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 2: Management of Symptoms/Role of Hormone Therapy,,MSB 227,Yuksel,lecture,80 minutes,2019-03-21,Direct Lecture,face to face,"Hormone Therapy, Menopause",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 1: Hormonal Contraception cases,,TBA,Yuksel,seminar,170 minutes,2019-03-20,"Team Based Learning, Problem Based Learning, Active Learning",face to face,Hormonal Contraception ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Endometriosis,,MSB 227,Yuksel,lecture,50 minutes,2019-03-18,Direct Lecture,face to face,Endometriosis ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,Online,Patrick,lecture,50 minutes,2019-03-15,Direct Lecture,distance,Anatomy/Physiology of Reproductive System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Emergency Contraception,,MSB 227,Yuksel,lecture,50 minutes,2019-03-13,Direct Lecture,face to face,Emergency Contraception and Medical Abortion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception cont,,MSB 227,Yuksel,lecture,50 minutes,2019-03-13,Direct Lecture,face to face,Hormonal Contraception,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,Online,Patrick,lecture,50 minutes,2019-03-13,Direct Lecture,distance,Anatomy/Physiology of Reproductive System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception cont,,MSB 227,Yuksel,lecture,80 minutes,2019-03-12,Direct Lecture,face to face,Hormonal Contraception,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Hormonal Contraception,,MSB 227,Yuksel,lecture,50 minutes,2019-03-11,Direct Lecture,face to face,Hormonal Contraception,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Anatomy/Physiology,,Online,Patrick,lecture,80 minutes,2019-03-07,Direct Lecture,distance,Anatomy/Physiology of the Reproductive System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,"Introduction, Anatomy/Physiology",,MSB 227,Yuksel/Patrick,lecture,80 minutes,2019-03-05,Direct Lecture,face to face,Anatomy/Physiology of the Reproductive System,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 3: Menopause Cases,,TBA,Yuksel,seminar,170 minutes,2019-04-03,"Team Based Learning, Problem Based Learning, Active Learning",face to face,"Hormone Therapy, Menopause",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 4: Care of the Transgender Patient,,TBA,Grant,seminar,170 minutes,2019-04-10,"Problem Based Learning, Active Learning",face to face,Transgender Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Topics in Men's Health: Andropause/Male Pattern Baldness,,MSB 227,TBA,lecture,110 minutes,2019-03-26,Direct Lecture,face to face,"Male Pattern Baldness, Andropause",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menstrual Related Disorders/PMS/PMDD,,MSB 227,Yuksel,lecture,110 minutes,2019-03-19,Direct Lecture,face to face,"PMS/PMDD, Menstrual Related Disorders (Dysmenorrhea, Abnormal Uterine Bleeding)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Topics in Men's Health: Sexual Dysfunction/Erectile Dysfunction,,MSB 227,Sadowski,lecture,110 minutes,2019-03-28,Direct Lecture,face to face,Sexual Dysfunction/Erectile Dysfunction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Midterm Exam,,TBA,Yuksel,lecture,50 minutes,2019-03-27,Other,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Polycystic Ovarian Syndrome,,MSB 227,Yuksel,lecture,50 minutes,2019-03-25,Direct Lecture,face to face,Polycystic Ovarian Syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Menopause 2: Management of Symptoms/Role of Hormone Therapy cont,,MSB 227,Yuksel,lecture,50 minutes,2019-03-22,Direct Lecture,face to face,Menopause,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 1,,Practice Lab,Necyk,lecture,50 minutes,2019-01-10,,face to face,"Course introduction / expectations, , Introduction to drug-related problems (DRP) and documentation of DRPs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 1,,CS 2-191,Necyk,lecture,170 minutes,2019-01-10,,face to face,"Patient care process (focus: identify drug-related problems) , Health literacy activity, Pharmaceutical calculations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 2,,Practice Lab,Necyk,lecture,50 minutes,2019-01-17,,face to face,"Debrief of Lab 1, Allergy assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 2,,CS 2-191,Necyk,lecture,170 minutes,2019-01-17,,face to face,"Patient care process (allergy assessment), Documentation,, Patient education ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 3,,CS 2-191,Necyk,lecture,170 minutes,2019-01-24,,face to face,"Patient education (inhalers, peak flow meter, aerochambers),, Adverse drug reaction reporting, , Pharmaceutical calculations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 3,,Practice Lab,Necyk,lecture,50 minutes,2019-01-24,,face to face,"Debrief Lab 2, Adverse drug reaction reporting",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 2,,Practice Lab,Necyk,lecture,50 minutes,2019-01-31,,face to face,"Debrief Lab 3, Medication incident reporting, Motivational interviewing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 2,,CS 2-191,Necyk,lecture,170 minutes,2019-01-31,,face to face,"Medication incident reporting (management, communication), Communicating with an emotional patient, Introduction to motivational interviewing, Patient education (nicotine replacement therapy devices: gum, inhalers, patch)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 3,,Practice Lab,Necyk,lecture,50 minutes,2019-02-07,,face to face,"Debrief Lab 4, Incorporating assessment into the patient care process",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 3,,CS 2-191,Necyk,lecture,170 minutes,2019-02-07,,face to face,"Patient care process (minor ailment assessment), Patient education (eye drops, eye ointment, nasal spray), Receipt, assessment (legal), and processing of a controlled drug",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 4,,Practice Lab,Necyk,lecture,50 minutes,2019-02-14,,face to face,"Debrief Lab 5, Incorporating pharmacotherapy workup/plan into patient care process, including documentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 4,,CS 2-191,Necyk,lecture,170 minutes,2019-02-14,,face to face,"Patient care process (minor ailment assessment and pharmacotherapy workup) , Receipt and assessment (legal), and processing of a narcotic drug, Documentation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 5,,CS 2-191,Necyk,lecture,170 minutes,2019-02-28,,face to face,Midpoint skills assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 5,,Practice Lab,Necyk,lecture,50 minutes,2019-02-28,,face to face,Midpoint skills assessment preparation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 6,,Practice Lab,Necyk,lecture,50 minutes,2019-03-07,,face to face,"Debrief Lab 6, Debrief midterm exam, Integrating pharmaceutics into pharmacy practice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 6,,CS 2-191,Necyk,lecture,170 minutes,2019-03-07,,face to face,"Collaboration with Pharmaceutics (receipt, assess, compound, perform final check, and educate on prescription), Pharmaceutical calculations, Patient education ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 7,,Practice Lab,Necyk,lecture,50 minutes,2019-03-14,,face to face,"Debrief Lab 8, Developing a basic care plan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 7,,CS 2-191,Necyk,lecture,170 minutes,2019-03-14,,face to face,"Patient care process (database, assessment, pharmacotherapy workup related to minor ailment), Drug information, Patient education (rectal and vaginal preparations)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 8,,CS 2-191,Necyk,lecture,170 minutes,2019-03-21,,face to face,"Physical assessment (minor ailments, pulmonary), Develop a care plan using the patient care process , Using evidence-based medicine to collaborate with another health professional",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 8,,Practice Lab,Necyk,lecture,50 minutes,2019-03-21,,face to face,"Debrief Lab 9, Principles of physical assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 9,,Practice Lab,Necyk,lecture,50 minutes,2019-03-28,,face to face,"Debrief Lab 10, Preparation for Pharmacy/PT joint lab",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 9,,CS 2-191,Necyk,lecture,170 minutes,2019-03-28,,face to face,"Pharmacy-Physical Therapy (PT) Collaborative Lab, Interprofessional collaboration and education",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 10,,Practice Lab,Necyk,lecture,50 minutes,2019-04-04,,face to face,"Debrief Lab 11, Scope of practice (extend, adapt, emergency prescribe)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 11,,CS 2-191,Necyk,lecture,170 minutes,2019-04-04,,face to face,"Patient care process (database, assessment, pharmacotherapy workup), Incorporating clinical decision-making into patient care process, Scope of practice (adapt/extend), Leadership/management ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Seminar 12,,Practice Lab,Necyk,lecture,50 minutes,2019-04-11,,face to face,Final exam orientation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab 12,,CS 2-191,Necyk,lecture,170 minutes,2019-04-11,,face to face,"Adherence assessment, Assessment of patient device technique, Scope of practice (emergency prescribing)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Final Exam,,TBD,Necyk,lecture,170 minutes,2019-04-26,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Deprescribing,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-02-07,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Geriatrics home care; community resources,,MSB 227,Haggarty; Featherstone,seminar,110 minutes,2018-02-06,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,End of life care; MAID,,MSB 227,Schindel; Mayo,lecture,80 minutes,2018-02-06,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Geriatric Assessment,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-02-05,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Medication problems in the elderly; evidence based research,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-02-02,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Geriatric Syndromes; Falls; Frail elderly,,MSB 227,Schindel; Mayo,lecture,80 minutes,2018-02-01,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Geriatric elder abuse,,MSB 227,Power,seminar,110 minutes,2018-01-31,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Adverse drug events/Drug Safety; Manifestations of toxicity in the elderly,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-01-31,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Physiologic changes with aging; Pharmacokinetics; Pharmacodynamics; High risk medications in older adults,,MSB 227,Schindel; Mayo,lecture,80 minutes,2018-01-30,,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Introductory Geriatrics; Health care utilization; Principles of geriatric care; Psychosocial aspects of aging,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-01-29,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Geriatrics; Pre-test; Demographics; Pharmacists' role,,MSB 227,Schindel; Mayo,lecture,50 minutes,2018-01-26,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Indigenous Health/Diversity in Vulnerable Populations,,MSB 231,Schindel; Swirovich,seminar,170 minutes,2018-01-23,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Pediatric Toxicology/common poisonings; Pediatric abuse,,MSB 227,Gukert; Dibden,lecture,80 minutes,2018-01-23,Direct Lecture,face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Autism Spectrum Disorder; Medication challenges,,MSB 227,Schindel; Gagon,lecture,50 minutes,2018-01-22,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Prevention of medication errors in children,,MSB 227,Schindel; Dersch; Romanick,seminar,110 minutes,2018-01-19,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Commuication challenges in pediatrics,,MSB 227,Schindel; ChildLife,lecture,50 minutes,2018-01-19,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Clinical issues in pediatrics; Pediatrice references; Physiologial differences; Dosing formulations; Administrative challenges,,MSB 227,Schindel; Dersch; Romanick,lecture,80 minutes,2018-01-18,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Challenges and Controversies; Immunization; Alternate Therapies; Ethical,,MSB 227,Schindel; Dersch; Romanick,seminar,110 minutes,2018-01-17,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Respiratory; Croup; Bronchitis; Pneumonia,,MSB 227,Schindel; Dersch,lecture,50 minutes,2018-01-17,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Pain; Fever; Teething; Sprains/fractures; Febrile seizures; Normal newborn/Neonatal care,,MSB 227,Schindel; Dersch,lecture,80 minutes,2018-01-16,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,GI; Diarrhea; Hydration; Vomiting; Constipation; Colic,,MSB 227,Schindel; Romanick,lecture,50 minutes,2018-01-15,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Physiologic differences in children; Pharmacokinetics; Pharmacodynamics; GI,,MSB 227,Schindel; Romanick,lecture,80 minutes,2018-01-09,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Course Introduction;Introduction to Assignments;Pediatrics; Pre-test; Demographics,,MSB 628,Schindel; Romanick,lecture,50 minutes,2018-01-08,"Active Learning, Direct Lecture",face to face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,